date generated: 2020-09-10
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
## t0_v_pod pod_crp t0_crp
## A1BG 2.6192564 -0.3065476 -3.3462109
## A1BG-AS1 0.5230655 0.2667380 -0.1855420
## A1CF 0.5526173 -0.1889397 0.1865445
## A2M -3.3389616 -0.4487032 1.3466992
## A2M-AS1 -3.1580711 -0.9062206 0.8962988
## A2ML1 -0.3535245 1.1221162 1.9364758
Here are some metrics about the input data profile:
Profile metrics | |
---|---|
num_genes_in_profile | 21381 |
duplicated_genes_present | 0 |
num_profile_genes_in_sets | 8376 |
num_profile_genes_not_in_sets | 13005 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Here are some metrics about the gene sets used: GMT file of genesets: ReactomePathways.gmt
Gene sets metrics | |
---|---|
num_genesets | 2400 |
num_genesets_excluded | 1040 |
num_genesets_included | 1360 |
t0_v_pod | pod_crp | t0_crp | Count | |
---|---|---|---|---|
1 | -1 | -1 | -1 | 3715 |
2 | 0 | -1 | -1 | 1 |
3 | 1 | -1 | -1 | 754 |
4 | -1 | 1 | -1 | 796 |
5 | 1 | 1 | -1 | 3769 |
6 | -1 | -1 | 0 | 1 |
7 | -1 | -1 | 1 | 4991 |
8 | 1 | -1 | 1 | 671 |
9 | -1 | 0 | 1 | 1 |
10 | -1 | 1 | 1 | 2513 |
11 | 1 | 1 | 1 | 4169 |
s.t0_v_pod | s.pod_crp | s.t0_crp | Count | |
---|---|---|---|---|
1 | -1 | -1 | -1 | 95 |
2 | 1 | -1 | -1 | 57 |
3 | -1 | 1 | -1 | 1 |
4 | 1 | 1 | -1 | 487 |
5 | -1 | -1 | 1 | 74 |
6 | 1 | -1 | 1 | 17 |
7 | -1 | 1 | 1 | 1 |
8 | 1 | 1 | 1 | 17 |
All sets with FDR<0.05. Try hovering over the points.
Significance is the -log2(p.adjustMANOVA) and effect size is the s.dist which is the hypotenuse of the s scores.
Top N= 100 gene sets
set | setSize | pMANOVA | p.adjustMANOVA | s.dist | s.t0_v_pod | s.pod_crp | s.t0_crp | p.t0_v_pod | p.pod_crp | p.t0_crp |
---|---|---|---|---|---|---|---|---|---|---|
IRAK4 deficiency (TLR2/4) | 10 | 7.50e-06 | 4.34e-05 | 1.250 | 0.89900 | 0.8680 | -0.0598 | 8.36e-07 | 1.99e-06 | 7.43e-01 |
MyD88 deficiency (TLR2/4) | 10 | 7.50e-06 | 4.34e-05 | 1.250 | 0.89900 | 0.8680 | -0.0598 | 8.36e-07 | 1.99e-06 | 7.43e-01 |
Peptide chain elongation | 88 | 9.12e-75 | 1.24e-72 | 1.150 | -0.28100 | -0.7690 | -0.8110 | 5.05e-06 | 7.95e-36 | 1.13e-39 |
Eukaryotic Translation Elongation | 93 | 8.41e-79 | 1.91e-76 | 1.150 | -0.27300 | -0.7650 | -0.8090 | 5.39e-06 | 2.35e-37 | 1.20e-41 |
Viral mRNA Translation | 88 | 9.81e-71 | 1.03e-68 | 1.110 | -0.26200 | -0.7450 | -0.7870 | 2.13e-05 | 1.06e-33 | 2.15e-37 |
Selenocysteine synthesis | 92 | 9.10e-70 | 8.25e-68 | 1.100 | -0.29900 | -0.7480 | -0.7560 | 7.43e-07 | 2.21e-35 | 3.66e-36 |
Formation of a pool of free 40S subunits | 100 | 9.21e-83 | 3.13e-80 | 1.090 | -0.20800 | -0.7430 | -0.7690 | 3.27e-04 | 7.09e-38 | 1.81e-40 |
Eukaryotic Translation Termination | 92 | 4.20e-70 | 4.08e-68 | 1.090 | -0.26500 | -0.7320 | -0.7620 | 1.13e-05 | 5.45e-34 | 9.76e-37 |
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | 12 | 3.03e-05 | 1.42e-04 | 1.080 | 0.78500 | 0.7260 | -0.1330 | 2.48e-06 | 1.34e-05 | 4.24e-01 |
alpha-linolenic acid (ALA) metabolism | 12 | 3.03e-05 | 1.42e-04 | 1.080 | 0.78500 | 0.7260 | -0.1330 | 2.48e-06 | 1.34e-05 | 4.24e-01 |
WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | 11 | 2.04e-05 | 1.00e-04 | 1.080 | 0.67000 | 0.6640 | -0.5160 | 1.19e-04 | 1.36e-04 | 3.04e-03 |
Hyaluronan uptake and degradation | 10 | 1.40e-04 | 5.48e-04 | 1.040 | 0.72900 | 0.5740 | -0.4710 | 6.53e-05 | 1.66e-03 | 9.90e-03 |
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 94 | 3.19e-66 | 2.55e-64 | 1.040 | -0.24400 | -0.7050 | -0.7240 | 4.23e-05 | 2.60e-32 | 6.14e-34 |
Translocation of ZAP-70 to Immunological synapse | 24 | 1.27e-09 | 1.62e-08 | 1.030 | -0.74300 | -0.7050 | -0.0817 | 2.86e-10 | 2.27e-09 | 4.89e-01 |
Uptake and function of anthrax toxins | 10 | 3.14e-04 | 1.10e-03 | 1.020 | 0.70400 | 0.6170 | -0.4030 | 1.17e-04 | 7.33e-04 | 2.74e-02 |
Regulation of TLR by endogenous ligand | 11 | 2.54e-04 | 9.11e-04 | 1.000 | 0.74300 | 0.6450 | -0.2020 | 1.95e-05 | 2.14e-04 | 2.46e-01 |
VLDLR internalisation and degradation | 11 | 9.65e-06 | 5.40e-05 | 0.987 | 0.46800 | 0.5390 | -0.6820 | 7.18e-03 | 1.96e-03 | 8.98e-05 |
L13a-mediated translational silencing of Ceruloplasmin expression | 110 | 6.80e-80 | 1.85e-77 | 0.987 | -0.14300 | -0.6760 | -0.7040 | 9.49e-03 | 1.43e-34 | 1.92e-37 |
GTP hydrolysis and joining of the 60S ribosomal subunit | 111 | 4.93e-78 | 9.59e-76 | 0.972 | -0.14700 | -0.6710 | -0.6880 | 7.38e-03 | 2.12e-34 | 4.08e-36 |
Response of EIF2AK4 (GCN2) to amino acid deficiency | 100 | 2.15e-62 | 1.63e-60 | 0.969 | -0.22200 | -0.6690 | -0.6660 | 1.28e-04 | 5.65e-31 | 1.06e-30 |
Advanced glycosylation endproduct receptor signaling | 12 | 9.21e-05 | 3.81e-04 | 0.968 | 0.65000 | 0.5420 | -0.4700 | 9.71e-05 | 1.14e-03 | 4.78e-03 |
Cap-dependent Translation Initiation | 118 | 3.48e-76 | 5.26e-74 | 0.927 | -0.13200 | -0.6370 | -0.6610 | 1.35e-02 | 5.36e-33 | 1.74e-35 |
Eukaryotic Translation Initiation | 118 | 3.48e-76 | 5.26e-74 | 0.927 | -0.13200 | -0.6370 | -0.6610 | 1.35e-02 | 5.36e-33 | 1.74e-35 |
Formation of the ternary complex, and subsequently, the 43S complex | 51 | 1.55e-36 | 6.18e-35 | 0.922 | -0.08310 | -0.6620 | -0.6360 | 3.05e-01 | 2.68e-16 | 3.83e-15 |
WNT5A-dependent internalization of FZD4 | 13 | 9.70e-06 | 5.41e-05 | 0.917 | 0.44900 | 0.5250 | -0.6030 | 5.07e-03 | 1.05e-03 | 1.68e-04 |
Erythrocytes take up carbon dioxide and release oxygen | 11 | 1.11e-03 | 3.22e-03 | 0.895 | 0.68000 | 0.5270 | -0.2470 | 9.48e-05 | 2.48e-03 | 1.57e-01 |
O2/CO2 exchange in erythrocytes | 11 | 1.11e-03 | 3.22e-03 | 0.895 | 0.68000 | 0.5270 | -0.2470 | 9.48e-05 | 2.48e-03 | 1.57e-01 |
Retrograde neurotrophin signalling | 12 | 3.63e-04 | 1.25e-03 | 0.893 | 0.56600 | 0.5170 | -0.4570 | 6.80e-04 | 1.93e-03 | 6.11e-03 |
RNA Polymerase I Promoter Opening | 19 | 8.92e-07 | 6.77e-06 | 0.886 | 0.61600 | 0.4120 | -0.4860 | 3.31e-06 | 1.89e-03 | 2.46e-04 |
Selenoamino acid metabolism | 114 | 2.96e-56 | 1.92e-54 | 0.876 | -0.22800 | -0.6170 | -0.5790 | 2.52e-05 | 4.37e-30 | 1.11e-26 |
Gap junction trafficking | 13 | 3.88e-04 | 1.32e-03 | 0.872 | 0.56400 | 0.5530 | -0.3700 | 4.32e-04 | 5.56e-04 | 2.11e-02 |
SRP-dependent cotranslational protein targeting to membrane | 111 | 8.28e-60 | 5.63e-58 | 0.861 | -0.13400 | -0.5830 | -0.6200 | 1.48e-02 | 2.36e-26 | 1.27e-29 |
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 114 | 2.07e-55 | 1.17e-53 | 0.859 | -0.19500 | -0.5850 | -0.5970 | 3.16e-04 | 3.11e-27 | 2.66e-28 |
Nonsense-Mediated Decay (NMD) | 114 | 2.07e-55 | 1.17e-53 | 0.859 | -0.19500 | -0.5850 | -0.5970 | 3.16e-04 | 3.11e-27 | 2.66e-28 |
Unwinding of DNA | 12 | 1.63e-03 | 4.55e-03 | 0.854 | -0.63700 | -0.5680 | 0.0087 | 1.33e-04 | 6.52e-04 | 9.58e-01 |
RHO GTPases Activate WASPs and WAVEs | 35 | 2.05e-09 | 2.58e-08 | 0.847 | 0.60800 | 0.5420 | -0.2320 | 4.76e-10 | 2.90e-08 | 1.78e-02 |
RHO GTPases Activate NADPH Oxidases | 21 | 2.87e-06 | 1.87e-05 | 0.844 | 0.55900 | 0.4720 | -0.4220 | 9.31e-06 | 1.79e-04 | 8.25e-04 |
Translation initiation complex formation | 58 | 2.43e-36 | 9.45e-35 | 0.829 | -0.02010 | -0.5820 | -0.5900 | 7.92e-01 | 1.77e-14 | 7.54e-15 |
RHO GTPases Activate ROCKs | 18 | 8.92e-05 | 3.71e-04 | 0.824 | 0.54100 | 0.6210 | -0.0253 | 7.03e-05 | 5.02e-06 | 8.53e-01 |
MET activates RAP1 and RAC1 | 10 | 6.15e-03 | 1.39e-02 | 0.824 | 0.53000 | 0.6060 | 0.1780 | 3.71e-03 | 9.10e-04 | 3.31e-01 |
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | 59 | 1.34e-36 | 5.53e-35 | 0.821 | -0.00808 | -0.5680 | -0.5930 | 9.15e-01 | 4.24e-14 | 3.25e-15 |
Ribosomal scanning and start codon recognition | 58 | 6.98e-35 | 2.50e-33 | 0.817 | -0.02510 | -0.5720 | -0.5830 | 7.41e-01 | 4.68e-14 | 1.57e-14 |
Trafficking of GluR2-containing AMPA receptors | 12 | 8.28e-04 | 2.51e-03 | 0.816 | 0.46900 | 0.4460 | -0.4970 | 4.91e-03 | 7.46e-03 | 2.88e-03 |
Josephin domain DUBs | 10 | 8.95e-04 | 2.69e-03 | 0.815 | 0.47000 | 0.2270 | -0.6270 | 1.01e-02 | 2.14e-01 | 5.99e-04 |
Influenza Viral RNA Transcription and Replication | 135 | 7.99e-56 | 4.94e-54 | 0.811 | -0.22500 | -0.5730 | -0.5290 | 6.45e-06 | 1.21e-30 | 2.39e-26 |
PD-1 signaling | 28 | 4.90e-07 | 4.09e-06 | 0.811 | -0.57900 | -0.5620 | -0.0759 | 1.13e-07 | 2.60e-07 | 4.87e-01 |
Neutrophil degranulation | 458 | 0.00e+00 | 0.00e+00 | 0.809 | 0.58600 | 0.4540 | -0.3260 | 0.00e+00 | 1.37e-62 | 5.89e-33 |
Major pathway of rRNA processing in the nucleolus and cytosol | 180 | 2.04e-68 | 1.73e-66 | 0.808 | -0.30600 | -0.6370 | -0.3910 | 1.30e-12 | 1.75e-49 | 1.36e-19 |
rRNA processing in the nucleus and cytosol | 190 | 2.79e-71 | 3.17e-69 | 0.806 | -0.30700 | -0.6330 | -0.3930 | 2.77e-13 | 2.17e-51 | 9.47e-21 |
Platelet sensitization by LDL | 16 | 6.33e-04 | 2.00e-03 | 0.798 | 0.55200 | 0.5660 | -0.1070 | 1.31e-04 | 8.90e-05 | 4.58e-01 |
p130Cas linkage to MAPK signaling for integrins | 11 | 9.97e-04 | 2.96e-03 | 0.798 | 0.66600 | 0.3820 | -0.2180 | 1.32e-04 | 2.82e-02 | 2.11e-01 |
NOTCH4 Activation and Transmission of Signal to the Nucleus | 10 | 1.12e-02 | 2.33e-02 | 0.797 | 0.52800 | 0.5770 | -0.1550 | 3.86e-03 | 1.58e-03 | 3.95e-01 |
Hyaluronan metabolism | 13 | 1.12e-03 | 3.26e-03 | 0.795 | 0.51300 | 0.4290 | -0.4300 | 1.37e-03 | 7.41e-03 | 7.32e-03 |
Detoxification of Reactive Oxygen Species | 32 | 3.13e-08 | 3.27e-07 | 0.792 | 0.56100 | 0.4360 | -0.3500 | 3.93e-08 | 1.93e-05 | 6.09e-04 |
Insulin receptor recycling | 21 | 1.06e-05 | 5.76e-05 | 0.790 | 0.56800 | 0.4040 | -0.3710 | 6.47e-06 | 1.34e-03 | 3.26e-03 |
Activation of the pre-replicative complex | 32 | 6.26e-08 | 6.35e-07 | 0.779 | -0.48200 | -0.6040 | 0.1050 | 2.37e-06 | 3.40e-09 | 3.04e-01 |
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases | 13 | 4.27e-03 | 1.02e-02 | 0.776 | 0.55500 | 0.5350 | -0.0839 | 5.28e-04 | 8.32e-04 | 6.01e-01 |
ROS and RNS production in phagocytes | 31 | 1.40e-08 | 1.54e-07 | 0.775 | 0.59700 | 0.3710 | -0.3240 | 8.47e-09 | 3.46e-04 | 1.77e-03 |
Signaling by Leptin | 10 | 8.24e-03 | 1.80e-02 | 0.768 | 0.56500 | 0.3880 | -0.3470 | 1.98e-03 | 3.37e-02 | 5.76e-02 |
rRNA processing | 217 | 8.40e-73 | 1.04e-70 | 0.766 | -0.28900 | -0.5890 | -0.3940 | 2.16e-13 | 7.88e-51 | 1.25e-23 |
DNA strand elongation | 32 | 6.40e-07 | 5.09e-06 | 0.762 | -0.52200 | -0.5550 | 0.0270 | 3.22e-07 | 5.52e-08 | 7.91e-01 |
Dissolution of Fibrin Clot | 12 | 3.97e-03 | 9.69e-03 | 0.762 | 0.56600 | 0.4120 | -0.3010 | 6.87e-04 | 1.36e-02 | 7.08e-02 |
Mucopolysaccharidoses | 11 | 6.38e-03 | 1.44e-02 | 0.751 | 0.45500 | 0.4420 | -0.4030 | 9.00e-03 | 1.12e-02 | 2.07e-02 |
Spry regulation of FGF signaling | 16 | 3.98e-04 | 1.35e-03 | 0.749 | 0.47500 | 0.3720 | -0.4450 | 1.01e-03 | 1.01e-02 | 2.08e-03 |
Pentose phosphate pathway | 13 | 2.23e-03 | 6.01e-03 | 0.748 | 0.48800 | 0.3750 | -0.4250 | 2.33e-03 | 1.91e-02 | 7.96e-03 |
DNA methylation | 20 | 2.54e-05 | 1.22e-04 | 0.747 | 0.51700 | 0.3250 | -0.4310 | 6.35e-05 | 1.19e-02 | 8.36e-04 |
COPI-independent Golgi-to-ER retrograde traffic | 33 | 4.56e-07 | 3.83e-06 | 0.745 | 0.56300 | 0.4640 | -0.1510 | 2.13e-08 | 3.98e-06 | 1.32e-01 |
Formation of ATP by chemiosmotic coupling | 18 | 3.36e-07 | 2.93e-06 | 0.743 | 0.42700 | 0.0375 | -0.6070 | 1.71e-03 | 7.83e-01 | 8.20e-06 |
Diseases associated with the TLR signaling cascade | 23 | 7.96e-05 | 3.35e-04 | 0.739 | 0.53400 | 0.4800 | -0.1770 | 9.12e-06 | 6.80e-05 | 1.43e-01 |
Diseases of Immune System | 23 | 7.96e-05 | 3.35e-04 | 0.739 | 0.53400 | 0.4800 | -0.1770 | 9.12e-06 | 6.80e-05 | 1.43e-01 |
Pre-NOTCH Processing in Golgi | 18 | 1.20e-04 | 4.80e-04 | 0.735 | 0.41100 | 0.4870 | -0.3670 | 2.57e-03 | 3.49e-04 | 7.01e-03 |
Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | 11 | 1.54e-02 | 3.05e-02 | 0.732 | 0.47600 | 0.5490 | -0.0880 | 6.29e-03 | 1.61e-03 | 6.13e-01 |
Golgi Cisternae Pericentriolar Stack Reorganization | 14 | 3.97e-03 | 9.69e-03 | 0.731 | 0.54900 | 0.4810 | 0.0291 | 3.74e-04 | 1.83e-03 | 8.51e-01 |
Phosphorylation of CD3 and TCR zeta chains | 27 | 1.07e-05 | 5.80e-05 | 0.728 | -0.53700 | -0.4860 | -0.0775 | 1.39e-06 | 1.22e-05 | 4.86e-01 |
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | 20 | 1.46e-04 | 5.66e-04 | 0.725 | 0.51300 | 0.3830 | -0.3420 | 7.17e-05 | 3.06e-03 | 8.08e-03 |
Neurodegenerative Diseases | 20 | 1.46e-04 | 5.66e-04 | 0.725 | 0.51300 | 0.3830 | -0.3420 | 7.17e-05 | 3.06e-03 | 8.08e-03 |
rRNA modification in the nucleus and cytosol | 59 | 8.26e-14 | 1.54e-12 | 0.722 | -0.39700 | -0.5840 | -0.1520 | 1.32e-07 | 8.38e-15 | 4.35e-02 |
EGFR downregulation | 27 | 1.40e-06 | 9.99e-06 | 0.713 | 0.46000 | 0.2940 | -0.4590 | 3.48e-05 | 8.23e-03 | 3.69e-05 |
Activation of ATR in response to replication stress | 36 | 2.43e-07 | 2.15e-06 | 0.713 | -0.45200 | -0.5160 | 0.1940 | 2.73e-06 | 8.15e-08 | 4.35e-02 |
Lagging Strand Synthesis | 20 | 4.14e-04 | 1.40e-03 | 0.710 | -0.45200 | -0.5460 | 0.0380 | 4.65e-04 | 2.35e-05 | 7.69e-01 |
Budding and maturation of HIV virion | 26 | 1.32e-05 | 6.96e-05 | 0.708 | 0.52500 | 0.3730 | -0.2930 | 3.50e-06 | 9.80e-04 | 9.75e-03 |
Processive synthesis on the lagging strand | 15 | 3.33e-03 | 8.31e-03 | 0.700 | -0.43100 | -0.5520 | -0.0108 | 3.86e-03 | 2.14e-04 | 9.42e-01 |
InlB-mediated entry of Listeria monocytogenes into host cell | 12 | 8.69e-03 | 1.88e-02 | 0.700 | 0.52500 | 0.3610 | -0.2900 | 1.64e-03 | 3.06e-02 | 8.22e-02 |
Influenza Infection | 154 | 8.65e-49 | 4.36e-47 | 0.699 | -0.18100 | -0.4990 | -0.4550 | 1.07e-04 | 1.06e-26 | 1.61e-22 |
IRAK1 recruits IKK complex | 10 | 2.90e-02 | 5.22e-02 | 0.699 | 0.53300 | 0.4040 | -0.2030 | 3.52e-03 | 2.71e-02 | 2.67e-01 |
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | 10 | 2.90e-02 | 5.22e-02 | 0.699 | 0.53300 | 0.4040 | -0.2030 | 3.52e-03 | 2.71e-02 | 2.67e-01 |
Smooth Muscle Contraction | 31 | 2.08e-06 | 1.42e-05 | 0.698 | 0.49400 | 0.3690 | -0.3290 | 1.95e-06 | 3.81e-04 | 1.53e-03 |
Signal transduction by L1 | 20 | 4.29e-04 | 1.44e-03 | 0.698 | 0.43800 | 0.5070 | -0.1940 | 6.90e-04 | 8.61e-05 | 1.32e-01 |
Cargo concentration in the ER | 30 | 1.41e-05 | 7.42e-05 | 0.697 | 0.52000 | 0.4630 | -0.0357 | 8.05e-07 | 1.14e-05 | 7.35e-01 |
GRB2:SOS provides linkage to MAPK signaling for Integrins | 12 | 3.25e-03 | 8.12e-03 | 0.697 | 0.58100 | 0.3250 | -0.2080 | 4.97e-04 | 5.10e-02 | 2.12e-01 |
Transferrin endocytosis and recycling | 26 | 2.18e-05 | 1.06e-04 | 0.696 | 0.50900 | 0.3700 | -0.2980 | 7.03e-06 | 1.09e-03 | 8.47e-03 |
EPHB-mediated forward signaling | 32 | 8.88e-06 | 5.05e-05 | 0.696 | 0.50400 | 0.4750 | -0.0670 | 8.17e-07 | 3.24e-06 | 5.12e-01 |
Nucleobase biosynthesis | 13 | 2.59e-03 | 6.78e-03 | 0.696 | -0.35600 | -0.5780 | -0.1520 | 2.63e-02 | 3.06e-04 | 3.43e-01 |
AKT phosphorylates targets in the cytosol | 14 | 4.48e-03 | 1.07e-02 | 0.695 | 0.42700 | 0.4440 | -0.3220 | 5.63e-03 | 4.05e-03 | 3.68e-02 |
GAB1 signalosome | 15 | 1.42e-03 | 4.03e-03 | 0.695 | 0.47100 | 0.3010 | -0.4130 | 1.59e-03 | 4.33e-02 | 5.58e-03 |
MAP2K and MAPK activation | 34 | 1.53e-06 | 1.08e-05 | 0.694 | 0.51600 | 0.4050 | -0.2250 | 1.87e-07 | 4.36e-05 | 2.30e-02 |
ERKs are inactivated | 13 | 6.96e-03 | 1.54e-02 | 0.694 | 0.43200 | 0.4100 | -0.3550 | 6.97e-03 | 1.04e-02 | 2.66e-02 |
Signal regulatory protein family interactions | 12 | 7.77e-03 | 1.71e-02 | 0.689 | 0.40900 | 0.3430 | -0.4370 | 1.43e-02 | 3.96e-02 | 8.80e-03 |
Prolonged ERK activation events | 13 | 1.33e-02 | 2.71e-02 | 0.687 | 0.45200 | 0.5140 | -0.0617 | 4.80e-03 | 1.32e-03 | 7.00e-01 |
Endosomal Sorting Complex Required For Transport (ESCRT) | 29 | 1.02e-05 | 5.57e-05 | 0.687 | 0.51900 | 0.3810 | -0.2380 | 1.28e-06 | 3.82e-04 | 2.65e-02 |
set | setSize | pMANOVA | p.adjustMANOVA | s.dist | s.t0_v_pod | s.pod_crp | s.t0_crp | p.t0_v_pod | p.pod_crp | p.t0_crp |
---|---|---|---|---|---|---|---|---|---|---|
IRAK4 deficiency (TLR2/4) | 10 | 7.50e-06 | 4.34e-05 | 1.2500 | 0.899000 | 0.868000 | -0.059800 | 8.36e-07 | 1.99e-06 | 7.43e-01 |
MyD88 deficiency (TLR2/4) | 10 | 7.50e-06 | 4.34e-05 | 1.2500 | 0.899000 | 0.868000 | -0.059800 | 8.36e-07 | 1.99e-06 | 7.43e-01 |
Peptide chain elongation | 88 | 9.12e-75 | 1.24e-72 | 1.1500 | -0.281000 | -0.769000 | -0.811000 | 5.05e-06 | 7.95e-36 | 1.13e-39 |
Eukaryotic Translation Elongation | 93 | 8.41e-79 | 1.91e-76 | 1.1500 | -0.273000 | -0.765000 | -0.809000 | 5.39e-06 | 2.35e-37 | 1.20e-41 |
Viral mRNA Translation | 88 | 9.81e-71 | 1.03e-68 | 1.1100 | -0.262000 | -0.745000 | -0.787000 | 2.13e-05 | 1.06e-33 | 2.15e-37 |
Selenocysteine synthesis | 92 | 9.10e-70 | 8.25e-68 | 1.1000 | -0.299000 | -0.748000 | -0.756000 | 7.43e-07 | 2.21e-35 | 3.66e-36 |
Formation of a pool of free 40S subunits | 100 | 9.21e-83 | 3.13e-80 | 1.0900 | -0.208000 | -0.743000 | -0.769000 | 3.27e-04 | 7.09e-38 | 1.81e-40 |
Eukaryotic Translation Termination | 92 | 4.20e-70 | 4.08e-68 | 1.0900 | -0.265000 | -0.732000 | -0.762000 | 1.13e-05 | 5.45e-34 | 9.76e-37 |
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | 12 | 3.03e-05 | 1.42e-04 | 1.0800 | 0.785000 | 0.726000 | -0.133000 | 2.48e-06 | 1.34e-05 | 4.24e-01 |
alpha-linolenic acid (ALA) metabolism | 12 | 3.03e-05 | 1.42e-04 | 1.0800 | 0.785000 | 0.726000 | -0.133000 | 2.48e-06 | 1.34e-05 | 4.24e-01 |
WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | 11 | 2.04e-05 | 1.00e-04 | 1.0800 | 0.670000 | 0.664000 | -0.516000 | 1.19e-04 | 1.36e-04 | 3.04e-03 |
Hyaluronan uptake and degradation | 10 | 1.40e-04 | 5.48e-04 | 1.0400 | 0.729000 | 0.574000 | -0.471000 | 6.53e-05 | 1.66e-03 | 9.90e-03 |
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 94 | 3.19e-66 | 2.55e-64 | 1.0400 | -0.244000 | -0.705000 | -0.724000 | 4.23e-05 | 2.60e-32 | 6.14e-34 |
Translocation of ZAP-70 to Immunological synapse | 24 | 1.27e-09 | 1.62e-08 | 1.0300 | -0.743000 | -0.705000 | -0.081700 | 2.86e-10 | 2.27e-09 | 4.89e-01 |
Uptake and function of anthrax toxins | 10 | 3.14e-04 | 1.10e-03 | 1.0200 | 0.704000 | 0.617000 | -0.403000 | 1.17e-04 | 7.33e-04 | 2.74e-02 |
Regulation of TLR by endogenous ligand | 11 | 2.54e-04 | 9.11e-04 | 1.0000 | 0.743000 | 0.645000 | -0.202000 | 1.95e-05 | 2.14e-04 | 2.46e-01 |
VLDLR internalisation and degradation | 11 | 9.65e-06 | 5.40e-05 | 0.9870 | 0.468000 | 0.539000 | -0.682000 | 7.18e-03 | 1.96e-03 | 8.98e-05 |
L13a-mediated translational silencing of Ceruloplasmin expression | 110 | 6.80e-80 | 1.85e-77 | 0.9870 | -0.143000 | -0.676000 | -0.704000 | 9.49e-03 | 1.43e-34 | 1.92e-37 |
GTP hydrolysis and joining of the 60S ribosomal subunit | 111 | 4.93e-78 | 9.59e-76 | 0.9720 | -0.147000 | -0.671000 | -0.688000 | 7.38e-03 | 2.12e-34 | 4.08e-36 |
Response of EIF2AK4 (GCN2) to amino acid deficiency | 100 | 2.15e-62 | 1.63e-60 | 0.9690 | -0.222000 | -0.669000 | -0.666000 | 1.28e-04 | 5.65e-31 | 1.06e-30 |
Advanced glycosylation endproduct receptor signaling | 12 | 9.21e-05 | 3.81e-04 | 0.9680 | 0.650000 | 0.542000 | -0.470000 | 9.71e-05 | 1.14e-03 | 4.78e-03 |
Cap-dependent Translation Initiation | 118 | 3.48e-76 | 5.26e-74 | 0.9270 | -0.132000 | -0.637000 | -0.661000 | 1.35e-02 | 5.36e-33 | 1.74e-35 |
Eukaryotic Translation Initiation | 118 | 3.48e-76 | 5.26e-74 | 0.9270 | -0.132000 | -0.637000 | -0.661000 | 1.35e-02 | 5.36e-33 | 1.74e-35 |
Formation of the ternary complex, and subsequently, the 43S complex | 51 | 1.55e-36 | 6.18e-35 | 0.9220 | -0.083100 | -0.662000 | -0.636000 | 3.05e-01 | 2.68e-16 | 3.83e-15 |
WNT5A-dependent internalization of FZD4 | 13 | 9.70e-06 | 5.41e-05 | 0.9170 | 0.449000 | 0.525000 | -0.603000 | 5.07e-03 | 1.05e-03 | 1.68e-04 |
Erythrocytes take up carbon dioxide and release oxygen | 11 | 1.11e-03 | 3.22e-03 | 0.8950 | 0.680000 | 0.527000 | -0.247000 | 9.48e-05 | 2.48e-03 | 1.57e-01 |
O2/CO2 exchange in erythrocytes | 11 | 1.11e-03 | 3.22e-03 | 0.8950 | 0.680000 | 0.527000 | -0.247000 | 9.48e-05 | 2.48e-03 | 1.57e-01 |
Retrograde neurotrophin signalling | 12 | 3.63e-04 | 1.25e-03 | 0.8930 | 0.566000 | 0.517000 | -0.457000 | 6.80e-04 | 1.93e-03 | 6.11e-03 |
RNA Polymerase I Promoter Opening | 19 | 8.92e-07 | 6.77e-06 | 0.8860 | 0.616000 | 0.412000 | -0.486000 | 3.31e-06 | 1.89e-03 | 2.46e-04 |
Selenoamino acid metabolism | 114 | 2.96e-56 | 1.92e-54 | 0.8760 | -0.228000 | -0.617000 | -0.579000 | 2.52e-05 | 4.37e-30 | 1.11e-26 |
Gap junction trafficking | 13 | 3.88e-04 | 1.32e-03 | 0.8720 | 0.564000 | 0.553000 | -0.370000 | 4.32e-04 | 5.56e-04 | 2.11e-02 |
SRP-dependent cotranslational protein targeting to membrane | 111 | 8.28e-60 | 5.63e-58 | 0.8610 | -0.134000 | -0.583000 | -0.620000 | 1.48e-02 | 2.36e-26 | 1.27e-29 |
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 114 | 2.07e-55 | 1.17e-53 | 0.8590 | -0.195000 | -0.585000 | -0.597000 | 3.16e-04 | 3.11e-27 | 2.66e-28 |
Nonsense-Mediated Decay (NMD) | 114 | 2.07e-55 | 1.17e-53 | 0.8590 | -0.195000 | -0.585000 | -0.597000 | 3.16e-04 | 3.11e-27 | 2.66e-28 |
Unwinding of DNA | 12 | 1.63e-03 | 4.55e-03 | 0.8540 | -0.637000 | -0.568000 | 0.008700 | 1.33e-04 | 6.52e-04 | 9.58e-01 |
RHO GTPases Activate WASPs and WAVEs | 35 | 2.05e-09 | 2.58e-08 | 0.8470 | 0.608000 | 0.542000 | -0.232000 | 4.76e-10 | 2.90e-08 | 1.78e-02 |
RHO GTPases Activate NADPH Oxidases | 21 | 2.87e-06 | 1.87e-05 | 0.8440 | 0.559000 | 0.472000 | -0.422000 | 9.31e-06 | 1.79e-04 | 8.25e-04 |
Translation initiation complex formation | 58 | 2.43e-36 | 9.45e-35 | 0.8290 | -0.020100 | -0.582000 | -0.590000 | 7.92e-01 | 1.77e-14 | 7.54e-15 |
RHO GTPases Activate ROCKs | 18 | 8.92e-05 | 3.71e-04 | 0.8240 | 0.541000 | 0.621000 | -0.025300 | 7.03e-05 | 5.02e-06 | 8.53e-01 |
MET activates RAP1 and RAC1 | 10 | 6.15e-03 | 1.39e-02 | 0.8240 | 0.530000 | 0.606000 | 0.178000 | 3.71e-03 | 9.10e-04 | 3.31e-01 |
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | 59 | 1.34e-36 | 5.53e-35 | 0.8210 | -0.008080 | -0.568000 | -0.593000 | 9.15e-01 | 4.24e-14 | 3.25e-15 |
Ribosomal scanning and start codon recognition | 58 | 6.98e-35 | 2.50e-33 | 0.8170 | -0.025100 | -0.572000 | -0.583000 | 7.41e-01 | 4.68e-14 | 1.57e-14 |
Trafficking of GluR2-containing AMPA receptors | 12 | 8.28e-04 | 2.51e-03 | 0.8160 | 0.469000 | 0.446000 | -0.497000 | 4.91e-03 | 7.46e-03 | 2.88e-03 |
Josephin domain DUBs | 10 | 8.95e-04 | 2.69e-03 | 0.8150 | 0.470000 | 0.227000 | -0.627000 | 1.01e-02 | 2.14e-01 | 5.99e-04 |
Influenza Viral RNA Transcription and Replication | 135 | 7.99e-56 | 4.94e-54 | 0.8110 | -0.225000 | -0.573000 | -0.529000 | 6.45e-06 | 1.21e-30 | 2.39e-26 |
PD-1 signaling | 28 | 4.90e-07 | 4.09e-06 | 0.8110 | -0.579000 | -0.562000 | -0.075900 | 1.13e-07 | 2.60e-07 | 4.87e-01 |
Neutrophil degranulation | 458 | 1.10e-119 | 1.50e-116 | 0.8090 | 0.586000 | 0.454000 | -0.326000 | 2.13e-103 | 1.37e-62 | 5.89e-33 |
Major pathway of rRNA processing in the nucleolus and cytosol | 180 | 2.04e-68 | 1.73e-66 | 0.8080 | -0.306000 | -0.637000 | -0.391000 | 1.30e-12 | 1.75e-49 | 1.36e-19 |
rRNA processing in the nucleus and cytosol | 190 | 2.79e-71 | 3.17e-69 | 0.8060 | -0.307000 | -0.633000 | -0.393000 | 2.77e-13 | 2.17e-51 | 9.47e-21 |
Platelet sensitization by LDL | 16 | 6.33e-04 | 2.00e-03 | 0.7980 | 0.552000 | 0.566000 | -0.107000 | 1.31e-04 | 8.90e-05 | 4.58e-01 |
p130Cas linkage to MAPK signaling for integrins | 11 | 9.97e-04 | 2.96e-03 | 0.7980 | 0.666000 | 0.382000 | -0.218000 | 1.32e-04 | 2.82e-02 | 2.11e-01 |
NOTCH4 Activation and Transmission of Signal to the Nucleus | 10 | 1.12e-02 | 2.33e-02 | 0.7970 | 0.528000 | 0.577000 | -0.155000 | 3.86e-03 | 1.58e-03 | 3.95e-01 |
Hyaluronan metabolism | 13 | 1.12e-03 | 3.26e-03 | 0.7950 | 0.513000 | 0.429000 | -0.430000 | 1.37e-03 | 7.41e-03 | 7.32e-03 |
Detoxification of Reactive Oxygen Species | 32 | 3.13e-08 | 3.27e-07 | 0.7920 | 0.561000 | 0.436000 | -0.350000 | 3.93e-08 | 1.93e-05 | 6.09e-04 |
Insulin receptor recycling | 21 | 1.06e-05 | 5.76e-05 | 0.7900 | 0.568000 | 0.404000 | -0.371000 | 6.47e-06 | 1.34e-03 | 3.26e-03 |
Activation of the pre-replicative complex | 32 | 6.26e-08 | 6.35e-07 | 0.7790 | -0.482000 | -0.604000 | 0.105000 | 2.37e-06 | 3.40e-09 | 3.04e-01 |
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases | 13 | 4.27e-03 | 1.02e-02 | 0.7760 | 0.555000 | 0.535000 | -0.083900 | 5.28e-04 | 8.32e-04 | 6.01e-01 |
ROS and RNS production in phagocytes | 31 | 1.40e-08 | 1.54e-07 | 0.7750 | 0.597000 | 0.371000 | -0.324000 | 8.47e-09 | 3.46e-04 | 1.77e-03 |
Signaling by Leptin | 10 | 8.24e-03 | 1.80e-02 | 0.7680 | 0.565000 | 0.388000 | -0.347000 | 1.98e-03 | 3.37e-02 | 5.76e-02 |
rRNA processing | 217 | 8.40e-73 | 1.04e-70 | 0.7660 | -0.289000 | -0.589000 | -0.394000 | 2.16e-13 | 7.88e-51 | 1.25e-23 |
DNA strand elongation | 32 | 6.40e-07 | 5.09e-06 | 0.7620 | -0.522000 | -0.555000 | 0.027000 | 3.22e-07 | 5.52e-08 | 7.91e-01 |
Dissolution of Fibrin Clot | 12 | 3.97e-03 | 9.69e-03 | 0.7620 | 0.566000 | 0.412000 | -0.301000 | 6.87e-04 | 1.36e-02 | 7.08e-02 |
Mucopolysaccharidoses | 11 | 6.38e-03 | 1.44e-02 | 0.7510 | 0.455000 | 0.442000 | -0.403000 | 9.00e-03 | 1.12e-02 | 2.07e-02 |
Spry regulation of FGF signaling | 16 | 3.98e-04 | 1.35e-03 | 0.7490 | 0.475000 | 0.372000 | -0.445000 | 1.01e-03 | 1.01e-02 | 2.08e-03 |
Pentose phosphate pathway | 13 | 2.23e-03 | 6.01e-03 | 0.7480 | 0.488000 | 0.375000 | -0.425000 | 2.33e-03 | 1.91e-02 | 7.96e-03 |
DNA methylation | 20 | 2.54e-05 | 1.22e-04 | 0.7470 | 0.517000 | 0.325000 | -0.431000 | 6.35e-05 | 1.19e-02 | 8.36e-04 |
COPI-independent Golgi-to-ER retrograde traffic | 33 | 4.56e-07 | 3.83e-06 | 0.7450 | 0.563000 | 0.464000 | -0.151000 | 2.13e-08 | 3.98e-06 | 1.32e-01 |
Formation of ATP by chemiosmotic coupling | 18 | 3.36e-07 | 2.93e-06 | 0.7430 | 0.427000 | 0.037500 | -0.607000 | 1.71e-03 | 7.83e-01 | 8.20e-06 |
Diseases associated with the TLR signaling cascade | 23 | 7.96e-05 | 3.35e-04 | 0.7390 | 0.534000 | 0.480000 | -0.177000 | 9.12e-06 | 6.80e-05 | 1.43e-01 |
Diseases of Immune System | 23 | 7.96e-05 | 3.35e-04 | 0.7390 | 0.534000 | 0.480000 | -0.177000 | 9.12e-06 | 6.80e-05 | 1.43e-01 |
Pre-NOTCH Processing in Golgi | 18 | 1.20e-04 | 4.80e-04 | 0.7350 | 0.411000 | 0.487000 | -0.367000 | 2.57e-03 | 3.49e-04 | 7.01e-03 |
Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | 11 | 1.54e-02 | 3.05e-02 | 0.7320 | 0.476000 | 0.549000 | -0.088000 | 6.29e-03 | 1.61e-03 | 6.13e-01 |
Golgi Cisternae Pericentriolar Stack Reorganization | 14 | 3.97e-03 | 9.69e-03 | 0.7310 | 0.549000 | 0.481000 | 0.029100 | 3.74e-04 | 1.83e-03 | 8.51e-01 |
Phosphorylation of CD3 and TCR zeta chains | 27 | 1.07e-05 | 5.80e-05 | 0.7280 | -0.537000 | -0.486000 | -0.077500 | 1.39e-06 | 1.22e-05 | 4.86e-01 |
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | 20 | 1.46e-04 | 5.66e-04 | 0.7250 | 0.513000 | 0.383000 | -0.342000 | 7.17e-05 | 3.06e-03 | 8.08e-03 |
Neurodegenerative Diseases | 20 | 1.46e-04 | 5.66e-04 | 0.7250 | 0.513000 | 0.383000 | -0.342000 | 7.17e-05 | 3.06e-03 | 8.08e-03 |
rRNA modification in the nucleus and cytosol | 59 | 8.26e-14 | 1.54e-12 | 0.7220 | -0.397000 | -0.584000 | -0.152000 | 1.32e-07 | 8.38e-15 | 4.35e-02 |
EGFR downregulation | 27 | 1.40e-06 | 9.99e-06 | 0.7130 | 0.460000 | 0.294000 | -0.459000 | 3.48e-05 | 8.23e-03 | 3.69e-05 |
Activation of ATR in response to replication stress | 36 | 2.43e-07 | 2.15e-06 | 0.7130 | -0.452000 | -0.516000 | 0.194000 | 2.73e-06 | 8.15e-08 | 4.35e-02 |
Lagging Strand Synthesis | 20 | 4.14e-04 | 1.40e-03 | 0.7100 | -0.452000 | -0.546000 | 0.038000 | 4.65e-04 | 2.35e-05 | 7.69e-01 |
Budding and maturation of HIV virion | 26 | 1.32e-05 | 6.96e-05 | 0.7080 | 0.525000 | 0.373000 | -0.293000 | 3.50e-06 | 9.80e-04 | 9.75e-03 |
Processive synthesis on the lagging strand | 15 | 3.33e-03 | 8.31e-03 | 0.7000 | -0.431000 | -0.552000 | -0.010800 | 3.86e-03 | 2.14e-04 | 9.42e-01 |
InlB-mediated entry of Listeria monocytogenes into host cell | 12 | 8.69e-03 | 1.88e-02 | 0.7000 | 0.525000 | 0.361000 | -0.290000 | 1.64e-03 | 3.06e-02 | 8.22e-02 |
Influenza Infection | 154 | 8.65e-49 | 4.36e-47 | 0.6990 | -0.181000 | -0.499000 | -0.455000 | 1.07e-04 | 1.06e-26 | 1.61e-22 |
IRAK1 recruits IKK complex | 10 | 2.90e-02 | 5.22e-02 | 0.6990 | 0.533000 | 0.404000 | -0.203000 | 3.52e-03 | 2.71e-02 | 2.67e-01 |
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | 10 | 2.90e-02 | 5.22e-02 | 0.6990 | 0.533000 | 0.404000 | -0.203000 | 3.52e-03 | 2.71e-02 | 2.67e-01 |
Smooth Muscle Contraction | 31 | 2.08e-06 | 1.42e-05 | 0.6980 | 0.494000 | 0.369000 | -0.329000 | 1.95e-06 | 3.81e-04 | 1.53e-03 |
Signal transduction by L1 | 20 | 4.29e-04 | 1.44e-03 | 0.6980 | 0.438000 | 0.507000 | -0.194000 | 6.90e-04 | 8.61e-05 | 1.32e-01 |
Cargo concentration in the ER | 30 | 1.41e-05 | 7.42e-05 | 0.6970 | 0.520000 | 0.463000 | -0.035700 | 8.05e-07 | 1.14e-05 | 7.35e-01 |
GRB2:SOS provides linkage to MAPK signaling for Integrins | 12 | 3.25e-03 | 8.12e-03 | 0.6970 | 0.581000 | 0.325000 | -0.208000 | 4.97e-04 | 5.10e-02 | 2.12e-01 |
Transferrin endocytosis and recycling | 26 | 2.18e-05 | 1.06e-04 | 0.6960 | 0.509000 | 0.370000 | -0.298000 | 7.03e-06 | 1.09e-03 | 8.47e-03 |
EPHB-mediated forward signaling | 32 | 8.88e-06 | 5.05e-05 | 0.6960 | 0.504000 | 0.475000 | -0.067000 | 8.17e-07 | 3.24e-06 | 5.12e-01 |
Nucleobase biosynthesis | 13 | 2.59e-03 | 6.78e-03 | 0.6960 | -0.356000 | -0.578000 | -0.152000 | 2.63e-02 | 3.06e-04 | 3.43e-01 |
AKT phosphorylates targets in the cytosol | 14 | 4.48e-03 | 1.07e-02 | 0.6950 | 0.427000 | 0.444000 | -0.322000 | 5.63e-03 | 4.05e-03 | 3.68e-02 |
GAB1 signalosome | 15 | 1.42e-03 | 4.03e-03 | 0.6950 | 0.471000 | 0.301000 | -0.413000 | 1.59e-03 | 4.33e-02 | 5.58e-03 |
MAP2K and MAPK activation | 34 | 1.53e-06 | 1.08e-05 | 0.6940 | 0.516000 | 0.405000 | -0.225000 | 1.87e-07 | 4.36e-05 | 2.30e-02 |
ERKs are inactivated | 13 | 6.96e-03 | 1.54e-02 | 0.6940 | 0.432000 | 0.410000 | -0.355000 | 6.97e-03 | 1.04e-02 | 2.66e-02 |
Signal regulatory protein family interactions | 12 | 7.77e-03 | 1.71e-02 | 0.6890 | 0.409000 | 0.343000 | -0.437000 | 1.43e-02 | 3.96e-02 | 8.80e-03 |
Prolonged ERK activation events | 13 | 1.33e-02 | 2.71e-02 | 0.6870 | 0.452000 | 0.514000 | -0.061700 | 4.80e-03 | 1.32e-03 | 7.00e-01 |
Endosomal Sorting Complex Required For Transport (ESCRT) | 29 | 1.02e-05 | 5.57e-05 | 0.6870 | 0.519000 | 0.381000 | -0.238000 | 1.28e-06 | 3.82e-04 | 2.65e-02 |
Resolution of AP sites via the multiple-nucleotide patch replacement pathway | 24 | 1.81e-04 | 6.80e-04 | 0.6840 | -0.445000 | -0.513000 | -0.073800 | 1.59e-04 | 1.33e-05 | 5.32e-01 |
Negative regulation of MET activity | 18 | 1.69e-03 | 4.71e-03 | 0.6830 | 0.526000 | 0.415000 | -0.134000 | 1.12e-04 | 2.27e-03 | 3.27e-01 |
PCNA-Dependent Long Patch Base Excision Repair | 21 | 3.97e-04 | 1.35e-03 | 0.6830 | -0.420000 | -0.528000 | -0.109000 | 8.64e-04 | 2.81e-05 | 3.89e-01 |
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | 22 | 2.54e-04 | 9.11e-04 | 0.6790 | 0.471000 | 0.372000 | -0.316000 | 1.32e-04 | 2.50e-03 | 1.02e-02 |
Glycogen synthesis | 13 | 3.11e-03 | 7.84e-03 | 0.6770 | 0.404000 | 0.235000 | -0.490000 | 1.17e-02 | 1.43e-01 | 2.21e-03 |
Assembly Of The HIV Virion | 15 | 1.33e-03 | 3.82e-03 | 0.6770 | 0.417000 | 0.250000 | -0.471000 | 5.12e-03 | 9.42e-02 | 1.59e-03 |
Generation of second messenger molecules | 38 | 1.05e-06 | 7.82e-06 | 0.6750 | -0.464000 | -0.479000 | -0.101000 | 7.22e-07 | 3.12e-07 | 2.82e-01 |
SUMOylation of immune response proteins | 11 | 1.34e-02 | 2.73e-02 | 0.6720 | 0.408000 | 0.290000 | -0.448000 | 1.92e-02 | 9.57e-02 | 1.00e-02 |
Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | 12 | 1.08e-02 | 2.25e-02 | 0.6720 | 0.478000 | 0.317000 | -0.350000 | 4.12e-03 | 5.75e-02 | 3.59e-02 |
Diseases of hemostasis | 12 | 1.08e-02 | 2.25e-02 | 0.6720 | 0.478000 | 0.317000 | -0.350000 | 4.12e-03 | 5.75e-02 | 3.59e-02 |
Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | 11 | 3.16e-02 | 5.61e-02 | 0.6710 | 0.443000 | 0.452000 | -0.223000 | 1.10e-02 | 9.41e-03 | 2.01e-01 |
Signaling by high-kinase activity BRAF mutants | 31 | 1.48e-05 | 7.70e-05 | 0.6680 | 0.498000 | 0.391000 | -0.211000 | 1.59e-06 | 1.62e-04 | 4.20e-02 |
RHO GTPases activate PKNs | 47 | 7.83e-08 | 7.71e-07 | 0.6670 | 0.480000 | 0.430000 | -0.170000 | 1.24e-08 | 3.30e-07 | 4.44e-02 |
Gap junction trafficking and regulation | 15 | 5.29e-03 | 1.22e-02 | 0.6660 | 0.414000 | 0.431000 | -0.296000 | 5.54e-03 | 3.88e-03 | 4.74e-02 |
RHO GTPases activate PAKs | 20 | 1.81e-03 | 5.00e-03 | 0.6660 | 0.484000 | 0.454000 | -0.055600 | 1.78e-04 | 4.44e-04 | 6.67e-01 |
Platelet Aggregation (Plug Formation) | 28 | 2.71e-05 | 1.29e-04 | 0.6620 | 0.476000 | 0.346000 | -0.303000 | 1.29e-05 | 1.52e-03 | 5.46e-03 |
Erythropoietin activates RAS | 13 | 1.73e-02 | 3.34e-02 | 0.6610 | 0.423000 | 0.506000 | -0.045600 | 8.22e-03 | 1.59e-03 | 7.76e-01 |
Membrane binding and targetting of GAG proteins | 13 | 5.54e-03 | 1.27e-02 | 0.6610 | 0.445000 | 0.266000 | -0.410000 | 5.43e-03 | 9.74e-02 | 1.05e-02 |
Synthesis And Processing Of GAG, GAGPOL Polyproteins | 13 | 5.54e-03 | 1.27e-02 | 0.6610 | 0.445000 | 0.266000 | -0.410000 | 5.43e-03 | 9.74e-02 | 1.05e-02 |
Removal of the Flap Intermediate | 14 | 8.94e-03 | 1.93e-02 | 0.6590 | -0.399000 | -0.525000 | 0.009800 | 9.75e-03 | 6.78e-04 | 9.49e-01 |
Amyloid fiber formation | 51 | 8.44e-11 | 1.18e-09 | 0.6590 | 0.482000 | 0.273000 | -0.357000 | 2.59e-09 | 7.54e-04 | 1.06e-05 |
Heme degradation | 10 | 4.25e-02 | 7.19e-02 | 0.6550 | 0.401000 | 0.483000 | -0.185000 | 2.80e-02 | 8.20e-03 | 3.10e-01 |
RHO GTPases activate IQGAPs | 11 | 4.31e-02 | 7.28e-02 | 0.6530 | 0.434000 | 0.476000 | -0.107000 | 1.27e-02 | 6.24e-03 | 5.39e-01 |
Diseases of programmed cell death | 22 | 2.57e-04 | 9.17e-04 | 0.6500 | 0.452000 | 0.305000 | -0.353000 | 2.39e-04 | 1.34e-02 | 4.17e-03 |
Recycling pathway of L1 | 26 | 2.17e-04 | 7.99e-04 | 0.6450 | 0.426000 | 0.419000 | -0.242000 | 1.70e-04 | 2.13e-04 | 3.27e-02 |
Response of Mtb to phagocytosis | 22 | 2.26e-04 | 8.25e-04 | 0.6430 | 0.459000 | 0.287000 | -0.348000 | 1.96e-04 | 1.99e-02 | 4.77e-03 |
GP1b-IX-V activation signalling | 10 | 1.36e-02 | 2.75e-02 | 0.6420 | 0.357000 | 0.147000 | -0.512000 | 5.07e-02 | 4.21e-01 | 5.01e-03 |
Late endosomal microautophagy | 30 | 1.16e-05 | 6.21e-05 | 0.6370 | 0.423000 | 0.286000 | -0.382000 | 6.12e-05 | 6.66e-03 | 2.95e-04 |
Regulation of expression of SLITs and ROBOs | 159 | 2.51e-48 | 1.22e-46 | 0.6370 | -0.041600 | -0.379000 | -0.511000 | 3.65e-01 | 1.50e-16 | 9.36e-29 |
FOXO-mediated transcription of cell death genes | 16 | 2.19e-03 | 5.91e-03 | 0.6370 | 0.332000 | 0.356000 | -0.411000 | 2.15e-02 | 1.37e-02 | 4.43e-03 |
Pexophagy | 11 | 5.58e-03 | 1.28e-02 | 0.6350 | 0.357000 | 0.098400 | -0.517000 | 4.06e-02 | 5.72e-01 | 3.00e-03 |
PKA activation in glucagon signalling | 14 | 6.21e-03 | 1.40e-02 | 0.6350 | 0.345000 | 0.313000 | -0.432000 | 2.53e-02 | 4.25e-02 | 5.17e-03 |
Integrin signaling | 22 | 1.46e-03 | 4.13e-03 | 0.6350 | 0.456000 | 0.400000 | -0.187000 | 2.10e-04 | 1.15e-03 | 1.30e-01 |
Sealing of the nuclear envelope (NE) by ESCRT-III | 25 | 4.28e-04 | 1.44e-03 | 0.6320 | 0.431000 | 0.382000 | -0.258000 | 1.88e-04 | 9.33e-04 | 2.57e-02 |
Packaging Of Telomere Ends | 20 | 3.46e-04 | 1.20e-03 | 0.6300 | 0.448000 | 0.240000 | -0.373000 | 5.29e-04 | 6.31e-02 | 3.88e-03 |
Suppression of phagosomal maturation | 12 | 2.05e-02 | 3.92e-02 | 0.6290 | 0.437000 | 0.296000 | -0.343000 | 8.73e-03 | 7.56e-02 | 3.99e-02 |
Telomere C-strand (Lagging Strand) Synthesis | 34 | 1.61e-05 | 8.34e-05 | 0.6290 | -0.387000 | -0.490000 | -0.074800 | 9.40e-05 | 7.66e-07 | 4.51e-01 |
Sema4D in semaphorin signaling | 22 | 7.32e-04 | 2.26e-03 | 0.6280 | 0.379000 | 0.473000 | -0.167000 | 2.09e-03 | 1.23e-04 | 1.76e-01 |
Collagen degradation | 28 | 9.53e-05 | 3.93e-04 | 0.6260 | 0.394000 | 0.362000 | -0.325000 | 3.10e-04 | 9.04e-04 | 2.96e-03 |
Diseases of carbohydrate metabolism | 29 | 9.96e-06 | 5.51e-05 | 0.6250 | 0.333000 | 0.243000 | -0.469000 | 1.93e-03 | 2.35e-02 | 1.21e-05 |
Signaling by RAF1 mutants | 34 | 2.45e-05 | 1.18e-04 | 0.6240 | 0.471000 | 0.368000 | -0.181000 | 2.03e-06 | 2.06e-04 | 6.77e-02 |
Glycogen storage diseases | 13 | 6.64e-03 | 1.48e-02 | 0.6230 | 0.301000 | 0.200000 | -0.507000 | 6.04e-02 | 2.12e-01 | 1.54e-03 |
Lysosome Vesicle Biogenesis | 32 | 1.84e-05 | 9.36e-05 | 0.6210 | 0.404000 | 0.315000 | -0.351000 | 7.55e-05 | 2.06e-03 | 5.78e-04 |
Sema4D induced cell migration and growth-cone collapse | 19 | 2.59e-03 | 6.78e-03 | 0.6210 | 0.375000 | 0.463000 | -0.176000 | 4.64e-03 | 4.81e-04 | 1.85e-01 |
Response to elevated platelet cytosolic Ca2+ | 108 | 8.64e-19 | 2.10e-17 | 0.6210 | 0.453000 | 0.288000 | -0.311000 | 3.81e-16 | 2.32e-07 | 2.23e-08 |
RHO GTPases activate CIT | 18 | 3.74e-03 | 9.17e-03 | 0.6190 | 0.369000 | 0.496000 | -0.028800 | 6.79e-03 | 2.67e-04 | 8.32e-01 |
Regulated proteolysis of p75NTR | 11 | 6.47e-02 | 1.04e-01 | 0.6190 | 0.416000 | 0.449000 | -0.088400 | 1.69e-02 | 9.86e-03 | 6.12e-01 |
Platelet degranulation | 104 | 3.89e-18 | 8.97e-17 | 0.6190 | 0.451000 | 0.283000 | -0.315000 | 1.74e-15 | 6.21e-07 | 2.90e-08 |
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | 16 | 1.09e-03 | 3.18e-03 | 0.6190 | 0.304000 | 0.121000 | -0.525000 | 3.50e-02 | 4.01e-01 | 2.78e-04 |
Common Pathway of Fibrin Clot Formation | 14 | 8.66e-03 | 1.88e-02 | 0.6160 | 0.335000 | 0.304000 | -0.419000 | 2.99e-02 | 4.92e-02 | 6.62e-03 |
Notch-HLH transcription pathway | 28 | 2.17e-04 | 7.99e-04 | 0.6090 | 0.407000 | 0.347000 | -0.291000 | 1.92e-04 | 1.50e-03 | 7.71e-03 |
Signaling by Erythropoietin | 24 | 9.01e-04 | 2.70e-03 | 0.6070 | 0.377000 | 0.458000 | -0.127000 | 1.38e-03 | 1.04e-04 | 2.80e-01 |
Glycogen breakdown (glycogenolysis) | 13 | 3.72e-02 | 6.46e-02 | 0.6040 | 0.410000 | 0.379000 | -0.229000 | 1.04e-02 | 1.80e-02 | 1.53e-01 |
Infection with Mycobacterium tuberculosis | 26 | 1.04e-04 | 4.23e-04 | 0.6030 | 0.449000 | 0.260000 | -0.307000 | 7.40e-05 | 2.19e-02 | 6.68e-03 |
Frs2-mediated activation | 11 | 6.31e-02 | 1.02e-01 | 0.6000 | 0.377000 | 0.452000 | -0.115000 | 3.02e-02 | 9.39e-03 | 5.07e-01 |
Chondroitin sulfate biosynthesis | 12 | 1.50e-02 | 2.99e-02 | 0.6000 | 0.296000 | 0.387000 | -0.351000 | 7.61e-02 | 2.04e-02 | 3.52e-02 |
EPH-Ephrin signaling | 78 | 3.69e-11 | 5.46e-10 | 0.6000 | 0.399000 | 0.362000 | -0.264000 | 1.13e-09 | 3.14e-08 | 5.60e-05 |
GPVI-mediated activation cascade | 31 | 1.87e-05 | 9.48e-05 | 0.5990 | 0.329000 | 0.454000 | -0.209000 | 1.52e-03 | 1.19e-05 | 4.39e-02 |
NF-kB is activated and signals survival | 12 | 1.02e-02 | 2.17e-02 | 0.5990 | 0.264000 | 0.112000 | -0.525000 | 1.14e-01 | 5.00e-01 | 1.62e-03 |
MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 92 | 4.40e-14 | 8.32e-13 | 0.5940 | 0.438000 | 0.296000 | -0.270000 | 3.52e-13 | 9.52e-07 | 7.46e-06 |
Toll Like Receptor 2 (TLR2) Cascade | 92 | 4.40e-14 | 8.32e-13 | 0.5940 | 0.438000 | 0.296000 | -0.270000 | 3.52e-13 | 9.52e-07 | 7.46e-06 |
Toll Like Receptor TLR1:TLR2 Cascade | 92 | 4.40e-14 | 8.32e-13 | 0.5940 | 0.438000 | 0.296000 | -0.270000 | 3.52e-13 | 9.52e-07 | 7.46e-06 |
Toll Like Receptor TLR6:TLR2 Cascade | 92 | 4.40e-14 | 8.32e-13 | 0.5940 | 0.438000 | 0.296000 | -0.270000 | 3.52e-13 | 9.52e-07 | 7.46e-06 |
SHC1 events in EGFR signaling | 12 | 2.13e-02 | 4.05e-02 | 0.5940 | 0.480000 | 0.272000 | -0.219000 | 4.00e-03 | 1.02e-01 | 1.88e-01 |
Regulation of IFNG signaling | 14 | 3.12e-02 | 5.54e-02 | 0.5940 | 0.396000 | 0.427000 | 0.115000 | 1.03e-02 | 5.65e-03 | 4.56e-01 |
Platelet Adhesion to exposed collagen | 13 | 4.20e-03 | 1.01e-02 | 0.5930 | 0.500000 | 0.211000 | -0.239000 | 1.80e-03 | 1.87e-01 | 1.36e-01 |
Pyrimidine salvage | 10 | 6.54e-02 | 1.05e-01 | 0.5920 | 0.345000 | 0.330000 | -0.350000 | 5.90e-02 | 7.07e-02 | 5.54e-02 |
Antimicrobial peptides | 33 | 2.58e-11 | 4.18e-10 | 0.5900 | 0.459000 | 0.019900 | -0.371000 | 5.09e-06 | 8.43e-01 | 2.27e-04 |
Telomere C-strand synthesis initiation | 13 | 3.74e-02 | 6.49e-02 | 0.5900 | -0.361000 | -0.464000 | -0.056700 | 2.43e-02 | 3.81e-03 | 7.23e-01 |
activated TAK1 mediates p38 MAPK activation | 19 | 7.06e-03 | 1.56e-02 | 0.5870 | 0.455000 | 0.346000 | -0.135000 | 5.93e-04 | 9.06e-03 | 3.07e-01 |
GRB2 events in EGFR signaling | 11 | 1.85e-02 | 3.56e-02 | 0.5870 | 0.477000 | 0.222000 | -0.261000 | 6.15e-03 | 2.03e-01 | 1.34e-01 |
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | 22 | 2.93e-04 | 1.03e-03 | 0.5830 | 0.367000 | 0.166000 | -0.422000 | 2.88e-03 | 1.78e-01 | 6.16e-04 |
Purine ribonucleoside monophosphate biosynthesis | 10 | 3.06e-02 | 5.46e-02 | 0.5830 | -0.266000 | -0.505000 | -0.121000 | 1.46e-01 | 5.70e-03 | 5.09e-01 |
Leading Strand Synthesis | 14 | 3.30e-02 | 5.80e-02 | 0.5820 | -0.364000 | -0.451000 | 0.058500 | 1.84e-02 | 3.51e-03 | 7.05e-01 |
Polymerase switching | 14 | 3.30e-02 | 5.80e-02 | 0.5820 | -0.364000 | -0.451000 | 0.058500 | 1.84e-02 | 3.51e-03 | 7.05e-01 |
SLBP independent Processing of Histone Pre-mRNAs | 10 | 4.92e-03 | 1.15e-02 | 0.5790 | -0.153000 | -0.517000 | -0.212000 | 4.03e-01 | 4.64e-03 | 2.46e-01 |
Synthesis of Leukotrienes (LT) and Eoxins (EX) | 15 | 3.95e-03 | 9.66e-03 | 0.5790 | 0.281000 | 0.503000 | -0.060400 | 5.99e-02 | 7.48e-04 | 6.85e-01 |
The NLRP3 inflammasome | 15 | 1.22e-02 | 2.50e-02 | 0.5760 | 0.457000 | 0.273000 | -0.221000 | 2.18e-03 | 6.76e-02 | 1.39e-01 |
Homologous DNA Pairing and Strand Exchange | 42 | 2.71e-06 | 1.77e-05 | 0.5760 | -0.354000 | -0.285000 | 0.355000 | 7.31e-05 | 1.42e-03 | 6.98e-05 |
LDL clearance | 17 | 1.10e-02 | 2.28e-02 | 0.5700 | 0.345000 | 0.307000 | -0.334000 | 1.37e-02 | 2.86e-02 | 1.72e-02 |
Paradoxical activation of RAF signaling by kinase inactive BRAF | 38 | 4.31e-05 | 1.93e-04 | 0.5690 | 0.432000 | 0.324000 | -0.179000 | 4.09e-06 | 5.43e-04 | 5.59e-02 |
Signaling by RAS mutants | 38 | 4.31e-05 | 1.93e-04 | 0.5690 | 0.432000 | 0.324000 | -0.179000 | 4.09e-06 | 5.43e-04 | 5.59e-02 |
Signaling by moderate kinase activity BRAF mutants | 38 | 4.31e-05 | 1.93e-04 | 0.5690 | 0.432000 | 0.324000 | -0.179000 | 4.09e-06 | 5.43e-04 | 5.59e-02 |
Signaling downstream of RAS mutants | 38 | 4.31e-05 | 1.93e-04 | 0.5690 | 0.432000 | 0.324000 | -0.179000 | 4.09e-06 | 5.43e-04 | 5.59e-02 |
Presynaptic phase of homologous DNA pairing and strand exchange | 39 | 6.91e-06 | 4.03e-05 | 0.5680 | -0.329000 | -0.277000 | 0.372000 | 3.83e-04 | 2.74e-03 | 5.92e-05 |
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | 15 | 1.30e-02 | 2.64e-02 | 0.5680 | 0.454000 | 0.266000 | -0.214000 | 2.34e-03 | 7.48e-02 | 1.50e-01 |
Gastrin-CREB signalling pathway via PKC and MAPK | 14 | 3.83e-02 | 6.59e-02 | 0.5680 | 0.408000 | 0.317000 | -0.234000 | 8.16e-03 | 3.97e-02 | 1.30e-01 |
G-protein beta:gamma signalling | 29 | 1.06e-03 | 3.12e-03 | 0.5630 | 0.375000 | 0.386000 | -0.163000 | 4.69e-04 | 3.15e-04 | 1.29e-01 |
Butyrophilin (BTN) family interactions | 10 | 6.59e-02 | 1.06e-01 | 0.5620 | -0.423000 | -0.237000 | 0.285000 | 2.04e-02 | 1.95e-01 | 1.19e-01 |
Plasma lipoprotein clearance | 28 | 1.21e-04 | 4.80e-04 | 0.5620 | 0.278000 | 0.229000 | -0.432000 | 1.09e-02 | 3.59e-02 | 7.69e-05 |
Translation | 295 | 5.55e-85 | 2.52e-82 | 0.5620 | -0.055800 | -0.441000 | -0.344000 | 9.90e-02 | 5.79e-39 | 2.80e-24 |
Signal amplification | 28 | 8.06e-04 | 2.45e-03 | 0.5600 | 0.440000 | 0.318000 | -0.136000 | 5.62e-05 | 3.54e-03 | 2.13e-01 |
Glycogen metabolism | 23 | 1.96e-03 | 5.32e-03 | 0.5580 | 0.357000 | 0.261000 | -0.340000 | 3.01e-03 | 3.03e-02 | 4.72e-03 |
Activation of Matrix Metalloproteinases | 22 | 1.43e-03 | 4.04e-03 | 0.5580 | 0.374000 | 0.215000 | -0.354000 | 2.41e-03 | 8.11e-02 | 4.02e-03 |
HDR through MMEJ (alt-NHEJ) | 10 | 1.22e-01 | 1.76e-01 | 0.5580 | -0.429000 | -0.321000 | 0.153000 | 1.88e-02 | 7.84e-02 | 4.02e-01 |
ERK/MAPK targets | 22 | 3.04e-03 | 7.71e-03 | 0.5540 | 0.407000 | 0.267000 | -0.265000 | 9.43e-04 | 3.04e-02 | 3.14e-02 |
Growth hormone receptor signaling | 20 | 1.26e-02 | 2.58e-02 | 0.5540 | 0.421000 | 0.360000 | -0.019500 | 1.13e-03 | 5.30e-03 | 8.80e-01 |
Interleukin-1 signaling | 97 | 2.47e-14 | 4.94e-13 | 0.5520 | 0.431000 | 0.247000 | -0.242000 | 2.20e-13 | 2.71e-05 | 3.70e-05 |
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 88 | 2.95e-12 | 5.20e-11 | 0.5520 | 0.415000 | 0.257000 | -0.257000 | 1.73e-11 | 2.98e-05 | 3.08e-05 |
NOTCH3 Activation and Transmission of Signal to the Nucleus | 23 | 8.52e-04 | 2.57e-03 | 0.5510 | 0.264000 | 0.223000 | -0.429000 | 2.86e-02 | 6.41e-02 | 3.63e-04 |
Cleavage of the damaged purine | 24 | 5.06e-04 | 1.65e-03 | 0.5500 | 0.352000 | 0.173000 | -0.385000 | 2.80e-03 | 1.42e-01 | 1.10e-03 |
Depurination | 24 | 5.06e-04 | 1.65e-03 | 0.5500 | 0.352000 | 0.173000 | -0.385000 | 2.80e-03 | 1.42e-01 | 1.10e-03 |
Recognition and association of DNA glycosylase with site containing an affected purine | 24 | 5.06e-04 | 1.65e-03 | 0.5500 | 0.352000 | 0.173000 | -0.385000 | 2.80e-03 | 1.42e-01 | 1.10e-03 |
Translesion synthesis by REV1 | 16 | 1.67e-02 | 3.26e-02 | 0.5500 | -0.294000 | -0.438000 | -0.155000 | 4.15e-02 | 2.43e-03 | 2.84e-01 |
COPI-mediated anterograde transport | 78 | 1.17e-08 | 1.31e-07 | 0.5490 | 0.392000 | 0.370000 | -0.107000 | 2.10e-09 | 1.64e-08 | 1.04e-01 |
Beta-catenin phosphorylation cascade | 17 | 3.01e-02 | 5.37e-02 | 0.5460 | 0.365000 | 0.369000 | -0.170000 | 9.25e-03 | 8.42e-03 | 2.25e-01 |
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | 11 | 1.19e-03 | 3.45e-03 | 0.5450 | -0.082600 | -0.499000 | -0.205000 | 6.35e-01 | 4.19e-03 | 2.39e-01 |
MAP3K8 (TPL2)-dependent MAPK1/3 activation | 16 | 8.16e-03 | 1.78e-02 | 0.5450 | 0.366000 | 0.173000 | -0.365000 | 1.12e-02 | 2.30e-01 | 1.15e-02 |
ADP signalling through P2Y purinoceptor 1 | 21 | 1.13e-02 | 2.33e-02 | 0.5450 | 0.406000 | 0.331000 | -0.151000 | 1.29e-03 | 8.72e-03 | 2.30e-01 |
tRNA processing in the mitochondrion | 30 | 6.74e-06 | 3.95e-05 | 0.5410 | -0.141000 | -0.152000 | -0.500000 | 1.82e-01 | 1.49e-01 | 2.17e-06 |
Resolution of Abasic Sites (AP sites) | 37 | 1.58e-04 | 6.05e-04 | 0.5400 | -0.348000 | -0.385000 | -0.151000 | 2.50e-04 | 5.09e-05 | 1.13e-01 |
TBC/RABGAPs | 45 | 2.38e-06 | 1.57e-05 | 0.5400 | 0.289000 | 0.328000 | -0.316000 | 7.88e-04 | 1.38e-04 | 2.48e-04 |
ERBB2 Regulates Cell Motility | 10 | 3.82e-02 | 6.59e-02 | 0.5380 | 0.315000 | 0.081800 | -0.429000 | 8.47e-02 | 6.54e-01 | 1.88e-02 |
MyD88 dependent cascade initiated on endosome | 89 | 1.65e-11 | 2.74e-10 | 0.5370 | 0.403000 | 0.258000 | -0.244000 | 5.11e-11 | 2.53e-05 | 6.76e-05 |
Toll Like Receptor 7/8 (TLR7/8) Cascade | 89 | 1.65e-11 | 2.74e-10 | 0.5370 | 0.403000 | 0.258000 | -0.244000 | 5.11e-11 | 2.53e-05 | 6.76e-05 |
MyD88 cascade initiated on plasma membrane | 82 | 3.50e-11 | 5.29e-10 | 0.5360 | 0.395000 | 0.233000 | -0.277000 | 6.13e-10 | 2.69e-04 | 1.44e-05 |
Toll Like Receptor 10 (TLR10) Cascade | 82 | 3.50e-11 | 5.29e-10 | 0.5360 | 0.395000 | 0.233000 | -0.277000 | 6.13e-10 | 2.69e-04 | 1.44e-05 |
Toll Like Receptor 5 (TLR5) Cascade | 82 | 3.50e-11 | 5.29e-10 | 0.5360 | 0.395000 | 0.233000 | -0.277000 | 6.13e-10 | 2.69e-04 | 1.44e-05 |
ATF6 (ATF6-alpha) activates chaperone genes | 10 | 8.58e-02 | 1.30e-01 | 0.5350 | 0.446000 | 0.294000 | 0.037500 | 1.46e-02 | 1.07e-01 | 8.37e-01 |
Interleukin-6 signaling | 10 | 1.76e-01 | 2.37e-01 | 0.5350 | 0.401000 | 0.350000 | -0.052600 | 2.81e-02 | 5.50e-02 | 7.73e-01 |
Gluconeogenesis | 28 | 2.08e-04 | 7.71e-04 | 0.5350 | 0.242000 | 0.227000 | -0.420000 | 2.68e-02 | 3.76e-02 | 1.20e-04 |
Thrombin signalling through proteinase activated receptors (PARs) | 27 | 2.48e-03 | 6.52e-03 | 0.5340 | 0.354000 | 0.314000 | -0.248000 | 1.47e-03 | 4.76e-03 | 2.58e-02 |
trans-Golgi Network Vesicle Budding | 69 | 1.35e-07 | 1.27e-06 | 0.5330 | 0.371000 | 0.331000 | -0.193000 | 1.01e-07 | 1.99e-06 | 5.46e-03 |
Transcriptional regulation of granulopoiesis | 46 | 6.40e-06 | 3.80e-05 | 0.5330 | 0.419000 | 0.272000 | -0.185000 | 8.80e-07 | 1.39e-03 | 2.98e-02 |
Negative regulation of FGFR3 signaling | 20 | 5.38e-03 | 1.24e-02 | 0.5310 | 0.338000 | 0.204000 | -0.356000 | 8.93e-03 | 1.15e-01 | 5.88e-03 |
Toll Like Receptor 4 (TLR4) Cascade | 121 | 2.06e-14 | 4.18e-13 | 0.5310 | 0.398000 | 0.277000 | -0.216000 | 3.68e-14 | 1.44e-07 | 4.18e-05 |
COPII-mediated vesicle transport | 65 | 8.56e-07 | 6.58e-06 | 0.5300 | 0.389000 | 0.356000 | -0.053800 | 5.77e-08 | 6.84e-07 | 4.53e-01 |
Platelet activation, signaling and aggregation | 219 | 6.37e-25 | 1.84e-23 | 0.5300 | 0.360000 | 0.293000 | -0.256000 | 3.93e-20 | 7.72e-14 | 6.53e-11 |
Inhibition of DNA recombination at telomere | 35 | 8.12e-06 | 4.66e-05 | 0.5290 | 0.343000 | 0.131000 | -0.382000 | 4.49e-04 | 1.81e-01 | 9.26e-05 |
Regulation of signaling by CBL | 18 | 5.06e-03 | 1.18e-02 | 0.5280 | 0.261000 | 0.408000 | -0.211000 | 5.48e-02 | 2.74e-03 | 1.21e-01 |
Activated NOTCH1 Transmits Signal to the Nucleus | 27 | 6.66e-04 | 2.09e-03 | 0.5270 | 0.268000 | 0.263000 | -0.370000 | 1.61e-02 | 1.78e-02 | 8.86e-04 |
Signalling to ERKs | 31 | 1.86e-03 | 5.11e-03 | 0.5270 | 0.397000 | 0.339000 | -0.071700 | 1.30e-04 | 1.10e-03 | 4.90e-01 |
Cristae formation | 31 | 7.48e-08 | 7.43e-07 | 0.5250 | 0.263000 | -0.091500 | -0.445000 | 1.11e-02 | 3.78e-01 | 1.78e-05 |
Cytosolic iron-sulfur cluster assembly | 13 | 1.70e-02 | 3.30e-02 | 0.5230 | -0.187000 | -0.203000 | -0.445000 | 2.43e-01 | 2.05e-01 | 5.50e-03 |
PKA activation | 15 | 2.26e-02 | 4.24e-02 | 0.5230 | 0.265000 | 0.203000 | -0.403000 | 7.57e-02 | 1.73e-01 | 6.91e-03 |
Rev-mediated nuclear export of HIV RNA | 35 | 5.94e-04 | 1.91e-03 | 0.5230 | -0.334000 | -0.381000 | 0.130000 | 6.31e-04 | 9.63e-05 | 1.82e-01 |
RHO GTPases activate KTN1 | 11 | 1.46e-01 | 2.02e-01 | 0.5220 | 0.391000 | 0.311000 | -0.149000 | 2.47e-02 | 7.38e-02 | 3.93e-01 |
Biotin transport and metabolism | 11 | 7.53e-02 | 1.18e-01 | 0.5210 | -0.439000 | -0.281000 | -0.003510 | 1.17e-02 | 1.07e-01 | 9.84e-01 |
DARPP-32 events | 22 | 9.44e-03 | 2.03e-02 | 0.5210 | 0.401000 | 0.286000 | -0.168000 | 1.11e-03 | 2.01e-02 | 1.74e-01 |
RORA activates gene expression | 18 | 2.25e-02 | 4.23e-02 | 0.5210 | 0.312000 | 0.401000 | -0.114000 | 2.21e-02 | 3.21e-03 | 4.02e-01 |
Polymerase switching on the C-strand of the telomere | 26 | 3.40e-03 | 8.44e-03 | 0.5200 | -0.305000 | -0.406000 | -0.113000 | 7.06e-03 | 3.37e-04 | 3.20e-01 |
The role of Nef in HIV-1 replication and disease pathogenesis | 28 | 2.87e-04 | 1.01e-03 | 0.5180 | 0.229000 | 0.143000 | -0.442000 | 3.63e-02 | 1.91e-01 | 5.11e-05 |
NEP/NS2 Interacts with the Cellular Export Machinery | 32 | 1.03e-03 | 3.04e-03 | 0.5170 | -0.321000 | -0.352000 | 0.201000 | 1.66e-03 | 5.69e-04 | 4.88e-02 |
Metabolism of Angiotensinogen to Angiotensins | 11 | 4.48e-02 | 7.53e-02 | 0.5170 | 0.392000 | 0.160000 | -0.297000 | 2.44e-02 | 3.58e-01 | 8.85e-02 |
Negative regulation of FGFR4 signaling | 21 | 4.11e-03 | 9.96e-03 | 0.5170 | 0.313000 | 0.172000 | -0.374000 | 1.29e-02 | 1.74e-01 | 3.02e-03 |
Clathrin-mediated endocytosis | 127 | 5.96e-13 | 1.10e-11 | 0.5160 | 0.357000 | 0.321000 | -0.190000 | 3.49e-12 | 4.24e-10 | 2.23e-04 |
Interactions of Rev with host cellular proteins | 37 | 4.18e-04 | 1.41e-03 | 0.5160 | -0.326000 | -0.375000 | 0.140000 | 5.92e-04 | 8.02e-05 | 1.41e-01 |
Signaling by ROBO receptors | 199 | 2.80e-39 | 1.23e-37 | 0.5160 | -0.010200 | -0.276000 | -0.435000 | 8.04e-01 | 1.82e-11 | 2.88e-26 |
Pausing and recovery of Tat-mediated HIV elongation | 30 | 5.55e-05 | 2.44e-04 | 0.5150 | 0.167000 | 0.034000 | -0.486000 | 1.14e-01 | 7.48e-01 | 4.08e-06 |
Tat-mediated HIV elongation arrest and recovery | 30 | 5.55e-05 | 2.44e-04 | 0.5150 | 0.167000 | 0.034000 | -0.486000 | 1.14e-01 | 7.48e-01 | 4.08e-06 |
Adenylate cyclase inhibitory pathway | 11 | 4.16e-02 | 7.08e-02 | 0.5150 | 0.216000 | 0.334000 | -0.326000 | 2.14e-01 | 5.49e-02 | 6.09e-02 |
ER to Golgi Anterograde Transport | 129 | 1.99e-12 | 3.55e-11 | 0.5150 | 0.371000 | 0.348000 | -0.077200 | 3.31e-13 | 8.05e-12 | 1.30e-01 |
HDACs deacetylate histones | 47 | 9.43e-06 | 5.32e-05 | 0.5150 | 0.358000 | 0.235000 | -0.286000 | 2.16e-05 | 5.33e-03 | 7.03e-04 |
Antigen processing-Cross presentation | 97 | 4.75e-11 | 6.87e-10 | 0.5140 | 0.401000 | 0.271000 | -0.172000 | 8.19e-12 | 3.89e-06 | 3.44e-03 |
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | 21 | 1.80e-03 | 4.99e-03 | 0.5120 | 0.192000 | 0.065800 | -0.470000 | 1.28e-01 | 6.01e-01 | 1.89e-04 |
VxPx cargo-targeting to cilium | 19 | 2.95e-02 | 5.29e-02 | 0.5120 | 0.325000 | 0.393000 | 0.044500 | 1.43e-02 | 2.99e-03 | 7.37e-01 |
Post-translational protein phosphorylation | 69 | 5.64e-07 | 4.56e-06 | 0.5120 | 0.344000 | 0.339000 | -0.169000 | 7.45e-07 | 1.15e-06 | 1.51e-02 |
Energy dependent regulation of mTOR by LKB1-AMPK | 27 | 6.45e-03 | 1.45e-02 | 0.5120 | 0.385000 | 0.326000 | -0.082400 | 5.31e-04 | 3.32e-03 | 4.59e-01 |
Pre-NOTCH Expression and Processing | 65 | 1.19e-06 | 8.76e-06 | 0.5110 | 0.348000 | 0.321000 | -0.193000 | 1.26e-06 | 7.52e-06 | 7.05e-03 |
p75NTR signals via NF-kB | 15 | 1.40e-02 | 2.82e-02 | 0.5110 | 0.291000 | 0.100000 | -0.407000 | 5.07e-02 | 5.01e-01 | 6.31e-03 |
BBSome-mediated cargo-targeting to cilium | 22 | 1.63e-04 | 6.21e-04 | 0.5100 | -0.195000 | -0.470000 | 0.026800 | 1.14e-01 | 1.34e-04 | 8.28e-01 |
Diseases of DNA repair | 10 | 2.18e-01 | 2.79e-01 | 0.5090 | -0.366000 | -0.354000 | -0.012100 | 4.52e-02 | 5.26e-02 | 9.47e-01 |
Toll Like Receptor 9 (TLR9) Cascade | 93 | 5.57e-11 | 7.90e-10 | 0.5080 | 0.389000 | 0.242000 | -0.221000 | 9.24e-11 | 5.43e-05 | 2.28e-04 |
rRNA processing in the mitochondrion | 27 | 3.55e-04 | 1.23e-03 | 0.5080 | -0.156000 | -0.274000 | -0.398000 | 1.60e-01 | 1.37e-02 | 3.39e-04 |
Extension of Telomeres | 51 | 2.03e-05 | 1.00e-04 | 0.5070 | -0.311000 | -0.393000 | -0.078500 | 1.21e-04 | 1.19e-06 | 3.32e-01 |
ATF6 (ATF6-alpha) activates chaperones | 12 | 8.51e-02 | 1.30e-01 | 0.5060 | 0.416000 | 0.287000 | 0.016400 | 1.26e-02 | 8.49e-02 | 9.22e-01 |
Metabolism of non-coding RNA | 53 | 1.92e-07 | 1.73e-06 | 0.5050 | -0.255000 | -0.425000 | 0.098000 | 1.31e-03 | 8.72e-08 | 2.17e-01 |
snRNP Assembly | 53 | 1.92e-07 | 1.73e-06 | 0.5050 | -0.255000 | -0.425000 | 0.098000 | 1.31e-03 | 8.72e-08 | 2.17e-01 |
Cell-extracellular matrix interactions | 14 | 3.98e-02 | 6.82e-02 | 0.5050 | 0.366000 | 0.195000 | -0.287000 | 1.78e-02 | 2.05e-01 | 6.27e-02 |
EPH-ephrin mediated repulsion of cells | 39 | 2.86e-05 | 1.35e-04 | 0.5040 | 0.238000 | 0.252000 | -0.366000 | 1.00e-02 | 6.53e-03 | 7.80e-05 |
Vpr-mediated nuclear import of PICs | 34 | 9.37e-04 | 2.79e-03 | 0.5030 | -0.309000 | -0.369000 | 0.147000 | 1.85e-03 | 1.96e-04 | 1.38e-01 |
Cellular response to hypoxia | 71 | 2.11e-08 | 2.26e-07 | 0.5030 | 0.388000 | 0.236000 | -0.215000 | 1.49e-08 | 5.75e-04 | 1.74e-03 |
Glycosphingolipid metabolism | 36 | 1.02e-04 | 4.17e-04 | 0.5020 | 0.253000 | 0.296000 | -0.317000 | 8.55e-03 | 2.13e-03 | 1.01e-03 |
Pre-NOTCH Transcription and Translation | 49 | 7.44e-05 | 3.16e-04 | 0.5020 | 0.352000 | 0.315000 | -0.171000 | 2.05e-05 | 1.38e-04 | 3.83e-02 |
Disassembly of the destruction complex and recruitment of AXIN to the membrane | 29 | 1.55e-03 | 4.35e-03 | 0.5010 | 0.301000 | 0.235000 | -0.325000 | 4.99e-03 | 2.85e-02 | 2.47e-03 |
Toll-like Receptor Cascades | 143 | 3.56e-15 | 7.68e-14 | 0.5010 | 0.383000 | 0.263000 | -0.187000 | 2.72e-15 | 5.32e-08 | 1.16e-04 |
Iron uptake and transport | 52 | 8.97e-07 | 6.78e-06 | 0.4960 | 0.376000 | 0.191000 | -0.261000 | 2.76e-06 | 1.71e-02 | 1.12e-03 |
Signaling by BRAF and RAF fusions | 57 | 5.17e-06 | 3.15e-05 | 0.4950 | 0.390000 | 0.273000 | -0.137000 | 3.46e-07 | 3.62e-04 | 7.40e-02 |
Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. | 124 | 2.11e-24 | 5.99e-23 | 0.4950 | 0.263000 | -0.033900 | -0.418000 | 4.20e-07 | 5.15e-01 | 8.74e-16 |
Golgi Associated Vesicle Biogenesis | 55 | 2.44e-05 | 1.18e-04 | 0.4950 | 0.367000 | 0.297000 | -0.148000 | 2.49e-06 | 1.36e-04 | 5.79e-02 |
Complex I biogenesis | 55 | 3.16e-10 | 4.30e-09 | 0.4950 | 0.251000 | -0.022000 | -0.426000 | 1.30e-03 | 7.78e-01 | 4.58e-08 |
Mitochondrial tRNA aminoacylation | 21 | 2.37e-02 | 4.41e-02 | 0.4950 | -0.311000 | -0.371000 | 0.101000 | 1.36e-02 | 3.21e-03 | 4.23e-01 |
Cargo recognition for clathrin-mediated endocytosis | 90 | 9.47e-09 | 1.07e-07 | 0.4940 | 0.333000 | 0.296000 | -0.215000 | 4.64e-08 | 1.24e-06 | 4.33e-04 |
Signaling by NTRK1 (TRKA) | 100 | 5.47e-10 | 7.29e-09 | 0.4940 | 0.367000 | 0.272000 | -0.189000 | 2.21e-10 | 2.63e-06 | 1.09e-03 |
Innate Immune System | 966 | 2.31e-93 | 1.57e-90 | 0.4940 | 0.367000 | 0.270000 | -0.191000 | 8.55e-84 | 4.65e-46 | 8.58e-24 |
RAB geranylgeranylation | 60 | 1.25e-05 | 6.70e-05 | 0.4940 | 0.366000 | 0.311000 | -0.114000 | 9.21e-07 | 3.04e-05 | 1.27e-01 |
Signaling by NTRKs | 115 | 2.53e-11 | 4.15e-10 | 0.4930 | 0.363000 | 0.274000 | -0.191000 | 1.67e-11 | 4.00e-07 | 3.99e-04 |
Translesion synthesis by POLI | 17 | 2.90e-02 | 5.22e-02 | 0.4930 | -0.261000 | -0.407000 | -0.098600 | 6.24e-02 | 3.70e-03 | 4.82e-01 |
Glucagon signaling in metabolic regulation | 27 | 5.92e-03 | 1.34e-02 | 0.4930 | 0.333000 | 0.271000 | -0.242000 | 2.73e-03 | 1.49e-02 | 2.93e-02 |
Activation of the AP-1 family of transcription factors | 10 | 1.12e-01 | 1.63e-01 | 0.4910 | 0.390000 | 0.196000 | -0.226000 | 3.26e-02 | 2.84e-01 | 2.17e-01 |
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | 14 | 1.01e-01 | 1.51e-01 | 0.4910 | -0.307000 | -0.381000 | 0.046000 | 4.70e-02 | 1.36e-02 | 7.66e-01 |
Interactions of Vpr with host cellular proteins | 37 | 3.86e-04 | 1.32e-03 | 0.4910 | -0.285000 | -0.389000 | 0.093300 | 2.71e-03 | 4.25e-05 | 3.26e-01 |
Gap-filling DNA repair synthesis and ligation in GG-NER | 25 | 2.66e-03 | 6.93e-03 | 0.4900 | -0.223000 | -0.376000 | -0.222000 | 5.40e-02 | 1.13e-03 | 5.47e-02 |
Calnexin/calreticulin cycle | 26 | 6.20e-03 | 1.40e-02 | 0.4890 | 0.365000 | 0.250000 | -0.210000 | 1.29e-03 | 2.73e-02 | 6.41e-02 |
RAF activation | 32 | 3.22e-03 | 8.09e-03 | 0.4890 | 0.365000 | 0.323000 | 0.040100 | 3.52e-04 | 1.59e-03 | 6.95e-01 |
Folding of actin by CCT/TriC | 10 | 7.67e-04 | 2.35e-03 | 0.4880 | 0.135000 | -0.355000 | -0.306000 | 4.61e-01 | 5.18e-02 | 9.35e-02 |
Nuclear import of Rev protein | 34 | 1.81e-03 | 4.99e-03 | 0.4870 | -0.306000 | -0.348000 | 0.151000 | 2.03e-03 | 4.39e-04 | 1.28e-01 |
Formation of Fibrin Clot (Clotting Cascade) | 26 | 2.95e-03 | 7.55e-03 | 0.4870 | 0.287000 | 0.183000 | -0.349000 | 1.14e-02 | 1.06e-01 | 2.09e-03 |
Signaling by EGFR | 46 | 3.34e-05 | 1.55e-04 | 0.4870 | 0.334000 | 0.211000 | -0.284000 | 8.69e-05 | 1.33e-02 | 8.45e-04 |
TAK1 activates NFkB by phosphorylation and activation of IKKs complex | 27 | 2.99e-03 | 7.62e-03 | 0.4870 | 0.336000 | 0.205000 | -0.286000 | 2.52e-03 | 6.55e-02 | 1.00e-02 |
tRNA modification in the nucleus and cytosol | 43 | 8.31e-05 | 3.49e-04 | 0.4860 | -0.274000 | -0.397000 | 0.052000 | 1.85e-03 | 6.47e-06 | 5.55e-01 |
NS1 Mediated Effects on Host Pathways | 40 | 4.30e-04 | 1.44e-03 | 0.4840 | -0.305000 | -0.286000 | 0.245000 | 8.43e-04 | 1.77e-03 | 7.30e-03 |
Heparan sulfate/heparin (HS-GAG) metabolism | 37 | 1.13e-05 | 6.12e-05 | 0.4840 | 0.116000 | 0.120000 | -0.455000 | 2.23e-01 | 2.07e-01 | 1.70e-06 |
MET activates RAS signaling | 10 | 1.85e-01 | 2.45e-01 | 0.4840 | 0.355000 | 0.300000 | 0.135000 | 5.19e-02 | 1.01e-01 | 4.59e-01 |
mTORC1-mediated signalling | 23 | 4.55e-03 | 1.08e-02 | 0.4830 | 0.372000 | 0.189000 | -0.243000 | 2.01e-03 | 1.17e-01 | 4.39e-02 |
Senescence-Associated Secretory Phenotype (SASP) | 66 | 1.24e-07 | 1.18e-06 | 0.4820 | 0.299000 | 0.177000 | -0.334000 | 2.67e-05 | 1.28e-02 | 2.60e-06 |
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | 31 | 4.12e-03 | 9.96e-03 | 0.4810 | -0.309000 | -0.316000 | 0.191000 | 2.93e-03 | 2.29e-03 | 6.60e-02 |
Regulation of Glucokinase by Glucokinase Regulatory Protein | 31 | 4.12e-03 | 9.96e-03 | 0.4810 | -0.309000 | -0.316000 | 0.191000 | 2.93e-03 | 2.29e-03 | 6.60e-02 |
HSP90 chaperone cycle for steroid hormone receptors (SHR) | 36 | 2.03e-04 | 7.56e-04 | 0.4810 | 0.404000 | 0.229000 | -0.125000 | 2.73e-05 | 1.72e-02 | 1.94e-01 |
Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | 26 | 1.61e-03 | 4.53e-03 | 0.4800 | -0.243000 | -0.114000 | 0.398000 | 3.17e-02 | 3.14e-01 | 4.42e-04 |
Respiratory electron transport | 101 | 6.60e-19 | 1.63e-17 | 0.4800 | 0.265000 | -0.027700 | -0.399000 | 4.04e-06 | 6.30e-01 | 4.30e-12 |
Plasma lipoprotein assembly | 10 | 1.37e-01 | 1.93e-01 | 0.4790 | 0.234000 | 0.289000 | -0.302000 | 1.99e-01 | 1.14e-01 | 9.77e-02 |
HuR (ELAVL1) binds and stabilizes mRNA | 10 | 1.38e-01 | 1.94e-01 | 0.4790 | 0.408000 | 0.251000 | -0.003050 | 2.53e-02 | 1.70e-01 | 9.87e-01 |
tRNA processing in the nucleus | 59 | 9.82e-06 | 5.45e-05 | 0.4780 | -0.291000 | -0.363000 | 0.111000 | 1.12e-04 | 1.37e-06 | 1.42e-01 |
Hh mutants that don't undergo autocatalytic processing are degraded by ERAD | 53 | 6.71e-07 | 5.22e-06 | 0.4780 | 0.387000 | 0.183000 | -0.212000 | 1.08e-06 | 2.11e-02 | 7.54e-03 |
G beta:gamma signalling through PI3Kgamma | 22 | 2.00e-02 | 3.83e-02 | 0.4770 | 0.286000 | 0.331000 | -0.189000 | 2.01e-02 | 7.11e-03 | 1.26e-01 |
Thromboxane signalling through TP receptor | 20 | 2.64e-02 | 4.83e-02 | 0.4770 | 0.374000 | 0.247000 | -0.163000 | 3.82e-03 | 5.56e-02 | 2.06e-01 |
MAP kinase activation | 63 | 6.03e-07 | 4.85e-06 | 0.4770 | 0.366000 | 0.213000 | -0.218000 | 4.93e-07 | 3.41e-03 | 2.74e-03 |
Apoptosis induced DNA fragmentation | 10 | 2.33e-01 | 2.95e-01 | 0.4760 | 0.377000 | 0.290000 | -0.026500 | 3.91e-02 | 1.12e-01 | 8.85e-01 |
Regulation of localization of FOXO transcription factors | 11 | 1.23e-01 | 1.77e-01 | 0.4760 | 0.241000 | 0.198000 | -0.360000 | 1.67e-01 | 2.55e-01 | 3.87e-02 |
Presynaptic function of Kainate receptors | 18 | 5.44e-02 | 8.98e-02 | 0.4760 | 0.320000 | 0.272000 | -0.223000 | 1.87e-02 | 4.54e-02 | 1.01e-01 |
Estrogen-dependent nuclear events downstream of ESR-membrane signaling | 22 | 3.08e-03 | 7.79e-03 | 0.4750 | 0.302000 | 0.100000 | -0.353000 | 1.42e-02 | 4.16e-01 | 4.18e-03 |
A tetrasaccharide linker sequence is required for GAG synthesis | 17 | 1.23e-02 | 2.51e-02 | 0.4740 | -0.158000 | -0.182000 | -0.408000 | 2.61e-01 | 1.95e-01 | 3.56e-03 |
Interleukin-1 family signaling | 124 | 1.80e-12 | 3.26e-11 | 0.4740 | 0.360000 | 0.230000 | -0.205000 | 4.29e-12 | 1.01e-05 | 7.97e-05 |
ADP signalling through P2Y purinoceptor 12 | 18 | 5.40e-02 | 8.92e-02 | 0.4740 | 0.376000 | 0.282000 | -0.055100 | 5.73e-03 | 3.80e-02 | 6.86e-01 |
Signaling by MET | 61 | 1.93e-05 | 9.65e-05 | 0.4730 | 0.366000 | 0.294000 | -0.064400 | 7.71e-07 | 7.27e-05 | 3.84e-01 |
G beta:gamma signalling through PLC beta | 17 | 6.70e-02 | 1.07e-01 | 0.4730 | 0.340000 | 0.261000 | -0.201000 | 1.53e-02 | 6.23e-02 | 1.51e-01 |
Olfactory Signaling Pathway | 57 | 4.90e-08 | 5.02e-07 | 0.4730 | 0.086100 | 0.155000 | 0.438000 | 2.61e-01 | 4.29e-02 | 1.04e-08 |
Syndecan interactions | 19 | 5.99e-04 | 1.92e-03 | 0.4720 | 0.352000 | 0.030300 | -0.314000 | 7.93e-03 | 8.19e-01 | 1.79e-02 |
Alpha-protein kinase 1 signaling pathway | 11 | 2.19e-02 | 4.12e-02 | 0.4720 | 0.436000 | 0.135000 | -0.118000 | 1.22e-02 | 4.38e-01 | 4.97e-01 |
Regulation of ornithine decarboxylase (ODC) | 49 | 1.84e-06 | 1.27e-05 | 0.4720 | 0.386000 | 0.175000 | -0.207000 | 2.90e-06 | 3.46e-02 | 1.23e-02 |
Postmitotic nuclear pore complex (NPC) reformation | 27 | 4.64e-03 | 1.10e-02 | 0.4710 | -0.263000 | -0.373000 | 0.116000 | 1.81e-02 | 8.00e-04 | 2.95e-01 |
Cross-presentation of soluble exogenous antigens (endosomes) | 47 | 5.93e-06 | 3.55e-05 | 0.4710 | 0.398000 | 0.199000 | -0.154000 | 2.35e-06 | 1.83e-02 | 6.83e-02 |
HDR through Single Strand Annealing (SSA) | 37 | 6.78e-04 | 2.12e-03 | 0.4710 | -0.278000 | -0.234000 | 0.299000 | 3.44e-03 | 1.36e-02 | 1.66e-03 |
HDMs demethylate histones | 22 | 8.28e-03 | 1.80e-02 | 0.4700 | 0.244000 | 0.371000 | -0.156000 | 4.78e-02 | 2.60e-03 | 2.05e-01 |
Transport of Ribonucleoproteins into the Host Nucleus | 32 | 3.38e-03 | 8.39e-03 | 0.4700 | -0.288000 | -0.305000 | 0.212000 | 4.84e-03 | 2.79e-03 | 3.78e-02 |
Scavenging by Class A Receptors | 11 | 1.96e-01 | 2.57e-01 | 0.4700 | 0.370000 | 0.289000 | 0.018000 | 3.36e-02 | 9.72e-02 | 9.18e-01 |
Translation of Replicase and Assembly of the Replication Transcription Complex | 12 | 1.29e-01 | 1.84e-01 | 0.4690 | 0.388000 | 0.248000 | -0.088800 | 1.99e-02 | 1.37e-01 | 5.94e-01 |
tRNA Aminoacylation | 42 | 5.63e-05 | 2.47e-04 | 0.4690 | -0.243000 | -0.373000 | 0.147000 | 6.51e-03 | 2.90e-05 | 9.87e-02 |
Class C/3 (Metabotropic glutamate/pheromone receptors) | 11 | 8.79e-02 | 1.33e-01 | 0.4680 | -0.274000 | -0.095500 | 0.367000 | 1.15e-01 | 5.84e-01 | 3.50e-02 |
Interleukin-3, Interleukin-5 and GM-CSF signaling | 40 | 8.47e-05 | 3.53e-04 | 0.4680 | 0.239000 | 0.365000 | -0.169000 | 8.83e-03 | 6.50e-05 | 6.43e-02 |
ER-Phagosome pathway | 82 | 2.88e-08 | 3.03e-07 | 0.4680 | 0.366000 | 0.227000 | -0.182000 | 1.02e-08 | 3.73e-04 | 4.36e-03 |
G beta:gamma signalling through CDC42 | 17 | 7.96e-02 | 1.23e-01 | 0.4670 | 0.359000 | 0.299000 | 0.010700 | 1.05e-02 | 3.26e-02 | 9.39e-01 |
PINK1-PRKN Mediated Mitophagy | 21 | 2.31e-06 | 1.54e-05 | 0.4670 | 0.187000 | -0.250000 | -0.347000 | 1.39e-01 | 4.70e-02 | 5.89e-03 |
Synthesis of PIPs at the late endosome membrane | 11 | 7.22e-02 | 1.14e-01 | 0.4670 | 0.205000 | 0.185000 | 0.376000 | 2.39e-01 | 2.89e-01 | 3.07e-02 |
Regulation of activated PAK-2p34 by proteasome mediated degradation | 48 | 2.27e-06 | 1.52e-05 | 0.4660 | 0.377000 | 0.161000 | -0.221000 | 6.02e-06 | 5.38e-02 | 7.98e-03 |
TRAF6-mediated induction of TAK1 complex within TLR4 complex | 16 | 4.39e-02 | 7.39e-02 | 0.4660 | 0.364000 | 0.198000 | -0.212000 | 1.16e-02 | 1.71e-01 | 1.42e-01 |
Mitochondrial translation elongation | 91 | 2.10e-20 | 5.49e-19 | 0.4650 | -0.011100 | -0.366000 | -0.287000 | 8.55e-01 | 1.54e-09 | 2.28e-06 |
PCP/CE pathway | 86 | 7.75e-09 | 9.00e-08 | 0.4650 | 0.305000 | 0.190000 | -0.295000 | 1.03e-06 | 2.32e-03 | 2.21e-06 |
AUF1 (hnRNP D0) binds and destabilizes mRNA | 53 | 1.49e-07 | 1.38e-06 | 0.4650 | 0.366000 | 0.129000 | -0.255000 | 3.95e-06 | 1.05e-01 | 1.32e-03 |
Plasma lipoprotein assembly, remodeling, and clearance | 52 | 1.95e-05 | 9.71e-05 | 0.4640 | 0.250000 | 0.256000 | -0.296000 | 1.81e-03 | 1.38e-03 | 2.27e-04 |
Processive synthesis on the C-strand of the telomere | 19 | 3.60e-02 | 6.28e-02 | 0.4640 | -0.255000 | -0.377000 | -0.092300 | 5.44e-02 | 4.47e-03 | 4.86e-01 |
Inflammasomes | 20 | 1.13e-02 | 2.33e-02 | 0.4640 | 0.399000 | 0.208000 | -0.112000 | 1.99e-03 | 1.07e-01 | 3.88e-01 |
RAB GEFs exchange GTP for GDP on RABs | 87 | 5.02e-07 | 4.11e-06 | 0.4630 | 0.316000 | 0.317000 | -0.119000 | 3.51e-07 | 3.28e-07 | 5.50e-02 |
Defective CFTR causes cystic fibrosis | 59 | 6.53e-07 | 5.13e-06 | 0.4630 | 0.366000 | 0.180000 | -0.219000 | 1.17e-06 | 1.66e-02 | 3.67e-03 |
Negative regulation of FGFR1 signaling | 24 | 1.65e-02 | 3.23e-02 | 0.4620 | 0.299000 | 0.232000 | -0.265000 | 1.13e-02 | 4.90e-02 | 2.47e-02 |
Synthesis of active ubiquitin: roles of E1 and E2 enzymes | 30 | 5.87e-05 | 2.56e-04 | 0.4620 | 0.391000 | 0.118000 | -0.216000 | 2.13e-04 | 2.64e-01 | 4.04e-02 |
Fanconi Anemia Pathway | 36 | 3.46e-03 | 8.56e-03 | 0.4610 | -0.354000 | -0.288000 | 0.066800 | 2.37e-04 | 2.74e-03 | 4.88e-01 |
Translesion synthesis by POLK | 17 | 4.51e-02 | 7.57e-02 | 0.4610 | -0.240000 | -0.383000 | -0.092300 | 8.61e-02 | 6.30e-03 | 5.10e-01 |
Regulation of FZD by ubiquitination | 15 | 9.40e-03 | 2.03e-02 | 0.4610 | -0.009250 | -0.264000 | -0.378000 | 9.51e-01 | 7.69e-02 | 1.12e-02 |
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | 64 | 5.08e-07 | 4.13e-06 | 0.4610 | 0.367000 | 0.198000 | -0.196000 | 3.69e-07 | 6.09e-03 | 6.76e-03 |
Abortive elongation of HIV-1 transcript in the absence of Tat | 23 | 2.84e-03 | 7.30e-03 | 0.4600 | 0.155000 | 0.008530 | -0.433000 | 1.99e-01 | 9.44e-01 | 3.28e-04 |
Export of Viral Ribonucleoproteins from Nucleus | 33 | 4.35e-03 | 1.04e-02 | 0.4590 | -0.285000 | -0.317000 | 0.171000 | 4.58e-03 | 1.64e-03 | 8.99e-02 |
Beta-oxidation of very long chain fatty acids | 10 | 2.54e-01 | 3.17e-01 | 0.4590 | 0.278000 | 0.344000 | -0.122000 | 1.28e-01 | 5.98e-02 | 5.03e-01 |
Downregulation of ERBB2 signaling | 24 | 9.71e-04 | 2.89e-03 | 0.4580 | 0.216000 | -0.005660 | -0.404000 | 6.66e-02 | 9.62e-01 | 6.19e-04 |
Amino acids regulate mTORC1 | 50 | 1.63e-04 | 6.21e-04 | 0.4580 | 0.315000 | 0.246000 | -0.225000 | 1.19e-04 | 2.66e-03 | 5.98e-03 |
Transport of the SLBP independent Mature mRNA | 35 | 2.12e-03 | 5.73e-03 | 0.4580 | -0.270000 | -0.309000 | 0.202000 | 5.64e-03 | 1.54e-03 | 3.91e-02 |
Hh mutants abrogate ligand secretion | 54 | 1.75e-06 | 1.22e-05 | 0.4570 | 0.367000 | 0.170000 | -0.212000 | 3.12e-06 | 3.08e-02 | 6.97e-03 |
Aquaporin-mediated transport | 37 | 1.73e-03 | 4.82e-03 | 0.4560 | 0.313000 | 0.234000 | -0.236000 | 9.99e-04 | 1.38e-02 | 1.30e-02 |
Regulation of TP53 Activity through Association with Co-factors | 11 | 8.63e-02 | 1.31e-01 | 0.4560 | -0.074200 | -0.157000 | -0.421000 | 6.70e-01 | 3.66e-01 | 1.56e-02 |
N-glycan trimming in the ER and Calnexin/Calreticulin cycle | 35 | 1.37e-03 | 3.92e-03 | 0.4550 | 0.314000 | 0.197000 | -0.264000 | 1.30e-03 | 4.41e-02 | 6.77e-03 |
Degradation of DVL | 54 | 1.30e-06 | 9.40e-06 | 0.4550 | 0.360000 | 0.157000 | -0.230000 | 4.80e-06 | 4.57e-02 | 3.40e-03 |
mRNA decay by 3' to 5' exoribonuclease | 16 | 5.78e-02 | 9.45e-02 | 0.4550 | -0.235000 | -0.380000 | -0.087400 | 1.04e-01 | 8.48e-03 | 5.45e-01 |
Formation of the cornified envelope | 21 | 2.87e-02 | 5.20e-02 | 0.4540 | 0.372000 | 0.244000 | -0.094400 | 3.19e-03 | 5.33e-02 | 4.54e-01 |
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | 79 | 2.28e-06 | 1.52e-05 | 0.4540 | 0.307000 | 0.288000 | -0.169000 | 2.30e-06 | 9.79e-06 | 9.36e-03 |
Early Phase of HIV Life Cycle | 14 | 3.83e-02 | 6.59e-02 | 0.4540 | -0.150000 | -0.358000 | -0.235000 | 3.31e-01 | 2.04e-02 | 1.28e-01 |
MTOR signalling | 38 | 1.35e-03 | 3.86e-03 | 0.4530 | 0.354000 | 0.238000 | -0.154000 | 1.60e-04 | 1.12e-02 | 1.01e-01 |
HS-GAG degradation | 16 | 2.73e-02 | 4.97e-02 | 0.4520 | 0.141000 | 0.032500 | -0.428000 | 3.29e-01 | 8.22e-01 | 3.03e-03 |
XBP1(S) activates chaperone genes | 47 | 3.25e-04 | 1.13e-03 | 0.4520 | 0.278000 | 0.273000 | -0.228000 | 9.69e-04 | 1.18e-03 | 6.87e-03 |
Interleukin-17 signaling | 68 | 1.02e-06 | 7.66e-06 | 0.4520 | 0.337000 | 0.197000 | -0.228000 | 1.58e-06 | 5.06e-03 | 1.13e-03 |
MyD88-independent TLR4 cascade | 96 | 1.33e-08 | 1.47e-07 | 0.4510 | 0.339000 | 0.225000 | -0.194000 | 8.95e-09 | 1.40e-04 | 1.01e-03 |
TRIF(TICAM1)-mediated TLR4 signaling | 96 | 1.33e-08 | 1.47e-07 | 0.4510 | 0.339000 | 0.225000 | -0.194000 | 8.95e-09 | 1.40e-04 | 1.01e-03 |
Formation of apoptosome | 11 | 1.57e-01 | 2.14e-01 | 0.4500 | 0.383000 | 0.233000 | -0.033200 | 2.79e-02 | 1.80e-01 | 8.49e-01 |
Regulation of the apoptosome activity | 11 | 1.57e-01 | 2.14e-01 | 0.4500 | 0.383000 | 0.233000 | -0.033200 | 2.79e-02 | 1.80e-01 | 8.49e-01 |
Surfactant metabolism | 21 | 4.21e-02 | 7.14e-02 | 0.4490 | 0.300000 | 0.241000 | -0.233000 | 1.75e-02 | 5.64e-02 | 6.44e-02 |
Signaling by NOTCH | 182 | 9.75e-16 | 2.14e-14 | 0.4480 | 0.316000 | 0.221000 | -0.229000 | 1.86e-13 | 2.87e-07 | 9.96e-08 |
RUNX1 regulates transcription of genes involved in differentiation of HSCs | 82 | 7.94e-09 | 9.15e-08 | 0.4480 | 0.356000 | 0.179000 | -0.206000 | 2.56e-08 | 5.07e-03 | 1.29e-03 |
MAPK targets/ Nuclear events mediated by MAP kinases | 31 | 2.67e-03 | 6.93e-03 | 0.4470 | 0.349000 | 0.195000 | -0.201000 | 7.76e-04 | 6.02e-02 | 5.25e-02 |
Nucleotide salvage | 21 | 4.11e-02 | 7.00e-02 | 0.4460 | 0.316000 | 0.227000 | -0.219000 | 1.22e-02 | 7.21e-02 | 8.23e-02 |
EPHA-mediated growth cone collapse | 13 | 2.01e-01 | 2.62e-01 | 0.4460 | 0.287000 | 0.333000 | -0.074000 | 7.35e-02 | 3.74e-02 | 6.44e-01 |
Ca-dependent events | 29 | 5.28e-03 | 1.22e-02 | 0.4460 | 0.246000 | 0.197000 | -0.315000 | 2.19e-02 | 6.67e-02 | 3.28e-03 |
Signaling by NOTCH3 | 42 | 4.57e-04 | 1.52e-03 | 0.4460 | 0.247000 | 0.233000 | -0.288000 | 5.69e-03 | 8.86e-03 | 1.22e-03 |
Signaling by EGFR in Cancer | 23 | 2.64e-03 | 6.89e-03 | 0.4460 | 0.344000 | 0.110000 | -0.261000 | 4.31e-03 | 3.62e-01 | 3.01e-02 |
Golgi-to-ER retrograde transport | 111 | 3.62e-08 | 3.76e-07 | 0.4450 | 0.329000 | 0.290000 | -0.071700 | 1.99e-09 | 1.32e-07 | 1.92e-01 |
Synthesis of PC | 23 | 4.46e-02 | 7.50e-02 | 0.4440 | 0.322000 | 0.302000 | 0.049500 | 7.45e-03 | 1.22e-02 | 6.81e-01 |
Transport to the Golgi and subsequent modification | 155 | 3.07e-11 | 4.81e-10 | 0.4440 | 0.312000 | 0.298000 | -0.106000 | 1.87e-11 | 1.57e-10 | 2.33e-02 |
Hedgehog ligand biogenesis | 58 | 4.90e-06 | 3.03e-05 | 0.4440 | 0.356000 | 0.189000 | -0.186000 | 2.66e-06 | 1.29e-02 | 1.44e-02 |
IRE1alpha activates chaperones | 49 | 2.55e-04 | 9.11e-04 | 0.4440 | 0.268000 | 0.264000 | -0.236000 | 1.19e-03 | 1.40e-03 | 4.22e-03 |
HIV elongation arrest and recovery | 32 | 6.33e-04 | 2.00e-03 | 0.4430 | 0.158000 | 0.050000 | -0.411000 | 1.22e-01 | 6.25e-01 | 5.78e-05 |
Pausing and recovery of HIV elongation | 32 | 6.33e-04 | 2.00e-03 | 0.4430 | 0.158000 | 0.050000 | -0.411000 | 1.22e-01 | 6.25e-01 | 5.78e-05 |
Vif-mediated degradation of APOBEC3G | 52 | 2.55e-06 | 1.68e-05 | 0.4420 | 0.358000 | 0.148000 | -0.214000 | 8.04e-06 | 6.48e-02 | 7.59e-03 |
Metabolism of amine-derived hormones | 10 | 1.19e-01 | 1.72e-01 | 0.4420 | -0.193000 | -0.351000 | 0.188000 | 2.91e-01 | 5.46e-02 | 3.03e-01 |
VEGFA-VEGFR2 Pathway | 90 | 4.19e-07 | 3.58e-06 | 0.4420 | 0.295000 | 0.261000 | -0.200000 | 1.29e-06 | 1.90e-05 | 1.02e-03 |
Negative regulation of NOTCH4 signaling | 54 | 2.15e-06 | 1.46e-05 | 0.4420 | 0.353000 | 0.149000 | -0.220000 | 7.32e-06 | 5.76e-02 | 5.17e-03 |
PLC beta mediated events | 43 | 6.01e-04 | 1.92e-03 | 0.4420 | 0.270000 | 0.214000 | -0.276000 | 2.19e-03 | 1.50e-02 | 1.73e-03 |
CD28 dependent PI3K/Akt signaling | 22 | 4.03e-03 | 9.81e-03 | 0.4410 | -0.296000 | -0.190000 | -0.266000 | 1.63e-02 | 1.23e-01 | 3.07e-02 |
Signaling by NOTCH4 | 78 | 4.41e-07 | 3.73e-06 | 0.4410 | 0.336000 | 0.206000 | -0.197000 | 2.84e-07 | 1.64e-03 | 2.61e-03 |
Post-chaperonin tubulin folding pathway | 19 | 7.83e-02 | 1.21e-01 | 0.4400 | 0.280000 | 0.291000 | -0.174000 | 3.46e-02 | 2.80e-02 | 1.90e-01 |
Nuclear Events (kinase and transcription factor activation) | 53 | 1.58e-04 | 6.05e-04 | 0.4400 | 0.319000 | 0.225000 | -0.202000 | 5.83e-05 | 4.61e-03 | 1.10e-02 |
Transport of the SLBP Dependant Mature mRNA | 36 | 1.92e-03 | 5.24e-03 | 0.4390 | -0.246000 | -0.309000 | 0.192000 | 1.07e-02 | 1.31e-03 | 4.60e-02 |
HS-GAG biosynthesis | 20 | 1.82e-02 | 3.51e-02 | 0.4390 | 0.169000 | 0.140000 | -0.381000 | 1.91e-01 | 2.79e-01 | 3.21e-03 |
Semaphorin interactions | 57 | 4.79e-05 | 2.14e-04 | 0.4390 | 0.253000 | 0.295000 | -0.205000 | 9.61e-04 | 1.16e-04 | 7.53e-03 |
Constitutive Signaling by AKT1 E17K in Cancer | 25 | 5.69e-03 | 1.30e-02 | 0.4380 | 0.185000 | 0.228000 | -0.326000 | 1.10e-01 | 4.88e-02 | 4.81e-03 |
Downregulation of ERBB2:ERBB3 signaling | 12 | 6.11e-02 | 9.91e-02 | 0.4380 | 0.153000 | -0.040600 | -0.408000 | 3.57e-01 | 8.08e-01 | 1.44e-02 |
Rap1 signalling | 13 | 1.77e-01 | 2.38e-01 | 0.4370 | 0.302000 | 0.284000 | 0.139000 | 5.98e-02 | 7.57e-02 | 3.85e-01 |
CDC6 association with the ORC:origin complex | 11 | 5.21e-02 | 8.64e-02 | 0.4370 | -0.040600 | -0.126000 | 0.417000 | 8.16e-01 | 4.69e-01 | 1.67e-02 |
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | 32 | 9.22e-04 | 2.76e-03 | 0.4370 | 0.242000 | 0.084700 | -0.353000 | 1.76e-02 | 4.07e-01 | 5.46e-04 |
Acetylcholine Neurotransmitter Release Cycle | 11 | 1.03e-01 | 1.52e-01 | 0.4360 | -0.105000 | -0.135000 | -0.401000 | 5.48e-01 | 4.38e-01 | 2.12e-02 |
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | 14 | 1.56e-01 | 2.14e-01 | 0.4350 | -0.254000 | -0.351000 | -0.030300 | 1.00e-01 | 2.28e-02 | 8.44e-01 |
Translocation of SLC2A4 (GLUT4) to the plasma membrane | 48 | 6.88e-04 | 2.14e-03 | 0.4340 | 0.340000 | 0.270000 | 0.007980 | 4.61e-05 | 1.19e-03 | 9.24e-01 |
Mitochondrial translation initiation | 91 | 9.56e-19 | 2.28e-17 | 0.4340 | -0.006320 | -0.352000 | -0.254000 | 9.17e-01 | 6.45e-09 | 2.81e-05 |
L1CAM interactions | 84 | 5.98e-06 | 3.57e-05 | 0.4340 | 0.303000 | 0.293000 | -0.104000 | 1.63e-06 | 3.36e-06 | 1.00e-01 |
Intraflagellar transport | 39 | 2.44e-03 | 6.44e-03 | 0.4340 | -0.254000 | -0.348000 | -0.051900 | 6.11e-03 | 1.69e-04 | 5.75e-01 |
Intrinsic Pathway of Fibrin Clot Formation | 16 | 7.93e-02 | 1.22e-01 | 0.4340 | 0.269000 | 0.165000 | -0.297000 | 6.22e-02 | 2.54e-01 | 3.95e-02 |
Membrane Trafficking | 557 | 3.34e-38 | 1.42e-36 | 0.4340 | 0.309000 | 0.279000 | -0.123000 | 1.11e-35 | 2.10e-29 | 6.82e-07 |
Mitochondrial translation termination | 91 | 2.28e-18 | 5.33e-17 | 0.4340 | -0.011800 | -0.352000 | -0.252000 | 8.46e-01 | 6.22e-09 | 3.17e-05 |
Caspase activation via extrinsic apoptotic signalling pathway | 25 | 3.43e-02 | 6.00e-02 | 0.4330 | 0.304000 | 0.294000 | 0.094100 | 8.58e-03 | 1.10e-02 | 4.15e-01 |
Interleukin-2 signaling | 11 | 7.30e-02 | 1.15e-01 | 0.4330 | 0.038700 | 0.082400 | -0.423000 | 8.24e-01 | 6.36e-01 | 1.52e-02 |
Activation of BAD and translocation to mitochondria | 15 | 1.35e-01 | 1.90e-01 | 0.4320 | 0.310000 | 0.218000 | -0.207000 | 3.73e-02 | 1.44e-01 | 1.65e-01 |
Interferon alpha/beta signaling | 57 | 2.93e-10 | 4.02e-09 | 0.4320 | -0.283000 | 0.030400 | 0.325000 | 2.20e-04 | 6.92e-01 | 2.19e-05 |
IKK complex recruitment mediated by RIP1 | 23 | 2.86e-02 | 5.18e-02 | 0.4320 | 0.357000 | 0.237000 | -0.052200 | 3.03e-03 | 4.90e-02 | 6.65e-01 |
Rab regulation of trafficking | 120 | 4.23e-09 | 5.19e-08 | 0.4310 | 0.269000 | 0.290000 | -0.172000 | 3.41e-07 | 4.26e-08 | 1.16e-03 |
G-protein mediated events | 44 | 6.45e-04 | 2.03e-03 | 0.4310 | 0.252000 | 0.210000 | -0.279000 | 3.80e-03 | 1.58e-02 | 1.36e-03 |
RNA Polymerase III Transcription Initiation From Type 1 Promoter | 28 | 1.61e-02 | 3.16e-02 | 0.4310 | -0.259000 | -0.301000 | -0.167000 | 1.77e-02 | 5.84e-03 | 1.27e-01 |
Integration of energy metabolism | 86 | 2.13e-06 | 1.45e-05 | 0.4300 | 0.287000 | 0.262000 | -0.185000 | 4.19e-06 | 2.61e-05 | 3.07e-03 |
Activation of G protein gated Potassium channels | 19 | 7.36e-02 | 1.15e-01 | 0.4300 | 0.323000 | 0.270000 | 0.086300 | 1.48e-02 | 4.13e-02 | 5.15e-01 |
G protein gated Potassium channels | 19 | 7.36e-02 | 1.15e-01 | 0.4300 | 0.323000 | 0.270000 | 0.086300 | 1.48e-02 | 4.13e-02 | 5.15e-01 |
Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | 19 | 7.36e-02 | 1.15e-01 | 0.4300 | 0.323000 | 0.270000 | 0.086300 | 1.48e-02 | 4.13e-02 | 5.15e-01 |
Degradation of GLI2 by the proteasome | 56 | 1.11e-06 | 8.17e-06 | 0.4290 | 0.349000 | 0.135000 | -0.210000 | 6.06e-06 | 8.09e-02 | 6.66e-03 |
G beta:gamma signalling through BTK | 15 | 1.89e-01 | 2.49e-01 | 0.4290 | 0.322000 | 0.282000 | -0.032000 | 3.09e-02 | 5.88e-02 | 8.30e-01 |
Oncogenic MAPK signaling | 73 | 1.68e-05 | 8.60e-05 | 0.4290 | 0.334000 | 0.252000 | -0.095200 | 8.24e-07 | 1.93e-04 | 1.59e-01 |
Regulation of PTEN stability and activity | 66 | 6.60e-06 | 3.89e-05 | 0.4290 | 0.341000 | 0.202000 | -0.164000 | 1.63e-06 | 4.53e-03 | 2.15e-02 |
Vpu mediated degradation of CD4 | 50 | 1.38e-06 | 9.89e-06 | 0.4280 | 0.342000 | 0.103000 | -0.237000 | 2.94e-05 | 2.07e-01 | 3.70e-03 |
Signaling by NOTCH1 | 66 | 1.64e-05 | 8.43e-05 | 0.4280 | 0.284000 | 0.199000 | -0.250000 | 6.56e-05 | 5.20e-03 | 4.41e-04 |
Regulation of cholesterol biosynthesis by SREBP (SREBF) | 55 | 1.55e-04 | 5.96e-04 | 0.4270 | 0.246000 | 0.348000 | 0.033100 | 1.62e-03 | 8.02e-06 | 6.71e-01 |
Cytochrome c-mediated apoptotic response | 13 | 1.23e-01 | 1.76e-01 | 0.4260 | 0.339000 | 0.232000 | 0.113000 | 3.44e-02 | 1.47e-01 | 4.79e-01 |
tRNA processing | 134 | 5.80e-10 | 7.66e-09 | 0.4260 | -0.256000 | -0.336000 | -0.050800 | 3.12e-07 | 1.72e-11 | 3.10e-01 |
ER Quality Control Compartment (ERQC) | 21 | 4.67e-02 | 7.80e-02 | 0.4260 | 0.333000 | 0.211000 | -0.162000 | 8.31e-03 | 9.46e-02 | 2.00e-01 |
Carnitine metabolism | 10 | 2.94e-01 | 3.59e-01 | 0.4250 | 0.281000 | 0.201000 | -0.248000 | 1.24e-01 | 2.72e-01 | 1.74e-01 |
Vasopressin regulates renal water homeostasis via Aquaporins | 34 | 7.96e-03 | 1.74e-02 | 0.4250 | 0.291000 | 0.225000 | -0.213000 | 3.36e-03 | 2.29e-02 | 3.17e-02 |
Metabolism of porphyrins | 22 | 6.38e-02 | 1.03e-01 | 0.4250 | 0.310000 | 0.245000 | -0.156000 | 1.18e-02 | 4.70e-02 | 2.05e-01 |
Mismatch Repair | 15 | 1.34e-01 | 1.89e-01 | 0.4250 | -0.242000 | -0.349000 | -0.001240 | 1.05e-01 | 1.93e-02 | 9.93e-01 |
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A | 50 | 4.12e-06 | 2.60e-05 | 0.4250 | 0.345000 | 0.123000 | -0.214000 | 2.40e-05 | 1.32e-01 | 8.71e-03 |
p53-Independent DNA Damage Response | 50 | 4.12e-06 | 2.60e-05 | 0.4250 | 0.345000 | 0.123000 | -0.214000 | 2.40e-05 | 1.32e-01 | 8.71e-03 |
p53-Independent G1/S DNA damage checkpoint | 50 | 4.12e-06 | 2.60e-05 | 0.4250 | 0.345000 | 0.123000 | -0.214000 | 2.40e-05 | 1.32e-01 | 8.71e-03 |
Regulation of Apoptosis | 51 | 3.41e-06 | 2.19e-05 | 0.4250 | 0.357000 | 0.137000 | -0.184000 | 1.01e-05 | 9.17e-02 | 2.29e-02 |
Mitochondrial protein import | 64 | 3.30e-12 | 5.68e-11 | 0.4240 | 0.034300 | -0.294000 | -0.304000 | 6.35e-01 | 4.86e-05 | 2.56e-05 |
G alpha (z) signalling events | 36 | 4.88e-03 | 1.15e-02 | 0.4240 | 0.275000 | 0.214000 | -0.241000 | 4.27e-03 | 2.63e-02 | 1.25e-02 |
PPARA activates gene expression | 104 | 2.36e-07 | 2.10e-06 | 0.4230 | 0.270000 | 0.315000 | -0.085700 | 2.03e-06 | 2.92e-08 | 1.31e-01 |
RNA Polymerase III Chain Elongation | 18 | 5.53e-02 | 9.11e-02 | 0.4230 | -0.189000 | -0.316000 | -0.207000 | 1.64e-01 | 2.03e-02 | 1.28e-01 |
CD22 mediated BCR regulation | 59 | 2.85e-08 | 3.03e-07 | 0.4230 | -0.135000 | -0.293000 | 0.273000 | 7.25e-02 | 9.76e-05 | 2.91e-04 |
Uptake and actions of bacterial toxins | 27 | 2.29e-02 | 4.29e-02 | 0.4230 | 0.306000 | 0.215000 | -0.198000 | 5.95e-03 | 5.35e-02 | 7.56e-02 |
Misspliced GSK3beta mutants stabilize beta-catenin | 15 | 2.03e-01 | 2.63e-01 | 0.4230 | 0.287000 | 0.295000 | -0.094000 | 5.40e-02 | 4.78e-02 | 5.28e-01 |
S33 mutants of beta-catenin aren't phosphorylated | 15 | 2.03e-01 | 2.63e-01 | 0.4230 | 0.287000 | 0.295000 | -0.094000 | 5.40e-02 | 4.78e-02 | 5.28e-01 |
S37 mutants of beta-catenin aren't phosphorylated | 15 | 2.03e-01 | 2.63e-01 | 0.4230 | 0.287000 | 0.295000 | -0.094000 | 5.40e-02 | 4.78e-02 | 5.28e-01 |
S45 mutants of beta-catenin aren't phosphorylated | 15 | 2.03e-01 | 2.63e-01 | 0.4230 | 0.287000 | 0.295000 | -0.094000 | 5.40e-02 | 4.78e-02 | 5.28e-01 |
T41 mutants of beta-catenin aren't phosphorylated | 15 | 2.03e-01 | 2.63e-01 | 0.4230 | 0.287000 | 0.295000 | -0.094000 | 5.40e-02 | 4.78e-02 | 5.28e-01 |
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex | 15 | 2.03e-01 | 2.63e-01 | 0.4230 | 0.287000 | 0.295000 | -0.094000 | 5.40e-02 | 4.78e-02 | 5.28e-01 |
TRAF6 mediated NF-kB activation | 23 | 4.48e-02 | 7.52e-02 | 0.4220 | 0.270000 | 0.224000 | -0.234000 | 2.48e-02 | 6.32e-02 | 5.19e-02 |
Ubiquitin-dependent degradation of Cyclin D | 50 | 1.01e-05 | 5.54e-05 | 0.4210 | 0.331000 | 0.125000 | -0.228000 | 5.00e-05 | 1.27e-01 | 5.27e-03 |
ABC transporter disorders | 70 | 6.71e-07 | 5.22e-06 | 0.4200 | 0.318000 | 0.147000 | -0.230000 | 4.11e-06 | 3.33e-02 | 8.62e-04 |
p75NTR recruits signalling complexes | 12 | 1.16e-01 | 1.68e-01 | 0.4190 | 0.246000 | 0.075900 | -0.331000 | 1.40e-01 | 6.49e-01 | 4.72e-02 |
Signaling by Insulin receptor | 59 | 1.24e-04 | 4.92e-04 | 0.4190 | 0.295000 | 0.208000 | -0.212000 | 8.65e-05 | 5.69e-03 | 4.84e-03 |
Interleukin-10 signaling | 34 | 1.17e-02 | 2.39e-02 | 0.4190 | 0.307000 | 0.238000 | -0.157000 | 1.94e-03 | 1.64e-02 | 1.14e-01 |
Mitophagy | 28 | 9.48e-06 | 5.33e-05 | 0.4180 | 0.184000 | -0.161000 | -0.339000 | 9.21e-02 | 1.40e-01 | 1.90e-03 |
Mitochondrial translation | 97 | 1.55e-19 | 3.97e-18 | 0.4180 | 0.002610 | -0.344000 | -0.237000 | 9.65e-01 | 4.79e-09 | 5.49e-05 |
GLI3 is processed to GLI3R by the proteasome | 57 | 1.22e-06 | 8.93e-06 | 0.4180 | 0.333000 | 0.117000 | -0.223000 | 1.37e-05 | 1.25e-01 | 3.60e-03 |
Classical antibody-mediated complement activation | 69 | 1.76e-08 | 1.89e-07 | 0.4170 | -0.135000 | -0.242000 | 0.312000 | 5.18e-02 | 5.10e-04 | 7.32e-06 |
Degradation of GLI1 by the proteasome | 57 | 4.10e-06 | 2.60e-05 | 0.4170 | 0.344000 | 0.149000 | -0.183000 | 6.83e-06 | 5.23e-02 | 1.69e-02 |
Cleavage of the damaged pyrimidine | 29 | 4.93e-03 | 1.15e-02 | 0.4170 | 0.274000 | 0.121000 | -0.290000 | 1.06e-02 | 2.61e-01 | 6.82e-03 |
Depyrimidination | 29 | 4.93e-03 | 1.15e-02 | 0.4170 | 0.274000 | 0.121000 | -0.290000 | 1.06e-02 | 2.61e-01 | 6.82e-03 |
Recognition and association of DNA glycosylase with site containing an affected pyrimidine | 29 | 4.93e-03 | 1.15e-02 | 0.4170 | 0.274000 | 0.121000 | -0.290000 | 1.06e-02 | 2.61e-01 | 6.82e-03 |
Opioid Signalling | 75 | 2.06e-05 | 1.01e-04 | 0.4170 | 0.287000 | 0.233000 | -0.192000 | 1.69e-05 | 4.84e-04 | 3.99e-03 |
NIK-->noncanonical NF-kB signaling | 57 | 6.50e-07 | 5.13e-06 | 0.4160 | 0.339000 | 0.112000 | -0.214000 | 9.72e-06 | 1.44e-01 | 5.18e-03 |
Base-Excision Repair, AP Site Formation | 31 | 3.24e-03 | 8.11e-03 | 0.4160 | 0.252000 | 0.108000 | -0.313000 | 1.51e-02 | 3.00e-01 | 2.57e-03 |
Endogenous sterols | 16 | 1.31e-01 | 1.86e-01 | 0.4160 | 0.319000 | 0.210000 | -0.163000 | 2.69e-02 | 1.46e-01 | 2.60e-01 |
Dectin-1 mediated noncanonical NF-kB signaling | 58 | 6.22e-07 | 4.98e-06 | 0.4150 | 0.332000 | 0.109000 | -0.225000 | 1.21e-05 | 1.52e-01 | 3.09e-03 |
Cytosolic tRNA aminoacylation | 24 | 6.45e-04 | 2.03e-03 | 0.4150 | -0.130000 | -0.355000 | 0.172000 | 2.71e-01 | 2.64e-03 | 1.46e-01 |
Activation of GABAB receptors | 30 | 3.31e-02 | 5.80e-02 | 0.4140 | 0.284000 | 0.294000 | -0.065000 | 7.09e-03 | 5.31e-03 | 5.38e-01 |
GABA B receptor activation | 30 | 3.31e-02 | 5.80e-02 | 0.4140 | 0.284000 | 0.294000 | -0.065000 | 7.09e-03 | 5.31e-03 | 5.38e-01 |
Triglyceride catabolism | 16 | 1.80e-01 | 2.40e-01 | 0.4140 | 0.317000 | 0.255000 | -0.076900 | 2.82e-02 | 7.74e-02 | 5.94e-01 |
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | 52 | 5.52e-06 | 3.34e-05 | 0.4140 | 0.350000 | 0.136000 | -0.173000 | 1.24e-05 | 8.94e-02 | 3.10e-02 |
Other semaphorin interactions | 16 | 7.12e-02 | 1.13e-01 | 0.4130 | 0.165000 | 0.145000 | -0.350000 | 2.53e-01 | 3.16e-01 | 1.54e-02 |
Degradation of the extracellular matrix | 77 | 5.45e-06 | 3.31e-05 | 0.4130 | 0.236000 | 0.269000 | -0.206000 | 3.38e-04 | 4.55e-05 | 1.78e-03 |
Autophagy | 124 | 1.20e-10 | 1.67e-09 | 0.4130 | 0.310000 | 0.166000 | -0.215000 | 2.38e-09 | 1.40e-03 | 3.45e-05 |
Glycosaminoglycan metabolism | 92 | 2.48e-09 | 3.09e-08 | 0.4120 | 0.149000 | 0.177000 | -0.341000 | 1.33e-02 | 3.41e-03 | 1.50e-08 |
NOTCH2 Activation and Transmission of Signal to the Nucleus | 20 | 2.41e-02 | 4.49e-02 | 0.4120 | 0.124000 | 0.101000 | -0.380000 | 3.38e-01 | 4.36e-01 | 3.29e-03 |
G-protein activation | 23 | 6.29e-02 | 1.02e-01 | 0.4120 | 0.325000 | 0.247000 | -0.052900 | 6.91e-03 | 4.05e-02 | 6.61e-01 |
PIWI-interacting RNA (piRNA) biogenesis | 23 | 2.60e-03 | 6.78e-03 | 0.4120 | 0.039600 | -0.187000 | -0.364000 | 7.42e-01 | 1.20e-01 | 2.49e-03 |
Cell recruitment (pro-inflammatory response) | 22 | 6.92e-03 | 1.54e-02 | 0.4100 | 0.359000 | 0.132000 | -0.148000 | 3.55e-03 | 2.84e-01 | 2.30e-01 |
Purinergic signaling in leishmaniasis infection | 22 | 6.92e-03 | 1.54e-02 | 0.4100 | 0.359000 | 0.132000 | -0.148000 | 3.55e-03 | 2.84e-01 | 2.30e-01 |
NOTCH3 Intracellular Domain Regulates Transcription | 20 | 1.02e-01 | 1.51e-01 | 0.4080 | 0.257000 | 0.283000 | -0.144000 | 4.69e-02 | 2.84e-02 | 2.65e-01 |
Removal of the Flap Intermediate from the C-strand | 17 | 1.04e-01 | 1.53e-01 | 0.4080 | -0.216000 | -0.335000 | -0.089600 | 1.24e-01 | 1.69e-02 | 5.22e-01 |
BMAL1:CLOCK,NPAS2 activates circadian gene expression | 25 | 1.50e-02 | 2.99e-02 | 0.4080 | 0.203000 | 0.354000 | -0.005050 | 7.89e-02 | 2.19e-03 | 9.65e-01 |
RNA Polymerase I Transcription Initiation | 47 | 4.95e-04 | 1.63e-03 | 0.4080 | -0.209000 | -0.341000 | -0.080400 | 1.31e-02 | 5.26e-05 | 3.40e-01 |
RNA Polymerase III Transcription Initiation From Type 2 Promoter | 27 | 2.94e-02 | 5.28e-02 | 0.4080 | -0.248000 | -0.279000 | -0.164000 | 2.56e-02 | 1.22e-02 | 1.40e-01 |
Nuclear signaling by ERBB4 | 24 | 1.59e-02 | 3.12e-02 | 0.4070 | 0.243000 | 0.099900 | -0.311000 | 3.92e-02 | 3.97e-01 | 8.29e-03 |
Activation of gene expression by SREBF (SREBP) | 42 | 2.69e-03 | 6.97e-03 | 0.4070 | 0.236000 | 0.330000 | -0.037000 | 8.13e-03 | 2.19e-04 | 6.79e-01 |
Response of EIF2AK1 (HRI) to heme deficiency | 14 | 1.79e-02 | 3.46e-02 | 0.4050 | 0.369000 | 0.132000 | 0.103000 | 1.68e-02 | 3.91e-01 | 5.03e-01 |
Regulation of lipid metabolism by PPARalpha | 106 | 4.99e-07 | 4.11e-06 | 0.4050 | 0.254000 | 0.303000 | -0.089800 | 6.09e-06 | 7.16e-08 | 1.10e-01 |
Constitutive Signaling by NOTCH1 HD Domain Mutants | 14 | 5.59e-02 | 9.15e-02 | 0.4050 | 0.027700 | 0.049800 | -0.401000 | 8.58e-01 | 7.47e-01 | 9.33e-03 |
Signaling by NOTCH1 HD Domain Mutants in Cancer | 14 | 5.59e-02 | 9.15e-02 | 0.4050 | 0.027700 | 0.049800 | -0.401000 | 8.58e-01 | 7.47e-01 | 9.33e-03 |
GABA receptor activation | 35 | 1.99e-02 | 3.81e-02 | 0.4040 | 0.270000 | 0.299000 | -0.034800 | 5.78e-03 | 2.20e-03 | 7.22e-01 |
NOTCH1 Intracellular Domain Regulates Transcription | 44 | 4.13e-04 | 1.40e-03 | 0.4030 | 0.297000 | 0.137000 | -0.236000 | 6.57e-04 | 1.15e-01 | 6.76e-03 |
The citric acid (TCA) cycle and respiratory electron transport | 172 | 9.90e-23 | 2.64e-21 | 0.4030 | 0.239000 | -0.010500 | -0.325000 | 6.56e-08 | 8.11e-01 | 1.97e-13 |
Toll Like Receptor 3 (TLR3) Cascade | 92 | 7.85e-07 | 6.07e-06 | 0.4030 | 0.299000 | 0.190000 | -0.193000 | 7.41e-07 | 1.64e-03 | 1.40e-03 |
PI3K events in ERBB2 signaling | 11 | 5.96e-02 | 9.66e-02 | 0.4030 | 0.247000 | -0.026300 | -0.317000 | 1.55e-01 | 8.80e-01 | 6.90e-02 |
Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | 29 | 6.86e-05 | 2.94e-04 | 0.4020 | 0.318000 | 0.012600 | -0.246000 | 3.06e-03 | 9.07e-01 | 2.20e-02 |
CaM pathway | 27 | 1.58e-02 | 3.12e-02 | 0.4020 | 0.198000 | 0.144000 | -0.318000 | 7.51e-02 | 1.96e-01 | 4.18e-03 |
Calmodulin induced events | 27 | 1.58e-02 | 3.12e-02 | 0.4020 | 0.198000 | 0.144000 | -0.318000 | 7.51e-02 | 1.96e-01 | 4.18e-03 |
Recognition of DNA damage by PCNA-containing replication complex | 30 | 2.94e-03 | 7.54e-03 | 0.4010 | -0.165000 | -0.353000 | -0.094600 | 1.18e-01 | 8.16e-04 | 3.70e-01 |
Effects of PIP2 hydrolysis | 24 | 4.55e-03 | 1.08e-02 | 0.4010 | -0.307000 | -0.167000 | -0.197000 | 9.19e-03 | 1.57e-01 | 9.55e-02 |
Condensation of Prophase Chromosomes | 29 | 1.48e-02 | 2.97e-02 | 0.4010 | 0.304000 | 0.172000 | -0.196000 | 4.63e-03 | 1.08e-01 | 6.70e-02 |
Autodegradation of the E3 ubiquitin ligase COP1 | 49 | 2.22e-05 | 1.08e-04 | 0.4010 | 0.316000 | 0.107000 | -0.222000 | 1.29e-04 | 1.96e-01 | 7.23e-03 |
Signaling by VEGF | 97 | 1.48e-06 | 1.05e-05 | 0.4000 | 0.254000 | 0.231000 | -0.206000 | 1.50e-05 | 8.63e-05 | 4.51e-04 |
Chondroitin sulfate/dermatan sulfate metabolism | 38 | 5.19e-04 | 1.69e-03 | 0.3990 | 0.079200 | 0.049300 | -0.388000 | 3.98e-01 | 5.99e-01 | 3.56e-05 |
Listeria monocytogenes entry into host cells | 17 | 1.44e-01 | 2.00e-01 | 0.3990 | 0.243000 | 0.218000 | -0.228000 | 8.26e-02 | 1.19e-01 | 1.04e-01 |
Metabolism of steroid hormones | 19 | 1.27e-01 | 1.81e-01 | 0.3980 | 0.311000 | 0.228000 | -0.099100 | 1.87e-02 | 8.57e-02 | 4.55e-01 |
Disorders of developmental biology | 12 | 2.00e-01 | 2.61e-01 | 0.3980 | 0.180000 | 0.170000 | -0.311000 | 2.79e-01 | 3.07e-01 | 6.18e-02 |
Loss of function of MECP2 in Rett syndrome | 12 | 2.00e-01 | 2.61e-01 | 0.3980 | 0.180000 | 0.170000 | -0.311000 | 2.79e-01 | 3.07e-01 | 6.18e-02 |
Pervasive developmental disorders | 12 | 2.00e-01 | 2.61e-01 | 0.3980 | 0.180000 | 0.170000 | -0.311000 | 2.79e-01 | 3.07e-01 | 6.18e-02 |
IRAK2 mediated activation of TAK1 complex | 10 | 1.58e-01 | 2.16e-01 | 0.3980 | 0.254000 | 0.042000 | -0.303000 | 1.64e-01 | 8.18e-01 | 9.66e-02 |
Regulation of RUNX3 expression and activity | 55 | 3.32e-05 | 1.55e-04 | 0.3980 | 0.307000 | 0.131000 | -0.217000 | 8.41e-05 | 9.28e-02 | 5.39e-03 |
Creation of C4 and C2 activators | 71 | 3.90e-08 | 4.02e-07 | 0.3970 | -0.123000 | -0.231000 | 0.299000 | 7.29e-02 | 7.66e-04 | 1.36e-05 |
Prefoldin mediated transfer of substrate to CCT/TriC | 26 | 6.73e-05 | 2.91e-04 | 0.3960 | 0.289000 | -0.044500 | -0.268000 | 1.08e-02 | 6.94e-01 | 1.81e-02 |
MET promotes cell motility | 26 | 6.86e-02 | 1.09e-01 | 0.3950 | 0.294000 | 0.264000 | 0.008440 | 9.47e-03 | 2.00e-02 | 9.41e-01 |
Oxidative Stress Induced Senescence | 79 | 8.81e-06 | 5.03e-05 | 0.3950 | 0.270000 | 0.173000 | -0.230000 | 3.35e-05 | 7.93e-03 | 4.05e-04 |
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon | 17 | 1.43e-01 | 1.99e-01 | 0.3940 | 0.295000 | 0.192000 | -0.176000 | 3.51e-02 | 1.71e-01 | 2.08e-01 |
Regulation of IFNA signaling | 12 | 1.74e-01 | 2.35e-01 | 0.3930 | 0.185000 | 0.346000 | 0.009230 | 2.66e-01 | 3.77e-02 | 9.56e-01 |
Platelet homeostasis | 69 | 3.20e-04 | 1.12e-03 | 0.3920 | 0.279000 | 0.243000 | -0.129000 | 5.95e-05 | 4.71e-04 | 6.38e-02 |
Activation of NF-kappaB in B cells | 65 | 4.17e-06 | 2.61e-05 | 0.3920 | 0.307000 | 0.126000 | -0.210000 | 1.91e-05 | 7.96e-02 | 3.48e-03 |
NRIF signals cell death from the nucleus | 15 | 1.02e-01 | 1.51e-01 | 0.3910 | 0.217000 | 0.074600 | -0.317000 | 1.46e-01 | 6.17e-01 | 3.34e-02 |
TGF-beta receptor signaling activates SMADs | 32 | 9.12e-03 | 1.97e-02 | 0.3910 | 0.270000 | 0.141000 | -0.244000 | 8.14e-03 | 1.67e-01 | 1.68e-02 |
Diseases associated with glycosylation precursor biosynthesis | 18 | 1.68e-01 | 2.29e-01 | 0.3900 | 0.290000 | 0.224000 | -0.136000 | 3.34e-02 | 1.00e-01 | 3.18e-01 |
Signaling by Receptor Tyrosine Kinases | 411 | 1.57e-25 | 4.63e-24 | 0.3900 | 0.261000 | 0.210000 | -0.200000 | 1.01e-19 | 2.69e-13 | 3.64e-12 |
Metabolism of polyamines | 57 | 2.27e-06 | 1.52e-05 | 0.3900 | 0.330000 | 0.108000 | -0.179000 | 1.67e-05 | 1.60e-01 | 1.97e-02 |
Biosynthesis of specialized proresolving mediators (SPMs) | 16 | 2.07e-01 | 2.67e-01 | 0.3900 | 0.287000 | 0.216000 | -0.151000 | 4.69e-02 | 1.35e-01 | 2.95e-01 |
Interleukin-27 signaling | 11 | 3.47e-01 | 4.17e-01 | 0.3900 | 0.276000 | 0.251000 | 0.112000 | 1.13e-01 | 1.49e-01 | 5.20e-01 |
Termination of translesion DNA synthesis | 32 | 1.08e-02 | 2.25e-02 | 0.3890 | -0.206000 | -0.329000 | 0.016700 | 4.40e-02 | 1.27e-03 | 8.70e-01 |
SARS-CoV-1 Infection | 47 | 2.59e-03 | 6.78e-03 | 0.3870 | 0.244000 | 0.194000 | -0.230000 | 3.87e-03 | 2.13e-02 | 6.37e-03 |
Chaperone Mediated Autophagy | 20 | 9.83e-03 | 2.11e-02 | 0.3860 | 0.214000 | -0.024400 | -0.320000 | 9.77e-02 | 8.50e-01 | 1.31e-02 |
PKA-mediated phosphorylation of CREB | 17 | 9.61e-02 | 1.44e-01 | 0.3860 | 0.185000 | 0.101000 | -0.323000 | 1.86e-01 | 4.73e-01 | 2.10e-02 |
Interleukin-15 signaling | 14 | 2.61e-01 | 3.25e-01 | 0.3860 | 0.238000 | 0.248000 | -0.175000 | 1.23e-01 | 1.08e-01 | 2.56e-01 |
Defective B3GALT6 causes EDSP2 and SEMDJL1 | 11 | 1.78e-01 | 2.40e-01 | 0.3860 | -0.020900 | -0.147000 | -0.356000 | 9.05e-01 | 3.99e-01 | 4.09e-02 |
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | 32 | 4.07e-02 | 6.96e-02 | 0.3860 | 0.272000 | 0.247000 | -0.117000 | 7.77e-03 | 1.55e-02 | 2.51e-01 |
CLEC7A (Dectin-1) signaling | 96 | 1.43e-08 | 1.56e-07 | 0.3850 | 0.309000 | 0.130000 | -0.189000 | 1.70e-07 | 2.77e-02 | 1.38e-03 |
Transport of Mature mRNA Derived from an Intronless Transcript | 42 | 9.70e-03 | 2.08e-02 | 0.3840 | -0.248000 | -0.247000 | 0.158000 | 5.35e-03 | 5.54e-03 | 7.72e-02 |
Transcriptional regulation of white adipocyte differentiation | 77 | 1.68e-04 | 6.35e-04 | 0.3830 | 0.250000 | 0.272000 | -0.099400 | 1.48e-04 | 3.57e-05 | 1.32e-01 |
The role of GTSE1 in G2/M progression after G2 checkpoint | 58 | 5.17e-06 | 3.15e-05 | 0.3820 | 0.331000 | 0.122000 | -0.147000 | 1.31e-05 | 1.07e-01 | 5.23e-02 |
Nef mediated downregulation of MHC class I complex cell surface expression | 10 | 1.69e-01 | 2.29e-01 | 0.3820 | 0.172000 | -0.029900 | -0.339000 | 3.45e-01 | 8.70e-01 | 6.31e-02 |
Citric acid cycle (TCA cycle) | 22 | 6.72e-02 | 1.07e-01 | 0.3790 | 0.269000 | 0.152000 | -0.220000 | 2.92e-02 | 2.17e-01 | 7.37e-02 |
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | 53 | 1.89e-03 | 5.16e-03 | 0.3790 | 0.256000 | 0.195000 | -0.200000 | 1.26e-03 | 1.40e-02 | 1.18e-02 |
Plasma lipoprotein remodeling | 18 | 1.56e-01 | 2.14e-01 | 0.3790 | 0.222000 | 0.290000 | -0.101000 | 1.03e-01 | 3.34e-02 | 4.57e-01 |
Asparagine N-linked glycosylation | 269 | 1.05e-14 | 2.17e-13 | 0.3790 | 0.276000 | 0.227000 | -0.126000 | 6.90e-15 | 1.44e-10 | 3.95e-04 |
Condensation of Prometaphase Chromosomes | 11 | 1.79e-01 | 2.40e-01 | 0.3770 | 0.096300 | 0.093900 | 0.353000 | 5.80e-01 | 5.90e-01 | 4.28e-02 |
Signaling by SCF-KIT | 40 | 1.64e-02 | 3.21e-02 | 0.3770 | 0.245000 | 0.251000 | -0.137000 | 7.31e-03 | 6.08e-03 | 1.33e-01 |
Oncogene Induced Senescence | 33 | 2.56e-02 | 4.71e-02 | 0.3760 | 0.226000 | 0.225000 | -0.199000 | 2.44e-02 | 2.52e-02 | 4.74e-02 |
Signaling by Non-Receptor Tyrosine Kinases | 48 | 1.87e-03 | 5.11e-03 | 0.3760 | 0.277000 | 0.162000 | -0.195000 | 9.02e-04 | 5.19e-02 | 1.92e-02 |
Signaling by PTK6 | 48 | 1.87e-03 | 5.11e-03 | 0.3760 | 0.277000 | 0.162000 | -0.195000 | 9.02e-04 | 5.19e-02 | 1.92e-02 |
SARS-CoV Infections | 83 | 5.45e-05 | 2.41e-04 | 0.3760 | 0.251000 | 0.205000 | -0.190000 | 7.89e-05 | 1.23e-03 | 2.72e-03 |
E3 ubiquitin ligases ubiquitinate target proteins | 52 | 7.38e-05 | 3.15e-04 | 0.3760 | 0.322000 | 0.135000 | -0.138000 | 5.75e-05 | 9.29e-02 | 8.61e-02 |
Acyl chain remodelling of PI | 10 | 3.77e-01 | 4.44e-01 | 0.3760 | 0.301000 | 0.180000 | -0.134000 | 9.92e-02 | 3.24e-01 | 4.64e-01 |
Signaling by Interleukins | 383 | 4.27e-23 | 1.16e-21 | 0.3750 | 0.270000 | 0.184000 | -0.184000 | 9.51e-20 | 6.07e-10 | 6.85e-10 |
Protein ubiquitination | 72 | 1.28e-06 | 9.31e-06 | 0.3750 | 0.317000 | 0.128000 | -0.154000 | 3.21e-06 | 6.03e-02 | 2.42e-02 |
RUNX3 regulates NOTCH signaling | 14 | 2.22e-01 | 2.83e-01 | 0.3740 | 0.204000 | 0.285000 | -0.130000 | 1.87e-01 | 6.45e-02 | 3.98e-01 |
Assembly of active LPL and LIPC lipase complexes | 10 | 3.76e-01 | 4.43e-01 | 0.3740 | 0.204000 | 0.274000 | -0.152000 | 2.64e-01 | 1.34e-01 | 4.05e-01 |
Defective B3GAT3 causes JDSSDHD | 11 | 2.07e-01 | 2.67e-01 | 0.3730 | -0.008330 | -0.110000 | -0.357000 | 9.62e-01 | 5.28e-01 | 4.04e-02 |
SUMOylation of SUMOylation proteins | 35 | 1.65e-02 | 3.22e-02 | 0.3730 | -0.212000 | -0.276000 | 0.135000 | 3.00e-02 | 4.78e-03 | 1.67e-01 |
SUMOylation of DNA methylation proteins | 16 | 8.48e-02 | 1.29e-01 | 0.3730 | -0.040500 | -0.170000 | -0.329000 | 7.79e-01 | 2.40e-01 | 2.25e-02 |
Degradation of AXIN | 53 | 1.52e-04 | 5.88e-04 | 0.3720 | 0.290000 | 0.120000 | -0.201000 | 2.66e-04 | 1.32e-01 | 1.14e-02 |
Signaling by PDGFRA extracellular domain mutants | 12 | 2.37e-01 | 2.98e-01 | 0.3720 | 0.287000 | 0.198000 | 0.129000 | 8.47e-02 | 2.36e-01 | 4.40e-01 |
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | 12 | 2.37e-01 | 2.98e-01 | 0.3720 | 0.287000 | 0.198000 | 0.129000 | 8.47e-02 | 2.36e-01 | 4.40e-01 |
Myogenesis | 21 | 1.77e-01 | 2.38e-01 | 0.3720 | 0.270000 | 0.246000 | -0.067600 | 3.23e-02 | 5.06e-02 | 5.92e-01 |
SHC1 events in ERBB4 signaling | 10 | 1.22e-01 | 1.76e-01 | 0.3710 | 0.331000 | 0.075100 | -0.149000 | 6.96e-02 | 6.81e-01 | 4.13e-01 |
Transcriptional Regulation by E2F6 | 34 | 1.90e-02 | 3.65e-02 | 0.3710 | -0.210000 | -0.275000 | 0.135000 | 3.44e-02 | 5.51e-03 | 1.75e-01 |
mRNA Splicing - Minor Pathway | 52 | 1.49e-06 | 1.05e-05 | 0.3710 | 0.045100 | -0.199000 | -0.310000 | 5.74e-01 | 1.30e-02 | 1.11e-04 |
AMER1 mutants destabilize the destruction complex | 14 | 3.51e-01 | 4.18e-01 | 0.3710 | 0.257000 | 0.256000 | -0.076800 | 9.63e-02 | 9.68e-02 | 6.19e-01 |
APC truncation mutants have impaired AXIN binding | 14 | 3.51e-01 | 4.18e-01 | 0.3710 | 0.257000 | 0.256000 | -0.076800 | 9.63e-02 | 9.68e-02 | 6.19e-01 |
AXIN missense mutants destabilize the destruction complex | 14 | 3.51e-01 | 4.18e-01 | 0.3710 | 0.257000 | 0.256000 | -0.076800 | 9.63e-02 | 9.68e-02 | 6.19e-01 |
AXIN mutants destabilize the destruction complex, activating WNT signaling | 14 | 3.51e-01 | 4.18e-01 | 0.3710 | 0.257000 | 0.256000 | -0.076800 | 9.63e-02 | 9.68e-02 | 6.19e-01 |
Truncations of AMER1 destabilize the destruction complex | 14 | 3.51e-01 | 4.18e-01 | 0.3710 | 0.257000 | 0.256000 | -0.076800 | 9.63e-02 | 9.68e-02 | 6.19e-01 |
truncated APC mutants destabilize the destruction complex | 14 | 3.51e-01 | 4.18e-01 | 0.3710 | 0.257000 | 0.256000 | -0.076800 | 9.63e-02 | 9.68e-02 | 6.19e-01 |
p38MAPK events | 13 | 2.41e-01 | 3.02e-01 | 0.3700 | 0.298000 | 0.162000 | -0.149000 | 6.29e-02 | 3.11e-01 | 3.53e-01 |
Initial triggering of complement | 78 | 2.25e-07 | 2.01e-06 | 0.3700 | -0.116000 | -0.193000 | 0.294000 | 7.63e-02 | 3.26e-03 | 7.02e-06 |
Signaling by FGFR2 IIIa TM | 18 | 2.18e-02 | 4.12e-02 | 0.3700 | 0.141000 | -0.086700 | -0.331000 | 3.02e-01 | 5.24e-01 | 1.50e-02 |
Transport of Mature mRNAs Derived from Intronless Transcripts | 43 | 1.06e-02 | 2.23e-02 | 0.3700 | -0.228000 | -0.249000 | 0.151000 | 9.62e-03 | 4.74e-03 | 8.71e-02 |
TRAF6 mediated IRF7 activation | 15 | 1.04e-01 | 1.53e-01 | 0.3690 | 0.065700 | 0.219000 | 0.290000 | 6.59e-01 | 1.43e-01 | 5.20e-02 |
NR1H2 and NR1H3-mediated signaling | 39 | 7.26e-03 | 1.60e-02 | 0.3690 | 0.192000 | 0.231000 | -0.214000 | 3.77e-02 | 1.27e-02 | 2.08e-02 |
Long-term potentiation | 14 | 1.79e-01 | 2.40e-01 | 0.3680 | -0.130000 | -0.246000 | -0.242000 | 4.00e-01 | 1.11e-01 | 1.17e-01 |
Degradation of cysteine and homocysteine | 12 | 2.50e-01 | 3.13e-01 | 0.3680 | 0.153000 | 0.125000 | -0.310000 | 3.58e-01 | 4.52e-01 | 6.29e-02 |
Intra-Golgi and retrograde Golgi-to-ER traffic | 179 | 4.80e-09 | 5.78e-08 | 0.3680 | 0.268000 | 0.233000 | -0.093800 | 5.92e-10 | 7.32e-08 | 3.04e-02 |
SCF-beta-TrCP mediated degradation of Emi1 | 53 | 2.05e-05 | 1.01e-04 | 0.3670 | 0.302000 | 0.088500 | -0.189000 | 1.41e-04 | 2.65e-01 | 1.72e-02 |
SHC1 events in ERBB2 signaling | 17 | 1.55e-01 | 2.13e-01 | 0.3670 | 0.279000 | 0.155000 | -0.182000 | 4.67e-02 | 2.70e-01 | 1.93e-01 |
Retinoid metabolism and transport | 24 | 8.18e-02 | 1.25e-01 | 0.3670 | 0.209000 | 0.229000 | -0.196000 | 7.57e-02 | 5.25e-02 | 9.65e-02 |
Collagen formation | 64 | 9.10e-05 | 3.77e-04 | 0.3670 | 0.162000 | 0.162000 | -0.287000 | 2.53e-02 | 2.54e-02 | 7.29e-05 |
Potential therapeutics for SARS | 36 | 3.43e-02 | 6.00e-02 | 0.3660 | 0.259000 | 0.219000 | -0.138000 | 7.20e-03 | 2.32e-02 | 1.53e-01 |
Macroautophagy | 110 | 6.96e-08 | 7.00e-07 | 0.3650 | 0.271000 | 0.131000 | -0.205000 | 8.72e-07 | 1.72e-02 | 2.00e-04 |
RNA Polymerase I Transcription Termination | 30 | 3.52e-03 | 8.68e-03 | 0.3640 | -0.141000 | -0.335000 | 0.004240 | 1.80e-01 | 1.47e-03 | 9.68e-01 |
Negative regulation of FGFR2 signaling | 23 | 5.58e-02 | 9.15e-02 | 0.3640 | 0.213000 | 0.101000 | -0.277000 | 7.73e-02 | 4.00e-01 | 2.14e-02 |
cGMP effects | 13 | 2.02e-01 | 2.63e-01 | 0.3640 | 0.296000 | 0.134000 | -0.164000 | 6.51e-02 | 4.04e-01 | 3.06e-01 |
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | 33 | 1.52e-02 | 3.02e-02 | 0.3630 | 0.185000 | 0.260000 | -0.174000 | 6.54e-02 | 9.86e-03 | 8.37e-02 |
Sphingolipid metabolism | 77 | 2.79e-04 | 9.87e-04 | 0.3630 | 0.232000 | 0.228000 | -0.162000 | 4.29e-04 | 5.46e-04 | 1.42e-02 |
Defects in vitamin and cofactor metabolism | 21 | 1.96e-01 | 2.57e-01 | 0.3630 | -0.255000 | -0.248000 | 0.071800 | 4.27e-02 | 4.94e-02 | 5.69e-01 |
UCH proteinases | 86 | 1.47e-05 | 7.69e-05 | 0.3630 | 0.234000 | 0.144000 | -0.238000 | 1.81e-04 | 2.14e-02 | 1.36e-04 |
Asymmetric localization of PCP proteins | 60 | 1.55e-04 | 5.96e-04 | 0.3630 | 0.259000 | 0.116000 | -0.225000 | 5.14e-04 | 1.21e-01 | 2.53e-03 |
Hedgehog 'on' state | 75 | 6.49e-05 | 2.81e-04 | 0.3610 | 0.267000 | 0.151000 | -0.190000 | 6.36e-05 | 2.38e-02 | 4.39e-03 |
Aggrephagy | 22 | 1.44e-02 | 2.91e-02 | 0.3610 | 0.244000 | 0.023100 | -0.265000 | 4.77e-02 | 8.51e-01 | 3.16e-02 |
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 53 | 2.28e-03 | 6.06e-03 | 0.3600 | 0.255000 | 0.163000 | -0.195000 | 1.30e-03 | 4.02e-02 | 1.38e-02 |
Constitutive Signaling by NOTCH1 PEST Domain Mutants | 53 | 2.28e-03 | 6.06e-03 | 0.3600 | 0.255000 | 0.163000 | -0.195000 | 1.30e-03 | 4.02e-02 | 1.38e-02 |
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 53 | 2.28e-03 | 6.06e-03 | 0.3600 | 0.255000 | 0.163000 | -0.195000 | 1.30e-03 | 4.02e-02 | 1.38e-02 |
Signaling by NOTCH1 PEST Domain Mutants in Cancer | 53 | 2.28e-03 | 6.06e-03 | 0.3600 | 0.255000 | 0.163000 | -0.195000 | 1.30e-03 | 4.02e-02 | 1.38e-02 |
Signaling by NOTCH1 in Cancer | 53 | 2.28e-03 | 6.06e-03 | 0.3600 | 0.255000 | 0.163000 | -0.195000 | 1.30e-03 | 4.02e-02 | 1.38e-02 |
Regulation of insulin secretion | 60 | 3.15e-03 | 7.93e-03 | 0.3600 | 0.253000 | 0.221000 | -0.130000 | 7.09e-04 | 3.03e-03 | 8.08e-02 |
GRB2 events in ERBB2 signaling | 11 | 8.76e-02 | 1.33e-01 | 0.3600 | 0.244000 | -0.024000 | -0.264000 | 1.61e-01 | 8.90e-01 | 1.30e-01 |
Trafficking and processing of endosomal TLR | 13 | 2.94e-01 | 3.59e-01 | 0.3600 | 0.301000 | 0.196000 | -0.022500 | 6.00e-02 | 2.21e-01 | 8.88e-01 |
Ephrin signaling | 17 | 1.21e-01 | 1.75e-01 | 0.3600 | 0.157000 | 0.064800 | -0.317000 | 2.63e-01 | 6.44e-01 | 2.35e-02 |
Signaling by NODAL | 13 | 1.42e-01 | 1.98e-01 | 0.3600 | -0.048400 | -0.044800 | -0.354000 | 7.63e-01 | 7.80e-01 | 2.73e-02 |
FCGR activation | 76 | 3.14e-06 | 2.02e-05 | 0.3590 | -0.144000 | -0.227000 | 0.238000 | 2.98e-02 | 6.21e-04 | 3.42e-04 |
Scavenging of heme from plasma | 71 | 9.37e-09 | 1.07e-07 | 0.3590 | -0.069700 | -0.231000 | 0.265000 | 3.10e-01 | 7.64e-04 | 1.11e-04 |
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | 27 | 1.01e-02 | 2.16e-02 | 0.3580 | 0.058200 | -0.099200 | -0.339000 | 6.01e-01 | 3.72e-01 | 2.32e-03 |
Translation of structural proteins | 28 | 2.50e-02 | 4.64e-02 | 0.3580 | 0.138000 | 0.129000 | -0.304000 | 2.06e-01 | 2.38e-01 | 5.43e-03 |
Prostacyclin signalling through prostacyclin receptor | 16 | 2.80e-01 | 3.46e-01 | 0.3560 | 0.262000 | 0.196000 | -0.141000 | 6.95e-02 | 1.75e-01 | 3.29e-01 |
HDR through Homologous Recombination (HRR) | 66 | 1.58e-03 | 4.43e-03 | 0.3560 | -0.232000 | -0.227000 | 0.146000 | 1.10e-03 | 1.45e-03 | 3.97e-02 |
Mitochondrial calcium ion transport | 22 | 3.30e-03 | 8.23e-03 | 0.3560 | 0.100000 | -0.175000 | -0.293000 | 4.15e-01 | 1.56e-01 | 1.73e-02 |
Metabolism of fat-soluble vitamins | 28 | 5.88e-02 | 9.58e-02 | 0.3560 | 0.207000 | 0.176000 | -0.229000 | 5.82e-02 | 1.07e-01 | 3.56e-02 |
Incretin synthesis, secretion, and inactivation | 10 | 8.95e-02 | 1.35e-01 | 0.3550 | 0.163000 | 0.005450 | 0.316000 | 3.73e-01 | 9.76e-01 | 8.35e-02 |
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | 10 | 8.95e-02 | 1.35e-01 | 0.3550 | 0.163000 | 0.005450 | 0.316000 | 3.73e-01 | 9.76e-01 | 8.35e-02 |
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | 16 | 3.31e-01 | 3.99e-01 | 0.3550 | 0.246000 | 0.250000 | -0.055400 | 8.85e-02 | 8.29e-02 | 7.01e-01 |
Keratinization | 32 | 2.18e-02 | 4.12e-02 | 0.3550 | 0.261000 | 0.133000 | -0.200000 | 1.07e-02 | 1.92e-01 | 4.97e-02 |
Norepinephrine Neurotransmitter Release Cycle | 13 | 1.77e-01 | 2.38e-01 | 0.3540 | -0.033800 | -0.071000 | -0.346000 | 8.33e-01 | 6.58e-01 | 3.10e-02 |
Vesicle-mediated transport | 646 | 4.10e-30 | 1.36e-28 | 0.3540 | 0.268000 | 0.218000 | -0.077300 | 2.66e-31 | 2.55e-21 | 8.02e-04 |
HSF1-dependent transactivation | 29 | 1.35e-02 | 2.75e-02 | 0.3540 | 0.123000 | 0.000191 | -0.332000 | 2.51e-01 | 9.99e-01 | 1.98e-03 |
Formation of tubulin folding intermediates by CCT/TriC | 22 | 5.52e-03 | 1.27e-02 | 0.3540 | 0.289000 | 0.024100 | -0.203000 | 1.91e-02 | 8.45e-01 | 9.95e-02 |
Dectin-2 family | 19 | 7.68e-02 | 1.20e-01 | 0.3530 | 0.161000 | 0.293000 | -0.115000 | 2.25e-01 | 2.72e-02 | 3.87e-01 |
Synthesis of IP3 and IP4 in the cytosol | 22 | 3.22e-02 | 5.69e-02 | 0.3530 | 0.091300 | 0.148000 | -0.307000 | 4.59e-01 | 2.28e-01 | 1.28e-02 |
SIRT1 negatively regulates rRNA expression | 24 | 3.20e-02 | 5.67e-02 | 0.3530 | 0.279000 | 0.103000 | -0.189000 | 1.80e-02 | 3.80e-01 | 1.08e-01 |
Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | 14 | 3.73e-01 | 4.41e-01 | 0.3520 | 0.224000 | 0.272000 | 0.004540 | 1.46e-01 | 7.82e-02 | 9.77e-01 |
E2F mediated regulation of DNA replication | 22 | 3.31e-02 | 5.81e-02 | 0.3520 | -0.120000 | -0.212000 | 0.254000 | 3.28e-01 | 8.51e-02 | 3.89e-02 |
Attenuation phase | 23 | 1.97e-02 | 3.77e-02 | 0.3520 | 0.208000 | 0.011800 | -0.283000 | 8.35e-02 | 9.22e-01 | 1.86e-02 |
Chemokine receptors bind chemokines | 37 | 7.81e-03 | 1.71e-02 | 0.3520 | -0.118000 | -0.218000 | -0.249000 | 2.14e-01 | 2.14e-02 | 8.73e-03 |
Acyl chain remodelling of PC | 19 | 2.35e-01 | 2.97e-01 | 0.3520 | 0.234000 | 0.222000 | -0.141000 | 7.80e-02 | 9.41e-02 | 2.87e-01 |
Regulation of TP53 Activity through Acetylation | 29 | 1.08e-02 | 2.25e-02 | 0.3510 | -0.198000 | -0.138000 | -0.256000 | 6.55e-02 | 1.98e-01 | 1.72e-02 |
Degradation of beta-catenin by the destruction complex | 83 | 1.27e-05 | 6.73e-05 | 0.3510 | 0.261000 | 0.126000 | -0.199000 | 3.98e-05 | 4.80e-02 | 1.71e-03 |
Intra-Golgi traffic | 43 | 2.40e-02 | 4.47e-02 | 0.3510 | 0.227000 | 0.259000 | -0.066900 | 1.00e-02 | 3.26e-03 | 4.48e-01 |
Collagen biosynthesis and modifying enzymes | 46 | 1.31e-03 | 3.78e-03 | 0.3500 | 0.107000 | 0.094600 | -0.320000 | 2.08e-01 | 2.67e-01 | 1.74e-04 |
Translesion Synthesis by POLH | 18 | 9.62e-02 | 1.44e-01 | 0.3500 | -0.126000 | -0.286000 | -0.159000 | 3.55e-01 | 3.59e-02 | 2.44e-01 |
Defective B4GALT7 causes EDS, progeroid type | 11 | 2.71e-01 | 3.36e-01 | 0.3500 | -0.044600 | -0.140000 | -0.318000 | 7.98e-01 | 4.23e-01 | 6.78e-02 |
Metabolism of RNA | 685 | 1.76e-61 | 1.26e-59 | 0.3490 | -0.088600 | -0.289000 | -0.175000 | 7.79e-05 | 3.79e-38 | 5.10e-15 |
RIP-mediated NFkB activation via ZBP1 | 17 | 2.20e-01 | 2.81e-01 | 0.3490 | 0.195000 | 0.236000 | -0.167000 | 1.63e-01 | 9.18e-02 | 2.33e-01 |
Signaling by FGFR3 | 31 | 5.12e-02 | 8.51e-02 | 0.3480 | 0.273000 | 0.176000 | -0.126000 | 8.56e-03 | 8.97e-02 | 2.25e-01 |
SUMOylation of intracellular receptors | 25 | 1.12e-01 | 1.63e-01 | 0.3480 | 0.218000 | 0.188000 | -0.195000 | 5.90e-02 | 1.04e-01 | 9.07e-02 |
Signaling by cytosolic FGFR1 fusion mutants | 18 | 2.41e-01 | 3.02e-01 | 0.3480 | 0.244000 | 0.229000 | 0.094000 | 7.25e-02 | 9.24e-02 | 4.90e-01 |
Caspase activation via Death Receptors in the presence of ligand | 16 | 2.28e-01 | 2.89e-01 | 0.3480 | 0.259000 | 0.204000 | 0.111000 | 7.27e-02 | 1.59e-01 | 4.40e-01 |
Glutamate binding, activation of AMPA receptors and synaptic plasticity | 20 | 1.11e-01 | 1.62e-01 | 0.3480 | 0.163000 | 0.209000 | -0.225000 | 2.06e-01 | 1.06e-01 | 8.20e-02 |
Trafficking of AMPA receptors | 20 | 1.11e-01 | 1.62e-01 | 0.3480 | 0.163000 | 0.209000 | -0.225000 | 2.06e-01 | 1.06e-01 | 8.20e-02 |
Synaptic adhesion-like molecules | 14 | 1.04e-01 | 1.53e-01 | 0.3480 | 0.070000 | 0.159000 | -0.301000 | 6.50e-01 | 3.03e-01 | 5.11e-02 |
RET signaling | 32 | 4.56e-02 | 7.64e-02 | 0.3470 | 0.198000 | 0.235000 | -0.161000 | 5.27e-02 | 2.15e-02 | 1.14e-01 |
DAP12 interactions | 39 | 1.89e-02 | 3.64e-02 | 0.3470 | 0.194000 | 0.213000 | -0.193000 | 3.65e-02 | 2.11e-02 | 3.70e-02 |
Regulation of mRNA stability by proteins that bind AU-rich elements | 87 | 7.90e-08 | 7.73e-07 | 0.3470 | 0.293000 | 0.090600 | -0.161000 | 2.22e-06 | 1.44e-01 | 9.66e-03 |
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | 51 | 4.15e-03 | 1.00e-02 | 0.3460 | 0.288000 | 0.184000 | -0.051700 | 3.72e-04 | 2.30e-02 | 5.23e-01 |
Metabolism of carbohydrates | 241 | 4.16e-15 | 8.85e-14 | 0.3450 | 0.154000 | 0.134000 | -0.279000 | 3.85e-05 | 3.46e-04 | 8.80e-14 |
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | 12 | 1.54e-01 | 2.12e-01 | 0.3430 | 0.275000 | 0.132000 | 0.157000 | 9.85e-02 | 4.30e-01 | 3.45e-01 |
Regulation of PTEN gene transcription | 59 | 4.65e-04 | 1.54e-03 | 0.3430 | 0.171000 | 0.075800 | -0.288000 | 2.31e-02 | 3.14e-01 | 1.30e-04 |
Nuclear Pore Complex (NPC) Disassembly | 36 | 2.46e-02 | 4.56e-02 | 0.3430 | -0.186000 | -0.237000 | 0.164000 | 5.32e-02 | 1.38e-02 | 8.85e-02 |
Autodegradation of Cdh1 by Cdh1:APC/C | 64 | 6.55e-06 | 3.87e-05 | 0.3430 | 0.276000 | 0.068400 | -0.192000 | 1.35e-04 | 3.44e-01 | 7.97e-03 |
Stabilization of p53 | 54 | 1.27e-04 | 4.99e-04 | 0.3430 | 0.284000 | 0.094400 | -0.167000 | 3.01e-04 | 2.30e-01 | 3.43e-02 |
Receptor Mediated Mitophagy | 11 | 2.64e-01 | 3.27e-01 | 0.3420 | 0.289000 | 0.110000 | -0.147000 | 9.70e-02 | 5.29e-01 | 3.97e-01 |
Apoptotic factor-mediated response | 18 | 7.36e-02 | 1.15e-01 | 0.3420 | 0.312000 | 0.141000 | -0.000791 | 2.19e-02 | 3.01e-01 | 9.95e-01 |
Signaling by FGFR4 | 31 | 3.60e-02 | 6.28e-02 | 0.3420 | 0.258000 | 0.136000 | -0.179000 | 1.30e-02 | 1.89e-01 | 8.47e-02 |
TNFR1-induced proapoptotic signaling | 12 | 1.47e-01 | 2.03e-01 | 0.3420 | -0.316000 | -0.126000 | -0.032700 | 5.80e-02 | 4.49e-01 | 8.45e-01 |
Interleukin-4 and Interleukin-13 signaling | 90 | 4.89e-06 | 3.03e-05 | 0.3410 | 0.285000 | 0.138000 | -0.127000 | 2.91e-06 | 2.34e-02 | 3.80e-02 |
Signaling by Hippo | 18 | 2.50e-01 | 3.13e-01 | 0.3410 | 0.235000 | 0.223000 | 0.105000 | 8.42e-02 | 1.01e-01 | 4.39e-01 |
C-type lectin receptors (CLRs) | 128 | 1.59e-07 | 1.46e-06 | 0.3400 | 0.265000 | 0.143000 | -0.158000 | 2.31e-07 | 5.18e-03 | 1.98e-03 |
Dual Incision in GG-NER | 41 | 7.56e-03 | 1.66e-02 | 0.3390 | -0.165000 | -0.295000 | -0.025400 | 6.73e-02 | 1.06e-03 | 7.78e-01 |
Apoptosis | 166 | 2.96e-09 | 3.66e-08 | 0.3390 | 0.279000 | 0.165000 | -0.102000 | 5.85e-10 | 2.49e-04 | 2.33e-02 |
Formation of the beta-catenin:TCF transactivating complex | 46 | 8.81e-03 | 1.91e-02 | 0.3390 | 0.212000 | 0.137000 | -0.227000 | 1.30e-02 | 1.08e-01 | 7.82e-03 |
Beta-catenin independent WNT signaling | 136 | 3.82e-07 | 3.29e-06 | 0.3390 | 0.232000 | 0.152000 | -0.194000 | 3.06e-06 | 2.17e-03 | 8.98e-05 |
Repression of WNT target genes | 14 | 1.60e-01 | 2.18e-01 | 0.3380 | -0.149000 | -0.108000 | -0.284000 | 3.35e-01 | 4.83e-01 | 6.60e-02 |
Resolution of D-loop Structures through Holliday Junction Intermediates | 32 | 2.92e-02 | 5.24e-02 | 0.3370 | -0.175000 | -0.090900 | 0.273000 | 8.63e-02 | 3.74e-01 | 7.48e-03 |
Metalloprotease DUBs | 21 | 2.13e-01 | 2.74e-01 | 0.3370 | 0.267000 | 0.200000 | -0.047100 | 3.43e-02 | 1.12e-01 | 7.09e-01 |
FGFR2 alternative splicing | 25 | 1.39e-02 | 2.81e-02 | 0.3370 | 0.061700 | -0.130000 | -0.304000 | 5.93e-01 | 2.59e-01 | 8.41e-03 |
Antiviral mechanism by IFN-stimulated genes | 80 | 1.19e-04 | 4.80e-04 | 0.3360 | -0.185000 | -0.125000 | 0.252000 | 4.23e-03 | 5.39e-02 | 9.78e-05 |
ZBP1(DAI) mediated induction of type I IFNs | 20 | 1.92e-01 | 2.53e-01 | 0.3350 | 0.190000 | 0.226000 | -0.159000 | 1.42e-01 | 7.98e-02 | 2.17e-01 |
Programmed Cell Death | 169 | 4.39e-09 | 5.33e-08 | 0.3350 | 0.276000 | 0.167000 | -0.090700 | 5.75e-10 | 1.80e-04 | 4.18e-02 |
N-Glycan antennae elongation | 13 | 7.81e-02 | 1.21e-01 | 0.3340 | -0.096000 | 0.021400 | -0.319000 | 5.49e-01 | 8.94e-01 | 4.62e-02 |
p75 NTR receptor-mediated signalling | 88 | 1.04e-04 | 4.23e-04 | 0.3340 | 0.197000 | 0.147000 | -0.225000 | 1.40e-03 | 1.69e-02 | 2.59e-04 |
Sialic acid metabolism | 28 | 1.16e-01 | 1.67e-01 | 0.3320 | 0.210000 | 0.196000 | -0.166000 | 5.43e-02 | 7.19e-02 | 1.28e-01 |
Constitutive Signaling by EGFRvIII | 14 | 2.37e-01 | 2.98e-01 | 0.3320 | 0.288000 | 0.163000 | 0.032700 | 6.23e-02 | 2.92e-01 | 8.32e-01 |
Signaling by EGFRvIII in Cancer | 14 | 2.37e-01 | 2.98e-01 | 0.3320 | 0.288000 | 0.163000 | 0.032700 | 6.23e-02 | 2.92e-01 | 8.32e-01 |
mitochondrial fatty acid beta-oxidation of saturated fatty acids | 11 | 1.80e-01 | 2.41e-01 | 0.3310 | 0.163000 | -0.052100 | -0.284000 | 3.50e-01 | 7.65e-01 | 1.03e-01 |
SUMOylation of ubiquitinylation proteins | 39 | 2.44e-02 | 4.54e-02 | 0.3310 | -0.178000 | -0.193000 | 0.202000 | 5.46e-02 | 3.69e-02 | 2.90e-02 |
HSF1 activation | 26 | 1.08e-02 | 2.25e-02 | 0.3300 | 0.092600 | -0.110000 | -0.297000 | 4.14e-01 | 3.32e-01 | 8.72e-03 |
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | 18 | 7.75e-02 | 1.20e-01 | 0.3290 | 0.279000 | 0.083400 | -0.152000 | 4.02e-02 | 5.40e-01 | 2.63e-01 |
Signaling by Ligand-Responsive EGFR Variants in Cancer | 18 | 7.75e-02 | 1.20e-01 | 0.3290 | 0.279000 | 0.083400 | -0.152000 | 4.02e-02 | 5.40e-01 | 2.63e-01 |
NGF-stimulated transcription | 31 | 6.60e-02 | 1.06e-01 | 0.3290 | 0.247000 | 0.151000 | -0.156000 | 1.73e-02 | 1.46e-01 | 1.32e-01 |
O-glycosylation of TSR domain-containing proteins | 26 | 2.17e-02 | 4.11e-02 | 0.3290 | -0.289000 | -0.138000 | -0.073800 | 1.07e-02 | 2.23e-01 | 5.15e-01 |
Initiation of Nuclear Envelope (NE) Reformation | 19 | 2.87e-01 | 3.53e-01 | 0.3280 | 0.255000 | 0.206000 | -0.003510 | 5.41e-02 | 1.20e-01 | 9.79e-01 |
MAPK6/MAPK4 signaling | 81 | 5.73e-06 | 3.45e-05 | 0.3280 | 0.280000 | 0.106000 | -0.135000 | 1.36e-05 | 9.81e-02 | 3.59e-02 |
Processing of SMDT1 | 15 | 5.22e-02 | 8.65e-02 | 0.3280 | 0.048900 | -0.198000 | -0.257000 | 7.43e-01 | 1.84e-01 | 8.54e-02 |
Regulation of KIT signaling | 15 | 1.74e-01 | 2.35e-01 | 0.3270 | 0.097800 | 0.149000 | -0.275000 | 5.12e-01 | 3.18e-01 | 6.54e-02 |
Apoptotic execution phase | 45 | 4.11e-02 | 7.00e-02 | 0.3270 | 0.242000 | 0.220000 | -0.015800 | 4.98e-03 | 1.08e-02 | 8.54e-01 |
Metabolism of amino acids and derivatives | 322 | 1.74e-30 | 5.92e-29 | 0.3270 | -0.004800 | -0.222000 | -0.240000 | 8.82e-01 | 6.99e-12 | 1.32e-13 |
RAF-independent MAPK1/3 activation | 21 | 1.30e-01 | 1.84e-01 | 0.3270 | 0.145000 | 0.089000 | -0.279000 | 2.49e-01 | 4.80e-01 | 2.68e-02 |
Costimulation by the CD28 family | 74 | 8.29e-04 | 2.51e-03 | 0.3260 | -0.224000 | -0.202000 | -0.126000 | 8.81e-04 | 2.66e-03 | 6.17e-02 |
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | 12 | 1.23e-01 | 1.77e-01 | 0.3260 | 0.041700 | 0.279000 | 0.164000 | 8.03e-01 | 9.46e-02 | 3.24e-01 |
Nuclear Receptor transcription pathway | 36 | 6.71e-03 | 1.50e-02 | 0.3260 | 0.006860 | 0.006080 | -0.326000 | 9.43e-01 | 9.50e-01 | 7.18e-04 |
APC/C:Cdc20 mediated degradation of Securin | 66 | 1.82e-05 | 9.26e-05 | 0.3250 | 0.269000 | 0.073700 | -0.166000 | 1.54e-04 | 3.01e-01 | 1.94e-02 |
RHO GTPase Effectors | 249 | 6.71e-10 | 8.77e-09 | 0.3250 | 0.242000 | 0.202000 | -0.079000 | 4.79e-11 | 3.97e-08 | 3.19e-02 |
Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | 12 | 1.96e-01 | 2.57e-01 | 0.3250 | 0.177000 | -0.016400 | -0.272000 | 2.89e-01 | 9.21e-01 | 1.03e-01 |
Glycerophospholipid biosynthesis | 106 | 1.20e-04 | 4.80e-04 | 0.3250 | 0.234000 | 0.181000 | -0.132000 | 3.07e-05 | 1.25e-03 | 1.86e-02 |
Negative regulation of NMDA receptor-mediated neuronal transmission | 14 | 2.06e-01 | 2.66e-01 | 0.3240 | -0.193000 | -0.132000 | -0.224000 | 2.11e-01 | 3.91e-01 | 1.46e-01 |
Elastic fibre formation | 32 | 8.34e-02 | 1.28e-01 | 0.3240 | 0.200000 | 0.179000 | -0.181000 | 4.99e-02 | 7.92e-02 | 7.59e-02 |
Defects in cobalamin (B12) metabolism | 13 | 3.58e-01 | 4.26e-01 | 0.3230 | -0.165000 | -0.222000 | 0.168000 | 3.04e-01 | 1.66e-01 | 2.95e-01 |
Hemostasis | 544 | 2.47e-24 | 6.86e-23 | 0.3230 | 0.244000 | 0.161000 | -0.137000 | 1.82e-22 | 1.34e-10 | 4.66e-08 |
Signaling by ERBB4 | 44 | 8.44e-03 | 1.84e-02 | 0.3230 | 0.247000 | 0.115000 | -0.172000 | 4.51e-03 | 1.85e-01 | 4.80e-02 |
TNFs bind their physiological receptors | 25 | 2.31e-02 | 4.31e-02 | 0.3230 | -0.082000 | -0.277000 | -0.145000 | 4.78e-01 | 1.67e-02 | 2.10e-01 |
Chaperonin-mediated protein folding | 84 | 3.44e-04 | 1.19e-03 | 0.3230 | 0.229000 | 0.144000 | -0.176000 | 2.89e-04 | 2.22e-02 | 5.39e-03 |
RIPK1-mediated regulated necrosis | 16 | 1.31e-01 | 1.85e-01 | 0.3220 | 0.070300 | 0.045700 | 0.311000 | 6.26e-01 | 7.51e-01 | 3.12e-02 |
Regulated Necrosis | 16 | 1.31e-01 | 1.85e-01 | 0.3220 | 0.070300 | 0.045700 | 0.311000 | 6.26e-01 | 7.51e-01 | 3.12e-02 |
Diseases of signal transduction by growth factor receptors and second messengers | 340 | 9.13e-15 | 1.91e-13 | 0.3220 | 0.231000 | 0.164000 | -0.153000 | 2.53e-13 | 2.09e-07 | 1.26e-06 |
Metabolism of nitric oxide: NOS3 activation and regulation | 12 | 1.75e-01 | 2.36e-01 | 0.3210 | 0.274000 | 0.058700 | -0.157000 | 1.01e-01 | 7.25e-01 | 3.45e-01 |
TICAM1,TRAF6-dependent induction of TAK1 complex | 11 | 2.19e-01 | 2.80e-01 | 0.3210 | 0.279000 | 0.068700 | -0.143000 | 1.09e-01 | 6.93e-01 | 4.11e-01 |
SUMOylation of RNA binding proteins | 47 | 1.68e-02 | 3.28e-02 | 0.3200 | -0.181000 | -0.261000 | 0.038700 | 3.17e-02 | 1.93e-03 | 6.46e-01 |
ESR-mediated signaling | 160 | 6.67e-09 | 7.82e-08 | 0.3190 | 0.238000 | 0.112000 | -0.182000 | 2.13e-07 | 1.49e-02 | 7.05e-05 |
Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | 36 | 3.20e-02 | 5.67e-02 | 0.3190 | 0.267000 | 0.147000 | -0.096400 | 5.59e-03 | 1.28e-01 | 3.17e-01 |
Regulation of RAS by GAPs | 66 | 8.59e-04 | 2.58e-03 | 0.3190 | 0.252000 | 0.126000 | -0.151000 | 4.06e-04 | 7.63e-02 | 3.44e-02 |
Resolution of D-Loop Structures | 33 | 3.22e-02 | 5.69e-02 | 0.3190 | -0.178000 | -0.070800 | 0.255000 | 7.61e-02 | 4.81e-01 | 1.12e-02 |
RMTs methylate histone arginines | 37 | 1.06e-02 | 2.23e-02 | 0.3190 | 0.006530 | -0.044000 | -0.316000 | 9.45e-01 | 6.44e-01 | 8.83e-04 |
Arachidonic acid metabolism | 43 | 3.23e-02 | 5.69e-02 | 0.3190 | 0.191000 | 0.181000 | -0.180000 | 3.04e-02 | 3.97e-02 | 4.12e-02 |
TCF dependent signaling in response to WNT | 165 | 8.95e-08 | 8.70e-07 | 0.3190 | 0.213000 | 0.138000 | -0.193000 | 2.30e-06 | 2.20e-03 | 1.94e-05 |
Elevation of cytosolic Ca2+ levels | 12 | 3.61e-01 | 4.28e-01 | 0.3170 | 0.119000 | 0.118000 | -0.270000 | 4.76e-01 | 4.80e-01 | 1.06e-01 |
Signaling by WNT | 253 | 5.44e-11 | 7.79e-10 | 0.3170 | 0.216000 | 0.154000 | -0.173000 | 3.09e-09 | 2.34e-05 | 2.18e-06 |
COPI-dependent Golgi-to-ER retrograde traffic | 78 | 4.27e-03 | 1.02e-02 | 0.3170 | 0.229000 | 0.215000 | -0.037600 | 4.61e-04 | 1.02e-03 | 5.66e-01 |
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | 72 | 5.31e-05 | 2.36e-04 | 0.3160 | 0.265000 | 0.096600 | -0.144000 | 1.04e-04 | 1.56e-01 | 3.47e-02 |
PTEN Regulation | 138 | 1.10e-06 | 8.17e-06 | 0.3160 | 0.219000 | 0.129000 | -0.188000 | 9.05e-06 | 8.94e-03 | 1.35e-04 |
MASTL Facilitates Mitotic Progression | 10 | 2.29e-01 | 2.91e-01 | 0.3160 | 0.289000 | 0.105000 | 0.074000 | 1.14e-01 | 5.66e-01 | 6.85e-01 |
Activation of kainate receptors upon glutamate binding | 26 | 1.30e-01 | 1.84e-01 | 0.3160 | 0.180000 | 0.139000 | -0.219000 | 1.11e-01 | 2.20e-01 | 5.35e-02 |
Synthesis of PE | 12 | 3.67e-01 | 4.34e-01 | 0.3160 | -0.182000 | -0.069500 | 0.249000 | 2.76e-01 | 6.77e-01 | 1.36e-01 |
Tie2 Signaling | 16 | 3.42e-01 | 4.11e-01 | 0.3150 | 0.260000 | 0.177000 | -0.014600 | 7.23e-02 | 2.19e-01 | 9.19e-01 |
Formation of Senescence-Associated Heterochromatin Foci (SAHF) | 13 | 2.84e-01 | 3.49e-01 | 0.3150 | 0.129000 | 0.215000 | -0.190000 | 4.21e-01 | 1.80e-01 | 2.35e-01 |
Selective autophagy | 58 | 1.53e-05 | 7.96e-05 | 0.3140 | 0.219000 | -0.006810 | -0.225000 | 3.98e-03 | 9.29e-01 | 2.99e-03 |
Axon guidance | 453 | 4.68e-28 | 1.45e-26 | 0.3130 | 0.120000 | 0.001290 | -0.289000 | 1.17e-05 | 9.62e-01 | 4.21e-26 |
MicroRNA (miRNA) biogenesis | 24 | 5.87e-02 | 9.58e-02 | 0.3130 | 0.067600 | -0.058600 | -0.300000 | 5.66e-01 | 6.19e-01 | 1.09e-02 |
Defective EXT1 causes exostoses 1, TRPS2 and CHDS | 10 | 3.95e-01 | 4.60e-01 | 0.3130 | 0.011400 | -0.090800 | -0.299000 | 9.50e-01 | 6.19e-01 | 1.01e-01 |
Defective EXT2 causes exostoses 2 | 10 | 3.95e-01 | 4.60e-01 | 0.3130 | 0.011400 | -0.090800 | -0.299000 | 9.50e-01 | 6.19e-01 | 1.01e-01 |
Extracellular matrix organization | 216 | 7.13e-10 | 9.23e-09 | 0.3130 | 0.183000 | 0.135000 | -0.215000 | 3.69e-06 | 6.24e-04 | 5.29e-08 |
Transport of bile salts and organic acids, metal ions and amine compounds | 54 | 3.07e-02 | 5.46e-02 | 0.3130 | 0.221000 | 0.215000 | -0.053000 | 5.00e-03 | 6.31e-03 | 5.01e-01 |
Striated Muscle Contraction | 23 | 2.57e-01 | 3.20e-01 | 0.3110 | 0.238000 | 0.184000 | -0.078900 | 4.86e-02 | 1.26e-01 | 5.13e-01 |
Glutamate and glutamine metabolism | 12 | 2.81e-01 | 3.46e-01 | 0.3100 | -0.097700 | -0.267000 | -0.125000 | 5.58e-01 | 1.09e-01 | 4.55e-01 |
Cellular responses to stress | 499 | 2.54e-35 | 9.60e-34 | 0.3100 | 0.142000 | -0.024100 | -0.275000 | 5.19e-08 | 3.56e-01 | 7.79e-26 |
Cellular responses to external stimuli | 505 | 3.42e-35 | 1.26e-33 | 0.3100 | 0.146000 | -0.017400 | -0.273000 | 1.77e-08 | 5.04e-01 | 8.38e-26 |
Carboxyterminal post-translational modifications of tubulin | 26 | 1.35e-01 | 1.90e-01 | 0.3100 | 0.170000 | 0.254000 | -0.048700 | 1.33e-01 | 2.47e-02 | 6.67e-01 |
Cellular Senescence | 144 | 1.67e-06 | 1.16e-05 | 0.3100 | 0.192000 | 0.132000 | -0.204000 | 7.23e-05 | 6.16e-03 | 2.32e-05 |
Signaling by NOTCH2 | 30 | 4.89e-02 | 8.14e-02 | 0.3100 | 0.116000 | 0.141000 | -0.250000 | 2.72e-01 | 1.82e-01 | 1.78e-02 |
Pregnenolone biosynthesis | 10 | 3.91e-01 | 4.57e-01 | 0.3070 | 0.063100 | 0.092700 | -0.286000 | 7.30e-01 | 6.12e-01 | 1.17e-01 |
Protein folding | 90 | 5.28e-04 | 1.71e-03 | 0.3070 | 0.207000 | 0.141000 | -0.179000 | 7.08e-04 | 2.11e-02 | 3.39e-03 |
NOTCH2 intracellular domain regulates transcription | 11 | 4.23e-01 | 4.86e-01 | 0.3070 | 0.146000 | 0.267000 | -0.038200 | 4.00e-01 | 1.26e-01 | 8.27e-01 |
FGFR2 mutant receptor activation | 22 | 4.03e-02 | 6.89e-02 | 0.3060 | 0.021400 | -0.172000 | -0.253000 | 8.62e-01 | 1.62e-01 | 4.02e-02 |
Purine catabolism | 16 | 1.23e-01 | 1.77e-01 | 0.3060 | 0.086900 | -0.094500 | -0.278000 | 5.47e-01 | 5.13e-01 | 5.40e-02 |
MHC class II antigen presentation | 101 | 7.03e-04 | 2.18e-03 | 0.3060 | 0.207000 | 0.190000 | -0.122000 | 3.22e-04 | 9.92e-04 | 3.41e-02 |
RA biosynthesis pathway | 13 | 3.18e-01 | 3.84e-01 | 0.3060 | -0.231000 | -0.147000 | -0.137000 | 1.50e-01 | 3.58e-01 | 3.92e-01 |
Extra-nuclear estrogen signaling | 66 | 1.96e-03 | 5.32e-03 | 0.3060 | 0.234000 | 0.120000 | -0.155000 | 9.85e-04 | 9.12e-02 | 2.99e-02 |
Downstream signaling events of B Cell Receptor (BCR) | 79 | 2.83e-05 | 1.34e-04 | 0.3050 | 0.243000 | 0.075700 | -0.168000 | 1.84e-04 | 2.45e-01 | 9.67e-03 |
Signalling to RAS | 18 | 2.01e-01 | 2.62e-01 | 0.3040 | 0.269000 | 0.137000 | -0.036300 | 4.79e-02 | 3.14e-01 | 7.90e-01 |
Signaling by Nuclear Receptors | 216 | 3.24e-10 | 4.37e-09 | 0.3040 | 0.210000 | 0.108000 | -0.191000 | 9.91e-08 | 6.21e-03 | 1.35e-06 |
Signaling by Activin | 10 | 5.06e-01 | 5.66e-01 | 0.3040 | -0.140000 | -0.159000 | -0.217000 | 4.42e-01 | 3.83e-01 | 2.34e-01 |
Keratan sulfate/keratin metabolism | 27 | 8.37e-02 | 1.28e-01 | 0.3040 | 0.116000 | 0.129000 | -0.249000 | 2.97e-01 | 2.44e-01 | 2.52e-02 |
Activation of HOX genes during differentiation | 68 | 4.96e-03 | 1.16e-02 | 0.3030 | 0.199000 | 0.141000 | -0.179000 | 4.46e-03 | 4.49e-02 | 1.06e-02 |
Activation of anterior HOX genes in hindbrain development during early embryogenesis | 68 | 4.96e-03 | 1.16e-02 | 0.3030 | 0.199000 | 0.141000 | -0.179000 | 4.46e-03 | 4.49e-02 | 1.06e-02 |
G1/S-Specific Transcription | 29 | 7.45e-03 | 1.64e-02 | 0.3020 | -0.084800 | -0.264000 | 0.120000 | 4.29e-01 | 1.39e-02 | 2.65e-01 |
Nervous system development | 472 | 1.11e-26 | 3.35e-25 | 0.3020 | 0.114000 | 0.005640 | -0.279000 | 2.22e-05 | 8.34e-01 | 2.18e-25 |
PRC2 methylates histones and DNA | 29 | 7.86e-02 | 1.21e-01 | 0.3010 | 0.191000 | 0.081000 | -0.219000 | 7.46e-02 | 4.50e-01 | 4.17e-02 |
TP53 Regulates Metabolic Genes | 84 | 2.61e-04 | 9.28e-04 | 0.3010 | 0.235000 | 0.114000 | -0.151000 | 2.01e-04 | 7.09e-02 | 1.67e-02 |
Constitutive Signaling by Overexpressed ERBB2 | 11 | 5.32e-01 | 5.89e-01 | 0.3010 | 0.246000 | 0.172000 | 0.030600 | 1.58e-01 | 3.24e-01 | 8.61e-01 |
Maturation of nucleoprotein | 10 | 2.36e-01 | 2.98e-01 | 0.3010 | -0.169000 | 0.056300 | 0.242000 | 3.53e-01 | 7.58e-01 | 1.85e-01 |
Intracellular signaling by second messengers | 271 | 3.03e-11 | 4.79e-10 | 0.3000 | 0.184000 | 0.130000 | -0.199000 | 1.93e-07 | 2.39e-04 | 1.71e-08 |
PIP3 activates AKT signaling | 239 | 7.41e-10 | 9.50e-09 | 0.2990 | 0.192000 | 0.129000 | -0.191000 | 3.34e-07 | 6.21e-04 | 3.86e-07 |
ABC-family proteins mediated transport | 93 | 1.99e-05 | 9.88e-05 | 0.2990 | 0.232000 | 0.084200 | -0.169000 | 1.08e-04 | 1.60e-01 | 4.91e-03 |
Regulation of necroptotic cell death | 14 | 1.87e-01 | 2.48e-01 | 0.2980 | -0.013500 | -0.079800 | 0.287000 | 9.30e-01 | 6.05e-01 | 6.27e-02 |
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | 36 | 1.07e-02 | 2.25e-02 | 0.2980 | 0.250000 | 0.073000 | -0.145000 | 9.34e-03 | 4.49e-01 | 1.33e-01 |
Mitotic Telophase/Cytokinesis | 13 | 1.63e-01 | 2.22e-01 | 0.2980 | 0.274000 | 0.095800 | 0.069000 | 8.75e-02 | 5.50e-01 | 6.67e-01 |
Defective B3GALTL causes Peters-plus syndrome (PpS) | 25 | 3.80e-02 | 6.58e-02 | 0.2980 | -0.267000 | -0.114000 | -0.065300 | 2.07e-02 | 3.26e-01 | 5.72e-01 |
Estrogen-dependent gene expression | 98 | 2.37e-05 | 1.15e-04 | 0.2980 | 0.215000 | 0.080800 | -0.190000 | 2.41e-04 | 1.67e-01 | 1.17e-03 |
FGFR1 mutant receptor activation | 24 | 2.82e-01 | 3.47e-01 | 0.2970 | 0.218000 | 0.199000 | 0.036000 | 6.49e-02 | 9.16e-02 | 7.60e-01 |
Adherens junctions interactions | 16 | 1.08e-01 | 1.58e-01 | 0.2970 | 0.050800 | 0.171000 | -0.237000 | 7.25e-01 | 2.37e-01 | 1.00e-01 |
Metabolism of steroids | 117 | 3.80e-04 | 1.30e-03 | 0.2960 | 0.189000 | 0.226000 | 0.027700 | 4.00e-04 | 2.40e-05 | 6.05e-01 |
Ion channel transport | 131 | 1.20e-04 | 4.80e-04 | 0.2950 | 0.199000 | 0.177000 | -0.127000 | 8.28e-05 | 4.75e-04 | 1.24e-02 |
Other interleukin signaling | 18 | 1.33e-01 | 1.88e-01 | 0.2950 | 0.051800 | 0.116000 | -0.266000 | 7.03e-01 | 3.95e-01 | 5.07e-02 |
Nicotinamide salvaging | 14 | 1.95e-01 | 2.57e-01 | 0.2940 | -0.097600 | 0.080400 | 0.265000 | 5.27e-01 | 6.02e-01 | 8.59e-02 |
NOTCH4 Intracellular Domain Regulates Transcription | 17 | 1.36e-01 | 1.91e-01 | 0.2940 | 0.106000 | 0.261000 | -0.082800 | 4.51e-01 | 6.25e-02 | 5.54e-01 |
CDT1 association with the CDC6:ORC:origin complex | 57 | 9.81e-05 | 4.03e-04 | 0.2930 | 0.259000 | 0.051600 | -0.125000 | 7.05e-04 | 5.00e-01 | 1.02e-01 |
Signaling by Rho GTPases | 365 | 1.43e-11 | 2.43e-10 | 0.2920 | 0.207000 | 0.185000 | -0.091000 | 1.12e-11 | 1.29e-09 | 2.82e-03 |
RNA Polymerase III Transcription Initiation | 36 | 1.07e-01 | 1.56e-01 | 0.2920 | -0.172000 | -0.208000 | -0.112000 | 7.48e-02 | 3.07e-02 | 2.46e-01 |
Signaling by ERBB2 | 44 | 2.58e-02 | 4.73e-02 | 0.2910 | 0.167000 | 0.080100 | -0.225000 | 5.59e-02 | 3.58e-01 | 9.70e-03 |
Transport of Mature mRNA derived from an Intron-Containing Transcript | 72 | 3.01e-03 | 7.65e-03 | 0.2910 | -0.156000 | -0.244000 | 0.028800 | 2.25e-02 | 3.48e-04 | 6.73e-01 |
Nucleobase catabolism | 28 | 8.33e-02 | 1.27e-01 | 0.2910 | 0.247000 | 0.110000 | -0.107000 | 2.37e-02 | 3.15e-01 | 3.27e-01 |
RUNX3 regulates p14-ARF | 10 | 5.18e-01 | 5.78e-01 | 0.2900 | 0.124000 | 0.248000 | 0.088300 | 4.98e-01 | 1.75e-01 | 6.29e-01 |
Inwardly rectifying K+ channels | 23 | 2.68e-01 | 3.32e-01 | 0.2900 | 0.222000 | 0.178000 | 0.055300 | 6.49e-02 | 1.38e-01 | 6.46e-01 |
Base Excision Repair | 58 | 2.99e-03 | 7.62e-03 | 0.2900 | -0.063400 | -0.166000 | -0.229000 | 4.03e-01 | 2.84e-02 | 2.54e-03 |
Serotonin Neurotransmitter Release Cycle | 14 | 2.81e-01 | 3.46e-01 | 0.2900 | -0.040800 | -0.036300 | -0.285000 | 7.91e-01 | 8.14e-01 | 6.49e-02 |
Integrin cell surface interactions | 52 | 1.20e-02 | 2.47e-02 | 0.2900 | 0.208000 | 0.097400 | -0.177000 | 9.46e-03 | 2.25e-01 | 2.73e-02 |
ISG15 antiviral mechanism | 72 | 3.66e-03 | 8.98e-03 | 0.2900 | -0.152000 | -0.142000 | 0.202000 | 2.58e-02 | 3.67e-02 | 3.10e-03 |
Interconversion of nucleotide di- and triphosphates | 27 | 6.92e-04 | 2.15e-03 | 0.2890 | 0.097000 | -0.206000 | -0.178000 | 3.83e-01 | 6.39e-02 | 1.10e-01 |
Neurexins and neuroligins | 36 | 2.14e-02 | 4.06e-02 | 0.2890 | -0.066000 | -0.057000 | -0.275000 | 4.93e-01 | 5.54e-01 | 4.27e-03 |
DAG and IP3 signaling | 33 | 7.08e-02 | 1.12e-01 | 0.2880 | 0.117000 | 0.118000 | -0.235000 | 2.44e-01 | 2.40e-01 | 1.95e-02 |
Signaling by FGFR1 | 38 | 1.42e-01 | 1.98e-01 | 0.2880 | 0.198000 | 0.192000 | -0.080800 | 3.44e-02 | 4.03e-02 | 3.89e-01 |
Negative regulation of MAPK pathway | 42 | 7.58e-02 | 1.18e-01 | 0.2880 | 0.192000 | 0.146000 | -0.157000 | 3.13e-02 | 1.01e-01 | 7.85e-02 |
Cell-Cell communication | 85 | 3.89e-04 | 1.32e-03 | 0.2870 | 0.143000 | 0.058300 | -0.242000 | 2.24e-02 | 3.53e-01 | 1.16e-04 |
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 80 | 3.04e-03 | 7.71e-03 | 0.2870 | 0.172000 | 0.133000 | -0.187000 | 7.69e-03 | 4.01e-02 | 3.78e-03 |
Cyclin A/B1/B2 associated events during G2/M transition | 24 | 3.62e-02 | 6.30e-02 | 0.2870 | 0.119000 | 0.029200 | 0.260000 | 3.15e-01 | 8.05e-01 | 2.76e-02 |
CRMPs in Sema3A signaling | 14 | 9.87e-02 | 1.48e-01 | 0.2870 | -0.016100 | 0.128000 | -0.256000 | 9.17e-01 | 4.07e-01 | 9.70e-02 |
TICAM1, RIP1-mediated IKK complex recruitment | 19 | 2.70e-01 | 3.35e-01 | 0.2870 | 0.248000 | 0.144000 | -0.010000 | 6.15e-02 | 2.78e-01 | 9.40e-01 |
DNA Damage/Telomere Stress Induced Senescence | 44 | 6.14e-02 | 9.94e-02 | 0.2860 | 0.190000 | 0.137000 | -0.165000 | 2.90e-02 | 1.17e-01 | 5.85e-02 |
Cell junction organization | 57 | 5.87e-03 | 1.34e-02 | 0.2860 | 0.162000 | 0.057800 | -0.228000 | 3.45e-02 | 4.50e-01 | 2.85e-03 |
Interleukin receptor SHC signaling | 23 | 6.94e-02 | 1.10e-01 | 0.2860 | 0.100000 | 0.239000 | -0.119000 | 4.04e-01 | 4.68e-02 | 3.21e-01 |
Termination of O-glycan biosynthesis | 16 | 1.87e-01 | 2.48e-01 | 0.2860 | 0.034200 | 0.094300 | -0.267000 | 8.13e-01 | 5.14e-01 | 6.40e-02 |
Tryptophan catabolism | 12 | 3.66e-01 | 4.34e-01 | 0.2850 | 0.225000 | 0.125000 | 0.123000 | 1.77e-01 | 4.54e-01 | 4.62e-01 |
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | 18 | 3.52e-01 | 4.19e-01 | 0.2850 | 0.236000 | 0.142000 | -0.071500 | 8.25e-02 | 2.97e-01 | 5.99e-01 |
CDK-mediated phosphorylation and removal of Cdc6 | 71 | 7.62e-05 | 3.23e-04 | 0.2840 | 0.245000 | 0.063400 | -0.129000 | 3.64e-04 | 3.55e-01 | 5.94e-02 |
Telomere Maintenance | 80 | 1.21e-04 | 4.80e-04 | 0.2840 | -0.045900 | -0.184000 | -0.211000 | 4.77e-01 | 4.50e-03 | 1.10e-03 |
Role of LAT2/NTAL/LAB on calcium mobilization | 74 | 5.16e-06 | 3.15e-05 | 0.2830 | -0.052600 | -0.190000 | 0.203000 | 4.34e-01 | 4.76e-03 | 2.48e-03 |
Signaling by TGF-beta Receptor Complex | 72 | 5.73e-03 | 1.31e-02 | 0.2830 | 0.194000 | 0.119000 | -0.168000 | 4.42e-03 | 8.12e-02 | 1.35e-02 |
Diseases associated with glycosaminoglycan metabolism | 26 | 1.29e-01 | 1.84e-01 | 0.2830 | 0.091200 | 0.052100 | -0.263000 | 4.21e-01 | 6.46e-01 | 2.05e-02 |
Neurotransmitter receptors and postsynaptic signal transmission | 123 | 2.34e-04 | 8.50e-04 | 0.2830 | 0.172000 | 0.166000 | -0.151000 | 1.01e-03 | 1.43e-03 | 3.91e-03 |
NOD1/2 Signaling Pathway | 32 | 1.70e-01 | 2.31e-01 | 0.2820 | 0.225000 | 0.169000 | 0.005720 | 2.75e-02 | 9.70e-02 | 9.55e-01 |
DCC mediated attractive signaling | 13 | 3.78e-01 | 4.45e-01 | 0.2820 | 0.001390 | -0.078400 | -0.271000 | 9.93e-01 | 6.24e-01 | 9.11e-02 |
SCF(Skp2)-mediated degradation of p27/p21 | 60 | 5.73e-04 | 1.85e-03 | 0.2820 | 0.246000 | 0.071400 | -0.118000 | 1.00e-03 | 3.39e-01 | 1.14e-01 |
p53-Dependent G1 DNA Damage Response | 63 | 1.07e-03 | 3.12e-03 | 0.2810 | 0.236000 | 0.080600 | -0.129000 | 1.19e-03 | 2.69e-01 | 7.70e-02 |
p53-Dependent G1/S DNA damage checkpoint | 63 | 1.07e-03 | 3.12e-03 | 0.2810 | 0.236000 | 0.080600 | -0.129000 | 1.19e-03 | 2.69e-01 | 7.70e-02 |
Phospholipid metabolism | 184 | 7.69e-06 | 4.43e-05 | 0.2810 | 0.181000 | 0.183000 | -0.112000 | 2.30e-05 | 1.81e-05 | 9.06e-03 |
Assembly and cell surface presentation of NMDA receptors | 18 | 3.09e-01 | 3.74e-01 | 0.2800 | -0.109000 | -0.207000 | -0.153000 | 4.23e-01 | 1.28e-01 | 2.61e-01 |
Assembly of collagen fibrils and other multimeric structures | 42 | 5.09e-02 | 8.47e-02 | 0.2800 | 0.137000 | 0.156000 | -0.188000 | 1.25e-01 | 8.06e-02 | 3.52e-02 |
Bile acid and bile salt metabolism | 28 | 2.17e-01 | 2.79e-01 | 0.2800 | 0.156000 | 0.218000 | 0.080900 | 1.53e-01 | 4.62e-02 | 4.59e-01 |
Role of phospholipids in phagocytosis | 88 | 1.26e-04 | 4.96e-04 | 0.2800 | -0.109000 | -0.182000 | 0.183000 | 7.72e-02 | 3.22e-03 | 3.08e-03 |
Heme biosynthesis | 14 | 3.41e-01 | 4.10e-01 | 0.2790 | 0.242000 | 0.097800 | -0.098200 | 1.17e-01 | 5.26e-01 | 5.24e-01 |
Immune System | 1888 | 1.96e-54 | 1.07e-52 | 0.2790 | 0.197000 | 0.155000 | -0.122000 | 9.40e-46 | 5.65e-29 | 1.67e-18 |
Regulation of FOXO transcriptional activity by acetylation | 10 | 5.51e-01 | 6.04e-01 | 0.2770 | 0.115000 | 0.163000 | -0.193000 | 5.28e-01 | 3.73e-01 | 2.92e-01 |
Collagen chain trimerization | 27 | 1.03e-01 | 1.52e-01 | 0.2770 | 0.003530 | -0.071800 | -0.268000 | 9.75e-01 | 5.19e-01 | 1.61e-02 |
Endosomal/Vacuolar pathway | 12 | 3.94e-01 | 4.60e-01 | 0.2770 | -0.098900 | -0.075500 | -0.247000 | 5.53e-01 | 6.51e-01 | 1.38e-01 |
Mitochondrial iron-sulfur cluster biogenesis | 13 | 6.79e-02 | 1.08e-01 | 0.2760 | 0.254000 | -0.022400 | -0.108000 | 1.13e-01 | 8.89e-01 | 5.02e-01 |
Downregulation of TGF-beta receptor signaling | 26 | 8.74e-02 | 1.32e-01 | 0.2760 | 0.193000 | 0.040600 | -0.193000 | 8.91e-02 | 7.20e-01 | 8.83e-02 |
G1/S DNA Damage Checkpoints | 65 | 5.95e-04 | 1.91e-03 | 0.2750 | 0.233000 | 0.068100 | -0.128000 | 1.14e-03 | 3.42e-01 | 7.47e-02 |
DNA Damage Recognition in GG-NER | 38 | 3.61e-02 | 6.28e-02 | 0.2740 | -0.010500 | -0.093700 | -0.258000 | 9.10e-01 | 3.18e-01 | 5.96e-03 |
Transport of small molecules | 553 | 1.43e-17 | 3.25e-16 | 0.2740 | 0.193000 | 0.134000 | -0.141000 | 9.37e-15 | 6.51e-08 | 1.38e-08 |
Cdc20:Phospho-APC/C mediated degradation of Cyclin A | 71 | 1.93e-05 | 9.65e-05 | 0.2740 | 0.245000 | 0.041500 | -0.115000 | 3.54e-04 | 5.45e-01 | 9.39e-02 |
Transcriptional regulation by RUNX3 | 90 | 3.52e-03 | 8.68e-03 | 0.2740 | 0.200000 | 0.135000 | -0.129000 | 1.04e-03 | 2.66e-02 | 3.38e-02 |
Caspase-mediated cleavage of cytoskeletal proteins | 12 | 4.47e-01 | 5.10e-01 | 0.2740 | 0.099200 | 0.151000 | -0.206000 | 5.52e-01 | 3.67e-01 | 2.17e-01 |
Formation of HIV-1 elongation complex containing HIV-1 Tat | 42 | 1.53e-02 | 3.04e-02 | 0.2730 | 0.105000 | -0.027800 | -0.251000 | 2.40e-01 | 7.56e-01 | 4.90e-03 |
HIV Transcription Elongation | 42 | 1.53e-02 | 3.04e-02 | 0.2730 | 0.105000 | -0.027800 | -0.251000 | 2.40e-01 | 7.56e-01 | 4.90e-03 |
Tat-mediated elongation of the HIV-1 transcript | 42 | 1.53e-02 | 3.04e-02 | 0.2730 | 0.105000 | -0.027800 | -0.251000 | 2.40e-01 | 7.56e-01 | 4.90e-03 |
FCERI mediated Ca+2 mobilization | 89 | 1.26e-05 | 6.73e-05 | 0.2720 | -0.077600 | -0.188000 | 0.180000 | 2.05e-01 | 2.13e-03 | 3.28e-03 |
Sphingolipid de novo biosynthesis | 41 | 1.35e-01 | 1.90e-01 | 0.2720 | 0.213000 | 0.167000 | -0.024900 | 1.84e-02 | 6.37e-02 | 7.83e-01 |
SUMOylation of DNA damage response and repair proteins | 77 | 1.03e-02 | 2.18e-02 | 0.2720 | -0.161000 | -0.210000 | 0.060000 | 1.45e-02 | 1.41e-03 | 3.63e-01 |
Interleukin-7 signaling | 21 | 2.27e-01 | 2.89e-01 | 0.2720 | 0.077700 | 0.060000 | -0.253000 | 5.38e-01 | 6.34e-01 | 4.45e-02 |
CD28 dependent Vav1 pathway | 12 | 5.42e-01 | 5.97e-01 | 0.2720 | 0.169000 | 0.084600 | -0.195000 | 3.09e-01 | 6.12e-01 | 2.43e-01 |
RNA Polymerase III Transcription Termination | 23 | 5.59e-02 | 9.15e-02 | 0.2710 | -0.043500 | -0.238000 | -0.122000 | 7.18e-01 | 4.78e-02 | 3.10e-01 |
SUMOylation of chromatin organization proteins | 57 | 1.91e-02 | 3.66e-02 | 0.2710 | -0.141000 | -0.231000 | 0.014400 | 6.50e-02 | 2.54e-03 | 8.50e-01 |
PI3K/AKT Signaling in Cancer | 80 | 1.82e-03 | 5.00e-03 | 0.2700 | 0.110000 | 0.071400 | -0.237000 | 9.01e-02 | 2.70e-01 | 2.53e-04 |
Interleukin-6 family signaling | 18 | 5.11e-01 | 5.71e-01 | 0.2700 | 0.205000 | 0.171000 | -0.038200 | 1.31e-01 | 2.08e-01 | 7.79e-01 |
Platelet calcium homeostasis | 21 | 3.13e-01 | 3.78e-01 | 0.2700 | 0.140000 | 0.188000 | -0.133000 | 2.67e-01 | 1.36e-01 | 2.90e-01 |
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | 72 | 2.71e-05 | 1.29e-04 | 0.2700 | 0.244000 | 0.046000 | -0.105000 | 3.43e-04 | 5.00e-01 | 1.24e-01 |
Metabolism of lipids | 620 | 1.00e-16 | 2.24e-15 | 0.2690 | 0.178000 | 0.183000 | -0.084400 | 3.73e-14 | 6.35e-15 | 3.34e-04 |
Developmental Biology | 725 | 1.16e-28 | 3.75e-27 | 0.2690 | 0.136000 | 0.055200 | -0.225000 | 4.01e-10 | 1.14e-02 | 4.56e-25 |
Synthesis of PIPs at the plasma membrane | 52 | 2.28e-02 | 4.27e-02 | 0.2690 | 0.135000 | 0.219000 | -0.079800 | 9.26e-02 | 6.38e-03 | 3.20e-01 |
Biosynthesis of DHA-derived SPMs | 14 | 5.32e-01 | 5.89e-01 | 0.2680 | 0.198000 | 0.118000 | -0.137000 | 1.99e-01 | 4.44e-01 | 3.76e-01 |
SUMOylation of DNA replication proteins | 46 | 6.22e-02 | 1.01e-01 | 0.2680 | -0.145000 | -0.184000 | 0.130000 | 8.95e-02 | 3.10e-02 | 1.26e-01 |
Rho GTPase cycle | 125 | 4.78e-04 | 1.58e-03 | 0.2680 | 0.158000 | 0.184000 | -0.112000 | 2.25e-03 | 3.73e-04 | 3.01e-02 |
Inositol phosphate metabolism | 42 | 2.08e-02 | 3.95e-02 | 0.2670 | 0.084400 | 0.150000 | -0.205000 | 3.44e-01 | 9.27e-02 | 2.17e-02 |
Chromosome Maintenance | 105 | 1.40e-04 | 5.47e-04 | 0.2670 | -0.108000 | -0.223000 | -0.100000 | 5.64e-02 | 7.86e-05 | 7.55e-02 |
ADORA2B mediated anti-inflammatory cytokines production | 73 | 1.75e-03 | 4.86e-03 | 0.2670 | 0.075100 | 0.082500 | -0.243000 | 2.68e-01 | 2.23e-01 | 3.35e-04 |
Signaling by Hedgehog | 120 | 1.44e-04 | 5.62e-04 | 0.2670 | 0.177000 | 0.091000 | -0.178000 | 8.13e-04 | 8.51e-02 | 7.55e-04 |
Cell death signalling via NRAGE, NRIF and NADE | 69 | 1.11e-02 | 2.30e-02 | 0.2670 | 0.138000 | 0.120000 | -0.194000 | 4.70e-02 | 8.54e-02 | 5.28e-03 |
Lewis blood group biosynthesis | 13 | 4.19e-01 | 4.83e-01 | 0.2670 | 0.038700 | 0.034000 | -0.262000 | 8.09e-01 | 8.32e-01 | 1.02e-01 |
Negative regulation of the PI3K/AKT network | 87 | 2.91e-03 | 7.46e-03 | 0.2670 | 0.139000 | 0.114000 | -0.196000 | 2.47e-02 | 6.57e-02 | 1.54e-03 |
Laminin interactions | 21 | 1.60e-01 | 2.19e-01 | 0.2660 | 0.241000 | 0.087600 | -0.071400 | 5.62e-02 | 4.87e-01 | 5.71e-01 |
Establishment of Sister Chromatid Cohesion | 11 | 1.05e-01 | 1.54e-01 | 0.2660 | 0.064700 | -0.143000 | 0.215000 | 7.10e-01 | 4.12e-01 | 2.17e-01 |
mRNA Splicing - Major Pathway | 179 | 3.55e-11 | 5.30e-10 | 0.2660 | -0.003840 | -0.178000 | -0.197000 | 9.29e-01 | 3.83e-05 | 5.39e-06 |
Interleukin-12 signaling | 44 | 8.19e-02 | 1.25e-01 | 0.2660 | 0.211000 | 0.128000 | -0.099100 | 1.56e-02 | 1.41e-01 | 2.56e-01 |
Depolymerisation of the Nuclear Lamina | 15 | 4.21e-01 | 4.84e-01 | 0.2650 | 0.231000 | 0.130000 | 0.010000 | 1.22e-01 | 3.82e-01 | 9.46e-01 |
Formation of the Early Elongation Complex | 33 | 3.82e-02 | 6.59e-02 | 0.2650 | 0.124000 | -0.027200 | -0.232000 | 2.17e-01 | 7.87e-01 | 2.11e-02 |
Formation of the HIV-1 Early Elongation Complex | 33 | 3.82e-02 | 6.59e-02 | 0.2650 | 0.124000 | -0.027200 | -0.232000 | 2.17e-01 | 7.87e-01 | 2.11e-02 |
Transcriptional Regulation by MECP2 | 47 | 5.92e-02 | 9.62e-02 | 0.2640 | 0.146000 | 0.103000 | -0.195000 | 8.39e-02 | 2.24e-01 | 2.07e-02 |
PECAM1 interactions | 12 | 1.96e-01 | 2.57e-01 | 0.2640 | -0.007720 | 0.134000 | -0.228000 | 9.63e-01 | 4.23e-01 | 1.72e-01 |
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | 75 | 4.30e-05 | 1.93e-04 | 0.2640 | 0.242000 | 0.054400 | -0.090800 | 2.98e-04 | 4.15e-01 | 1.74e-01 |
Hedgehog 'off' state | 92 | 3.13e-04 | 1.10e-03 | 0.2640 | 0.164000 | 0.044300 | -0.201000 | 6.52e-03 | 4.63e-01 | 8.36e-04 |
Nitric oxide stimulates guanylate cyclase | 16 | 1.97e-01 | 2.58e-01 | 0.2640 | 0.231000 | 0.047800 | -0.118000 | 1.10e-01 | 7.41e-01 | 4.15e-01 |
CD209 (DC-SIGN) signaling | 20 | 4.38e-01 | 5.01e-01 | 0.2630 | 0.185000 | 0.136000 | -0.129000 | 1.51e-01 | 2.93e-01 | 3.19e-01 |
Synthesis of PIPs at the early endosome membrane | 16 | 2.91e-01 | 3.56e-01 | 0.2630 | -0.010200 | 0.117000 | 0.235000 | 9.44e-01 | 4.17e-01 | 1.04e-01 |
Pyruvate metabolism | 28 | 5.83e-02 | 9.51e-02 | 0.2630 | 0.244000 | 0.080100 | -0.055100 | 2.54e-02 | 4.63e-01 | 6.14e-01 |
Gap-filling DNA repair synthesis and ligation in TC-NER | 64 | 7.85e-04 | 2.40e-03 | 0.2620 | -0.029700 | -0.191000 | -0.176000 | 6.82e-01 | 8.08e-03 | 1.49e-02 |
Regulation of Complement cascade | 94 | 4.52e-06 | 2.82e-05 | 0.2620 | -0.031400 | -0.127000 | 0.227000 | 5.99e-01 | 3.32e-02 | 1.47e-04 |
Signaling by TGFB family members | 91 | 1.64e-03 | 4.57e-03 | 0.2620 | 0.180000 | 0.087400 | -0.168000 | 2.93e-03 | 1.49e-01 | 5.63e-03 |
Apoptotic cleavage of cellular proteins | 34 | 2.60e-01 | 3.23e-01 | 0.2610 | 0.173000 | 0.195000 | -0.013200 | 8.03e-02 | 4.88e-02 | 8.94e-01 |
Regulation of RUNX2 expression and activity | 66 | 7.66e-04 | 2.35e-03 | 0.2610 | 0.233000 | 0.069300 | -0.096300 | 1.08e-03 | 3.30e-01 | 1.76e-01 |
APC/C:Cdc20 mediated degradation of mitotic proteins | 74 | 4.30e-05 | 1.93e-04 | 0.2610 | 0.239000 | 0.049100 | -0.092200 | 3.71e-04 | 4.65e-01 | 1.70e-01 |
N-glycan antennae elongation in the medial/trans-Golgi | 21 | 1.13e-01 | 1.64e-01 | 0.2610 | -0.026800 | 0.041600 | -0.256000 | 8.31e-01 | 7.42e-01 | 4.22e-02 |
G alpha (12/13) signalling events | 68 | 2.96e-02 | 5.30e-02 | 0.2600 | 0.158000 | 0.169000 | -0.120000 | 2.43e-02 | 1.61e-02 | 8.74e-02 |
Transcriptional regulation of pluripotent stem cells | 19 | 5.06e-01 | 5.66e-01 | 0.2600 | 0.183000 | 0.178000 | 0.050300 | 1.68e-01 | 1.79e-01 | 7.05e-01 |
Triglyceride metabolism | 25 | 3.97e-01 | 4.62e-01 | 0.2600 | 0.187000 | 0.179000 | 0.025900 | 1.06e-01 | 1.22e-01 | 8.23e-01 |
Activation of SMO | 13 | 3.06e-01 | 3.72e-01 | 0.2590 | 0.027000 | 0.111000 | -0.232000 | 8.66e-01 | 4.88e-01 | 1.48e-01 |
Signaling by FGFR1 in disease | 31 | 1.90e-01 | 2.51e-01 | 0.2550 | 0.171000 | 0.145000 | 0.122000 | 9.84e-02 | 1.64e-01 | 2.41e-01 |
Transport of Mature Transcript to Cytoplasm | 81 | 6.83e-03 | 1.52e-02 | 0.2550 | -0.136000 | -0.214000 | 0.028100 | 3.49e-02 | 8.72e-04 | 6.62e-01 |
IRF3-mediated induction of type I IFN | 12 | 4.60e-01 | 5.22e-01 | 0.2540 | -0.034000 | -0.163000 | -0.193000 | 8.39e-01 | 3.29e-01 | 2.48e-01 |
Stimuli-sensing channels | 71 | 4.11e-02 | 7.00e-02 | 0.2540 | 0.184000 | 0.151000 | -0.090800 | 7.48e-03 | 2.79e-02 | 1.86e-01 |
FLT3 Signaling | 243 | 1.43e-07 | 1.33e-06 | 0.2540 | 0.163000 | 0.098600 | -0.168000 | 1.27e-05 | 8.11e-03 | 6.35e-06 |
MAPK1/MAPK3 signaling | 234 | 1.85e-07 | 1.68e-06 | 0.2530 | 0.169000 | 0.094500 | -0.163000 | 8.07e-06 | 1.27e-02 | 1.78e-05 |
O-linked glycosylation of mucins | 47 | 5.91e-02 | 9.61e-02 | 0.2530 | 0.129000 | 0.203000 | -0.077500 | 1.26e-01 | 1.58e-02 | 3.58e-01 |
Gamma carboxylation, hypusine formation and arylsulfatase activation | 34 | 8.59e-02 | 1.30e-01 | 0.2530 | 0.050400 | -0.035000 | -0.245000 | 6.11e-01 | 7.24e-01 | 1.33e-02 |
ABC transporters in lipid homeostasis | 14 | 5.44e-01 | 5.99e-01 | 0.2520 | -0.205000 | -0.138000 | -0.051000 | 1.85e-01 | 3.70e-01 | 7.41e-01 |
Circadian Clock | 67 | 3.91e-02 | 6.71e-02 | 0.2520 | 0.173000 | 0.128000 | -0.131000 | 1.46e-02 | 7.02e-02 | 6.29e-02 |
Viral Messenger RNA Synthesis | 44 | 9.48e-02 | 1.43e-01 | 0.2520 | -0.129000 | -0.212000 | -0.043400 | 1.39e-01 | 1.51e-02 | 6.19e-01 |
Interleukin-12 family signaling | 53 | 5.54e-02 | 9.11e-02 | 0.2510 | 0.211000 | 0.128000 | -0.047700 | 7.79e-03 | 1.08e-01 | 5.48e-01 |
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | 11 | 3.66e-01 | 4.33e-01 | 0.2510 | 0.032300 | -0.149000 | -0.200000 | 8.53e-01 | 3.92e-01 | 2.52e-01 |
Transcriptional regulation by RUNX2 | 100 | 5.06e-03 | 1.18e-02 | 0.2510 | 0.196000 | 0.129000 | -0.089300 | 6.97e-04 | 2.58e-02 | 1.23e-01 |
mRNA Splicing | 187 | 4.33e-11 | 6.33e-10 | 0.2510 | -0.000579 | -0.176000 | -0.179000 | 9.89e-01 | 3.19e-05 | 2.52e-05 |
Interferon Signaling | 177 | 3.24e-07 | 2.85e-06 | 0.2510 | -0.155000 | -0.038500 | 0.193000 | 3.74e-04 | 3.77e-01 | 9.23e-06 |
NCAM1 interactions | 23 | 4.91e-01 | 5.53e-01 | 0.2500 | -0.180000 | -0.172000 | 0.023500 | 1.36e-01 | 1.54e-01 | 8.46e-01 |
Xenobiotics | 11 | 5.22e-01 | 5.82e-01 | 0.2490 | -0.007920 | -0.125000 | -0.215000 | 9.64e-01 | 4.74e-01 | 2.16e-01 |
FOXO-mediated transcription | 58 | 5.47e-02 | 9.02e-02 | 0.2490 | 0.147000 | 0.116000 | -0.164000 | 5.24e-02 | 1.27e-01 | 3.08e-02 |
Regulation of innate immune responses to cytosolic DNA | 14 | 3.87e-01 | 4.53e-01 | 0.2480 | 0.018700 | -0.110000 | -0.222000 | 9.03e-01 | 4.76e-01 | 1.51e-01 |
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | 17 | 3.38e-01 | 4.07e-01 | 0.2480 | 0.139000 | 0.014000 | -0.204000 | 3.20e-01 | 9.20e-01 | 1.45e-01 |
RNA Polymerase III Transcription Initiation From Type 3 Promoter | 28 | 2.79e-01 | 3.45e-01 | 0.2470 | -0.127000 | -0.205000 | -0.055400 | 2.44e-01 | 6.08e-02 | 6.12e-01 |
RAF/MAP kinase cascade | 229 | 5.00e-07 | 4.11e-06 | 0.2470 | 0.160000 | 0.088700 | -0.166000 | 3.15e-05 | 2.07e-02 | 1.42e-05 |
Activation of BH3-only proteins | 29 | 1.77e-01 | 2.38e-01 | 0.2470 | 0.117000 | 0.031000 | -0.215000 | 2.75e-01 | 7.72e-01 | 4.47e-02 |
VEGFR2 mediated cell proliferation | 18 | 5.38e-01 | 5.95e-01 | 0.2470 | 0.165000 | 0.126000 | -0.134000 | 2.25e-01 | 3.56e-01 | 3.27e-01 |
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | 19 | 1.83e-01 | 2.44e-01 | 0.2470 | -0.076800 | -0.211000 | 0.102000 | 5.62e-01 | 1.11e-01 | 4.42e-01 |
Cholesterol biosynthesis | 24 | 2.79e-01 | 3.45e-01 | 0.2470 | 0.092000 | 0.185000 | 0.135000 | 4.35e-01 | 1.17e-01 | 2.51e-01 |
B-WICH complex positively regulates rRNA expression | 47 | 2.48e-03 | 6.52e-03 | 0.2470 | 0.141000 | -0.055200 | -0.195000 | 9.52e-02 | 5.13e-01 | 2.07e-02 |
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | 14 | 1.28e-01 | 1.83e-01 | 0.2460 | -0.030200 | 0.133000 | -0.204000 | 8.45e-01 | 3.87e-01 | 1.86e-01 |
Protein localization | 157 | 5.06e-09 | 6.04e-08 | 0.2460 | 0.117000 | -0.056100 | -0.208000 | 1.14e-02 | 2.25e-01 | 6.55e-06 |
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | 38 | 9.92e-02 | 1.48e-01 | 0.2450 | -0.107000 | -0.215000 | -0.050100 | 2.54e-01 | 2.21e-02 | 5.93e-01 |
Unfolded Protein Response (UPR) | 86 | 1.05e-02 | 2.21e-02 | 0.2430 | 0.183000 | 0.107000 | -0.119000 | 3.28e-03 | 8.72e-02 | 5.65e-02 |
Protein-protein interactions at synapses | 56 | 1.28e-02 | 2.61e-02 | 0.2430 | 0.005970 | 0.015400 | -0.242000 | 9.38e-01 | 8.42e-01 | 1.73e-03 |
Polo-like kinase mediated events | 15 | 2.92e-01 | 3.58e-01 | 0.2430 | 0.108000 | 0.033700 | 0.215000 | 4.70e-01 | 8.21e-01 | 1.50e-01 |
Downstream signal transduction | 27 | 4.40e-01 | 5.02e-01 | 0.2420 | 0.163000 | 0.177000 | -0.024800 | 1.42e-01 | 1.12e-01 | 8.24e-01 |
Competing endogenous RNAs (ceRNAs) regulate PTEN translation | 11 | 3.86e-01 | 4.53e-01 | 0.2420 | -0.076200 | 0.104000 | 0.205000 | 6.62e-01 | 5.52e-01 | 2.40e-01 |
Complement cascade | 98 | 1.46e-05 | 7.67e-05 | 0.2410 | -0.030500 | -0.126000 | 0.203000 | 6.02e-01 | 3.06e-02 | 5.06e-04 |
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | 84 | 1.25e-04 | 4.93e-04 | 0.2410 | -0.062100 | -0.176000 | 0.153000 | 3.25e-01 | 5.32e-03 | 1.54e-02 |
Muscle contraction | 140 | 1.39e-03 | 3.96e-03 | 0.2410 | 0.147000 | 0.172000 | -0.082200 | 2.68e-03 | 4.29e-04 | 9.30e-02 |
Transcription of E2F targets under negative control by DREAM complex | 19 | 2.74e-02 | 4.98e-02 | 0.2410 | 0.011100 | -0.241000 | -0.010200 | 9.33e-01 | 6.95e-02 | 9.39e-01 |
TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | 17 | 6.02e-01 | 6.51e-01 | 0.2410 | -0.147000 | -0.190000 | 0.012400 | 2.93e-01 | 1.74e-01 | 9.30e-01 |
Synthesis, secretion, and deacylation of Ghrelin | 11 | 4.85e-01 | 5.47e-01 | 0.2410 | -0.064100 | -0.216000 | -0.084700 | 7.13e-01 | 2.15e-01 | 6.27e-01 |
Signaling by PDGFR in disease | 19 | 3.84e-01 | 4.51e-01 | 0.2400 | 0.169000 | 0.117000 | 0.124000 | 2.03e-01 | 3.75e-01 | 3.50e-01 |
MAPK family signaling cascades | 267 | 1.04e-07 | 1.00e-06 | 0.2400 | 0.168000 | 0.090400 | -0.145000 | 2.31e-06 | 1.10e-02 | 4.38e-05 |
Signaling by ERBB2 in Cancer | 21 | 8.81e-02 | 1.33e-01 | 0.2400 | 0.217000 | 0.017100 | -0.100000 | 8.51e-02 | 8.92e-01 | 4.27e-01 |
Peroxisomal protein import | 57 | 1.18e-01 | 1.71e-01 | 0.2400 | 0.182000 | 0.144000 | -0.058200 | 1.74e-02 | 5.93e-02 | 4.47e-01 |
Acyl chain remodelling of PE | 20 | 3.81e-01 | 4.48e-01 | 0.2390 | 0.187000 | 0.081800 | -0.125000 | 1.47e-01 | 5.27e-01 | 3.34e-01 |
Formation of TC-NER Pre-Incision Complex | 53 | 5.20e-04 | 1.69e-03 | 0.2390 | 0.110000 | -0.102000 | -0.187000 | 1.68e-01 | 1.98e-01 | 1.88e-02 |
Insulin receptor signalling cascade | 39 | 2.15e-01 | 2.76e-01 | 0.2390 | 0.163000 | 0.118000 | -0.130000 | 7.82e-02 | 2.04e-01 | 1.61e-01 |
Cobalamin (Cbl, vitamin B12) transport and metabolism | 16 | 5.86e-01 | 6.36e-01 | 0.2390 | -0.135000 | -0.162000 | 0.113000 | 3.51e-01 | 2.62e-01 | 4.33e-01 |
Signaling by FGFR2 | 60 | 1.03e-02 | 2.19e-02 | 0.2390 | 0.103000 | -0.014300 | -0.215000 | 1.70e-01 | 8.48e-01 | 3.95e-03 |
Pyruvate metabolism and Citric Acid (TCA) cycle | 52 | 2.67e-02 | 4.87e-02 | 0.2390 | 0.201000 | 0.074500 | -0.106000 | 1.23e-02 | 3.53e-01 | 1.88e-01 |
Dopamine Neurotransmitter Release Cycle | 19 | 3.78e-01 | 4.45e-01 | 0.2380 | -0.040300 | -0.087800 | -0.218000 | 7.61e-01 | 5.07e-01 | 1.00e-01 |
Adrenaline,noradrenaline inhibits insulin secretion | 24 | 4.35e-01 | 4.98e-01 | 0.2380 | 0.142000 | 0.136000 | -0.133000 | 2.27e-01 | 2.48e-01 | 2.58e-01 |
Transcription-Coupled Nucleotide Excision Repair (TC-NER) | 78 | 2.20e-04 | 8.09e-04 | 0.2380 | -0.007110 | -0.176000 | -0.160000 | 9.14e-01 | 7.33e-03 | 1.44e-02 |
Transcriptional regulation by RUNX1 | 184 | 2.83e-05 | 1.34e-04 | 0.2380 | 0.152000 | 0.086500 | -0.161000 | 3.60e-04 | 4.30e-02 | 1.73e-04 |
DNA Damage Bypass | 47 | 2.70e-02 | 4.92e-02 | 0.2380 | -0.091100 | -0.219000 | 0.002160 | 2.80e-01 | 9.23e-03 | 9.80e-01 |
Binding and Uptake of Ligands by Scavenger Receptors | 91 | 1.20e-07 | 1.15e-06 | 0.2380 | 0.022500 | -0.142000 | 0.189000 | 7.10e-01 | 1.93e-02 | 1.81e-03 |
Synthesis of bile acids and bile salts | 24 | 4.57e-01 | 5.19e-01 | 0.2380 | 0.143000 | 0.176000 | 0.072000 | 2.25e-01 | 1.36e-01 | 5.41e-01 |
Unblocking of NMDA receptors, glutamate binding and activation | 12 | 6.30e-01 | 6.78e-01 | 0.2380 | -0.197000 | -0.125000 | -0.045400 | 2.37e-01 | 4.55e-01 | 7.85e-01 |
Signaling by WNT in cancer | 30 | 1.12e-01 | 1.63e-01 | 0.2380 | 0.082200 | 0.175000 | -0.138000 | 4.36e-01 | 9.69e-02 | 1.91e-01 |
Signal Transduction | 1870 | 1.50e-40 | 6.81e-39 | 0.2370 | 0.153000 | 0.128000 | -0.128000 | 4.52e-28 | 3.57e-20 | 5.80e-20 |
HCMV Late Events | 69 | 2.59e-02 | 4.74e-02 | 0.2370 | 0.169000 | 0.086300 | -0.143000 | 1.54e-02 | 2.15e-01 | 4.01e-02 |
Tight junction interactions | 18 | 1.43e-01 | 1.99e-01 | 0.2370 | 0.005470 | -0.191000 | -0.140000 | 9.68e-01 | 1.61e-01 | 3.02e-01 |
Factors involved in megakaryocyte development and platelet production | 115 | 1.02e-02 | 2.17e-02 | 0.2370 | 0.180000 | 0.150000 | -0.037000 | 8.52e-04 | 5.51e-03 | 4.93e-01 |
Regulation of MECP2 expression and activity | 28 | 3.49e-01 | 4.18e-01 | 0.2370 | 0.135000 | 0.133000 | -0.142000 | 2.15e-01 | 2.22e-01 | 1.93e-01 |
Telomere Extension By Telomerase | 23 | 4.37e-01 | 5.00e-01 | 0.2370 | -0.126000 | -0.181000 | -0.086000 | 2.96e-01 | 1.32e-01 | 4.75e-01 |
Mitochondrial biogenesis | 88 | 1.13e-04 | 4.59e-04 | 0.2350 | 0.165000 | -0.001750 | -0.167000 | 7.61e-03 | 9.77e-01 | 6.62e-03 |
Interleukin-2 family signaling | 38 | 7.33e-02 | 1.15e-01 | 0.2350 | 0.093400 | 0.192000 | -0.097900 | 3.19e-01 | 4.08e-02 | 2.96e-01 |
Diseases associated with O-glycosylation of proteins | 48 | 2.37e-03 | 6.27e-03 | 0.2350 | -0.203000 | -0.050800 | -0.105000 | 1.48e-02 | 5.42e-01 | 2.07e-01 |
Intrinsic Pathway for Apoptosis | 52 | 6.74e-02 | 1.07e-01 | 0.2340 | 0.182000 | 0.087900 | -0.119000 | 2.35e-02 | 2.73e-01 | 1.38e-01 |
Retrograde transport at the Trans-Golgi-Network | 49 | 1.96e-01 | 2.57e-01 | 0.2340 | 0.176000 | 0.146000 | -0.047100 | 3.30e-02 | 7.70e-02 | 5.68e-01 |
G alpha (q) signalling events | 130 | 4.61e-04 | 1.53e-03 | 0.2330 | 0.097700 | 0.097000 | -0.188000 | 5.43e-02 | 5.62e-02 | 2.06e-04 |
Positive epigenetic regulation of rRNA expression | 62 | 1.19e-03 | 3.45e-03 | 0.2330 | 0.070900 | -0.103000 | -0.196000 | 3.34e-01 | 1.61e-01 | 7.55e-03 |
Sema3A PAK dependent Axon repulsion | 16 | 5.03e-01 | 5.65e-01 | 0.2320 | 0.076600 | 0.065000 | -0.209000 | 5.96e-01 | 6.53e-01 | 1.47e-01 |
TNFR2 non-canonical NF-kB pathway | 95 | 9.19e-06 | 5.21e-05 | 0.2320 | 0.158000 | -0.030400 | -0.167000 | 7.91e-03 | 6.09e-01 | 4.80e-03 |
Metabolism | 1756 | 1.05e-49 | 5.50e-48 | 0.2320 | 0.137000 | 0.052900 | -0.179000 | 1.26e-21 | 2.35e-04 | 8.76e-36 |
Transmission across Chemical Synapses | 169 | 4.71e-04 | 1.56e-03 | 0.2320 | 0.139000 | 0.141000 | -0.120000 | 1.77e-03 | 1.59e-03 | 7.13e-03 |
Insulin processing | 20 | 4.89e-01 | 5.52e-01 | 0.2310 | 0.162000 | 0.135000 | 0.095400 | 2.11e-01 | 2.95e-01 | 4.60e-01 |
Interleukin-37 signaling | 19 | 1.88e-01 | 2.49e-01 | 0.2310 | 0.063000 | 0.214000 | -0.060200 | 6.34e-01 | 1.07e-01 | 6.49e-01 |
Formation of HIV elongation complex in the absence of HIV Tat | 44 | 5.13e-02 | 8.51e-02 | 0.2310 | 0.101000 | -0.013300 | -0.207000 | 2.47e-01 | 8.79e-01 | 1.76e-02 |
Signaling by ERBB2 TMD/JMD mutants | 17 | 1.45e-01 | 2.01e-01 | 0.2300 | 0.189000 | -0.018800 | -0.129000 | 1.77e-01 | 8.93e-01 | 3.57e-01 |
Regulation of TP53 Activity through Methylation | 19 | 5.39e-01 | 5.95e-01 | 0.2300 | -0.120000 | -0.158000 | -0.115000 | 3.66e-01 | 2.32e-01 | 3.85e-01 |
RAS processing | 19 | 1.81e-01 | 2.41e-01 | 0.2300 | 0.126000 | -0.051500 | -0.185000 | 3.40e-01 | 6.98e-01 | 1.64e-01 |
Regulation of beta-cell development | 19 | 5.14e-01 | 5.73e-01 | 0.2290 | 0.122000 | 0.170000 | -0.092800 | 3.58e-01 | 1.99e-01 | 4.84e-01 |
Assembly of the pre-replicative complex | 66 | 7.56e-04 | 2.33e-03 | 0.2290 | 0.193000 | 0.013400 | -0.123000 | 6.82e-03 | 8.51e-01 | 8.34e-02 |
Processing of Capped Intron-Containing Pre-mRNA | 238 | 2.79e-11 | 4.46e-10 | 0.2280 | -0.035400 | -0.193000 | -0.118000 | 3.46e-01 | 3.11e-07 | 1.76e-03 |
Infectious disease | 723 | 2.77e-28 | 8.76e-27 | 0.2280 | 0.117000 | -0.013000 | -0.195000 | 8.14e-08 | 5.53e-01 | 3.45e-19 |
Glutathione conjugation | 26 | 4.92e-01 | 5.54e-01 | 0.2280 | 0.175000 | 0.145000 | -0.019400 | 1.22e-01 | 2.02e-01 | 8.64e-01 |
TRAF3-dependent IRF activation pathway | 13 | 5.31e-01 | 5.89e-01 | 0.2280 | 0.048400 | 0.165000 | 0.149000 | 7.63e-01 | 3.02e-01 | 3.52e-01 |
Dual incision in TC-NER | 65 | 1.50e-03 | 4.24e-03 | 0.2280 | -0.018100 | -0.185000 | -0.131000 | 8.00e-01 | 9.85e-03 | 6.73e-02 |
Peroxisomal lipid metabolism | 27 | 4.80e-01 | 5.43e-01 | 0.2270 | 0.173000 | 0.148000 | -0.003510 | 1.21e-01 | 1.84e-01 | 9.75e-01 |
Synthesis of very long-chain fatty acyl-CoAs | 21 | 3.66e-01 | 4.33e-01 | 0.2270 | 0.200000 | 0.089700 | -0.060500 | 1.13e-01 | 4.77e-01 | 6.31e-01 |
Acyl chain remodelling of PG | 11 | 7.96e-01 | 8.25e-01 | 0.2260 | 0.175000 | 0.138000 | -0.034900 | 3.14e-01 | 4.28e-01 | 8.41e-01 |
Purine salvage | 12 | 4.12e-01 | 4.77e-01 | 0.2240 | 0.210000 | 0.042800 | -0.063200 | 2.08e-01 | 7.97e-01 | 7.04e-01 |
Disorders of transmembrane transporters | 145 | 6.31e-05 | 2.74e-04 | 0.2230 | 0.152000 | 0.040500 | -0.159000 | 1.59e-03 | 4.00e-01 | 9.59e-04 |
Neuronal System | 253 | 1.85e-06 | 1.27e-05 | 0.2230 | 0.111000 | 0.132000 | -0.142000 | 2.35e-03 | 3.03e-04 | 1.02e-04 |
Antigen Presentation: Folding, assembly and peptide loading of class I MHC | 25 | 4.51e-01 | 5.13e-01 | 0.2230 | 0.123000 | 0.185000 | 0.014500 | 2.86e-01 | 1.09e-01 | 9.00e-01 |
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | 10 | 3.23e-01 | 3.89e-01 | 0.2230 | 0.133000 | -0.090500 | -0.154000 | 4.65e-01 | 6.20e-01 | 4.00e-01 |
Vitamin B5 (pantothenate) metabolism | 17 | 6.63e-01 | 7.08e-01 | 0.2230 | 0.142000 | 0.159000 | 0.065500 | 3.12e-01 | 2.57e-01 | 6.40e-01 |
Metabolism of nucleotides | 86 | 1.63e-05 | 8.38e-05 | 0.2220 | 0.109000 | -0.089400 | -0.172000 | 8.17e-02 | 1.52e-01 | 5.72e-03 |
RNA Pol II CTD phosphorylation and interaction with CE | 27 | 7.60e-02 | 1.18e-01 | 0.2220 | 0.138000 | -0.043000 | -0.169000 | 2.16e-01 | 6.99e-01 | 1.28e-01 |
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | 27 | 7.60e-02 | 1.18e-01 | 0.2220 | 0.138000 | -0.043000 | -0.169000 | 2.16e-01 | 6.99e-01 | 1.28e-01 |
Death Receptor Signalling | 131 | 5.07e-03 | 1.18e-02 | 0.2210 | 0.142000 | 0.110000 | -0.128000 | 4.98e-03 | 2.94e-02 | 1.12e-02 |
Deubiquitination | 241 | 5.82e-05 | 2.54e-04 | 0.2210 | 0.175000 | 0.127000 | -0.045000 | 2.90e-06 | 6.84e-04 | 2.29e-01 |
Phase 4 - resting membrane potential | 10 | 8.21e-01 | 8.45e-01 | 0.2200 | 0.133000 | 0.174000 | 0.023600 | 4.66e-01 | 3.40e-01 | 8.97e-01 |
Aflatoxin activation and detoxification | 14 | 6.34e-01 | 6.81e-01 | 0.2190 | 0.158000 | 0.071400 | -0.134000 | 3.07e-01 | 6.44e-01 | 3.86e-01 |
Deadenylation of mRNA | 22 | 4.72e-03 | 1.11e-02 | 0.2190 | 0.153000 | -0.106000 | 0.116000 | 2.15e-01 | 3.91e-01 | 3.47e-01 |
Fatty acid metabolism | 151 | 3.54e-03 | 8.70e-03 | 0.2180 | 0.149000 | 0.119000 | -0.105000 | 1.56e-03 | 1.13e-02 | 2.53e-02 |
Regulation of APC/C activators between G1/S and early anaphase | 79 | 4.07e-05 | 1.86e-04 | 0.2180 | 0.202000 | 0.004980 | -0.083200 | 1.94e-03 | 9.39e-01 | 2.01e-01 |
Meiotic synapsis | 45 | 1.99e-01 | 2.60e-01 | 0.2170 | 0.171000 | 0.102000 | -0.085800 | 4.66e-02 | 2.38e-01 | 3.19e-01 |
Disease | 1292 | 2.36e-33 | 8.24e-32 | 0.2160 | 0.125000 | 0.043300 | -0.171000 | 4.62e-14 | 9.01e-03 | 4.04e-25 |
Class I MHC mediated antigen processing & presentation | 348 | 8.80e-07 | 6.72e-06 | 0.2160 | 0.172000 | 0.123000 | -0.044900 | 3.58e-08 | 7.73e-05 | 1.50e-01 |
Processing of Capped Intronless Pre-mRNA | 28 | 1.79e-01 | 2.40e-01 | 0.2160 | -0.049200 | -0.182000 | -0.105000 | 6.52e-01 | 9.47e-02 | 3.37e-01 |
Potassium Channels | 62 | 9.65e-02 | 1.44e-01 | 0.2160 | 0.119000 | 0.179000 | -0.017800 | 1.06e-01 | 1.46e-02 | 8.09e-01 |
VEGFR2 mediated vascular permeability | 26 | 3.01e-01 | 3.66e-01 | 0.2150 | 0.081100 | 0.135000 | -0.146000 | 4.74e-01 | 2.33e-01 | 1.96e-01 |
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | 36 | 2.18e-01 | 2.80e-01 | 0.2150 | 0.085600 | 0.104000 | -0.167000 | 3.74e-01 | 2.81e-01 | 8.24e-02 |
Metabolism of cofactors | 19 | 4.39e-01 | 5.02e-01 | 0.2150 | 0.191000 | 0.096400 | 0.022700 | 1.50e-01 | 4.67e-01 | 8.64e-01 |
Inactivation of APC/C via direct inhibition of the APC/C complex | 21 | 1.01e-01 | 1.51e-01 | 0.2150 | -0.027600 | -0.210000 | 0.033900 | 8.27e-01 | 9.57e-02 | 7.88e-01 |
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | 21 | 1.01e-01 | 1.51e-01 | 0.2150 | -0.027600 | -0.210000 | 0.033900 | 8.27e-01 | 9.57e-02 | 7.88e-01 |
NRAGE signals death through JNK | 52 | 6.93e-02 | 1.10e-01 | 0.2140 | 0.069500 | 0.097700 | -0.178000 | 3.86e-01 | 2.23e-01 | 2.66e-02 |
MECP2 regulates neuronal receptors and channels | 13 | 6.44e-01 | 6.90e-01 | 0.2140 | 0.113000 | 0.031300 | -0.179000 | 4.81e-01 | 8.45e-01 | 2.63e-01 |
RNA Polymerase III Abortive And Retractive Initiation | 41 | 1.82e-01 | 2.42e-01 | 0.2140 | -0.091800 | -0.178000 | -0.075700 | 3.09e-01 | 4.90e-02 | 4.01e-01 |
RNA Polymerase III Transcription | 41 | 1.82e-01 | 2.42e-01 | 0.2140 | -0.091800 | -0.178000 | -0.075700 | 3.09e-01 | 4.90e-02 | 4.01e-01 |
Nephrin family interactions | 17 | 5.48e-01 | 6.03e-01 | 0.2130 | -0.059600 | -0.095000 | -0.181000 | 6.71e-01 | 4.98e-01 | 1.95e-01 |
RNA Polymerase I Promoter Clearance | 66 | 2.72e-03 | 7.01e-03 | 0.2130 | 0.049300 | -0.109000 | -0.176000 | 4.89e-01 | 1.25e-01 | 1.33e-02 |
RNA Polymerase I Transcription | 66 | 2.72e-03 | 7.01e-03 | 0.2130 | 0.049300 | -0.109000 | -0.176000 | 4.89e-01 | 1.25e-01 | 1.33e-02 |
PI Metabolism | 79 | 1.81e-02 | 3.49e-02 | 0.2130 | 0.098900 | 0.175000 | -0.070500 | 1.29e-01 | 7.18e-03 | 2.78e-01 |
RNA Polymerase I Promoter Escape | 47 | 3.46e-03 | 8.56e-03 | 0.2130 | 0.131000 | -0.071000 | -0.152000 | 1.21e-01 | 4.00e-01 | 7.11e-02 |
CD28 co-stimulation | 33 | 1.04e-01 | 1.53e-01 | 0.2130 | -0.050600 | 0.002070 | -0.207000 | 6.15e-01 | 9.84e-01 | 3.98e-02 |
Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | 17 | 4.25e-01 | 4.88e-01 | 0.2130 | -0.080000 | -0.194000 | 0.034000 | 5.68e-01 | 1.66e-01 | 8.08e-01 |
RNA Polymerase II Transcription Termination | 65 | 4.27e-03 | 1.02e-02 | 0.2120 | -0.029500 | -0.183000 | -0.103000 | 6.81e-01 | 1.06e-02 | 1.53e-01 |
FCGR3A-mediated IL10 synthesis | 99 | 2.16e-03 | 5.83e-03 | 0.2110 | -0.072400 | -0.138000 | 0.142000 | 2.13e-01 | 1.74e-02 | 1.46e-02 |
Constitutive Signaling by Aberrant PI3K in Cancer | 54 | 6.58e-02 | 1.06e-01 | 0.2100 | 0.059700 | -0.015300 | -0.201000 | 4.48e-01 | 8.46e-01 | 1.06e-02 |
Cytosolic sulfonation of small molecules | 19 | 6.80e-01 | 7.24e-01 | 0.2100 | 0.142000 | 0.131000 | -0.082400 | 2.85e-01 | 3.22e-01 | 5.34e-01 |
Keratan sulfate biosynthesis | 22 | 2.58e-01 | 3.22e-01 | 0.2070 | -0.016400 | 0.042700 | -0.202000 | 8.94e-01 | 7.29e-01 | 1.01e-01 |
Nucleotide Excision Repair | 110 | 2.74e-04 | 9.73e-04 | 0.2070 | -0.009150 | -0.143000 | -0.149000 | 8.68e-01 | 9.35e-03 | 6.99e-03 |
Ub-specific processing proteases | 170 | 2.08e-04 | 7.72e-04 | 0.2070 | 0.182000 | 0.095400 | -0.022200 | 4.18e-05 | 3.18e-02 | 6.17e-01 |
Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | 16 | 2.26e-01 | 2.88e-01 | 0.2070 | -0.027300 | -0.193000 | 0.068800 | 8.50e-01 | 1.81e-01 | 6.34e-01 |
Deadenylation-dependent mRNA decay | 53 | 1.00e-03 | 2.97e-03 | 0.2070 | -0.010200 | -0.206000 | -0.001770 | 8.97e-01 | 9.32e-03 | 9.82e-01 |
Molecules associated with elastic fibres | 22 | 5.28e-01 | 5.87e-01 | 0.2070 | 0.111000 | 0.068600 | -0.160000 | 3.68e-01 | 5.77e-01 | 1.93e-01 |
Protein methylation | 15 | 8.64e-02 | 1.31e-01 | 0.2060 | 0.128000 | -0.130000 | -0.095800 | 3.91e-01 | 3.84e-01 | 5.21e-01 |
Cohesin Loading onto Chromatin | 10 | 3.77e-01 | 4.44e-01 | 0.2050 | 0.193000 | 0.015000 | 0.069500 | 2.92e-01 | 9.35e-01 | 7.04e-01 |
Fertilization | 12 | 7.17e-01 | 7.59e-01 | 0.2050 | 0.082700 | 0.032900 | -0.185000 | 6.20e-01 | 8.44e-01 | 2.68e-01 |
Transport of vitamins, nucleosides, and related molecules | 33 | 4.97e-01 | 5.60e-01 | 0.2050 | 0.147000 | 0.133000 | -0.052200 | 1.45e-01 | 1.85e-01 | 6.04e-01 |
Synthesis of substrates in N-glycan biosythesis | 58 | 1.35e-01 | 1.90e-01 | 0.2050 | 0.128000 | 0.074600 | -0.141000 | 9.10e-02 | 3.26e-01 | 6.28e-02 |
Post-translational protein modification | 1188 | 1.62e-19 | 4.09e-18 | 0.2050 | 0.152000 | 0.110000 | -0.082300 | 1.13e-18 | 1.78e-10 | 1.81e-06 |
Association of TriC/CCT with target proteins during biosynthesis | 37 | 2.19e-01 | 2.80e-01 | 0.2040 | 0.046900 | 0.004010 | -0.199000 | 6.21e-01 | 9.66e-01 | 3.65e-02 |
FRS-mediated FGFR3 signaling | 11 | 3.99e-01 | 4.64e-01 | 0.2040 | 0.188000 | 0.029500 | 0.073900 | 2.81e-01 | 8.66e-01 | 6.71e-01 |
RUNX2 regulates bone development | 23 | 7.86e-02 | 1.21e-01 | 0.2040 | 0.013700 | 0.203000 | -0.013600 | 9.10e-01 | 9.18e-02 | 9.10e-01 |
Host Interactions of HIV factors | 129 | 1.91e-05 | 9.62e-05 | 0.2040 | 0.085100 | -0.063600 | -0.174000 | 9.50e-02 | 2.12e-01 | 6.41e-04 |
NoRC negatively regulates rRNA expression | 62 | 4.46e-03 | 1.07e-02 | 0.2040 | 0.138000 | -0.026200 | -0.147000 | 5.95e-02 | 7.22e-01 | 4.49e-02 |
Synthesis of IP2, IP, and Ins in the cytosol | 13 | 6.60e-01 | 7.06e-01 | 0.2030 | 0.080900 | 0.179000 | 0.052300 | 6.14e-01 | 2.63e-01 | 7.44e-01 |
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | 91 | 6.62e-03 | 1.48e-02 | 0.2030 | -0.038900 | -0.063200 | 0.189000 | 5.21e-01 | 2.98e-01 | 1.80e-03 |
Amplification of signal from the kinetochores | 91 | 6.62e-03 | 1.48e-02 | 0.2030 | -0.038900 | -0.063200 | 0.189000 | 5.21e-01 | 2.98e-01 | 1.80e-03 |
Resolution of Sister Chromatid Cohesion | 104 | 7.88e-04 | 2.40e-03 | 0.2030 | -0.007230 | -0.055100 | 0.196000 | 8.99e-01 | 3.31e-01 | 5.69e-04 |
Formation of RNA Pol II elongation complex | 57 | 7.81e-02 | 1.21e-01 | 0.2020 | 0.150000 | 0.051800 | -0.126000 | 5.06e-02 | 4.99e-01 | 1.00e-01 |
RNA Polymerase II Transcription Elongation | 57 | 7.81e-02 | 1.21e-01 | 0.2020 | 0.150000 | 0.051800 | -0.126000 | 5.06e-02 | 4.99e-01 | 1.00e-01 |
Glucose metabolism | 83 | 4.22e-02 | 7.15e-02 | 0.2020 | 0.097700 | 0.064200 | -0.165000 | 1.24e-01 | 3.12e-01 | 9.50e-03 |
Phase I - Functionalization of compounds | 61 | 1.07e-01 | 1.57e-01 | 0.2010 | 0.099000 | 0.055600 | -0.166000 | 1.81e-01 | 4.53e-01 | 2.49e-02 |
Downstream TCR signaling | 100 | 2.34e-04 | 8.50e-04 | 0.2010 | 0.077100 | -0.075000 | -0.170000 | 1.83e-01 | 1.95e-01 | 3.33e-03 |
Signaling by ERBB2 KD Mutants | 20 | 1.26e-01 | 1.80e-01 | 0.2010 | 0.184000 | -0.015100 | -0.078200 | 1.54e-01 | 9.07e-01 | 5.45e-01 |
APC-Cdc20 mediated degradation of Nek2A | 26 | 4.57e-02 | 7.65e-02 | 0.2000 | 0.022400 | -0.186000 | -0.072300 | 8.43e-01 | 1.01e-01 | 5.23e-01 |
Cyclin E associated events during G1/S transition | 83 | 1.11e-03 | 3.22e-03 | 0.2000 | 0.175000 | 0.020600 | -0.094100 | 5.71e-03 | 7.46e-01 | 1.39e-01 |
G0 and Early G1 | 27 | 2.22e-02 | 4.18e-02 | 0.2000 | 0.019100 | -0.177000 | 0.090500 | 8.63e-01 | 1.11e-01 | 4.16e-01 |
KSRP (KHSRP) binds and destabilizes mRNA | 17 | 2.94e-01 | 3.59e-01 | 0.2000 | -0.024100 | -0.189000 | -0.059200 | 8.64e-01 | 1.77e-01 | 6.73e-01 |
Regulation of HSF1-mediated heat shock response | 79 | 2.28e-02 | 4.27e-02 | 0.1990 | -0.079900 | -0.179000 | -0.037100 | 2.20e-01 | 6.03e-03 | 5.69e-01 |
ECM proteoglycans | 35 | 4.20e-01 | 4.84e-01 | 0.1990 | 0.115000 | 0.118000 | -0.110000 | 2.37e-01 | 2.27e-01 | 2.59e-01 |
HCMV Infection | 96 | 1.14e-02 | 2.35e-02 | 0.1980 | 0.150000 | 0.053100 | -0.118000 | 1.09e-02 | 3.69e-01 | 4.63e-02 |
Leishmania infection | 245 | 2.80e-04 | 9.88e-04 | 0.1980 | 0.149000 | 0.101000 | -0.082900 | 6.19e-05 | 6.59e-03 | 2.54e-02 |
APC/C-mediated degradation of cell cycle proteins | 86 | 1.76e-04 | 6.60e-04 | 0.1970 | 0.189000 | 0.016200 | -0.056200 | 2.51e-03 | 7.96e-01 | 3.67e-01 |
Regulation of mitotic cell cycle | 86 | 1.76e-04 | 6.60e-04 | 0.1970 | 0.189000 | 0.016200 | -0.056200 | 2.51e-03 | 7.96e-01 | 3.67e-01 |
Phase 0 - rapid depolarisation | 28 | 1.69e-01 | 2.29e-01 | 0.1970 | -0.160000 | -0.011800 | 0.114000 | 1.42e-01 | 9.14e-01 | 2.95e-01 |
Glucagon-type ligand receptors | 20 | 5.25e-01 | 5.85e-01 | 0.1970 | 0.043200 | 0.022300 | -0.191000 | 7.38e-01 | 8.63e-01 | 1.39e-01 |
Metabolism of proteins | 1710 | 4.91e-46 | 2.30e-44 | 0.1970 | 0.130000 | 0.017100 | -0.146000 | 2.90e-19 | 2.40e-01 | 8.97e-24 |
Signaling by PDGF | 44 | 4.08e-01 | 4.73e-01 | 0.1960 | 0.138000 | 0.132000 | -0.046400 | 1.13e-01 | 1.30e-01 | 5.94e-01 |
Nuclear Envelope Breakdown | 53 | 1.49e-01 | 2.06e-01 | 0.1960 | -0.092600 | -0.139000 | 0.104000 | 2.44e-01 | 8.08e-02 | 1.91e-01 |
Signaling by FGFR | 69 | 7.32e-02 | 1.15e-01 | 0.1950 | 0.091200 | 0.035500 | -0.169000 | 1.90e-01 | 6.10e-01 | 1.51e-02 |
Neddylation | 218 | 1.05e-05 | 5.75e-05 | 0.1950 | 0.162000 | 0.058400 | -0.091300 | 3.56e-05 | 1.37e-01 | 2.02e-02 |
Processing and activation of SUMO | 10 | 3.49e-01 | 4.18e-01 | 0.1950 | 0.060600 | -0.105000 | 0.152000 | 7.40e-01 | 5.64e-01 | 4.04e-01 |
Global Genome Nucleotide Excision Repair (GG-NER) | 84 | 5.81e-03 | 1.32e-02 | 0.1950 | -0.044800 | -0.170000 | -0.083300 | 4.78e-01 | 6.93e-03 | 1.87e-01 |
FCERI mediated MAPK activation | 90 | 8.34e-05 | 3.49e-04 | 0.1940 | 0.012200 | -0.111000 | 0.159000 | 8.41e-01 | 6.87e-02 | 9.05e-03 |
Interaction between L1 and Ankyrins | 21 | 5.05e-01 | 5.66e-01 | 0.1940 | 0.006030 | 0.052700 | 0.187000 | 9.62e-01 | 6.76e-01 | 1.39e-01 |
FRS-mediated FGFR1 signaling | 14 | 6.76e-01 | 7.21e-01 | 0.1940 | 0.143000 | 0.092500 | 0.092500 | 3.54e-01 | 5.49e-01 | 5.49e-01 |
APC/C:Cdc20 mediated degradation of Cyclin B | 24 | 4.23e-02 | 7.16e-02 | 0.1940 | 0.082700 | -0.143000 | -0.101000 | 4.83e-01 | 2.25e-01 | 3.93e-01 |
Post NMDA receptor activation events | 48 | 2.02e-01 | 2.63e-01 | 0.1930 | 0.097900 | 0.043000 | -0.161000 | 2.41e-01 | 6.06e-01 | 5.34e-02 |
Synthesis of PIPs at the Golgi membrane | 16 | 4.08e-01 | 4.73e-01 | 0.1930 | 0.050100 | 0.180000 | -0.046300 | 7.28e-01 | 2.12e-01 | 7.49e-01 |
SHC-mediated cascade:FGFR2 | 12 | 5.73e-01 | 6.25e-01 | 0.1930 | -0.042700 | -0.137000 | 0.128000 | 7.98e-01 | 4.10e-01 | 4.42e-01 |
Activation of NMDA receptors and postsynaptic events | 58 | 1.02e-01 | 1.51e-01 | 0.1920 | 0.103000 | 0.023300 | -0.160000 | 1.74e-01 | 7.59e-01 | 3.45e-02 |
Cellular response to heat stress | 93 | 1.69e-02 | 3.29e-02 | 0.1920 | -0.068300 | -0.161000 | -0.078200 | 2.55e-01 | 7.16e-03 | 1.92e-01 |
PI-3K cascade:FGFR2 | 12 | 5.61e-01 | 6.14e-01 | 0.1920 | -0.053400 | -0.176000 | 0.055300 | 7.49e-01 | 2.92e-01 | 7.40e-01 |
EGR2 and SOX10-mediated initiation of Schwann cell myelination | 22 | 1.51e-01 | 2.08e-01 | 0.1920 | 0.020500 | 0.175000 | -0.075000 | 8.68e-01 | 1.55e-01 | 5.43e-01 |
Interleukin-20 family signaling | 17 | 7.39e-01 | 7.78e-01 | 0.1910 | 0.111000 | 0.152000 | -0.032500 | 4.28e-01 | 2.79e-01 | 8.16e-01 |
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | 182 | 4.39e-03 | 1.05e-02 | 0.1900 | -0.135000 | -0.121000 | -0.056400 | 1.63e-03 | 4.80e-03 | 1.90e-01 |
Voltage gated Potassium channels | 24 | 1.41e-01 | 1.97e-01 | 0.1900 | 0.014800 | 0.150000 | -0.115000 | 9.00e-01 | 2.02e-01 | 3.28e-01 |
Fatty acyl-CoA biosynthesis | 33 | 5.50e-01 | 6.04e-01 | 0.1900 | 0.142000 | 0.115000 | -0.051800 | 1.59e-01 | 2.53e-01 | 6.06e-01 |
Deactivation of the beta-catenin transactivating complex | 36 | 2.88e-01 | 3.53e-01 | 0.1890 | 0.034500 | 0.012300 | -0.186000 | 7.20e-01 | 8.99e-01 | 5.36e-02 |
Regulation of actin dynamics for phagocytic cup formation | 123 | 1.95e-03 | 5.31e-03 | 0.1890 | 0.160000 | 0.080700 | 0.061100 | 2.20e-03 | 1.22e-01 | 2.42e-01 |
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | 46 | 2.42e-01 | 3.03e-01 | 0.1880 | 0.092000 | 0.041000 | -0.159000 | 2.80e-01 | 6.30e-01 | 6.23e-02 |
SUMOylation of transcription cofactors | 44 | 2.20e-01 | 2.81e-01 | 0.1880 | 0.063800 | 0.008980 | -0.177000 | 4.64e-01 | 9.18e-01 | 4.27e-02 |
mRNA decay by 5' to 3' exoribonuclease | 15 | 4.05e-01 | 4.71e-01 | 0.1870 | -0.009810 | -0.168000 | -0.082700 | 9.48e-01 | 2.61e-01 | 5.79e-01 |
Signaling by FGFR3 in disease | 13 | 3.08e-01 | 3.74e-01 | 0.1870 | 0.017900 | -0.138000 | 0.125000 | 9.11e-01 | 3.87e-01 | 4.36e-01 |
Signaling by FGFR3 point mutants in cancer | 13 | 3.08e-01 | 3.74e-01 | 0.1870 | 0.017900 | -0.138000 | 0.125000 | 9.11e-01 | 3.87e-01 | 4.36e-01 |
Cyclin A:Cdk2-associated events at S phase entry | 85 | 2.29e-03 | 6.08e-03 | 0.1870 | 0.159000 | 0.012500 | -0.097300 | 1.13e-02 | 8.42e-01 | 1.21e-01 |
TP53 Regulates Transcription of Death Receptors and Ligands | 11 | 4.08e-01 | 4.73e-01 | 0.1870 | 0.159000 | -0.034900 | -0.090600 | 3.60e-01 | 8.41e-01 | 6.03e-01 |
Class B/2 (Secretin family receptors) | 56 | 4.62e-02 | 7.71e-02 | 0.1860 | 0.020200 | 0.079500 | -0.167000 | 7.94e-01 | 3.04e-01 | 3.02e-02 |
Metal ion SLC transporters | 21 | 7.26e-01 | 7.68e-01 | 0.1860 | 0.132000 | 0.110000 | -0.070100 | 2.94e-01 | 3.81e-01 | 5.78e-01 |
Blood group systems biosynthesis | 17 | 5.36e-01 | 5.93e-01 | 0.1850 | 0.150000 | 0.033100 | -0.103000 | 2.84e-01 | 8.13e-01 | 4.60e-01 |
Regulation of TP53 Activity through Phosphorylation | 88 | 7.53e-02 | 1.18e-01 | 0.1840 | -0.093500 | -0.108000 | 0.116000 | 1.30e-01 | 7.93e-02 | 5.92e-02 |
Ion homeostasis | 40 | 1.50e-01 | 2.07e-01 | 0.1840 | 0.016400 | 0.064900 | -0.171000 | 8.58e-01 | 4.77e-01 | 6.10e-02 |
Activation of RAC1 | 11 | 7.93e-01 | 8.23e-01 | 0.1840 | 0.161000 | 0.078500 | -0.038300 | 3.54e-01 | 6.52e-01 | 8.26e-01 |
TCR signaling | 121 | 6.51e-04 | 2.04e-03 | 0.1830 | 0.077600 | -0.046000 | -0.160000 | 1.41e-01 | 3.82e-01 | 2.40e-03 |
FOXO-mediated transcription of cell cycle genes | 15 | 6.82e-01 | 7.26e-01 | 0.1830 | 0.011900 | -0.011300 | -0.182000 | 9.37e-01 | 9.40e-01 | 2.22e-01 |
Negative epigenetic regulation of rRNA expression | 65 | 6.64e-03 | 1.48e-02 | 0.1820 | 0.101000 | -0.057300 | -0.140000 | 1.57e-01 | 4.24e-01 | 5.03e-02 |
Peptide ligand-binding receptors | 91 | 9.92e-02 | 1.48e-01 | 0.1820 | 0.108000 | 0.088400 | -0.117000 | 7.57e-02 | 1.45e-01 | 5.46e-02 |
HATs acetylate histones | 93 | 2.75e-02 | 5.00e-02 | 0.1820 | -0.016900 | -0.039900 | -0.176000 | 7.78e-01 | 5.06e-01 | 3.29e-03 |
CASP8 activity is inhibited | 11 | 7.46e-01 | 7.82e-01 | 0.1810 | -0.010700 | -0.028000 | 0.179000 | 9.51e-01 | 8.72e-01 | 3.05e-01 |
Dimerization of procaspase-8 | 11 | 7.46e-01 | 7.82e-01 | 0.1810 | -0.010700 | -0.028000 | 0.179000 | 9.51e-01 | 8.72e-01 | 3.05e-01 |
Regulation by c-FLIP | 11 | 7.46e-01 | 7.82e-01 | 0.1810 | -0.010700 | -0.028000 | 0.179000 | 9.51e-01 | 8.72e-01 | 3.05e-01 |
Mitotic Spindle Checkpoint | 108 | 4.55e-03 | 1.08e-02 | 0.1810 | -0.032300 | -0.078900 | 0.159000 | 5.62e-01 | 1.56e-01 | 4.19e-03 |
Synthesis of DNA | 118 | 1.69e-04 | 6.38e-04 | 0.1800 | -0.031500 | -0.174000 | -0.036000 | 5.55e-01 | 1.09e-03 | 4.99e-01 |
EML4 and NUDC in mitotic spindle formation | 95 | 1.16e-02 | 2.38e-02 | 0.1800 | -0.020200 | -0.052500 | 0.171000 | 7.34e-01 | 3.76e-01 | 3.92e-03 |
HIV Infection | 224 | 4.21e-07 | 3.58e-06 | 0.1790 | 0.130000 | -0.002760 | -0.123000 | 7.72e-04 | 9.43e-01 | 1.57e-03 |
PI3K Cascade | 30 | 4.30e-01 | 4.94e-01 | 0.1790 | 0.056100 | 0.002460 | -0.170000 | 5.95e-01 | 9.81e-01 | 1.08e-01 |
Amino acid transport across the plasma membrane | 23 | 4.77e-01 | 5.40e-01 | 0.1780 | 0.147000 | 0.043600 | -0.091100 | 2.23e-01 | 7.18e-01 | 4.50e-01 |
Chromatin modifying enzymes | 217 | 2.46e-04 | 8.89e-04 | 0.1770 | 0.047800 | 0.041100 | -0.166000 | 2.25e-01 | 2.97e-01 | 2.64e-05 |
Chromatin organization | 217 | 2.46e-04 | 8.89e-04 | 0.1770 | 0.047800 | 0.041100 | -0.166000 | 2.25e-01 | 2.97e-01 | 2.64e-05 |
G alpha (i) signalling events | 241 | 1.27e-03 | 3.65e-03 | 0.1770 | 0.108000 | 0.080900 | -0.115000 | 3.93e-03 | 3.05e-02 | 2.19e-03 |
TICAM1-dependent activation of IRF3/IRF7 | 12 | 7.63e-01 | 7.97e-01 | 0.1770 | 0.074900 | -0.000749 | -0.160000 | 6.53e-01 | 9.96e-01 | 3.37e-01 |
TRP channels | 17 | 4.75e-01 | 5.38e-01 | 0.1760 | -0.065400 | 0.066200 | 0.150000 | 6.40e-01 | 6.37e-01 | 2.85e-01 |
Downstream signaling of activated FGFR1 | 20 | 5.66e-01 | 6.18e-01 | 0.1760 | 0.094300 | 0.062700 | 0.135000 | 4.65e-01 | 6.27e-01 | 2.95e-01 |
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | 17 | 6.94e-01 | 7.37e-01 | 0.1760 | -0.082300 | -0.156000 | 0.005300 | 5.57e-01 | 2.67e-01 | 9.70e-01 |
RNA polymerase II transcribes snRNA genes | 72 | 7.09e-02 | 1.12e-01 | 0.1750 | 0.110000 | 0.071100 | 0.116000 | 1.06e-01 | 2.97e-01 | 8.76e-02 |
SHC-mediated cascade:FGFR1 | 12 | 8.09e-01 | 8.37e-01 | 0.1750 | 0.107000 | 0.089000 | 0.107000 | 5.21e-01 | 5.93e-01 | 5.22e-01 |
Regulation of PTEN mRNA translation | 13 | 5.34e-01 | 5.91e-01 | 0.1750 | -0.057500 | 0.090400 | 0.139000 | 7.20e-01 | 5.72e-01 | 3.86e-01 |
Regulation of RUNX1 Expression and Activity | 18 | 5.84e-01 | 6.34e-01 | 0.1750 | -0.072900 | 0.021300 | 0.158000 | 5.92e-01 | 8.76e-01 | 2.46e-01 |
Cilium Assembly | 181 | 1.06e-02 | 2.24e-02 | 0.1750 | -0.101000 | -0.141000 | 0.022300 | 1.88e-02 | 1.10e-03 | 6.06e-01 |
Fcgamma receptor (FCGR) dependent phagocytosis | 147 | 1.53e-02 | 3.04e-02 | 0.1740 | 0.145000 | 0.095500 | 0.019000 | 2.44e-03 | 4.57e-02 | 6.90e-01 |
Cellular hexose transport | 15 | 7.75e-01 | 8.08e-01 | 0.1740 | -0.105000 | -0.095800 | -0.101000 | 4.83e-01 | 5.21e-01 | 4.97e-01 |
Lysine catabolism | 11 | 8.65e-01 | 8.85e-01 | 0.1730 | 0.087100 | 0.138000 | 0.057500 | 6.17e-01 | 4.27e-01 | 7.41e-01 |
Signaling by NTRK2 (TRKB) | 20 | 6.91e-01 | 7.34e-01 | 0.1730 | 0.148000 | 0.088100 | -0.006390 | 2.50e-01 | 4.95e-01 | 9.61e-01 |
DNA Double Strand Break Response | 47 | 3.05e-01 | 3.71e-01 | 0.1720 | 0.079400 | 0.034000 | -0.149000 | 3.46e-01 | 6.87e-01 | 7.79e-02 |
TP53 Regulates Transcription of Cell Death Genes | 42 | 1.61e-01 | 2.19e-01 | 0.1710 | 0.160000 | 0.045100 | -0.041300 | 7.29e-02 | 6.13e-01 | 6.43e-01 |
Eicosanoid ligand-binding receptors | 13 | 7.83e-01 | 8.14e-01 | 0.1710 | -0.051500 | -0.064500 | -0.149000 | 7.48e-01 | 6.87e-01 | 3.52e-01 |
Methylation | 12 | 7.65e-01 | 7.99e-01 | 0.1700 | -0.022700 | -0.108000 | -0.130000 | 8.92e-01 | 5.18e-01 | 4.37e-01 |
Basigin interactions | 23 | 3.81e-01 | 4.47e-01 | 0.1690 | 0.061900 | -0.062800 | -0.144000 | 6.07e-01 | 6.02e-01 | 2.31e-01 |
Non-integrin membrane-ECM interactions | 37 | 2.95e-01 | 3.59e-01 | 0.1690 | 0.111000 | 0.013000 | -0.127000 | 2.44e-01 | 8.91e-01 | 1.81e-01 |
Orc1 removal from chromatin | 69 | 1.39e-03 | 3.97e-03 | 0.1690 | 0.141000 | -0.040700 | -0.084600 | 4.36e-02 | 5.58e-01 | 2.24e-01 |
Downstream signaling of activated FGFR3 | 16 | 3.96e-01 | 4.61e-01 | 0.1690 | 0.135000 | 0.014900 | 0.100000 | 3.50e-01 | 9.18e-01 | 4.89e-01 |
Signaling by ERBB2 ECD mutants | 15 | 5.74e-01 | 6.25e-01 | 0.1680 | 0.153000 | 0.050100 | 0.049500 | 3.06e-01 | 7.37e-01 | 7.40e-01 |
Zinc transporters | 14 | 8.52e-01 | 8.74e-01 | 0.1680 | 0.130000 | 0.087800 | -0.058100 | 3.98e-01 | 5.70e-01 | 7.07e-01 |
Peptide hormone metabolism | 49 | 1.27e-01 | 1.82e-01 | 0.1670 | 0.159000 | 0.050600 | -0.018600 | 5.48e-02 | 5.40e-01 | 8.22e-01 |
Signaling by FGFR2 in disease | 32 | 1.08e-01 | 1.58e-01 | 0.1670 | 0.042500 | -0.121000 | -0.107000 | 6.77e-01 | 2.35e-01 | 2.94e-01 |
S Phase | 160 | 3.36e-05 | 1.56e-04 | 0.1670 | -0.032200 | -0.163000 | -0.016400 | 4.82e-01 | 3.78e-04 | 7.21e-01 |
GABA synthesis, release, reuptake and degradation | 13 | 7.94e-01 | 8.24e-01 | 0.1670 | -0.030600 | -0.065000 | -0.150000 | 8.48e-01 | 6.85e-01 | 3.48e-01 |
Interferon gamma signaling | 83 | 1.08e-02 | 2.25e-02 | 0.1650 | -0.144000 | -0.014000 | 0.078700 | 2.32e-02 | 8.25e-01 | 2.15e-01 |
Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | 20 | 3.95e-01 | 4.60e-01 | 0.1640 | -0.016100 | -0.153000 | -0.057500 | 9.01e-01 | 2.36e-01 | 6.56e-01 |
SLC-mediated transmembrane transport | 179 | 2.87e-02 | 5.20e-02 | 0.1640 | 0.103000 | 0.104000 | -0.074000 | 1.72e-02 | 1.66e-02 | 8.78e-02 |
Glycolysis | 66 | 2.30e-01 | 2.91e-01 | 0.1630 | 0.093400 | 0.046000 | -0.125000 | 1.89e-01 | 5.18e-01 | 7.85e-02 |
SUMOylation of transcription factors | 16 | 8.34e-01 | 8.58e-01 | 0.1610 | 0.132000 | 0.087100 | -0.032300 | 3.61e-01 | 5.46e-01 | 8.23e-01 |
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | 23 | 7.22e-01 | 7.63e-01 | 0.1610 | 0.090900 | 0.064800 | -0.116000 | 4.50e-01 | 5.90e-01 | 3.36e-01 |
Cell-cell junction organization | 36 | 4.13e-01 | 4.77e-01 | 0.1610 | 0.042900 | -0.018300 | -0.154000 | 6.56e-01 | 8.49e-01 | 1.10e-01 |
DNA Replication | 125 | 1.86e-04 | 6.97e-04 | 0.1610 | -0.018700 | -0.159000 | -0.015600 | 7.17e-01 | 2.17e-03 | 7.63e-01 |
FCGR3A-mediated phagocytosis | 121 | 1.50e-02 | 2.99e-02 | 0.1600 | 0.134000 | 0.068300 | 0.054800 | 1.08e-02 | 1.95e-01 | 2.98e-01 |
Leishmania phagocytosis | 121 | 1.50e-02 | 2.99e-02 | 0.1600 | 0.134000 | 0.068300 | 0.054800 | 1.08e-02 | 1.95e-01 | 2.98e-01 |
Parasite infection | 121 | 1.50e-02 | 2.99e-02 | 0.1600 | 0.134000 | 0.068300 | 0.054800 | 1.08e-02 | 1.95e-01 | 2.98e-01 |
The phototransduction cascade | 25 | 7.35e-01 | 7.75e-01 | 0.1590 | -0.092100 | -0.130000 | -0.004970 | 4.25e-01 | 2.61e-01 | 9.66e-01 |
Lysosphingolipid and LPA receptors | 11 | 8.12e-01 | 8.39e-01 | 0.1590 | -0.015100 | -0.003710 | -0.158000 | 9.31e-01 | 9.83e-01 | 3.63e-01 |
Signaling by GPCR | 530 | 1.34e-06 | 9.63e-06 | 0.1590 | 0.083300 | 0.108000 | -0.081100 | 1.04e-03 | 1.96e-05 | 1.40e-03 |
Gene expression (Transcription) | 1324 | 3.28e-12 | 5.68e-11 | 0.1590 | -0.101000 | -0.122000 | -0.014500 | 6.51e-10 | 1.06e-13 | 3.76e-01 |
G alpha (s) signalling events | 140 | 2.90e-02 | 5.22e-02 | 0.1590 | 0.068500 | 0.131000 | 0.057800 | 1.62e-01 | 7.46e-03 | 2.38e-01 |
CTLA4 inhibitory signaling | 21 | 5.65e-01 | 6.18e-01 | 0.1590 | -0.013900 | 0.016200 | -0.157000 | 9.12e-01 | 8.98e-01 | 2.12e-01 |
DNA Double-Strand Break Repair | 135 | 1.01e-01 | 1.51e-01 | 0.1590 | -0.102000 | -0.102000 | 0.064800 | 4.03e-02 | 3.99e-02 | 1.94e-01 |
Class I peroxisomal membrane protein import | 20 | 8.26e-01 | 8.49e-01 | 0.1580 | -0.122000 | -0.098800 | 0.019400 | 3.44e-01 | 4.44e-01 | 8.81e-01 |
FRS-mediated FGFR4 signaling | 12 | 4.36e-01 | 5.00e-01 | 0.1580 | 0.158000 | -0.012500 | 0.006510 | 3.44e-01 | 9.40e-01 | 9.69e-01 |
Metabolic disorders of biological oxidation enzymes | 23 | 7.44e-01 | 7.82e-01 | 0.1570 | 0.098200 | 0.065200 | -0.104000 | 4.15e-01 | 5.88e-01 | 3.88e-01 |
Cytosolic sensors of pathogen-associated DNA | 62 | 2.12e-01 | 2.73e-01 | 0.1570 | 0.035500 | -0.011300 | -0.152000 | 6.29e-01 | 8.78e-01 | 3.80e-02 |
PI-3K cascade:FGFR4 | 10 | 5.04e-01 | 5.65e-01 | 0.1560 | 0.104000 | -0.083800 | -0.081000 | 5.68e-01 | 6.46e-01 | 6.57e-01 |
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | 18 | 7.43e-01 | 7.82e-01 | 0.1560 | -0.030100 | -0.063800 | -0.139000 | 8.25e-01 | 6.39e-01 | 3.07e-01 |
DNA Replication Pre-Initiation | 82 | 8.31e-04 | 2.51e-03 | 0.1560 | 0.051000 | -0.122000 | -0.081800 | 4.25e-01 | 5.57e-02 | 2.00e-01 |
Formation of Incision Complex in GG-NER | 43 | 9.93e-03 | 2.13e-02 | 0.1550 | 0.037900 | -0.142000 | 0.048100 | 6.67e-01 | 1.06e-01 | 5.85e-01 |
Mitotic Prometaphase | 185 | 3.15e-03 | 7.93e-03 | 0.1550 | -0.049500 | -0.081300 | 0.122000 | 2.45e-01 | 5.65e-02 | 4.14e-03 |
Cytokine Signaling in Immune system | 732 | 3.50e-07 | 3.04e-06 | 0.1550 | 0.107000 | 0.081600 | -0.076900 | 8.59e-07 | 1.70e-04 | 4.00e-04 |
Miscellaneous transport and binding events | 20 | 4.74e-01 | 5.37e-01 | 0.1550 | 0.146000 | 0.022500 | -0.045400 | 2.57e-01 | 8.61e-01 | 7.25e-01 |
G2/M DNA damage checkpoint | 67 | 1.37e-01 | 1.93e-01 | 0.1550 | -0.038400 | -0.075300 | 0.130000 | 5.87e-01 | 2.87e-01 | 6.65e-02 |
Diseases of metabolism | 187 | 2.72e-03 | 7.01e-03 | 0.1550 | 0.028800 | 0.041400 | -0.146000 | 4.97e-01 | 3.29e-01 | 5.64e-04 |
Transcriptional regulation by small RNAs | 63 | 8.19e-02 | 1.25e-01 | 0.1540 | 0.074200 | -0.036400 | -0.130000 | 3.09e-01 | 6.18e-01 | 7.41e-02 |
Homology Directed Repair | 110 | 1.55e-01 | 2.13e-01 | 0.1540 | -0.089900 | -0.106000 | 0.064900 | 1.03e-01 | 5.38e-02 | 2.39e-01 |
RUNX2 regulates osteoblast differentiation | 18 | 1.39e-01 | 1.94e-01 | 0.1540 | -0.066900 | 0.132000 | -0.042500 | 6.23e-01 | 3.34e-01 | 7.55e-01 |
mRNA Capping | 29 | 1.44e-01 | 2.00e-01 | 0.1530 | 0.088700 | -0.077700 | -0.097100 | 4.09e-01 | 4.69e-01 | 3.65e-01 |
Metabolism of folate and pterines | 16 | 7.09e-01 | 7.51e-01 | 0.1530 | 0.140000 | 0.058300 | 0.015800 | 3.31e-01 | 6.86e-01 | 9.13e-01 |
Signaling by FGFR4 in disease | 11 | 5.71e-01 | 6.23e-01 | 0.1520 | 0.064700 | -0.051400 | 0.127000 | 7.10e-01 | 7.68e-01 | 4.66e-01 |
Ras activation upon Ca2+ influx through NMDA receptor | 15 | 9.01e-01 | 9.14e-01 | 0.1510 | -0.109000 | -0.102000 | 0.021500 | 4.63e-01 | 4.92e-01 | 8.85e-01 |
FRS-mediated FGFR2 signaling | 14 | 4.99e-01 | 5.61e-01 | 0.1510 | 0.014800 | -0.101000 | 0.111000 | 9.24e-01 | 5.11e-01 | 4.73e-01 |
Generic Transcription Pathway | 1075 | 5.35e-09 | 6.33e-08 | 0.1510 | -0.102000 | -0.108000 | -0.027400 | 1.87e-08 | 2.52e-09 | 1.29e-01 |
G1/S Transition | 130 | 3.57e-05 | 1.65e-04 | 0.1510 | 0.004980 | -0.150000 | -0.016100 | 9.22e-01 | 3.23e-03 | 7.51e-01 |
MET activates PTK2 signaling | 15 | 5.27e-01 | 5.86e-01 | 0.1500 | 0.145000 | 0.020100 | 0.033200 | 3.32e-01 | 8.93e-01 | 8.24e-01 |
Signaling by Retinoic Acid | 31 | 5.59e-01 | 6.12e-01 | 0.1490 | 0.029100 | -0.016800 | -0.146000 | 7.79e-01 | 8.71e-01 | 1.61e-01 |
Regulation of TP53 Expression and Degradation | 36 | 4.79e-01 | 5.41e-01 | 0.1490 | -0.014500 | -0.076800 | -0.127000 | 8.80e-01 | 4.25e-01 | 1.89e-01 |
GPCR downstream signalling | 488 | 3.85e-05 | 1.77e-04 | 0.1480 | 0.080200 | 0.098800 | -0.075700 | 2.41e-03 | 1.85e-04 | 4.19e-03 |
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | 31 | 5.62e-01 | 6.15e-01 | 0.1480 | 0.006040 | -0.040900 | -0.142000 | 9.54e-01 | 6.94e-01 | 1.72e-01 |
Phosphorylation of the APC/C | 20 | 1.71e-01 | 2.32e-01 | 0.1470 | 0.044700 | -0.130000 | 0.054500 | 7.29e-01 | 3.16e-01 | 6.73e-01 |
Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS) | 10 | 7.87e-01 | 8.18e-01 | 0.1470 | -0.085400 | 0.028900 | 0.117000 | 6.40e-01 | 8.74e-01 | 5.24e-01 |
Downstream signaling of activated FGFR2 | 19 | 4.42e-01 | 5.04e-01 | 0.1470 | 0.015700 | -0.079300 | 0.123000 | 9.05e-01 | 5.50e-01 | 3.53e-01 |
Regulation of TNFR1 signaling | 32 | 5.74e-01 | 6.25e-01 | 0.1470 | -0.110000 | -0.071100 | -0.067400 | 2.82e-01 | 4.86e-01 | 5.10e-01 |
mRNA 3'-end processing | 56 | 1.85e-01 | 2.45e-01 | 0.1470 | -0.038500 | -0.134000 | -0.047300 | 6.19e-01 | 8.29e-02 | 5.40e-01 |
Ca2+ pathway | 57 | 5.42e-01 | 5.98e-01 | 0.1470 | 0.109000 | 0.092500 | -0.034200 | 1.54e-01 | 2.27e-01 | 6.56e-01 |
Prolactin receptor signaling | 11 | 5.48e-01 | 6.03e-01 | 0.1470 | 0.082400 | -0.045000 | 0.113000 | 6.36e-01 | 7.96e-01 | 5.15e-01 |
Regulation of TP53 Activity | 151 | 1.29e-01 | 1.84e-01 | 0.1470 | -0.098500 | -0.107000 | -0.019700 | 3.67e-02 | 2.35e-02 | 6.77e-01 |
Cytochrome P450 - arranged by substrate type | 33 | 7.27e-01 | 7.68e-01 | 0.1460 | 0.098600 | 0.085600 | -0.066100 | 3.27e-01 | 3.95e-01 | 5.11e-01 |
DAP12 signaling | 28 | 5.04e-01 | 5.66e-01 | 0.1460 | 0.041800 | 0.104000 | -0.093200 | 7.02e-01 | 3.40e-01 | 3.93e-01 |
Ion transport by P-type ATPases | 42 | 4.17e-01 | 4.81e-01 | 0.1460 | 0.061100 | 0.123000 | -0.046800 | 4.93e-01 | 1.66e-01 | 6.00e-01 |
IGF1R signaling cascade | 36 | 6.04e-01 | 6.53e-01 | 0.1430 | 0.094000 | 0.042700 | -0.098700 | 3.29e-01 | 6.58e-01 | 3.05e-01 |
Branched-chain amino acid catabolism | 21 | 7.54e-01 | 7.90e-01 | 0.1420 | -0.056800 | -0.082600 | 0.101000 | 6.52e-01 | 5.13e-01 | 4.22e-01 |
HIV Transcription Initiation | 45 | 2.53e-02 | 4.66e-02 | 0.1420 | 0.140000 | -0.026400 | 0.001700 | 1.05e-01 | 7.59e-01 | 9.84e-01 |
RNA Polymerase II HIV Promoter Escape | 45 | 2.53e-02 | 4.66e-02 | 0.1420 | 0.140000 | -0.026400 | 0.001700 | 1.05e-01 | 7.59e-01 | 9.84e-01 |
RNA Polymerase II Promoter Escape | 45 | 2.53e-02 | 4.66e-02 | 0.1420 | 0.140000 | -0.026400 | 0.001700 | 1.05e-01 | 7.59e-01 | 9.84e-01 |
RNA Polymerase II Transcription Initiation | 45 | 2.53e-02 | 4.66e-02 | 0.1420 | 0.140000 | -0.026400 | 0.001700 | 1.05e-01 | 7.59e-01 | 9.84e-01 |
RNA Polymerase II Transcription Initiation And Promoter Clearance | 45 | 2.53e-02 | 4.66e-02 | 0.1420 | 0.140000 | -0.026400 | 0.001700 | 1.05e-01 | 7.59e-01 | 9.84e-01 |
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | 45 | 2.53e-02 | 4.66e-02 | 0.1420 | 0.140000 | -0.026400 | 0.001700 | 1.05e-01 | 7.59e-01 | 9.84e-01 |
FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | 24 | 7.08e-01 | 7.50e-01 | 0.1410 | 0.096800 | 0.031200 | -0.098300 | 4.12e-01 | 7.91e-01 | 4.05e-01 |
Glyoxylate metabolism and glycine degradation | 24 | 2.88e-01 | 3.53e-01 | 0.1410 | -0.001780 | -0.135000 | 0.042800 | 9.88e-01 | 2.54e-01 | 7.17e-01 |
DNA Repair | 289 | 1.05e-02 | 2.21e-02 | 0.1410 | -0.082600 | -0.114000 | -0.005730 | 1.57e-02 | 8.29e-04 | 8.67e-01 |
Gene Silencing by RNA | 87 | 4.36e-02 | 7.35e-02 | 0.1410 | 0.001400 | -0.104000 | -0.095300 | 9.82e-01 | 9.35e-02 | 1.24e-01 |
Nicotinate metabolism | 25 | 2.45e-01 | 3.06e-01 | 0.1410 | -0.012400 | 0.138000 | 0.022800 | 9.15e-01 | 2.31e-01 | 8.44e-01 |
PERK regulates gene expression | 30 | 3.70e-02 | 6.43e-02 | 0.1410 | 0.091400 | -0.104000 | 0.025200 | 3.86e-01 | 3.24e-01 | 8.11e-01 |
Downregulation of SMAD2/3:SMAD4 transcriptional activity | 23 | 8.19e-01 | 8.44e-01 | 0.1390 | 0.083000 | 0.068200 | -0.088400 | 4.91e-01 | 5.71e-01 | 4.63e-01 |
O-linked glycosylation | 83 | 1.39e-02 | 2.80e-02 | 0.1380 | -0.057000 | 0.030300 | -0.122000 | 3.69e-01 | 6.34e-01 | 5.44e-02 |
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | 37 | 5.88e-01 | 6.37e-01 | 0.1380 | 0.073200 | 0.022700 | -0.114000 | 4.41e-01 | 8.11e-01 | 2.29e-01 |
IRS-related events triggered by IGF1R | 35 | 5.83e-01 | 6.33e-01 | 0.1370 | 0.082100 | 0.020200 | -0.108000 | 4.00e-01 | 8.36e-01 | 2.67e-01 |
Switching of origins to a post-replicative state | 89 | 1.04e-03 | 3.06e-03 | 0.1370 | 0.105000 | -0.060500 | -0.063500 | 8.70e-02 | 3.24e-01 | 3.00e-01 |
TP53 Regulates Transcription of DNA Repair Genes | 61 | 4.22e-01 | 4.85e-01 | 0.1350 | -0.049100 | -0.085500 | -0.092300 | 5.07e-01 | 2.48e-01 | 2.13e-01 |
RNA Polymerase II Pre-transcription Events | 78 | 6.61e-02 | 1.06e-01 | 0.1350 | 0.130000 | 0.026900 | -0.023800 | 4.69e-02 | 6.81e-01 | 7.16e-01 |
Signaling by FGFR in disease | 51 | 3.14e-01 | 3.79e-01 | 0.1350 | 0.123000 | 0.037800 | -0.039600 | 1.29e-01 | 6.40e-01 | 6.25e-01 |
FCERI mediated NF-kB activation | 137 | 1.35e-07 | 1.27e-06 | 0.1350 | 0.106000 | -0.078400 | 0.026700 | 3.20e-02 | 1.13e-01 | 5.90e-01 |
Epigenetic regulation of gene expression | 103 | 2.99e-02 | 5.35e-02 | 0.1350 | 0.013500 | -0.088700 | -0.100000 | 8.13e-01 | 1.20e-01 | 7.86e-02 |
Meiotic recombination | 38 | 4.35e-01 | 4.98e-01 | 0.1340 | 0.121000 | 0.032700 | -0.047000 | 1.96e-01 | 7.27e-01 | 6.16e-01 |
Sulfur amino acid metabolism | 22 | 7.45e-01 | 7.82e-01 | 0.1340 | 0.038200 | -0.015700 | -0.127000 | 7.56e-01 | 8.99e-01 | 3.01e-01 |
Ovarian tumor domain proteases | 37 | 6.68e-01 | 7.13e-01 | 0.1340 | 0.070700 | 0.111000 | -0.025200 | 4.57e-01 | 2.44e-01 | 7.91e-01 |
Fc epsilon receptor (FCERI) signaling | 190 | 3.08e-06 | 2.00e-05 | 0.1340 | 0.133000 | -0.007600 | -0.011400 | 1.57e-03 | 8.57e-01 | 7.86e-01 |
Regulation of pyruvate dehydrogenase (PDH) complex | 15 | 5.87e-01 | 6.36e-01 | 0.1340 | 0.111000 | 0.005440 | 0.075000 | 4.59e-01 | 9.71e-01 | 6.15e-01 |
RNA Polymerase II Transcription | 1194 | 7.00e-08 | 7.00e-07 | 0.1340 | -0.085600 | -0.101000 | -0.017100 | 6.32e-07 | 4.07e-09 | 3.21e-01 |
Antigen processing: Ubiquitination & Proteasome degradation | 287 | 6.36e-03 | 1.43e-02 | 0.1330 | 0.112000 | 0.059500 | -0.041200 | 1.15e-03 | 8.29e-02 | 2.30e-01 |
Diseases of glycosylation | 108 | 5.25e-02 | 8.69e-02 | 0.1330 | -0.016300 | 0.015100 | -0.131000 | 7.69e-01 | 7.87e-01 | 1.89e-02 |
Regulation of TP53 Degradation | 35 | 5.34e-01 | 5.91e-01 | 0.1320 | 0.004450 | -0.066900 | -0.114000 | 9.64e-01 | 4.93e-01 | 2.43e-01 |
Mitotic Prophase | 98 | 1.52e-01 | 2.10e-01 | 0.1320 | 0.118000 | 0.049700 | -0.034600 | 4.43e-02 | 3.96e-01 | 5.54e-01 |
Biological oxidations | 133 | 1.33e-01 | 1.88e-01 | 0.1310 | 0.092500 | 0.045200 | -0.081800 | 6.55e-02 | 3.68e-01 | 1.03e-01 |
Phase II - Conjugation of compounds | 67 | 4.62e-01 | 5.24e-01 | 0.1310 | 0.106000 | 0.074600 | 0.019400 | 1.33e-01 | 2.91e-01 | 7.84e-01 |
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 104 | 2.37e-01 | 2.98e-01 | 0.1300 | -0.064600 | -0.085400 | 0.074000 | 2.55e-01 | 1.32e-01 | 1.92e-01 |
Nuclear Envelope (NE) Reassembly | 69 | 2.11e-01 | 2.71e-01 | 0.1300 | 0.116000 | 0.031800 | -0.048700 | 9.60e-02 | 6.47e-01 | 4.84e-01 |
Class A/1 (Rhodopsin-like receptors) | 160 | 8.18e-02 | 1.25e-01 | 0.1290 | 0.055400 | 0.058200 | -0.101000 | 2.26e-01 | 2.04e-01 | 2.71e-02 |
Mitochondrial Fatty Acid Beta-Oxidation | 36 | 5.74e-01 | 6.25e-01 | 0.1290 | 0.026400 | -0.033600 | -0.121000 | 7.84e-01 | 7.27e-01 | 2.08e-01 |
Downstream signaling of activated FGFR4 | 17 | 4.50e-01 | 5.12e-01 | 0.1280 | 0.117000 | -0.013900 | 0.050900 | 4.05e-01 | 9.21e-01 | 7.16e-01 |
WNT ligand biogenesis and trafficking | 21 | 8.36e-01 | 8.59e-01 | 0.1280 | 0.063300 | 0.111000 | 0.008440 | 6.16e-01 | 3.79e-01 | 9.47e-01 |
Transport of inorganic cations/anions and amino acids/oligopeptides | 79 | 3.68e-01 | 4.35e-01 | 0.1280 | 0.057700 | 0.061600 | -0.095600 | 3.75e-01 | 3.44e-01 | 1.42e-01 |
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 43 | 6.56e-01 | 7.02e-01 | 0.1270 | 0.063100 | 0.062500 | -0.091200 | 4.74e-01 | 4.78e-01 | 3.01e-01 |
Cell surface interactions at the vascular wall | 173 | 7.13e-05 | 3.05e-04 | 0.1270 | 0.116000 | -0.018400 | -0.049200 | 8.64e-03 | 6.76e-01 | 2.64e-01 |
SUMOylation | 165 | 9.55e-02 | 1.43e-01 | 0.1240 | -0.051700 | -0.097800 | -0.055200 | 2.52e-01 | 3.03e-02 | 2.21e-01 |
SHC-mediated cascade:FGFR4 | 10 | 6.19e-01 | 6.68e-01 | 0.1230 | 0.117000 | -0.037700 | 0.006430 | 5.21e-01 | 8.37e-01 | 9.72e-01 |
ATF4 activates genes in response to endoplasmic reticulum stress | 25 | 2.24e-01 | 2.85e-01 | 0.1230 | 0.036200 | -0.117000 | 0.011500 | 7.54e-01 | 3.10e-01 | 9.21e-01 |
SUMO E3 ligases SUMOylate target proteins | 159 | 9.30e-02 | 1.40e-01 | 0.1230 | -0.043700 | -0.091500 | -0.069400 | 3.42e-01 | 4.64e-02 | 1.31e-01 |
Anchoring of the basal body to the plasma membrane | 97 | 4.14e-01 | 4.78e-01 | 0.1220 | -0.073100 | -0.083500 | 0.051500 | 2.13e-01 | 1.55e-01 | 3.81e-01 |
Inactivation, recovery and regulation of the phototransduction cascade | 24 | 8.18e-01 | 8.44e-01 | 0.1220 | -0.059400 | -0.106000 | 0.004440 | 6.15e-01 | 3.67e-01 | 9.70e-01 |
Transcriptional activation of mitochondrial biogenesis | 51 | 5.88e-01 | 6.37e-01 | 0.1220 | 0.097400 | 0.047000 | -0.055900 | 2.29e-01 | 5.61e-01 | 4.90e-01 |
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | 73 | 3.45e-01 | 4.14e-01 | 0.1210 | 0.093500 | 0.030200 | -0.071400 | 1.67e-01 | 6.56e-01 | 2.92e-01 |
STING mediated induction of host immune responses | 15 | 7.72e-01 | 8.05e-01 | 0.1210 | 0.088600 | -0.009600 | -0.081700 | 5.52e-01 | 9.49e-01 | 5.84e-01 |
Processing of DNA double-strand break ends | 71 | 2.42e-01 | 3.04e-01 | 0.1210 | -0.031300 | -0.082400 | 0.082700 | 6.48e-01 | 2.30e-01 | 2.29e-01 |
Synthesis of glycosylphosphatidylinositol (GPI) | 17 | 9.14e-01 | 9.26e-01 | 0.1190 | -0.077000 | -0.050200 | 0.076200 | 5.83e-01 | 7.20e-01 | 5.87e-01 |
Mitotic Anaphase | 223 | 2.23e-04 | 8.17e-04 | 0.1190 | 0.116000 | 0.019600 | 0.020000 | 2.93e-03 | 6.14e-01 | 6.07e-01 |
IRS-mediated signalling | 34 | 6.65e-01 | 7.10e-01 | 0.1180 | 0.064600 | 0.003520 | -0.099200 | 5.14e-01 | 9.72e-01 | 3.17e-01 |
Recruitment of NuMA to mitotic centrosomes | 80 | 5.85e-01 | 6.35e-01 | 0.1180 | -0.081500 | -0.085200 | -0.011300 | 2.08e-01 | 1.88e-01 | 8.61e-01 |
GPCR ligand binding | 226 | 1.69e-02 | 3.29e-02 | 0.1180 | 0.034000 | 0.060000 | -0.095800 | 3.78e-01 | 1.20e-01 | 1.31e-02 |
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | 17 | 6.24e-01 | 6.72e-01 | 0.1170 | -0.029100 | 0.093000 | 0.065400 | 8.35e-01 | 5.07e-01 | 6.41e-01 |
Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | 17 | 6.24e-01 | 6.72e-01 | 0.1170 | -0.029100 | 0.093000 | 0.065400 | 8.35e-01 | 5.07e-01 | 6.41e-01 |
Visual phototransduction | 58 | 5.27e-01 | 5.86e-01 | 0.1160 | 0.032600 | 0.029800 | -0.108000 | 6.68e-01 | 6.94e-01 | 1.57e-01 |
Signaling by NTRK3 (TRKC) | 16 | 8.17e-01 | 8.43e-01 | 0.1160 | 0.072000 | -0.009820 | -0.090700 | 6.18e-01 | 9.46e-01 | 5.30e-01 |
Receptor-type tyrosine-protein phosphatases | 12 | 9.31e-01 | 9.41e-01 | 0.1160 | 0.057000 | 0.016800 | -0.099800 | 7.32e-01 | 9.20e-01 | 5.49e-01 |
NCAM signaling for neurite out-growth | 43 | 7.77e-01 | 8.09e-01 | 0.1160 | -0.087700 | -0.074000 | -0.016400 | 3.20e-01 | 4.01e-01 | 8.52e-01 |
Mitotic Metaphase and Anaphase | 224 | 2.39e-04 | 8.68e-04 | 0.1150 | 0.111000 | 0.015300 | 0.024300 | 4.23e-03 | 6.93e-01 | 5.32e-01 |
PI-3K cascade:FGFR1 | 12 | 9.18e-01 | 9.30e-01 | 0.1140 | 0.096200 | 0.050600 | 0.033900 | 5.64e-01 | 7.61e-01 | 8.39e-01 |
DDX58/IFIH1-mediated induction of interferon-alpha/beta | 63 | 6.50e-01 | 6.97e-01 | 0.1130 | 0.065900 | 0.070700 | -0.059000 | 3.66e-01 | 3.32e-01 | 4.18e-01 |
Post-translational modification: synthesis of GPI-anchored proteins | 57 | 6.53e-01 | 6.99e-01 | 0.1120 | 0.060100 | 0.082200 | -0.047100 | 4.33e-01 | 2.83e-01 | 5.39e-01 |
Nucleotide-like (purinergic) receptors | 12 | 8.71e-01 | 8.91e-01 | 0.1120 | 0.091300 | 0.005720 | -0.064700 | 5.84e-01 | 9.73e-01 | 6.98e-01 |
Centrosome maturation | 81 | 6.34e-01 | 6.81e-01 | 0.1110 | -0.077500 | -0.079600 | -0.005840 | 2.28e-01 | 2.16e-01 | 9.28e-01 |
Recruitment of mitotic centrosome proteins and complexes | 81 | 6.34e-01 | 6.81e-01 | 0.1110 | -0.077500 | -0.079600 | -0.005840 | 2.28e-01 | 2.16e-01 | 9.28e-01 |
Separation of Sister Chromatids | 167 | 4.89e-04 | 1.61e-03 | 0.1110 | 0.096200 | -0.007680 | 0.053900 | 3.19e-02 | 8.64e-01 | 2.29e-01 |
TP53 Regulates Transcription of Caspase Activators and Caspases | 11 | 7.61e-01 | 7.96e-01 | 0.1100 | 0.009810 | -0.110000 | -0.007850 | 9.55e-01 | 5.29e-01 | 9.64e-01 |
SLC transporter disorders | 75 | 3.89e-01 | 4.55e-01 | 0.1090 | -0.004470 | -0.059400 | -0.091100 | 9.47e-01 | 3.74e-01 | 1.72e-01 |
Processing of Intronless Pre-mRNAs | 19 | 8.97e-01 | 9.12e-01 | 0.1090 | -0.084900 | -0.037400 | 0.056300 | 5.22e-01 | 7.78e-01 | 6.71e-01 |
Adaptive Immune System | 755 | 6.08e-04 | 1.94e-03 | 0.1070 | 0.070700 | 0.048800 | -0.063400 | 9.45e-04 | 2.26e-02 | 3.04e-03 |
Cardiac conduction | 91 | 1.08e-01 | 1.58e-01 | 0.1060 | 0.018100 | 0.104000 | -0.012700 | 7.66e-01 | 8.60e-02 | 8.34e-01 |
Cell Cycle Checkpoints | 258 | 1.10e-04 | 4.45e-04 | 0.1050 | 0.015300 | -0.063300 | 0.082800 | 6.71e-01 | 8.02e-02 | 2.20e-02 |
Organelle biogenesis and maintenance | 269 | 2.29e-03 | 6.07e-03 | 0.1050 | -0.014100 | -0.095600 | -0.040200 | 6.90e-01 | 6.97e-03 | 2.56e-01 |
Acyl chain remodelling of PS | 14 | 9.28e-01 | 9.39e-01 | 0.1050 | 0.089300 | 0.036200 | -0.040400 | 5.63e-01 | 8.15e-01 | 7.93e-01 |
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | 14 | 9.01e-01 | 9.14e-01 | 0.1040 | 0.019200 | 0.000809 | 0.103000 | 9.01e-01 | 9.96e-01 | 5.06e-01 |
Phase 2 - plateau phase | 17 | 7.32e-01 | 7.72e-01 | 0.1040 | -0.089100 | 0.014200 | 0.051800 | 5.25e-01 | 9.19e-01 | 7.12e-01 |
Signaling by the B Cell Receptor (BCR) | 162 | 5.23e-05 | 2.33e-04 | 0.1020 | 0.087200 | -0.053400 | -0.003980 | 5.54e-02 | 2.41e-01 | 9.30e-01 |
Deposition of new CENPA-containing nucleosomes at the centromere | 40 | 2.62e-01 | 3.26e-01 | 0.1020 | 0.022200 | -0.097100 | -0.022700 | 8.08e-01 | 2.88e-01 | 8.04e-01 |
Nucleosome assembly | 40 | 2.62e-01 | 3.26e-01 | 0.1020 | 0.022200 | -0.097100 | -0.022700 | 8.08e-01 | 2.88e-01 | 8.04e-01 |
Nonhomologous End-Joining (NHEJ) | 42 | 7.55e-01 | 7.90e-01 | 0.1020 | 0.085300 | 0.050600 | 0.021700 | 3.39e-01 | 5.70e-01 | 8.08e-01 |
Mitotic G1 phase and G1/S transition | 148 | 7.86e-04 | 2.40e-03 | 0.1000 | 0.032400 | -0.094500 | -0.008510 | 4.96e-01 | 4.72e-02 | 8.58e-01 |
Netrin-1 signaling | 40 | 8.09e-01 | 8.36e-01 | 0.0980 | 0.042200 | 0.045200 | -0.076000 | 6.44e-01 | 6.21e-01 | 4.06e-01 |
RHO GTPases Activate Formins | 117 | 2.91e-01 | 3.56e-01 | 0.0969 | 0.018600 | 0.010800 | 0.094500 | 7.29e-01 | 8.39e-01 | 7.75e-02 |
Inhibition of replication initiation of damaged DNA by RB1/E2F1 | 13 | 8.42e-01 | 8.64e-01 | 0.0967 | 0.005520 | -0.063100 | 0.073100 | 9.73e-01 | 6.94e-01 | 6.48e-01 |
Transcription of the HIV genome | 67 | 1.29e-01 | 1.84e-01 | 0.0954 | 0.083400 | -0.028000 | -0.037000 | 2.38e-01 | 6.91e-01 | 6.00e-01 |
Glutamate Neurotransmitter Release Cycle | 20 | 8.82e-01 | 8.97e-01 | 0.0953 | -0.041700 | -0.022300 | -0.082700 | 7.47e-01 | 8.63e-01 | 5.22e-01 |
Aberrant regulation of mitotic exit in cancer due to RB1 defects | 20 | 6.17e-01 | 6.66e-01 | 0.0952 | 0.013900 | -0.091000 | 0.024300 | 9.14e-01 | 4.81e-01 | 8.51e-01 |
HIV Life Cycle | 144 | 1.03e-02 | 2.18e-02 | 0.0945 | 0.045100 | -0.063500 | -0.053600 | 3.50e-01 | 1.88e-01 | 2.67e-01 |
Glutathione synthesis and recycling | 10 | 9.69e-01 | 9.74e-01 | 0.0908 | -0.001390 | -0.032500 | -0.084800 | 9.94e-01 | 8.59e-01 | 6.43e-01 |
M Phase | 360 | 6.88e-04 | 2.14e-03 | 0.0895 | 0.088100 | 0.015100 | 0.004530 | 4.10e-03 | 6.23e-01 | 8.83e-01 |
Mitotic G2-G2/M phases | 181 | 1.56e-02 | 3.09e-02 | 0.0878 | 0.086700 | 0.005320 | 0.012900 | 4.42e-02 | 9.02e-01 | 7.65e-01 |
CLEC7A (Dectin-1) induces NFAT activation | 11 | 9.72e-01 | 9.76e-01 | 0.0878 | -0.035300 | -0.073700 | -0.032100 | 8.39e-01 | 6.72e-01 | 8.54e-01 |
HCMV Early Events | 74 | 1.95e-01 | 2.57e-01 | 0.0867 | 0.017400 | -0.078400 | -0.032700 | 7.96e-01 | 2.43e-01 | 6.27e-01 |
PKMTs methylate histone lysines | 44 | 7.60e-01 | 7.95e-01 | 0.0841 | -0.072600 | -0.019200 | 0.038000 | 4.05e-01 | 8.26e-01 | 6.63e-01 |
Late Phase of HIV Life Cycle | 131 | 3.86e-02 | 6.63e-02 | 0.0818 | 0.061900 | -0.036400 | -0.039300 | 2.21e-01 | 4.72e-01 | 4.38e-01 |
G2/M Checkpoints | 138 | 5.39e-03 | 1.24e-02 | 0.0803 | 0.054000 | -0.058400 | 0.011000 | 2.74e-01 | 2.36e-01 | 8.23e-01 |
G2/M Transition | 179 | 2.12e-02 | 4.03e-02 | 0.0799 | 0.079500 | -0.002450 | 0.007480 | 6.65e-02 | 9.55e-01 | 8.63e-01 |
Transcriptional Regulation by TP53 | 350 | 1.02e-02 | 2.17e-02 | 0.0782 | 0.041100 | -0.024200 | -0.062000 | 1.87e-01 | 4.37e-01 | 4.63e-02 |
Cyclin D associated events in G1 | 47 | 8.79e-01 | 8.95e-01 | 0.0779 | 0.066000 | 0.041300 | 0.001640 | 4.34e-01 | 6.24e-01 | 9.85e-01 |
G1 Phase | 47 | 8.79e-01 | 8.95e-01 | 0.0779 | 0.066000 | 0.041300 | 0.001640 | 4.34e-01 | 6.24e-01 | 9.85e-01 |
Cell Cycle | 623 | 6.77e-05 | 2.91e-04 | 0.0767 | -0.009680 | -0.066500 | 0.037000 | 6.80e-01 | 4.60e-03 | 1.15e-01 |
Loss of Nlp from mitotic centrosomes | 69 | 8.74e-01 | 8.91e-01 | 0.0761 | -0.055300 | -0.047300 | 0.022200 | 4.27e-01 | 4.97e-01 | 7.49e-01 |
Loss of proteins required for interphase microtubule organization from the centrosome | 69 | 8.74e-01 | 8.91e-01 | 0.0761 | -0.055300 | -0.047300 | 0.022200 | 4.27e-01 | 4.97e-01 | 7.49e-01 |
Cargo trafficking to the periciliary membrane | 47 | 2.94e-01 | 3.59e-01 | 0.0750 | 0.048100 | -0.053100 | 0.022000 | 5.68e-01 | 5.29e-01 | 7.94e-01 |
Transcriptional Regulation by VENTX | 38 | 8.62e-01 | 8.82e-01 | 0.0746 | -0.058800 | -0.029800 | -0.034900 | 5.30e-01 | 7.50e-01 | 7.10e-01 |
Metabolism of vitamins and cofactors | 155 | 5.57e-01 | 6.11e-01 | 0.0744 | 0.037600 | 0.053300 | -0.035900 | 4.20e-01 | 2.52e-01 | 4.41e-01 |
Diseases associated with N-glycosylation of proteins | 17 | 8.03e-01 | 8.32e-01 | 0.0724 | 0.054600 | -0.038900 | -0.027300 | 6.96e-01 | 7.81e-01 | 8.46e-01 |
TP53 Regulates Transcription of Cell Cycle Genes | 47 | 3.26e-01 | 3.93e-01 | 0.0723 | 0.047400 | -0.050300 | 0.021400 | 5.74e-01 | 5.51e-01 | 8.00e-01 |
Negative regulators of DDX58/IFIH1 signaling | 34 | 8.54e-01 | 8.75e-01 | 0.0673 | -0.014100 | -0.065400 | -0.007560 | 8.87e-01 | 5.09e-01 | 9.39e-01 |
TNF signaling | 42 | 9.01e-01 | 9.14e-01 | 0.0646 | 0.010600 | 0.018000 | -0.061200 | 9.06e-01 | 8.40e-01 | 4.93e-01 |
Regulation of PLK1 Activity at G2/M Transition | 87 | 6.87e-01 | 7.30e-01 | 0.0621 | -0.017700 | -0.053000 | 0.027000 | 7.75e-01 | 3.93e-01 | 6.64e-01 |
Aberrant regulation of mitotic cell cycle due to RB1 defects | 36 | 9.61e-01 | 9.67e-01 | 0.0605 | -0.031800 | -0.030400 | 0.041600 | 7.41e-01 | 7.52e-01 | 6.66e-01 |
Diseases of mitotic cell cycle | 36 | 9.61e-01 | 9.67e-01 | 0.0605 | -0.031800 | -0.030400 | 0.041600 | 7.41e-01 | 7.52e-01 | 6.66e-01 |
AURKA Activation by TPX2 | 72 | 9.31e-01 | 9.41e-01 | 0.0564 | -0.036500 | -0.030800 | 0.029900 | 5.92e-01 | 6.51e-01 | 6.61e-01 |
Cell Cycle, Mitotic | 501 | 5.21e-04 | 1.69e-03 | 0.0561 | 0.018800 | -0.045700 | 0.026600 | 4.71e-01 | 8.00e-02 | 3.09e-01 |
TNFR1-induced NFkappaB signaling pathway | 25 | 9.57e-01 | 9.64e-01 | 0.0525 | -0.037300 | 0.001940 | 0.036900 | 7.47e-01 | 9.87e-01 | 7.49e-01 |
Neurotransmitter release cycle | 37 | 9.72e-01 | 9.76e-01 | 0.0489 | 0.022800 | 0.034300 | -0.026500 | 8.11e-01 | 7.18e-01 | 7.80e-01 |
Signaling by BMP | 21 | 9.85e-01 | 9.88e-01 | 0.0485 | -0.019100 | -0.043700 | -0.009260 | 8.80e-01 | 7.29e-01 | 9.41e-01 |
Reproduction | 80 | 7.76e-01 | 8.08e-01 | 0.0472 | 0.043300 | 0.000175 | -0.018900 | 5.03e-01 | 9.98e-01 | 7.70e-01 |
Interleukin-35 Signalling | 12 | 9.96e-01 | 9.96e-01 | 0.0462 | -0.022900 | -0.034900 | 0.019900 | 8.91e-01 | 8.34e-01 | 9.05e-01 |
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | 13 | 9.52e-01 | 9.60e-01 | 0.0448 | 0.031000 | -0.025000 | 0.020400 | 8.47e-01 | 8.76e-01 | 8.98e-01 |
IL-6-type cytokine receptor ligand interactions | 12 | 9.94e-01 | 9.95e-01 | 0.0416 | 0.038800 | 0.014600 | 0.002360 | 8.16e-01 | 9.30e-01 | 9.89e-01 |
Signaling by KIT in disease | 20 | 9.49e-01 | 9.58e-01 | 0.0415 | -0.040100 | 0.009590 | 0.005120 | 7.56e-01 | 9.41e-01 | 9.68e-01 |
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | 20 | 9.49e-01 | 9.58e-01 | 0.0415 | -0.040100 | 0.009590 | 0.005120 | 7.56e-01 | 9.41e-01 | 9.68e-01 |
Meiosis | 68 | 8.02e-01 | 8.31e-01 | 0.0381 | 0.036200 | -0.005620 | 0.010500 | 6.05e-01 | 9.36e-01 | 8.81e-01 |
Synthesis of PA | 32 | 9.91e-01 | 9.93e-01 | 0.0371 | 0.018900 | 0.025300 | -0.019400 | 8.54e-01 | 8.04e-01 | 8.49e-01 |
Metabolism of water-soluble vitamins and cofactors | 109 | 7.01e-01 | 7.43e-01 | 0.0325 | -0.027800 | 0.015800 | 0.005650 | 6.16e-01 | 7.75e-01 | 9.19e-01 |
Anti-inflammatory response favouring Leishmania parasite infection | 169 | 8.73e-01 | 8.91e-01 | 0.0247 | 0.001800 | -0.022200 | -0.010500 | 9.68e-01 | 6.18e-01 | 8.13e-01 |
Leishmania parasite growth and survival | 169 | 8.73e-01 | 8.91e-01 | 0.0247 | 0.001800 | -0.022200 | -0.010500 | 9.68e-01 | 6.18e-01 | 8.13e-01 |
Kinesins | 39 | 9.99e-01 | 9.99e-01 | 0.0136 | 0.002780 | 0.010600 | 0.008000 | 9.76e-01 | 9.08e-01 | 9.31e-01 |
IRAK4 deficiency (TLR2/4)
metric | value |
---|---|
setSize | 10 |
pMANOVA | 7.5e-06 |
p.adjustMANOVA | 4.34e-05 |
s.dist | 1.25 |
s.t0_v_pod | 0.899 |
s.pod_crp | 0.868 |
s.t0_crp | -0.0598 |
p.t0_v_pod | 8.36e-07 |
p.pod_crp | 1.99e-06 |
p.t0_crp | 0.743 |
Gene | t0_v_pod | pod_crp |
---|---|---|
CD36 | 9283 | 10747 |
TLR2 | 8950 | 10352 |
MYD88 | 8009 | 11117 |
TLR1 | 8782 | 9888 |
CD14 | 8944 | 9321 |
TLR4 | 8864 | 9402 |
LY96 | 8649 | 9181 |
TLR6 | 8694 | 8940 |
BTK | 7100 | 10653 |
TIRAP | 5571 | 8733 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
BTK | 7100 | 10653 | 7751 |
CD14 | 8944 | 9321 | -7666 |
CD36 | 9283 | 10747 | -147 |
LY96 | 8649 | 9181 | 4818 |
MYD88 | 8009 | 11117 | 3555 |
TIRAP | 5571 | 8733 | -2324 |
TLR1 | 8782 | 9888 | 5302 |
TLR2 | 8950 | 10352 | 3541 |
TLR4 | 8864 | 9402 | -2478 |
TLR6 | 8694 | 8940 | -2193 |
MyD88 deficiency (TLR2/4)
metric | value |
---|---|
setSize | 10 |
pMANOVA | 7.5e-06 |
p.adjustMANOVA | 4.34e-05 |
s.dist | 1.25 |
s.t0_v_pod | 0.899 |
s.pod_crp | 0.868 |
s.t0_crp | -0.0598 |
p.t0_v_pod | 8.36e-07 |
p.pod_crp | 1.99e-06 |
p.t0_crp | 0.743 |
Gene | t0_v_pod | pod_crp |
---|---|---|
CD36 | 9283 | 10747 |
TLR2 | 8950 | 10352 |
MYD88 | 8009 | 11117 |
TLR1 | 8782 | 9888 |
CD14 | 8944 | 9321 |
TLR4 | 8864 | 9402 |
LY96 | 8649 | 9181 |
TLR6 | 8694 | 8940 |
BTK | 7100 | 10653 |
TIRAP | 5571 | 8733 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
BTK | 7100 | 10653 | 7751 |
CD14 | 8944 | 9321 | -7666 |
CD36 | 9283 | 10747 | -147 |
LY96 | 8649 | 9181 | 4818 |
MYD88 | 8009 | 11117 | 3555 |
TIRAP | 5571 | 8733 | -2324 |
TLR1 | 8782 | 9888 | 5302 |
TLR2 | 8950 | 10352 | 3541 |
TLR4 | 8864 | 9402 | -2478 |
TLR6 | 8694 | 8940 | -2193 |
Peptide chain elongation
metric | value |
---|---|
setSize | 88 |
pMANOVA | 9.12e-75 |
p.adjustMANOVA | 1.24e-72 |
s.dist | 1.15 |
s.t0_v_pod | -0.281 |
s.pod_crp | -0.769 |
s.t0_crp | -0.811 |
p.t0_v_pod | 5.05e-06 |
p.pod_crp | 7.95e-36 |
p.t0_crp | 1.13e-39 |
Gene | t0_crp | pod_crp |
---|---|---|
RPL3 | -8773 | -9928 |
RPS2 | -9021 | -9563 |
RPS27A | -8668 | -9695 |
RPL14 | -8650 | -9670 |
RPLP2 | -9001 | -9135 |
RPS12 | -8852 | -9242 |
RPS3 | -8726 | -9270 |
RPLP0 | -8702 | -9199 |
EEF1A1 | -8179 | -9723 |
RPS27 | -8693 | -9147 |
RPL10 | -8829 | -9003 |
RPL7 | -8087 | -9737 |
RPS23 | -8319 | -9359 |
RPL27A | -8573 | -9020 |
RPS29 | -8958 | -8609 |
RPS6 | -7892 | -9671 |
RPL31 | -8685 | -8741 |
RPL30 | -8504 | -8902 |
RPL29 | -8787 | -8593 |
RPS5 | -8342 | -9014 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
EEF1A1 | -4918 | -9723 | -8179 |
EEF2 | 304 | -6254 | -8868 |
FAU | -359 | -3599 | -8841 |
RPL10 | -6311 | -9003 | -8829 |
RPL10A | -6458 | -8900 | -6147 |
RPL11 | -6052 | -9089 | -6722 |
RPL12 | -6811 | -9149 | -8024 |
RPL13 | -3335 | -7644 | -6367 |
RPL13A | -7928 | -9374 | -6207 |
RPL14 | -6480 | -9670 | -8650 |
RPL15 | -953 | -8142 | -8235 |
RPL17 | -5249 | -9088 | -8079 |
RPL18 | -4911 | -8835 | -8406 |
RPL18A | -5869 | -8868 | -8439 |
RPL19 | -6071 | -8311 | -8149 |
RPL21 | -6241 | -9483 | -7230 |
RPL22 | -4587 | -9631 | -7480 |
RPL22L1 | -1593 | -8175 | 527 |
RPL23 | -3223 | -8346 | -7486 |
RPL23A | -9248 | -9950 | -4950 |
RPL24 | -5606 | -8873 | -7028 |
RPL26 | -6387 | -8678 | -8038 |
RPL26L1 | 7070 | 5940 | -5499 |
RPL27 | -2783 | -7783 | -8809 |
RPL27A | -6048 | -9020 | -8573 |
RPL28 | -1441 | -3852 | -5654 |
RPL29 | -3505 | -8593 | -8787 |
RPL3 | -8268 | -9928 | -8773 |
RPL30 | -6779 | -8902 | -8504 |
RPL31 | -4394 | -8741 | -8685 |
RPL32 | -6479 | -9317 | -7991 |
RPL34 | -6569 | -9464 | -6337 |
RPL35 | -7809 | -8156 | -7893 |
RPL35A | -5816 | -9263 | -7997 |
RPL36 | -5111 | -7467 | -8861 |
RPL36A | -7122 | -8881 | -8095 |
RPL36AL | 32 | -6621 | -8799 |
RPL37 | -6160 | -7834 | -9017 |
RPL37A | -3826 | -6808 | -8683 |
RPL38 | -5646 | -7941 | -8932 |
RPL39 | -2931 | -8607 | -8362 |
RPL39L | -8506 | -1648 | -4731 |
RPL3L | 4458 | 5102 | 10556 |
RPL4 | -3476 | -9521 | -7062 |
RPL41 | -6632 | -7535 | -8456 |
RPL5 | -4576 | -9853 | -7157 |
RPL6 | -3262 | -9281 | -3434 |
RPL7 | -1917 | -9737 | -8087 |
RPL7A | -3557 | -8259 | -8751 |
RPL8 | -1171 | -6076 | -8899 |
RPL9 | -1837 | -6796 | -4391 |
RPLP0 | -987 | -9199 | -8702 |
RPLP1 | 19 | -5994 | -8833 |
RPLP2 | -6844 | -9135 | -9001 |
RPS10 | -5601 | -8466 | -8823 |
RPS11 | -6992 | -7948 | -8743 |
RPS12 | -5788 | -9242 | -8852 |
RPS13 | -1717 | -8696 | -7869 |
RPS14 | -5278 | -8513 | -8637 |
RPS15 | -3565 | -6678 | -8273 |
RPS15A | -5550 | -8855 | -8431 |
RPS16 | -4518 | -8551 | -8704 |
RPS17 | -6038 | -8254 | -8928 |
RPS18 | -7474 | -8294 | -7671 |
RPS19 | -6725 | -7779 | -8460 |
RPS2 | -4354 | -9563 | -9021 |
RPS20 | -8585 | -9385 | -6156 |
RPS21 | -3952 | -8303 | -8855 |
RPS23 | -6081 | -9359 | -8319 |
RPS24 | -261 | -6793 | -4573 |
RPS25 | -6151 | -9636 | -7764 |
RPS26 | -1410 | -1143 | -462 |
RPS27 | -9432 | -9147 | -8693 |
RPS27A | -6700 | -9695 | -8668 |
RPS27L | 2048 | -490 | 9654 |
RPS28 | -4562 | -8056 | -8562 |
RPS29 | -7664 | -8609 | -8958 |
RPS3 | -5717 | -9270 | -8726 |
RPS3A | -4543 | -9806 | -4045 |
RPS4X | -6075 | -8620 | -4665 |
RPS4Y1 | 418 | 329 | 1713 |
RPS5 | -5502 | -9014 | -8342 |
RPS6 | -5956 | -9671 | -7892 |
RPS7 | -4803 | -9137 | -7874 |
RPS8 | -2041 | -8833 | -6710 |
RPS9 | 5358 | 1826 | -8433 |
RPSA | -6110 | -6604 | 3504 |
UBA52 | 1112 | -3471 | -8207 |
Eukaryotic Translation Elongation
metric | value |
---|---|
setSize | 93 |
pMANOVA | 8.41e-79 |
p.adjustMANOVA | 1.91e-76 |
s.dist | 1.15 |
s.t0_v_pod | -0.273 |
s.pod_crp | -0.765 |
s.t0_crp | -0.809 |
p.t0_v_pod | 5.39e-06 |
p.pod_crp | 2.35e-37 |
p.t0_crp | 1.2e-41 |
Gene | t0_crp | pod_crp |
---|---|---|
RPL3 | -8773 | -9928 |
RPS2 | -9021 | -9563 |
EEF1B2 | -8820 | -9704 |
RPS27A | -8668 | -9695 |
RPL14 | -8650 | -9670 |
EEF1G | -8936 | -9265 |
RPLP2 | -9001 | -9135 |
RPS12 | -8852 | -9242 |
RPS3 | -8726 | -9270 |
RPLP0 | -8702 | -9199 |
EEF1A1 | -8179 | -9723 |
RPS27 | -8693 | -9147 |
RPL10 | -8829 | -9003 |
RPL7 | -8087 | -9737 |
RPS23 | -8319 | -9359 |
RPL27A | -8573 | -9020 |
RPS29 | -8958 | -8609 |
RPS6 | -7892 | -9671 |
RPL31 | -8685 | -8741 |
RPL30 | -8504 | -8902 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
EEF1A1 | -4918 | -9723 | -8179 |
EEF1A1P5 | -1889 | -5853 | -5320 |
EEF1A2 | -4993 | -3227 | -1157 |
EEF1B2 | -4128 | -9704 | -8820 |
EEF1D | -805 | -5640 | -8673 |
EEF1G | -1364 | -9265 | -8936 |
EEF2 | 304 | -6254 | -8868 |
FAU | -359 | -3599 | -8841 |
RPL10 | -6311 | -9003 | -8829 |
RPL10A | -6458 | -8900 | -6147 |
RPL11 | -6052 | -9089 | -6722 |
RPL12 | -6811 | -9149 | -8024 |
RPL13 | -3335 | -7644 | -6367 |
RPL13A | -7928 | -9374 | -6207 |
RPL14 | -6480 | -9670 | -8650 |
RPL15 | -953 | -8142 | -8235 |
RPL17 | -5249 | -9088 | -8079 |
RPL18 | -4911 | -8835 | -8406 |
RPL18A | -5869 | -8868 | -8439 |
RPL19 | -6071 | -8311 | -8149 |
RPL21 | -6241 | -9483 | -7230 |
RPL22 | -4587 | -9631 | -7480 |
RPL22L1 | -1593 | -8175 | 527 |
RPL23 | -3223 | -8346 | -7486 |
RPL23A | -9248 | -9950 | -4950 |
RPL24 | -5606 | -8873 | -7028 |
RPL26 | -6387 | -8678 | -8038 |
RPL26L1 | 7070 | 5940 | -5499 |
RPL27 | -2783 | -7783 | -8809 |
RPL27A | -6048 | -9020 | -8573 |
RPL28 | -1441 | -3852 | -5654 |
RPL29 | -3505 | -8593 | -8787 |
RPL3 | -8268 | -9928 | -8773 |
RPL30 | -6779 | -8902 | -8504 |
RPL31 | -4394 | -8741 | -8685 |
RPL32 | -6479 | -9317 | -7991 |
RPL34 | -6569 | -9464 | -6337 |
RPL35 | -7809 | -8156 | -7893 |
RPL35A | -5816 | -9263 | -7997 |
RPL36 | -5111 | -7467 | -8861 |
RPL36A | -7122 | -8881 | -8095 |
RPL36AL | 32 | -6621 | -8799 |
RPL37 | -6160 | -7834 | -9017 |
RPL37A | -3826 | -6808 | -8683 |
RPL38 | -5646 | -7941 | -8932 |
RPL39 | -2931 | -8607 | -8362 |
RPL39L | -8506 | -1648 | -4731 |
RPL3L | 4458 | 5102 | 10556 |
RPL4 | -3476 | -9521 | -7062 |
RPL41 | -6632 | -7535 | -8456 |
RPL5 | -4576 | -9853 | -7157 |
RPL6 | -3262 | -9281 | -3434 |
RPL7 | -1917 | -9737 | -8087 |
RPL7A | -3557 | -8259 | -8751 |
RPL8 | -1171 | -6076 | -8899 |
RPL9 | -1837 | -6796 | -4391 |
RPLP0 | -987 | -9199 | -8702 |
RPLP1 | 19 | -5994 | -8833 |
RPLP2 | -6844 | -9135 | -9001 |
RPS10 | -5601 | -8466 | -8823 |
RPS11 | -6992 | -7948 | -8743 |
RPS12 | -5788 | -9242 | -8852 |
RPS13 | -1717 | -8696 | -7869 |
RPS14 | -5278 | -8513 | -8637 |
RPS15 | -3565 | -6678 | -8273 |
RPS15A | -5550 | -8855 | -8431 |
RPS16 | -4518 | -8551 | -8704 |
RPS17 | -6038 | -8254 | -8928 |
RPS18 | -7474 | -8294 | -7671 |
RPS19 | -6725 | -7779 | -8460 |
RPS2 | -4354 | -9563 | -9021 |
RPS20 | -8585 | -9385 | -6156 |
RPS21 | -3952 | -8303 | -8855 |
RPS23 | -6081 | -9359 | -8319 |
RPS24 | -261 | -6793 | -4573 |
RPS25 | -6151 | -9636 | -7764 |
RPS26 | -1410 | -1143 | -462 |
RPS27 | -9432 | -9147 | -8693 |
RPS27A | -6700 | -9695 | -8668 |
RPS27L | 2048 | -490 | 9654 |
RPS28 | -4562 | -8056 | -8562 |
RPS29 | -7664 | -8609 | -8958 |
RPS3 | -5717 | -9270 | -8726 |
RPS3A | -4543 | -9806 | -4045 |
RPS4X | -6075 | -8620 | -4665 |
RPS4Y1 | 418 | 329 | 1713 |
RPS5 | -5502 | -9014 | -8342 |
RPS6 | -5956 | -9671 | -7892 |
RPS7 | -4803 | -9137 | -7874 |
RPS8 | -2041 | -8833 | -6710 |
RPS9 | 5358 | 1826 | -8433 |
RPSA | -6110 | -6604 | 3504 |
UBA52 | 1112 | -3471 | -8207 |
Viral mRNA Translation
metric | value |
---|---|
setSize | 88 |
pMANOVA | 9.81e-71 |
p.adjustMANOVA | 1.03e-68 |
s.dist | 1.11 |
s.t0_v_pod | -0.262 |
s.pod_crp | -0.745 |
s.t0_crp | -0.787 |
p.t0_v_pod | 2.13e-05 |
p.pod_crp | 1.06e-33 |
p.t0_crp | 2.15e-37 |
Gene | t0_crp | pod_crp |
---|---|---|
RPL3 | -8773 | -9928 |
RPS2 | -9021 | -9563 |
RPS27A | -8668 | -9695 |
RPL14 | -8650 | -9670 |
RPLP2 | -9001 | -9135 |
RPS12 | -8852 | -9242 |
RPS3 | -8726 | -9270 |
RPLP0 | -8702 | -9199 |
RPS27 | -8693 | -9147 |
RPL10 | -8829 | -9003 |
RPL7 | -8087 | -9737 |
RPS23 | -8319 | -9359 |
RPL27A | -8573 | -9020 |
RPS29 | -8958 | -8609 |
RPS6 | -7892 | -9671 |
RPL31 | -8685 | -8741 |
RPL30 | -8504 | -8902 |
RPL29 | -8787 | -8593 |
RPS5 | -8342 | -9014 |
RPL18A | -8439 | -8868 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
DNAJC3 | 8302 | 9670 | 4528 |
FAU | -359 | -3599 | -8841 |
GRSF1 | 5110 | -2905 | 1530 |
RPL10 | -6311 | -9003 | -8829 |
RPL10A | -6458 | -8900 | -6147 |
RPL11 | -6052 | -9089 | -6722 |
RPL12 | -6811 | -9149 | -8024 |
RPL13 | -3335 | -7644 | -6367 |
RPL13A | -7928 | -9374 | -6207 |
RPL14 | -6480 | -9670 | -8650 |
RPL15 | -953 | -8142 | -8235 |
RPL17 | -5249 | -9088 | -8079 |
RPL18 | -4911 | -8835 | -8406 |
RPL18A | -5869 | -8868 | -8439 |
RPL19 | -6071 | -8311 | -8149 |
RPL21 | -6241 | -9483 | -7230 |
RPL22 | -4587 | -9631 | -7480 |
RPL22L1 | -1593 | -8175 | 527 |
RPL23 | -3223 | -8346 | -7486 |
RPL23A | -9248 | -9950 | -4950 |
RPL24 | -5606 | -8873 | -7028 |
RPL26 | -6387 | -8678 | -8038 |
RPL26L1 | 7070 | 5940 | -5499 |
RPL27 | -2783 | -7783 | -8809 |
RPL27A | -6048 | -9020 | -8573 |
RPL28 | -1441 | -3852 | -5654 |
RPL29 | -3505 | -8593 | -8787 |
RPL3 | -8268 | -9928 | -8773 |
RPL30 | -6779 | -8902 | -8504 |
RPL31 | -4394 | -8741 | -8685 |
RPL32 | -6479 | -9317 | -7991 |
RPL34 | -6569 | -9464 | -6337 |
RPL35 | -7809 | -8156 | -7893 |
RPL35A | -5816 | -9263 | -7997 |
RPL36 | -5111 | -7467 | -8861 |
RPL36A | -7122 | -8881 | -8095 |
RPL36AL | 32 | -6621 | -8799 |
RPL37 | -6160 | -7834 | -9017 |
RPL37A | -3826 | -6808 | -8683 |
RPL38 | -5646 | -7941 | -8932 |
RPL39 | -2931 | -8607 | -8362 |
RPL39L | -8506 | -1648 | -4731 |
RPL3L | 4458 | 5102 | 10556 |
RPL4 | -3476 | -9521 | -7062 |
RPL41 | -6632 | -7535 | -8456 |
RPL5 | -4576 | -9853 | -7157 |
RPL6 | -3262 | -9281 | -3434 |
RPL7 | -1917 | -9737 | -8087 |
RPL7A | -3557 | -8259 | -8751 |
RPL8 | -1171 | -6076 | -8899 |
RPL9 | -1837 | -6796 | -4391 |
RPLP0 | -987 | -9199 | -8702 |
RPLP1 | 19 | -5994 | -8833 |
RPLP2 | -6844 | -9135 | -9001 |
RPS10 | -5601 | -8466 | -8823 |
RPS11 | -6992 | -7948 | -8743 |
RPS12 | -5788 | -9242 | -8852 |
RPS13 | -1717 | -8696 | -7869 |
RPS14 | -5278 | -8513 | -8637 |
RPS15 | -3565 | -6678 | -8273 |
RPS15A | -5550 | -8855 | -8431 |
RPS16 | -4518 | -8551 | -8704 |
RPS17 | -6038 | -8254 | -8928 |
RPS18 | -7474 | -8294 | -7671 |
RPS19 | -6725 | -7779 | -8460 |
RPS2 | -4354 | -9563 | -9021 |
RPS20 | -8585 | -9385 | -6156 |
RPS21 | -3952 | -8303 | -8855 |
RPS23 | -6081 | -9359 | -8319 |
RPS24 | -261 | -6793 | -4573 |
RPS25 | -6151 | -9636 | -7764 |
RPS26 | -1410 | -1143 | -462 |
RPS27 | -9432 | -9147 | -8693 |
RPS27A | -6700 | -9695 | -8668 |
RPS27L | 2048 | -490 | 9654 |
RPS28 | -4562 | -8056 | -8562 |
RPS29 | -7664 | -8609 | -8958 |
RPS3 | -5717 | -9270 | -8726 |
RPS3A | -4543 | -9806 | -4045 |
RPS4X | -6075 | -8620 | -4665 |
RPS4Y1 | 418 | 329 | 1713 |
RPS5 | -5502 | -9014 | -8342 |
RPS6 | -5956 | -9671 | -7892 |
RPS7 | -4803 | -9137 | -7874 |
RPS8 | -2041 | -8833 | -6710 |
RPS9 | 5358 | 1826 | -8433 |
RPSA | -6110 | -6604 | 3504 |
UBA52 | 1112 | -3471 | -8207 |
Selenocysteine synthesis
metric | value |
---|---|
setSize | 92 |
pMANOVA | 9.1e-70 |
p.adjustMANOVA | 8.25e-68 |
s.dist | 1.1 |
s.t0_v_pod | -0.299 |
s.pod_crp | -0.748 |
s.t0_crp | -0.756 |
p.t0_v_pod | 7.43e-07 |
p.pod_crp | 2.21e-35 |
p.t0_crp | 3.66e-36 |
Gene | t0_crp | pod_crp |
---|---|---|
RPL3 | -8773 | -9928 |
RPS2 | -9021 | -9563 |
RPS27A | -8668 | -9695 |
RPL14 | -8650 | -9670 |
RPLP2 | -9001 | -9135 |
RPS12 | -8852 | -9242 |
RPS3 | -8726 | -9270 |
RPLP0 | -8702 | -9199 |
RPS27 | -8693 | -9147 |
RPL10 | -8829 | -9003 |
RPL7 | -8087 | -9737 |
RPS23 | -8319 | -9359 |
RPL27A | -8573 | -9020 |
RPS29 | -8958 | -8609 |
RPS6 | -7892 | -9671 |
RPL31 | -8685 | -8741 |
RPL30 | -8504 | -8902 |
RPL29 | -8787 | -8593 |
RPS5 | -8342 | -9014 |
RPL18A | -8439 | -8868 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
EEFSEC | -9700 | -6468 | -2666 |
FAU | -359 | -3599 | -8841 |
PSTK | -9857 | -5686 | 3544 |
RPL10 | -6311 | -9003 | -8829 |
RPL10A | -6458 | -8900 | -6147 |
RPL11 | -6052 | -9089 | -6722 |
RPL12 | -6811 | -9149 | -8024 |
RPL13 | -3335 | -7644 | -6367 |
RPL13A | -7928 | -9374 | -6207 |
RPL14 | -6480 | -9670 | -8650 |
RPL15 | -953 | -8142 | -8235 |
RPL17 | -5249 | -9088 | -8079 |
RPL18 | -4911 | -8835 | -8406 |
RPL18A | -5869 | -8868 | -8439 |
RPL19 | -6071 | -8311 | -8149 |
RPL21 | -6241 | -9483 | -7230 |
RPL22 | -4587 | -9631 | -7480 |
RPL22L1 | -1593 | -8175 | 527 |
RPL23 | -3223 | -8346 | -7486 |
RPL23A | -9248 | -9950 | -4950 |
RPL24 | -5606 | -8873 | -7028 |
RPL26 | -6387 | -8678 | -8038 |
RPL26L1 | 7070 | 5940 | -5499 |
RPL27 | -2783 | -7783 | -8809 |
RPL27A | -6048 | -9020 | -8573 |
RPL28 | -1441 | -3852 | -5654 |
RPL29 | -3505 | -8593 | -8787 |
RPL3 | -8268 | -9928 | -8773 |
RPL30 | -6779 | -8902 | -8504 |
RPL31 | -4394 | -8741 | -8685 |
RPL32 | -6479 | -9317 | -7991 |
RPL34 | -6569 | -9464 | -6337 |
RPL35 | -7809 | -8156 | -7893 |
RPL35A | -5816 | -9263 | -7997 |
RPL36 | -5111 | -7467 | -8861 |
RPL36A | -7122 | -8881 | -8095 |
RPL36AL | 32 | -6621 | -8799 |
RPL37 | -6160 | -7834 | -9017 |
RPL37A | -3826 | -6808 | -8683 |
RPL38 | -5646 | -7941 | -8932 |
RPL39 | -2931 | -8607 | -8362 |
RPL39L | -8506 | -1648 | -4731 |
RPL3L | 4458 | 5102 | 10556 |
RPL4 | -3476 | -9521 | -7062 |
RPL41 | -6632 | -7535 | -8456 |
RPL5 | -4576 | -9853 | -7157 |
RPL6 | -3262 | -9281 | -3434 |
RPL7 | -1917 | -9737 | -8087 |
RPL7A | -3557 | -8259 | -8751 |
RPL8 | -1171 | -6076 | -8899 |
RPL9 | -1837 | -6796 | -4391 |
RPLP0 | -987 | -9199 | -8702 |
RPLP1 | 19 | -5994 | -8833 |
RPLP2 | -6844 | -9135 | -9001 |
RPS10 | -5601 | -8466 | -8823 |
RPS11 | -6992 | -7948 | -8743 |
RPS12 | -5788 | -9242 | -8852 |
RPS13 | -1717 | -8696 | -7869 |
RPS14 | -5278 | -8513 | -8637 |
RPS15 | -3565 | -6678 | -8273 |
RPS15A | -5550 | -8855 | -8431 |
RPS16 | -4518 | -8551 | -8704 |
RPS17 | -6038 | -8254 | -8928 |
RPS18 | -7474 | -8294 | -7671 |
RPS19 | -6725 | -7779 | -8460 |
RPS2 | -4354 | -9563 | -9021 |
RPS20 | -8585 | -9385 | -6156 |
RPS21 | -3952 | -8303 | -8855 |
RPS23 | -6081 | -9359 | -8319 |
RPS24 | -261 | -6793 | -4573 |
RPS25 | -6151 | -9636 | -7764 |
RPS26 | -1410 | -1143 | -462 |
RPS27 | -9432 | -9147 | -8693 |
RPS27A | -6700 | -9695 | -8668 |
RPS27L | 2048 | -490 | 9654 |
RPS28 | -4562 | -8056 | -8562 |
RPS29 | -7664 | -8609 | -8958 |
RPS3 | -5717 | -9270 | -8726 |
RPS3A | -4543 | -9806 | -4045 |
RPS4X | -6075 | -8620 | -4665 |
RPS4Y1 | 418 | 329 | 1713 |
RPS5 | -5502 | -9014 | -8342 |
RPS6 | -5956 | -9671 | -7892 |
RPS7 | -4803 | -9137 | -7874 |
RPS8 | -2041 | -8833 | -6710 |
RPS9 | 5358 | 1826 | -8433 |
RPSA | -6110 | -6604 | 3504 |
SARS1 | -5712 | -6019 | -7676 |
SECISBP2 | -9999 | -6967 | 10570 |
SEPHS2 | 7535 | 7977 | -4587 |
SEPSECS | -10939 | -7931 | 10064 |
UBA52 | 1112 | -3471 | -8207 |
Formation of a pool of free 40S subunits
metric | value |
---|---|
setSize | 100 |
pMANOVA | 9.21e-83 |
p.adjustMANOVA | 3.13e-80 |
s.dist | 1.09 |
s.t0_v_pod | -0.208 |
s.pod_crp | -0.743 |
s.t0_crp | -0.769 |
p.t0_v_pod | 0.000327 |
p.pod_crp | 7.09e-38 |
p.t0_crp | 1.81e-40 |
Gene | t0_crp | pod_crp |
---|---|---|
RPL3 | -8773 | -9928 |
RPS2 | -9021 | -9563 |
RPS27A | -8668 | -9695 |
RPL14 | -8650 | -9670 |
RPLP2 | -9001 | -9135 |
RPS12 | -8852 | -9242 |
RPS3 | -8726 | -9270 |
RPLP0 | -8702 | -9199 |
RPS27 | -8693 | -9147 |
RPL10 | -8829 | -9003 |
RPL7 | -8087 | -9737 |
RPS23 | -8319 | -9359 |
RPL27A | -8573 | -9020 |
RPS29 | -8958 | -8609 |
RPS6 | -7892 | -9671 |
RPL31 | -8685 | -8741 |
RPL30 | -8504 | -8902 |
RPL29 | -8787 | -8593 |
RPS5 | -8342 | -9014 |
RPL18A | -8439 | -8868 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
EIF1AX | 1081 | -8356 | 3339 |
EIF3A | 2132 | -1264 | -723 |
EIF3B | -7776 | -9498 | -7620 |
EIF3C | 285 | -4694 | -8882 |
EIF3D | 2605 | -5135 | -7554 |
EIF3E | 1902 | -9021 | 1399 |
EIF3F | 970 | -5176 | -8803 |
EIF3G | 871 | -2729 | -8872 |
EIF3H | 4677 | -7066 | -6135 |
EIF3I | 4649 | -2563 | -8353 |
EIF3J | 1885 | -6423 | 9055 |
EIF3K | 1468 | -2354 | -7325 |
EIF3L | 2560 | -8228 | -8813 |
EIF3M | 4533 | -6792 | 3750 |
FAU | -359 | -3599 | -8841 |
RPL10 | -6311 | -9003 | -8829 |
RPL10A | -6458 | -8900 | -6147 |
RPL11 | -6052 | -9089 | -6722 |
RPL12 | -6811 | -9149 | -8024 |
RPL13 | -3335 | -7644 | -6367 |
RPL13A | -7928 | -9374 | -6207 |
RPL14 | -6480 | -9670 | -8650 |
RPL15 | -953 | -8142 | -8235 |
RPL17 | -5249 | -9088 | -8079 |
RPL18 | -4911 | -8835 | -8406 |
RPL18A | -5869 | -8868 | -8439 |
RPL19 | -6071 | -8311 | -8149 |
RPL21 | -6241 | -9483 | -7230 |
RPL22 | -4587 | -9631 | -7480 |
RPL22L1 | -1593 | -8175 | 527 |
RPL23 | -3223 | -8346 | -7486 |
RPL23A | -9248 | -9950 | -4950 |
RPL24 | -5606 | -8873 | -7028 |
RPL26 | -6387 | -8678 | -8038 |
RPL26L1 | 7070 | 5940 | -5499 |
RPL27 | -2783 | -7783 | -8809 |
RPL27A | -6048 | -9020 | -8573 |
RPL28 | -1441 | -3852 | -5654 |
RPL29 | -3505 | -8593 | -8787 |
RPL3 | -8268 | -9928 | -8773 |
RPL30 | -6779 | -8902 | -8504 |
RPL31 | -4394 | -8741 | -8685 |
RPL32 | -6479 | -9317 | -7991 |
RPL34 | -6569 | -9464 | -6337 |
RPL35 | -7809 | -8156 | -7893 |
RPL35A | -5816 | -9263 | -7997 |
RPL36 | -5111 | -7467 | -8861 |
RPL36A | -7122 | -8881 | -8095 |
RPL36AL | 32 | -6621 | -8799 |
RPL37 | -6160 | -7834 | -9017 |
RPL37A | -3826 | -6808 | -8683 |
RPL38 | -5646 | -7941 | -8932 |
RPL39 | -2931 | -8607 | -8362 |
RPL39L | -8506 | -1648 | -4731 |
RPL3L | 4458 | 5102 | 10556 |
RPL4 | -3476 | -9521 | -7062 |
RPL41 | -6632 | -7535 | -8456 |
RPL5 | -4576 | -9853 | -7157 |
RPL6 | -3262 | -9281 | -3434 |
RPL7 | -1917 | -9737 | -8087 |
RPL7A | -3557 | -8259 | -8751 |
RPL8 | -1171 | -6076 | -8899 |
RPL9 | -1837 | -6796 | -4391 |
RPLP0 | -987 | -9199 | -8702 |
RPLP1 | 19 | -5994 | -8833 |
RPLP2 | -6844 | -9135 | -9001 |
RPS10 | -5601 | -8466 | -8823 |
RPS11 | -6992 | -7948 | -8743 |
RPS12 | -5788 | -9242 | -8852 |
RPS13 | -1717 | -8696 | -7869 |
RPS14 | -5278 | -8513 | -8637 |
RPS15 | -3565 | -6678 | -8273 |
RPS15A | -5550 | -8855 | -8431 |
RPS16 | -4518 | -8551 | -8704 |
RPS17 | -6038 | -8254 | -8928 |
RPS18 | -7474 | -8294 | -7671 |
RPS19 | -6725 | -7779 | -8460 |
RPS2 | -4354 | -9563 | -9021 |
RPS20 | -8585 | -9385 | -6156 |
RPS21 | -3952 | -8303 | -8855 |
RPS23 | -6081 | -9359 | -8319 |
RPS24 | -261 | -6793 | -4573 |
RPS25 | -6151 | -9636 | -7764 |
RPS26 | -1410 | -1143 | -462 |
RPS27 | -9432 | -9147 | -8693 |
RPS27A | -6700 | -9695 | -8668 |
RPS27L | 2048 | -490 | 9654 |
RPS28 | -4562 | -8056 | -8562 |
RPS29 | -7664 | -8609 | -8958 |
RPS3 | -5717 | -9270 | -8726 |
RPS3A | -4543 | -9806 | -4045 |
RPS4X | -6075 | -8620 | -4665 |
RPS4Y1 | 418 | 329 | 1713 |
RPS5 | -5502 | -9014 | -8342 |
RPS6 | -5956 | -9671 | -7892 |
RPS7 | -4803 | -9137 | -7874 |
RPS8 | -2041 | -8833 | -6710 |
RPS9 | 5358 | 1826 | -8433 |
RPSA | -6110 | -6604 | 3504 |
UBA52 | 1112 | -3471 | -8207 |
Eukaryotic Translation Termination
metric | value |
---|---|
setSize | 92 |
pMANOVA | 4.2e-70 |
p.adjustMANOVA | 4.08e-68 |
s.dist | 1.09 |
s.t0_v_pod | -0.265 |
s.pod_crp | -0.732 |
s.t0_crp | -0.762 |
p.t0_v_pod | 1.13e-05 |
p.pod_crp | 5.45e-34 |
p.t0_crp | 9.76e-37 |
Gene | t0_crp | pod_crp |
---|---|---|
RPL3 | -8773 | -9928 |
RPS2 | -9021 | -9563 |
RPS27A | -8668 | -9695 |
RPL14 | -8650 | -9670 |
RPLP2 | -9001 | -9135 |
RPS12 | -8852 | -9242 |
RPS3 | -8726 | -9270 |
RPLP0 | -8702 | -9199 |
RPS27 | -8693 | -9147 |
RPL10 | -8829 | -9003 |
RPL7 | -8087 | -9737 |
RPS23 | -8319 | -9359 |
RPL27A | -8573 | -9020 |
RPS29 | -8958 | -8609 |
RPS6 | -7892 | -9671 |
RPL31 | -8685 | -8741 |
RPL30 | -8504 | -8902 |
RPL29 | -8787 | -8593 |
RPS5 | -8342 | -9014 |
RPL18A | -8439 | -8868 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
APEH | 989 | 4901 | -7164 |
ETF1 | 7308 | 6760 | 4048 |
FAU | -359 | -3599 | -8841 |
GSPT1 | 6387 | -2011 | 8737 |
GSPT2 | -10067 | -7968 | 1941 |
N6AMT1 | -10964 | -9254 | 4209 |
RPL10 | -6311 | -9003 | -8829 |
RPL10A | -6458 | -8900 | -6147 |
RPL11 | -6052 | -9089 | -6722 |
RPL12 | -6811 | -9149 | -8024 |
RPL13 | -3335 | -7644 | -6367 |
RPL13A | -7928 | -9374 | -6207 |
RPL14 | -6480 | -9670 | -8650 |
RPL15 | -953 | -8142 | -8235 |
RPL17 | -5249 | -9088 | -8079 |
RPL18 | -4911 | -8835 | -8406 |
RPL18A | -5869 | -8868 | -8439 |
RPL19 | -6071 | -8311 | -8149 |
RPL21 | -6241 | -9483 | -7230 |
RPL22 | -4587 | -9631 | -7480 |
RPL22L1 | -1593 | -8175 | 527 |
RPL23 | -3223 | -8346 | -7486 |
RPL23A | -9248 | -9950 | -4950 |
RPL24 | -5606 | -8873 | -7028 |
RPL26 | -6387 | -8678 | -8038 |
RPL26L1 | 7070 | 5940 | -5499 |
RPL27 | -2783 | -7783 | -8809 |
RPL27A | -6048 | -9020 | -8573 |
RPL28 | -1441 | -3852 | -5654 |
RPL29 | -3505 | -8593 | -8787 |
RPL3 | -8268 | -9928 | -8773 |
RPL30 | -6779 | -8902 | -8504 |
RPL31 | -4394 | -8741 | -8685 |
RPL32 | -6479 | -9317 | -7991 |
RPL34 | -6569 | -9464 | -6337 |
RPL35 | -7809 | -8156 | -7893 |
RPL35A | -5816 | -9263 | -7997 |
RPL36 | -5111 | -7467 | -8861 |
RPL36A | -7122 | -8881 | -8095 |
RPL36AL | 32 | -6621 | -8799 |
RPL37 | -6160 | -7834 | -9017 |
RPL37A | -3826 | -6808 | -8683 |
RPL38 | -5646 | -7941 | -8932 |
RPL39 | -2931 | -8607 | -8362 |
RPL39L | -8506 | -1648 | -4731 |
RPL3L | 4458 | 5102 | 10556 |
RPL4 | -3476 | -9521 | -7062 |
RPL41 | -6632 | -7535 | -8456 |
RPL5 | -4576 | -9853 | -7157 |
RPL6 | -3262 | -9281 | -3434 |
RPL7 | -1917 | -9737 | -8087 |
RPL7A | -3557 | -8259 | -8751 |
RPL8 | -1171 | -6076 | -8899 |
RPL9 | -1837 | -6796 | -4391 |
RPLP0 | -987 | -9199 | -8702 |
RPLP1 | 19 | -5994 | -8833 |
RPLP2 | -6844 | -9135 | -9001 |
RPS10 | -5601 | -8466 | -8823 |
RPS11 | -6992 | -7948 | -8743 |
RPS12 | -5788 | -9242 | -8852 |
RPS13 | -1717 | -8696 | -7869 |
RPS14 | -5278 | -8513 | -8637 |
RPS15 | -3565 | -6678 | -8273 |
RPS15A | -5550 | -8855 | -8431 |
RPS16 | -4518 | -8551 | -8704 |
RPS17 | -6038 | -8254 | -8928 |
RPS18 | -7474 | -8294 | -7671 |
RPS19 | -6725 | -7779 | -8460 |
RPS2 | -4354 | -9563 | -9021 |
RPS20 | -8585 | -9385 | -6156 |
RPS21 | -3952 | -8303 | -8855 |
RPS23 | -6081 | -9359 | -8319 |
RPS24 | -261 | -6793 | -4573 |
RPS25 | -6151 | -9636 | -7764 |
RPS26 | -1410 | -1143 | -462 |
RPS27 | -9432 | -9147 | -8693 |
RPS27A | -6700 | -9695 | -8668 |
RPS27L | 2048 | -490 | 9654 |
RPS28 | -4562 | -8056 | -8562 |
RPS29 | -7664 | -8609 | -8958 |
RPS3 | -5717 | -9270 | -8726 |
RPS3A | -4543 | -9806 | -4045 |
RPS4X | -6075 | -8620 | -4665 |
RPS4Y1 | 418 | 329 | 1713 |
RPS5 | -5502 | -9014 | -8342 |
RPS6 | -5956 | -9671 | -7892 |
RPS7 | -4803 | -9137 | -7874 |
RPS8 | -2041 | -8833 | -6710 |
RPS9 | 5358 | 1826 | -8433 |
RPSA | -6110 | -6604 | 3504 |
TRMT112 | 732 | -2281 | -8647 |
UBA52 | 1112 | -3471 | -8207 |
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism
metric | value |
---|---|
setSize | 12 |
pMANOVA | 3.03e-05 |
p.adjustMANOVA | 0.000142 |
s.dist | 1.08 |
s.t0_v_pod | 0.785 |
s.pod_crp | 0.726 |
s.t0_crp | -0.133 |
p.t0_v_pod | 2.48e-06 |
p.pod_crp | 1.34e-05 |
p.t0_crp | 0.424 |
Gene | t0_v_pod | pod_crp |
---|---|---|
ACSL1 | 9060 | 10895 |
ACAA1 | 8162 | 10869 |
ACOX1 | 8711 | 10100 |
ACOT8 | 7896 | 10626 |
FADS1 | 7583 | 10674 |
ELOVL3 | 8568 | 9406 |
HSD17B4 | 8710 | 8815 |
ELOVL1 | 6984 | 9678 |
ABCD1 | 7236 | 7891 |
ELOVL5 | 5930 | 5610 |
FADS2 | 1476 | 7129 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ABCD1 | 7236 | 7891 | -8401 |
ACAA1 | 8162 | 10869 | -5822 |
ACOT8 | 7896 | 10626 | -2931 |
ACOX1 | 8711 | 10100 | 4567 |
ACSL1 | 9060 | 10895 | -693 |
ELOVL1 | 6984 | 9678 | -5255 |
ELOVL3 | 8568 | 9406 | 7376 |
ELOVL5 | 5930 | 5610 | 3658 |
FADS1 | 7583 | 10674 | 8374 |
FADS2 | 1476 | 7129 | 836 |
HSD17B4 | 8710 | 8815 | -875 |
SCP2 | 4410 | -1967 | 1940 |
alpha-linolenic acid (ALA) metabolism
metric | value |
---|---|
setSize | 12 |
pMANOVA | 3.03e-05 |
p.adjustMANOVA | 0.000142 |
s.dist | 1.08 |
s.t0_v_pod | 0.785 |
s.pod_crp | 0.726 |
s.t0_crp | -0.133 |
p.t0_v_pod | 2.48e-06 |
p.pod_crp | 1.34e-05 |
p.t0_crp | 0.424 |
Gene | t0_v_pod | pod_crp |
---|---|---|
ACSL1 | 9060 | 10895 |
ACAA1 | 8162 | 10869 |
ACOX1 | 8711 | 10100 |
ACOT8 | 7896 | 10626 |
FADS1 | 7583 | 10674 |
ELOVL3 | 8568 | 9406 |
HSD17B4 | 8710 | 8815 |
ELOVL1 | 6984 | 9678 |
ABCD1 | 7236 | 7891 |
ELOVL5 | 5930 | 5610 |
FADS2 | 1476 | 7129 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ABCD1 | 7236 | 7891 | -8401 |
ACAA1 | 8162 | 10869 | -5822 |
ACOT8 | 7896 | 10626 | -2931 |
ACOX1 | 8711 | 10100 | 4567 |
ACSL1 | 9060 | 10895 | -693 |
ELOVL1 | 6984 | 9678 | -5255 |
ELOVL3 | 8568 | 9406 | 7376 |
ELOVL5 | 5930 | 5610 | 3658 |
FADS1 | 7583 | 10674 | 8374 |
FADS2 | 1476 | 7129 | 836 |
HSD17B4 | 8710 | 8815 | -875 |
SCP2 | 4410 | -1967 | 1940 |
WNT5A-dependent internalization of FZD2, FZD5 and ROR2
metric | value |
---|---|
setSize | 11 |
pMANOVA | 2.04e-05 |
p.adjustMANOVA | 1e-04 |
s.dist | 1.08 |
s.t0_v_pod | 0.67 |
s.pod_crp | 0.664 |
s.t0_crp | -0.516 |
p.t0_v_pod | 0.000119 |
p.pod_crp | 0.000136 |
p.t0_crp | 0.00304 |
Gene | t0_v_pod | pod_crp |
---|---|---|
FZD5 | 9350 | 11220 |
CLTC | 8849 | 10126 |
AP2A1 | 6737 | 11125 |
AP2M1 | 8486 | 8674 |
AP2A2 | 7150 | 10047 |
AP2S1 | 7903 | 7940 |
CLTA | 8244 | 7078 |
CLTB | 6002 | 7866 |
FZD2 | 6374 | 5069 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AP2A1 | 6737 | 11125 | -6175 |
AP2A2 | 7150 | 10047 | -6585 |
AP2B1 | -2641 | 2884 | -1439 |
AP2M1 | 8486 | 8674 | -8821 |
AP2S1 | 7903 | 7940 | -7630 |
CLTA | 8244 | 7078 | -5807 |
CLTB | 6002 | 7866 | -8646 |
CLTC | 8849 | 10126 | -1573 |
FZD2 | 6374 | 5069 | -7468 |
FZD5 | 9350 | 11220 | 2739 |
ROR1 | -2323 | 2176 | 8962 |
Hyaluronan uptake and degradation
metric | value |
---|---|
setSize | 10 |
pMANOVA | 0.00014 |
p.adjustMANOVA | 0.000548 |
s.dist | 1.04 |
s.t0_v_pod | 0.729 |
s.pod_crp | 0.574 |
s.t0_crp | -0.471 |
p.t0_v_pod | 6.53e-05 |
p.pod_crp | 0.00166 |
p.t0_crp | 0.0099 |
Gene | t0_v_pod | pod_crp |
---|---|---|
HYAL2 | 8935 | 11003 |
CHP1 | 9101 | 9868 |
SLC9A1 | 7847 | 11135 |
GUSB | 7607 | 10966 |
CD44 | 8201 | 9117 |
HEXB | 8631 | 7597 |
HYAL1 | 4123 | 8255 |
HMMR | 3770 | 1842 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CD44 | 8201 | 9117 | -5995 |
CHP1 | 9101 | 9868 | -5812 |
GUSB | 7607 | 10966 | -6245 |
HEXA | 1251 | -1954 | -6759 |
HEXB | 8631 | 7597 | -3321 |
HMMR | 3770 | 1842 | 1914 |
HYAL1 | 4123 | 8255 | 9608 |
HYAL2 | 8935 | 11003 | -8015 |
HYAL3 | 5168 | -884 | -3394 |
SLC9A1 | 7847 | 11135 | -5759 |
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
metric | value |
---|---|
setSize | 94 |
pMANOVA | 3.19e-66 |
p.adjustMANOVA | 2.55e-64 |
s.dist | 1.04 |
s.t0_v_pod | -0.244 |
s.pod_crp | -0.705 |
s.t0_crp | -0.724 |
p.t0_v_pod | 4.23e-05 |
p.pod_crp | 2.6e-32 |
p.t0_crp | 6.14e-34 |
Gene | t0_crp | pod_crp |
---|---|---|
RPL3 | -8773 | -9928 |
RPS2 | -9021 | -9563 |
RPS27A | -8668 | -9695 |
RPL14 | -8650 | -9670 |
RPLP2 | -9001 | -9135 |
RPS12 | -8852 | -9242 |
RPS3 | -8726 | -9270 |
RPLP0 | -8702 | -9199 |
RPS27 | -8693 | -9147 |
RPL10 | -8829 | -9003 |
RPL7 | -8087 | -9737 |
RPS23 | -8319 | -9359 |
RPL27A | -8573 | -9020 |
RPS29 | -8958 | -8609 |
RPS6 | -7892 | -9671 |
RPL31 | -8685 | -8741 |
RPL30 | -8504 | -8902 |
RPL29 | -8787 | -8593 |
RPS5 | -8342 | -9014 |
RPL18A | -8439 | -8868 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
EIF4G1 | 7908 | 10325 | -6629 |
ETF1 | 7308 | 6760 | 4048 |
FAU | -359 | -3599 | -8841 |
GSPT1 | 6387 | -2011 | 8737 |
GSPT2 | -10067 | -7968 | 1941 |
NCBP1 | -5659 | -933 | 11205 |
NCBP2 | -9239 | -9603 | 10774 |
PABPC1 | 5290 | -2972 | 2666 |
RPL10 | -6311 | -9003 | -8829 |
RPL10A | -6458 | -8900 | -6147 |
RPL11 | -6052 | -9089 | -6722 |
RPL12 | -6811 | -9149 | -8024 |
RPL13 | -3335 | -7644 | -6367 |
RPL13A | -7928 | -9374 | -6207 |
RPL14 | -6480 | -9670 | -8650 |
RPL15 | -953 | -8142 | -8235 |
RPL17 | -5249 | -9088 | -8079 |
RPL18 | -4911 | -8835 | -8406 |
RPL18A | -5869 | -8868 | -8439 |
RPL19 | -6071 | -8311 | -8149 |
RPL21 | -6241 | -9483 | -7230 |
RPL22 | -4587 | -9631 | -7480 |
RPL22L1 | -1593 | -8175 | 527 |
RPL23 | -3223 | -8346 | -7486 |
RPL23A | -9248 | -9950 | -4950 |
RPL24 | -5606 | -8873 | -7028 |
RPL26 | -6387 | -8678 | -8038 |
RPL26L1 | 7070 | 5940 | -5499 |
RPL27 | -2783 | -7783 | -8809 |
RPL27A | -6048 | -9020 | -8573 |
RPL28 | -1441 | -3852 | -5654 |
RPL29 | -3505 | -8593 | -8787 |
RPL3 | -8268 | -9928 | -8773 |
RPL30 | -6779 | -8902 | -8504 |
RPL31 | -4394 | -8741 | -8685 |
RPL32 | -6479 | -9317 | -7991 |
RPL34 | -6569 | -9464 | -6337 |
RPL35 | -7809 | -8156 | -7893 |
RPL35A | -5816 | -9263 | -7997 |
RPL36 | -5111 | -7467 | -8861 |
RPL36A | -7122 | -8881 | -8095 |
RPL36AL | 32 | -6621 | -8799 |
RPL37 | -6160 | -7834 | -9017 |
RPL37A | -3826 | -6808 | -8683 |
RPL38 | -5646 | -7941 | -8932 |
RPL39 | -2931 | -8607 | -8362 |
RPL39L | -8506 | -1648 | -4731 |
RPL3L | 4458 | 5102 | 10556 |
RPL4 | -3476 | -9521 | -7062 |
RPL41 | -6632 | -7535 | -8456 |
RPL5 | -4576 | -9853 | -7157 |
RPL6 | -3262 | -9281 | -3434 |
RPL7 | -1917 | -9737 | -8087 |
RPL7A | -3557 | -8259 | -8751 |
RPL8 | -1171 | -6076 | -8899 |
RPL9 | -1837 | -6796 | -4391 |
RPLP0 | -987 | -9199 | -8702 |
RPLP1 | 19 | -5994 | -8833 |
RPLP2 | -6844 | -9135 | -9001 |
RPS10 | -5601 | -8466 | -8823 |
RPS11 | -6992 | -7948 | -8743 |
RPS12 | -5788 | -9242 | -8852 |
RPS13 | -1717 | -8696 | -7869 |
RPS14 | -5278 | -8513 | -8637 |
RPS15 | -3565 | -6678 | -8273 |
RPS15A | -5550 | -8855 | -8431 |
RPS16 | -4518 | -8551 | -8704 |
RPS17 | -6038 | -8254 | -8928 |
RPS18 | -7474 | -8294 | -7671 |
RPS19 | -6725 | -7779 | -8460 |
RPS2 | -4354 | -9563 | -9021 |
RPS20 | -8585 | -9385 | -6156 |
RPS21 | -3952 | -8303 | -8855 |
RPS23 | -6081 | -9359 | -8319 |
RPS24 | -261 | -6793 | -4573 |
RPS25 | -6151 | -9636 | -7764 |
RPS26 | -1410 | -1143 | -462 |
RPS27 | -9432 | -9147 | -8693 |
RPS27A | -6700 | -9695 | -8668 |
RPS27L | 2048 | -490 | 9654 |
RPS28 | -4562 | -8056 | -8562 |
RPS29 | -7664 | -8609 | -8958 |
RPS3 | -5717 | -9270 | -8726 |
RPS3A | -4543 | -9806 | -4045 |
RPS4X | -6075 | -8620 | -4665 |
RPS4Y1 | 418 | 329 | 1713 |
RPS5 | -5502 | -9014 | -8342 |
RPS6 | -5956 | -9671 | -7892 |
RPS7 | -4803 | -9137 | -7874 |
RPS8 | -2041 | -8833 | -6710 |
RPS9 | 5358 | 1826 | -8433 |
RPSA | -6110 | -6604 | 3504 |
UBA52 | 1112 | -3471 | -8207 |
UPF1 | 4629 | 8973 | -3684 |
Translocation of ZAP-70 to Immunological synapse
metric | value |
---|---|
setSize | 24 |
pMANOVA | 1.27e-09 |
p.adjustMANOVA | 1.62e-08 |
s.dist | 1.03 |
s.t0_v_pod | -0.743 |
s.pod_crp | -0.705 |
s.t0_crp | -0.0817 |
p.t0_v_pod | 2.86e-10 |
p.pod_crp | 2.27e-09 |
p.t0_crp | 0.489 |
Gene | t0_v_pod | pod_crp |
---|---|---|
LCK | -11482 | -9528 |
TRBC1 | -11646 | -9275 |
TRAC | -11130 | -9675 |
HLA-DRA | -11649 | -8978 |
CD247 | -11982 | -8713 |
ZAP70 | -11590 | -8727 |
CD3E | -10952 | -9221 |
TRBV12-3 | -10099 | -9942 |
HLA-DPB1 | -11887 | -8370 |
HLA-DPA1 | -11954 | -8190 |
CD3D | -11049 | -8270 |
CD3G | -11173 | -8084 |
TRAV19 | -9587 | -9220 |
HLA-DQB2 | -9085 | -9628 |
TRAV29DV5 | -9353 | -9250 |
TRBV7-9 | -9220 | -8276 |
HLA-DQA1 | -11633 | -6364 |
HLA-DQA2 | -4652 | -8746 |
CD4 | -5228 | -6856 |
TRAV8-4 | -7010 | -4747 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CD247 | -11982 | -8713 | -6364 |
CD3D | -11049 | -8270 | 2178 |
CD3E | -10952 | -9221 | 5038 |
CD3G | -11173 | -8084 | 8697 |
CD4 | -5228 | -6856 | -6272 |
HLA-DPA1 | -11954 | -8190 | 4347 |
HLA-DPB1 | -11887 | -8370 | -2273 |
HLA-DQA1 | -11633 | -6364 | 10152 |
HLA-DQA2 | -4652 | -8746 | -8618 |
HLA-DQB1 | -6199 | -4437 | 3070 |
HLA-DQB2 | -9085 | -9628 | -6796 |
HLA-DRA | -11649 | -8978 | 726 |
HLA-DRB1 | -7792 | -330 | 8671 |
HLA-DRB5 | -4806 | 741 | 5896 |
LCK | -11482 | -9528 | -3384 |
PTPN22 | -1191 | 6886 | 8220 |
TRAC | -11130 | -9675 | 7034 |
TRAV19 | -9587 | -9220 | -3070 |
TRAV29DV5 | -9353 | -9250 | -1621 |
TRAV8-4 | -7010 | -4747 | 11211 |
TRBC1 | -11646 | -9275 | 1902 |
TRBV12-3 | -10099 | -9942 | -8483 |
TRBV7-9 | -9220 | -8276 | -4880 |
ZAP70 | -11590 | -8727 | -6587 |
Uptake and function of anthrax toxins
metric | value |
---|---|
setSize | 10 |
pMANOVA | 0.000314 |
p.adjustMANOVA | 0.0011 |
s.dist | 1.02 |
s.t0_v_pod | 0.704 |
s.pod_crp | 0.617 |
s.t0_crp | -0.403 |
p.t0_v_pod | 0.000117 |
p.pod_crp | 0.000733 |
p.t0_crp | 0.0274 |
Gene | t0_v_pod | pod_crp |
---|---|---|
FURIN | 8922 | 10706 |
MAP2K6 | 8739 | 10757 |
MAP2K1 | 8910 | 9974 |
MAP2K3 | 8604 | 10197 |
PDCD6IP | 6440 | 9153 |
MAP2K4 | 6770 | 7655 |
MAP2K2 | 6699 | 7135 |
ANTXR2 | 7221 | 5582 |
MAP2K7 | 1641 | 1537 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ANTXR2 | 7221 | 5582 | -7472 |
CALM1 | -2039 | -1234 | 3538 |
FURIN | 8922 | 10706 | -8995 |
MAP2K1 | 8910 | 9974 | -7128 |
MAP2K2 | 6699 | 7135 | -8945 |
MAP2K3 | 8604 | 10197 | -6582 |
MAP2K4 | 6770 | 7655 | 1313 |
MAP2K6 | 8739 | 10757 | 6512 |
MAP2K7 | 1641 | 1537 | -7635 |
PDCD6IP | 6440 | 9153 | 8901 |
Regulation of TLR by endogenous ligand
metric | value |
---|---|
setSize | 11 |
pMANOVA | 0.000254 |
p.adjustMANOVA | 0.000911 |
s.dist | 1 |
s.t0_v_pod | 0.743 |
s.pod_crp | 0.645 |
s.t0_crp | -0.202 |
p.t0_v_pod | 1.95e-05 |
p.pod_crp | 0.000214 |
p.t0_crp | 0.246 |
Gene | t0_v_pod | pod_crp |
---|---|---|
S100A8 | 9341 | 10975 |
CD36 | 9283 | 10747 |
S100A9 | 9353 | 10428 |
TLR2 | 8950 | 10352 |
TLR1 | 8782 | 9888 |
CD14 | 8944 | 9321 |
TLR4 | 8864 | 9402 |
LY96 | 8649 | 9181 |
TLR6 | 8694 | 8940 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CD14 | 8944 | 9321 | -7666 |
CD36 | 9283 | 10747 | -147 |
HMGB1 | -251 | -6674 | 2350 |
LY96 | 8649 | 9181 | 4818 |
S100A1 | -7825 | -680 | 3274 |
S100A8 | 9341 | 10975 | -5317 |
S100A9 | 9353 | 10428 | -7018 |
TLR1 | 8782 | 9888 | 5302 |
TLR2 | 8950 | 10352 | 3541 |
TLR4 | 8864 | 9402 | -2478 |
TLR6 | 8694 | 8940 | -2193 |
VLDLR internalisation and degradation
metric | value |
---|---|
setSize | 11 |
pMANOVA | 9.65e-06 |
p.adjustMANOVA | 5.4e-05 |
s.dist | 0.987 |
s.t0_v_pod | 0.468 |
s.pod_crp | 0.539 |
s.t0_crp | -0.682 |
p.t0_v_pod | 0.00718 |
p.pod_crp | 0.00196 |
p.t0_crp | 8.98e-05 |
Gene | t0_crp | pod_crp |
---|---|---|
AP2M1 | -8821 | 8674 |
AP2A1 | -6175 | 11125 |
AP2A2 | -6585 | 10047 |
NR1H2 | -6941 | 9374 |
AP2S1 | -7630 | 7940 |
CLTA | -5807 | 7078 |
CLTC | -1573 | 10126 |
VLDLR | -2403 | 6177 |
NR1H3 | -7769 | 944 |
AP2B1 | -1439 | 2884 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AP2A1 | 6737 | 11125 | -6175 |
AP2A2 | 7150 | 10047 | -6585 |
AP2B1 | -2641 | 2884 | -1439 |
AP2M1 | 8486 | 8674 | -8821 |
AP2S1 | 7903 | 7940 | -7630 |
CLTA | 8244 | 7078 | -5807 |
CLTC | 8849 | 10126 | -1573 |
MYLIP | -3870 | -4866 | -6799 |
NR1H2 | 7304 | 9374 | -6941 |
NR1H3 | -3491 | 944 | -7769 |
VLDLR | -4246 | 6177 | -2403 |
L13a-mediated translational silencing of Ceruloplasmin expression
metric | value |
---|---|
setSize | 110 |
pMANOVA | 6.8e-80 |
p.adjustMANOVA | 1.85e-77 |
s.dist | 0.987 |
s.t0_v_pod | -0.143 |
s.pod_crp | -0.676 |
s.t0_crp | -0.704 |
p.t0_v_pod | 0.00949 |
p.pod_crp | 1.43e-34 |
p.t0_crp | 1.92e-37 |
Gene | t0_crp | pod_crp |
---|---|---|
RPL3 | -8773 | -9928 |
RPS2 | -9021 | -9563 |
RPS27A | -8668 | -9695 |
RPL14 | -8650 | -9670 |
RPLP2 | -9001 | -9135 |
RPS12 | -8852 | -9242 |
RPS3 | -8726 | -9270 |
RPLP0 | -8702 | -9199 |
RPS27 | -8693 | -9147 |
RPL10 | -8829 | -9003 |
RPL7 | -8087 | -9737 |
RPS23 | -8319 | -9359 |
RPL27A | -8573 | -9020 |
RPS29 | -8958 | -8609 |
RPS6 | -7892 | -9671 |
RPL31 | -8685 | -8741 |
RPL30 | -8504 | -8902 |
RPL29 | -8787 | -8593 |
RPS5 | -8342 | -9014 |
RPL18A | -8439 | -8868 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
EIF1AX | 1081 | -8356 | 3339 |
EIF2S1 | 4235 | -1636 | 6996 |
EIF2S2 | 6091 | 549 | 7102 |
EIF2S3 | 6653 | 2481 | 4095 |
EIF3A | 2132 | -1264 | -723 |
EIF3B | -7776 | -9498 | -7620 |
EIF3C | 285 | -4694 | -8882 |
EIF3D | 2605 | -5135 | -7554 |
EIF3E | 1902 | -9021 | 1399 |
EIF3F | 970 | -5176 | -8803 |
EIF3G | 871 | -2729 | -8872 |
EIF3H | 4677 | -7066 | -6135 |
EIF3I | 4649 | -2563 | -8353 |
EIF3J | 1885 | -6423 | 9055 |
EIF3K | 1468 | -2354 | -7325 |
EIF3L | 2560 | -8228 | -8813 |
EIF3M | 4533 | -6792 | 3750 |
EIF4A1 | 7476 | 5489 | -4905 |
EIF4A2 | -10809 | -9565 | 7689 |
EIF4B | 1237 | -8163 | -7131 |
EIF4E | 4757 | 1648 | 9908 |
EIF4G1 | 7908 | 10325 | -6629 |
EIF4H | 7634 | 7669 | -8926 |
FAU | -359 | -3599 | -8841 |
PABPC1 | 5290 | -2972 | 2666 |
RPL10 | -6311 | -9003 | -8829 |
RPL10A | -6458 | -8900 | -6147 |
RPL11 | -6052 | -9089 | -6722 |
RPL12 | -6811 | -9149 | -8024 |
RPL13 | -3335 | -7644 | -6367 |
RPL13A | -7928 | -9374 | -6207 |
RPL14 | -6480 | -9670 | -8650 |
RPL15 | -953 | -8142 | -8235 |
RPL17 | -5249 | -9088 | -8079 |
RPL18 | -4911 | -8835 | -8406 |
RPL18A | -5869 | -8868 | -8439 |
RPL19 | -6071 | -8311 | -8149 |
RPL21 | -6241 | -9483 | -7230 |
RPL22 | -4587 | -9631 | -7480 |
RPL22L1 | -1593 | -8175 | 527 |
RPL23 | -3223 | -8346 | -7486 |
RPL23A | -9248 | -9950 | -4950 |
RPL24 | -5606 | -8873 | -7028 |
RPL26 | -6387 | -8678 | -8038 |
RPL26L1 | 7070 | 5940 | -5499 |
RPL27 | -2783 | -7783 | -8809 |
RPL27A | -6048 | -9020 | -8573 |
RPL28 | -1441 | -3852 | -5654 |
RPL29 | -3505 | -8593 | -8787 |
RPL3 | -8268 | -9928 | -8773 |
RPL30 | -6779 | -8902 | -8504 |
RPL31 | -4394 | -8741 | -8685 |
RPL32 | -6479 | -9317 | -7991 |
RPL34 | -6569 | -9464 | -6337 |
RPL35 | -7809 | -8156 | -7893 |
RPL35A | -5816 | -9263 | -7997 |
RPL36 | -5111 | -7467 | -8861 |
RPL36A | -7122 | -8881 | -8095 |
RPL36AL | 32 | -6621 | -8799 |
RPL37 | -6160 | -7834 | -9017 |
RPL37A | -3826 | -6808 | -8683 |
RPL38 | -5646 | -7941 | -8932 |
RPL39 | -2931 | -8607 | -8362 |
RPL39L | -8506 | -1648 | -4731 |
RPL3L | 4458 | 5102 | 10556 |
RPL4 | -3476 | -9521 | -7062 |
RPL41 | -6632 | -7535 | -8456 |
RPL5 | -4576 | -9853 | -7157 |
RPL6 | -3262 | -9281 | -3434 |
RPL7 | -1917 | -9737 | -8087 |
RPL7A | -3557 | -8259 | -8751 |
RPL8 | -1171 | -6076 | -8899 |
RPL9 | -1837 | -6796 | -4391 |
RPLP0 | -987 | -9199 | -8702 |
RPLP1 | 19 | -5994 | -8833 |
RPLP2 | -6844 | -9135 | -9001 |
RPS10 | -5601 | -8466 | -8823 |
RPS11 | -6992 | -7948 | -8743 |
RPS12 | -5788 | -9242 | -8852 |
RPS13 | -1717 | -8696 | -7869 |
RPS14 | -5278 | -8513 | -8637 |
RPS15 | -3565 | -6678 | -8273 |
RPS15A | -5550 | -8855 | -8431 |
RPS16 | -4518 | -8551 | -8704 |
RPS17 | -6038 | -8254 | -8928 |
RPS18 | -7474 | -8294 | -7671 |
RPS19 | -6725 | -7779 | -8460 |
RPS2 | -4354 | -9563 | -9021 |
RPS20 | -8585 | -9385 | -6156 |
RPS21 | -3952 | -8303 | -8855 |
RPS23 | -6081 | -9359 | -8319 |
RPS24 | -261 | -6793 | -4573 |
RPS25 | -6151 | -9636 | -7764 |
RPS26 | -1410 | -1143 | -462 |
RPS27 | -9432 | -9147 | -8693 |
RPS27A | -6700 | -9695 | -8668 |
RPS27L | 2048 | -490 | 9654 |
RPS28 | -4562 | -8056 | -8562 |
RPS29 | -7664 | -8609 | -8958 |
RPS3 | -5717 | -9270 | -8726 |
RPS3A | -4543 | -9806 | -4045 |
RPS4X | -6075 | -8620 | -4665 |
RPS4Y1 | 418 | 329 | 1713 |
RPS5 | -5502 | -9014 | -8342 |
RPS6 | -5956 | -9671 | -7892 |
RPS7 | -4803 | -9137 | -7874 |
RPS8 | -2041 | -8833 | -6710 |
RPS9 | 5358 | 1826 | -8433 |
RPSA | -6110 | -6604 | 3504 |
UBA52 | 1112 | -3471 | -8207 |
GTP hydrolysis and joining of the 60S ribosomal subunit
metric | value |
---|---|
setSize | 111 |
pMANOVA | 4.93e-78 |
p.adjustMANOVA | 9.59e-76 |
s.dist | 0.972 |
s.t0_v_pod | -0.147 |
s.pod_crp | -0.671 |
s.t0_crp | -0.688 |
p.t0_v_pod | 0.00738 |
p.pod_crp | 2.12e-34 |
p.t0_crp | 4.08e-36 |
Gene | t0_crp | pod_crp |
---|---|---|
RPL3 | -8773 | -9928 |
RPS2 | -9021 | -9563 |
RPS27A | -8668 | -9695 |
RPL14 | -8650 | -9670 |
RPLP2 | -9001 | -9135 |
RPS12 | -8852 | -9242 |
RPS3 | -8726 | -9270 |
RPLP0 | -8702 | -9199 |
RPS27 | -8693 | -9147 |
RPL10 | -8829 | -9003 |
RPL7 | -8087 | -9737 |
RPS23 | -8319 | -9359 |
RPL27A | -8573 | -9020 |
RPS29 | -8958 | -8609 |
RPS6 | -7892 | -9671 |
RPL31 | -8685 | -8741 |
RPL30 | -8504 | -8902 |
RPL29 | -8787 | -8593 |
RPS5 | -8342 | -9014 |
RPL18A | -8439 | -8868 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
EIF1AX | 1081 | -8356 | 3339 |
EIF2S1 | 4235 | -1636 | 6996 |
EIF2S2 | 6091 | 549 | 7102 |
EIF2S3 | 6653 | 2481 | 4095 |
EIF3A | 2132 | -1264 | -723 |
EIF3B | -7776 | -9498 | -7620 |
EIF3C | 285 | -4694 | -8882 |
EIF3D | 2605 | -5135 | -7554 |
EIF3E | 1902 | -9021 | 1399 |
EIF3F | 970 | -5176 | -8803 |
EIF3G | 871 | -2729 | -8872 |
EIF3H | 4677 | -7066 | -6135 |
EIF3I | 4649 | -2563 | -8353 |
EIF3J | 1885 | -6423 | 9055 |
EIF3K | 1468 | -2354 | -7325 |
EIF3L | 2560 | -8228 | -8813 |
EIF3M | 4533 | -6792 | 3750 |
EIF4A1 | 7476 | 5489 | -4905 |
EIF4A2 | -10809 | -9565 | 7689 |
EIF4B | 1237 | -8163 | -7131 |
EIF4E | 4757 | 1648 | 9908 |
EIF4G1 | 7908 | 10325 | -6629 |
EIF4H | 7634 | 7669 | -8926 |
EIF5 | 2162 | 2911 | 7027 |
EIF5B | -4487 | -6842 | 9045 |
FAU | -359 | -3599 | -8841 |
RPL10 | -6311 | -9003 | -8829 |
RPL10A | -6458 | -8900 | -6147 |
RPL11 | -6052 | -9089 | -6722 |
RPL12 | -6811 | -9149 | -8024 |
RPL13 | -3335 | -7644 | -6367 |
RPL13A | -7928 | -9374 | -6207 |
RPL14 | -6480 | -9670 | -8650 |
RPL15 | -953 | -8142 | -8235 |
RPL17 | -5249 | -9088 | -8079 |
RPL18 | -4911 | -8835 | -8406 |
RPL18A | -5869 | -8868 | -8439 |
RPL19 | -6071 | -8311 | -8149 |
RPL21 | -6241 | -9483 | -7230 |
RPL22 | -4587 | -9631 | -7480 |
RPL22L1 | -1593 | -8175 | 527 |
RPL23 | -3223 | -8346 | -7486 |
RPL23A | -9248 | -9950 | -4950 |
RPL24 | -5606 | -8873 | -7028 |
RPL26 | -6387 | -8678 | -8038 |
RPL26L1 | 7070 | 5940 | -5499 |
RPL27 | -2783 | -7783 | -8809 |
RPL27A | -6048 | -9020 | -8573 |
RPL28 | -1441 | -3852 | -5654 |
RPL29 | -3505 | -8593 | -8787 |
RPL3 | -8268 | -9928 | -8773 |
RPL30 | -6779 | -8902 | -8504 |
RPL31 | -4394 | -8741 | -8685 |
RPL32 | -6479 | -9317 | -7991 |
RPL34 | -6569 | -9464 | -6337 |
RPL35 | -7809 | -8156 | -7893 |
RPL35A | -5816 | -9263 | -7997 |
RPL36 | -5111 | -7467 | -8861 |
RPL36A | -7122 | -8881 | -8095 |
RPL36AL | 32 | -6621 | -8799 |
RPL37 | -6160 | -7834 | -9017 |
RPL37A | -3826 | -6808 | -8683 |
RPL38 | -5646 | -7941 | -8932 |
RPL39 | -2931 | -8607 | -8362 |
RPL39L | -8506 | -1648 | -4731 |
RPL3L | 4458 | 5102 | 10556 |
RPL4 | -3476 | -9521 | -7062 |
RPL41 | -6632 | -7535 | -8456 |
RPL5 | -4576 | -9853 | -7157 |
RPL6 | -3262 | -9281 | -3434 |
RPL7 | -1917 | -9737 | -8087 |
RPL7A | -3557 | -8259 | -8751 |
RPL8 | -1171 | -6076 | -8899 |
RPL9 | -1837 | -6796 | -4391 |
RPLP0 | -987 | -9199 | -8702 |
RPLP1 | 19 | -5994 | -8833 |
RPLP2 | -6844 | -9135 | -9001 |
RPS10 | -5601 | -8466 | -8823 |
RPS11 | -6992 | -7948 | -8743 |
RPS12 | -5788 | -9242 | -8852 |
RPS13 | -1717 | -8696 | -7869 |
RPS14 | -5278 | -8513 | -8637 |
RPS15 | -3565 | -6678 | -8273 |
RPS15A | -5550 | -8855 | -8431 |
RPS16 | -4518 | -8551 | -8704 |
RPS17 | -6038 | -8254 | -8928 |
RPS18 | -7474 | -8294 | -7671 |
RPS19 | -6725 | -7779 | -8460 |
RPS2 | -4354 | -9563 | -9021 |
RPS20 | -8585 | -9385 | -6156 |
RPS21 | -3952 | -8303 | -8855 |
RPS23 | -6081 | -9359 | -8319 |
RPS24 | -261 | -6793 | -4573 |
RPS25 | -6151 | -9636 | -7764 |
RPS26 | -1410 | -1143 | -462 |
RPS27 | -9432 | -9147 | -8693 |
RPS27A | -6700 | -9695 | -8668 |
RPS27L | 2048 | -490 | 9654 |
RPS28 | -4562 | -8056 | -8562 |
RPS29 | -7664 | -8609 | -8958 |
RPS3 | -5717 | -9270 | -8726 |
RPS3A | -4543 | -9806 | -4045 |
RPS4X | -6075 | -8620 | -4665 |
RPS4Y1 | 418 | 329 | 1713 |
RPS5 | -5502 | -9014 | -8342 |
RPS6 | -5956 | -9671 | -7892 |
RPS7 | -4803 | -9137 | -7874 |
RPS8 | -2041 | -8833 | -6710 |
RPS9 | 5358 | 1826 | -8433 |
RPSA | -6110 | -6604 | 3504 |
UBA52 | 1112 | -3471 | -8207 |
Response of EIF2AK4 (GCN2) to amino acid deficiency
metric | value |
---|---|
setSize | 100 |
pMANOVA | 2.15e-62 |
p.adjustMANOVA | 1.63e-60 |
s.dist | 0.969 |
s.t0_v_pod | -0.222 |
s.pod_crp | -0.669 |
s.t0_crp | -0.666 |
p.t0_v_pod | 0.000128 |
p.pod_crp | 5.65e-31 |
p.t0_crp | 1.06e-30 |
Gene | pod_crp | t0_crp |
---|---|---|
RPL3 | -9928 | -8773 |
RPS2 | -9563 | -9021 |
RPS27A | -9695 | -8668 |
RPL14 | -9670 | -8650 |
RPLP2 | -9135 | -9001 |
RPS12 | -9242 | -8852 |
RPS3 | -9270 | -8726 |
RPLP0 | -9199 | -8702 |
RPS27 | -9147 | -8693 |
RPL10 | -9003 | -8829 |
RPL7 | -9737 | -8087 |
RPS23 | -9359 | -8319 |
RPL27A | -9020 | -8573 |
RPS29 | -8609 | -8958 |
RPS6 | -9671 | -7892 |
RPL31 | -8741 | -8685 |
RPL30 | -8902 | -8504 |
RPL29 | -8593 | -8787 |
RPS5 | -9014 | -8342 |
RPL18A | -8868 | -8439 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ASNS | -8030 | -7745 | 6843 |
ATF2 | 2072 | -649 | 9372 |
ATF3 | -9357 | -4266 | 10016 |
ATF4 | 6151 | -53 | -5554 |
CEBPB | 7875 | 10929 | -2749 |
CEBPG | 5401 | 4172 | 6082 |
DDIT3 | 4850 | 6412 | 5869 |
EIF2AK4 | 41 | -1643 | -6653 |
EIF2S1 | 4235 | -1636 | 6996 |
EIF2S2 | 6091 | 549 | 7102 |
EIF2S3 | 6653 | 2481 | 4095 |
FAU | -359 | -3599 | -8841 |
GCN1 | -10036 | -5601 | -359 |
IMPACT | -3125 | -5573 | 8929 |
RPL10 | -6311 | -9003 | -8829 |
RPL10A | -6458 | -8900 | -6147 |
RPL11 | -6052 | -9089 | -6722 |
RPL12 | -6811 | -9149 | -8024 |
RPL13 | -3335 | -7644 | -6367 |
RPL13A | -7928 | -9374 | -6207 |
RPL14 | -6480 | -9670 | -8650 |
RPL15 | -953 | -8142 | -8235 |
RPL17 | -5249 | -9088 | -8079 |
RPL18 | -4911 | -8835 | -8406 |
RPL18A | -5869 | -8868 | -8439 |
RPL19 | -6071 | -8311 | -8149 |
RPL21 | -6241 | -9483 | -7230 |
RPL22 | -4587 | -9631 | -7480 |
RPL22L1 | -1593 | -8175 | 527 |
RPL23 | -3223 | -8346 | -7486 |
RPL23A | -9248 | -9950 | -4950 |
RPL24 | -5606 | -8873 | -7028 |
RPL26 | -6387 | -8678 | -8038 |
RPL26L1 | 7070 | 5940 | -5499 |
RPL27 | -2783 | -7783 | -8809 |
RPL27A | -6048 | -9020 | -8573 |
RPL28 | -1441 | -3852 | -5654 |
RPL29 | -3505 | -8593 | -8787 |
RPL3 | -8268 | -9928 | -8773 |
RPL30 | -6779 | -8902 | -8504 |
RPL31 | -4394 | -8741 | -8685 |
RPL32 | -6479 | -9317 | -7991 |
RPL34 | -6569 | -9464 | -6337 |
RPL35 | -7809 | -8156 | -7893 |
RPL35A | -5816 | -9263 | -7997 |
RPL36 | -5111 | -7467 | -8861 |
RPL36A | -7122 | -8881 | -8095 |
RPL36AL | 32 | -6621 | -8799 |
RPL37 | -6160 | -7834 | -9017 |
RPL37A | -3826 | -6808 | -8683 |
RPL38 | -5646 | -7941 | -8932 |
RPL39 | -2931 | -8607 | -8362 |
RPL39L | -8506 | -1648 | -4731 |
RPL3L | 4458 | 5102 | 10556 |
RPL4 | -3476 | -9521 | -7062 |
RPL41 | -6632 | -7535 | -8456 |
RPL5 | -4576 | -9853 | -7157 |
RPL6 | -3262 | -9281 | -3434 |
RPL7 | -1917 | -9737 | -8087 |
RPL7A | -3557 | -8259 | -8751 |
RPL8 | -1171 | -6076 | -8899 |
RPL9 | -1837 | -6796 | -4391 |
RPLP0 | -987 | -9199 | -8702 |
RPLP1 | 19 | -5994 | -8833 |
RPLP2 | -6844 | -9135 | -9001 |
RPS10 | -5601 | -8466 | -8823 |
RPS11 | -6992 | -7948 | -8743 |
RPS12 | -5788 | -9242 | -8852 |
RPS13 | -1717 | -8696 | -7869 |
RPS14 | -5278 | -8513 | -8637 |
RPS15 | -3565 | -6678 | -8273 |
RPS15A | -5550 | -8855 | -8431 |
RPS16 | -4518 | -8551 | -8704 |
RPS17 | -6038 | -8254 | -8928 |
RPS18 | -7474 | -8294 | -7671 |
RPS19 | -6725 | -7779 | -8460 |
RPS2 | -4354 | -9563 | -9021 |
RPS20 | -8585 | -9385 | -6156 |
RPS21 | -3952 | -8303 | -8855 |
RPS23 | -6081 | -9359 | -8319 |
RPS24 | -261 | -6793 | -4573 |
RPS25 | -6151 | -9636 | -7764 |
RPS26 | -1410 | -1143 | -462 |
RPS27 | -9432 | -9147 | -8693 |
RPS27A | -6700 | -9695 | -8668 |
RPS27L | 2048 | -490 | 9654 |
RPS28 | -4562 | -8056 | -8562 |
RPS29 | -7664 | -8609 | -8958 |
RPS3 | -5717 | -9270 | -8726 |
RPS3A | -4543 | -9806 | -4045 |
RPS4X | -6075 | -8620 | -4665 |
RPS4Y1 | 418 | 329 | 1713 |
RPS5 | -5502 | -9014 | -8342 |
RPS6 | -5956 | -9671 | -7892 |
RPS7 | -4803 | -9137 | -7874 |
RPS8 | -2041 | -8833 | -6710 |
RPS9 | 5358 | 1826 | -8433 |
RPSA | -6110 | -6604 | 3504 |
TRIB3 | -5649 | 2473 | 4697 |
UBA52 | 1112 | -3471 | -8207 |
Advanced glycosylation endproduct receptor signaling
metric | value |
---|---|
setSize | 12 |
pMANOVA | 9.21e-05 |
p.adjustMANOVA | 0.000381 |
s.dist | 0.968 |
s.t0_v_pod | 0.65 |
s.pod_crp | 0.542 |
s.t0_crp | -0.47 |
p.t0_v_pod | 9.71e-05 |
p.pod_crp | 0.00114 |
p.t0_crp | 0.00478 |
Gene | t0_v_pod | pod_crp |
---|---|---|
S100A12 | 9352 | 10996 |
MAPK3 | 8803 | 9593 |
MAPK1 | 7381 | 10983 |
LGALS3 | 8608 | 9045 |
CAPZA1 | 8008 | 9383 |
CAPZA2 | 8457 | 8110 |
DDOST | 6831 | 8345 |
APP | 9022 | 6180 |
PRKCSH | 5159 | 6756 |
AGER | 1284 | 4851 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AGER | 1284 | 4851 | -781 |
APP | 9022 | 6180 | -6109 |
CAPZA1 | 8008 | 9383 | 6293 |
CAPZA2 | 8457 | 8110 | 4868 |
DDOST | 6831 | 8345 | -8761 |
HMGB1 | -251 | -6674 | 2350 |
LGALS3 | 8608 | 9045 | -4982 |
MAPK1 | 7381 | 10983 | -1505 |
MAPK3 | 8803 | 9593 | -9014 |
PRKCSH | 5159 | 6756 | -8725 |
S100A12 | 9352 | 10996 | -7985 |
S100B | -5273 | -1338 | -6095 |
Cap-dependent Translation Initiation
metric | value |
---|---|
setSize | 118 |
pMANOVA | 3.48e-76 |
p.adjustMANOVA | 5.26e-74 |
s.dist | 0.927 |
s.t0_v_pod | -0.132 |
s.pod_crp | -0.637 |
s.t0_crp | -0.661 |
p.t0_v_pod | 0.0135 |
p.pod_crp | 5.36e-33 |
p.t0_crp | 1.74e-35 |
Gene | t0_crp | pod_crp |
---|---|---|
RPL3 | -8773 | -9928 |
RPS2 | -9021 | -9563 |
RPS27A | -8668 | -9695 |
RPL14 | -8650 | -9670 |
RPLP2 | -9001 | -9135 |
RPS12 | -8852 | -9242 |
RPS3 | -8726 | -9270 |
RPLP0 | -8702 | -9199 |
RPS27 | -8693 | -9147 |
RPL10 | -8829 | -9003 |
RPL7 | -8087 | -9737 |
RPS23 | -8319 | -9359 |
RPL27A | -8573 | -9020 |
RPS29 | -8958 | -8609 |
RPS6 | -7892 | -9671 |
RPL31 | -8685 | -8741 |
RPL30 | -8504 | -8902 |
RPL29 | -8787 | -8593 |
RPS5 | -8342 | -9014 |
RPL18A | -8439 | -8868 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
EIF1AX | 1081 | -8356 | 3339 |
EIF2B1 | -411 | -2213 | 5744 |
EIF2B2 | 3233 | 7405 | -4631 |
EIF2B3 | -7934 | -6624 | 3358 |
EIF2B4 | 2685 | 4256 | -5692 |
EIF2B5 | -9484 | -5556 | -804 |
EIF2S1 | 4235 | -1636 | 6996 |
EIF2S2 | 6091 | 549 | 7102 |
EIF2S3 | 6653 | 2481 | 4095 |
EIF3A | 2132 | -1264 | -723 |
EIF3B | -7776 | -9498 | -7620 |
EIF3C | 285 | -4694 | -8882 |
EIF3D | 2605 | -5135 | -7554 |
EIF3E | 1902 | -9021 | 1399 |
EIF3F | 970 | -5176 | -8803 |
EIF3G | 871 | -2729 | -8872 |
EIF3H | 4677 | -7066 | -6135 |
EIF3I | 4649 | -2563 | -8353 |
EIF3J | 1885 | -6423 | 9055 |
EIF3K | 1468 | -2354 | -7325 |
EIF3L | 2560 | -8228 | -8813 |
EIF3M | 4533 | -6792 | 3750 |
EIF4A1 | 7476 | 5489 | -4905 |
EIF4A2 | -10809 | -9565 | 7689 |
EIF4B | 1237 | -8163 | -7131 |
EIF4E | 4757 | 1648 | 9908 |
EIF4EBP1 | 5990 | 2800 | -6475 |
EIF4G1 | 7908 | 10325 | -6629 |
EIF4H | 7634 | 7669 | -8926 |
EIF5 | 2162 | 2911 | 7027 |
EIF5B | -4487 | -6842 | 9045 |
FAU | -359 | -3599 | -8841 |
PABPC1 | 5290 | -2972 | 2666 |
RPL10 | -6311 | -9003 | -8829 |
RPL10A | -6458 | -8900 | -6147 |
RPL11 | -6052 | -9089 | -6722 |
RPL12 | -6811 | -9149 | -8024 |
RPL13 | -3335 | -7644 | -6367 |
RPL13A | -7928 | -9374 | -6207 |
RPL14 | -6480 | -9670 | -8650 |
RPL15 | -953 | -8142 | -8235 |
RPL17 | -5249 | -9088 | -8079 |
RPL18 | -4911 | -8835 | -8406 |
RPL18A | -5869 | -8868 | -8439 |
RPL19 | -6071 | -8311 | -8149 |
RPL21 | -6241 | -9483 | -7230 |
RPL22 | -4587 | -9631 | -7480 |
RPL22L1 | -1593 | -8175 | 527 |
RPL23 | -3223 | -8346 | -7486 |
RPL23A | -9248 | -9950 | -4950 |
RPL24 | -5606 | -8873 | -7028 |
RPL26 | -6387 | -8678 | -8038 |
RPL26L1 | 7070 | 5940 | -5499 |
RPL27 | -2783 | -7783 | -8809 |
RPL27A | -6048 | -9020 | -8573 |
RPL28 | -1441 | -3852 | -5654 |
RPL29 | -3505 | -8593 | -8787 |
RPL3 | -8268 | -9928 | -8773 |
RPL30 | -6779 | -8902 | -8504 |
RPL31 | -4394 | -8741 | -8685 |
RPL32 | -6479 | -9317 | -7991 |
RPL34 | -6569 | -9464 | -6337 |
RPL35 | -7809 | -8156 | -7893 |
RPL35A | -5816 | -9263 | -7997 |
RPL36 | -5111 | -7467 | -8861 |
RPL36A | -7122 | -8881 | -8095 |
RPL36AL | 32 | -6621 | -8799 |
RPL37 | -6160 | -7834 | -9017 |
RPL37A | -3826 | -6808 | -8683 |
RPL38 | -5646 | -7941 | -8932 |
RPL39 | -2931 | -8607 | -8362 |
RPL39L | -8506 | -1648 | -4731 |
RPL3L | 4458 | 5102 | 10556 |
RPL4 | -3476 | -9521 | -7062 |
RPL41 | -6632 | -7535 | -8456 |
RPL5 | -4576 | -9853 | -7157 |
RPL6 | -3262 | -9281 | -3434 |
RPL7 | -1917 | -9737 | -8087 |
RPL7A | -3557 | -8259 | -8751 |
RPL8 | -1171 | -6076 | -8899 |
RPL9 | -1837 | -6796 | -4391 |
RPLP0 | -987 | -9199 | -8702 |
RPLP1 | 19 | -5994 | -8833 |
RPLP2 | -6844 | -9135 | -9001 |
RPS10 | -5601 | -8466 | -8823 |
RPS11 | -6992 | -7948 | -8743 |
RPS12 | -5788 | -9242 | -8852 |
RPS13 | -1717 | -8696 | -7869 |
RPS14 | -5278 | -8513 | -8637 |
RPS15 | -3565 | -6678 | -8273 |
RPS15A | -5550 | -8855 | -8431 |
RPS16 | -4518 | -8551 | -8704 |
RPS17 | -6038 | -8254 | -8928 |
RPS18 | -7474 | -8294 | -7671 |
RPS19 | -6725 | -7779 | -8460 |
RPS2 | -4354 | -9563 | -9021 |
RPS20 | -8585 | -9385 | -6156 |
RPS21 | -3952 | -8303 | -8855 |
RPS23 | -6081 | -9359 | -8319 |
RPS24 | -261 | -6793 | -4573 |
RPS25 | -6151 | -9636 | -7764 |
RPS26 | -1410 | -1143 | -462 |
RPS27 | -9432 | -9147 | -8693 |
RPS27A | -6700 | -9695 | -8668 |
RPS27L | 2048 | -490 | 9654 |
RPS28 | -4562 | -8056 | -8562 |
RPS29 | -7664 | -8609 | -8958 |
RPS3 | -5717 | -9270 | -8726 |
RPS3A | -4543 | -9806 | -4045 |
RPS4X | -6075 | -8620 | -4665 |
RPS4Y1 | 418 | 329 | 1713 |
RPS5 | -5502 | -9014 | -8342 |
RPS6 | -5956 | -9671 | -7892 |
RPS7 | -4803 | -9137 | -7874 |
RPS8 | -2041 | -8833 | -6710 |
RPS9 | 5358 | 1826 | -8433 |
RPSA | -6110 | -6604 | 3504 |
UBA52 | 1112 | -3471 | -8207 |
Eukaryotic Translation Initiation
metric | value |
---|---|
setSize | 118 |
pMANOVA | 3.48e-76 |
p.adjustMANOVA | 5.26e-74 |
s.dist | 0.927 |
s.t0_v_pod | -0.132 |
s.pod_crp | -0.637 |
s.t0_crp | -0.661 |
p.t0_v_pod | 0.0135 |
p.pod_crp | 5.36e-33 |
p.t0_crp | 1.74e-35 |
Gene | t0_crp | pod_crp |
---|---|---|
RPL3 | -8773 | -9928 |
RPS2 | -9021 | -9563 |
RPS27A | -8668 | -9695 |
RPL14 | -8650 | -9670 |
RPLP2 | -9001 | -9135 |
RPS12 | -8852 | -9242 |
RPS3 | -8726 | -9270 |
RPLP0 | -8702 | -9199 |
RPS27 | -8693 | -9147 |
RPL10 | -8829 | -9003 |
RPL7 | -8087 | -9737 |
RPS23 | -8319 | -9359 |
RPL27A | -8573 | -9020 |
RPS29 | -8958 | -8609 |
RPS6 | -7892 | -9671 |
RPL31 | -8685 | -8741 |
RPL30 | -8504 | -8902 |
RPL29 | -8787 | -8593 |
RPS5 | -8342 | -9014 |
RPL18A | -8439 | -8868 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
EIF1AX | 1081 | -8356 | 3339 |
EIF2B1 | -411 | -2213 | 5744 |
EIF2B2 | 3233 | 7405 | -4631 |
EIF2B3 | -7934 | -6624 | 3358 |
EIF2B4 | 2685 | 4256 | -5692 |
EIF2B5 | -9484 | -5556 | -804 |
EIF2S1 | 4235 | -1636 | 6996 |
EIF2S2 | 6091 | 549 | 7102 |
EIF2S3 | 6653 | 2481 | 4095 |
EIF3A | 2132 | -1264 | -723 |
EIF3B | -7776 | -9498 | -7620 |
EIF3C | 285 | -4694 | -8882 |
EIF3D | 2605 | -5135 | -7554 |
EIF3E | 1902 | -9021 | 1399 |
EIF3F | 970 | -5176 | -8803 |
EIF3G | 871 | -2729 | -8872 |
EIF3H | 4677 | -7066 | -6135 |
EIF3I | 4649 | -2563 | -8353 |
EIF3J | 1885 | -6423 | 9055 |
EIF3K | 1468 | -2354 | -7325 |
EIF3L | 2560 | -8228 | -8813 |
EIF3M | 4533 | -6792 | 3750 |
EIF4A1 | 7476 | 5489 | -4905 |
EIF4A2 | -10809 | -9565 | 7689 |
EIF4B | 1237 | -8163 | -7131 |
EIF4E | 4757 | 1648 | 9908 |
EIF4EBP1 | 5990 | 2800 | -6475 |
EIF4G1 | 7908 | 10325 | -6629 |
EIF4H | 7634 | 7669 | -8926 |
EIF5 | 2162 | 2911 | 7027 |
EIF5B | -4487 | -6842 | 9045 |
FAU | -359 | -3599 | -8841 |
PABPC1 | 5290 | -2972 | 2666 |
RPL10 | -6311 | -9003 | -8829 |
RPL10A | -6458 | -8900 | -6147 |
RPL11 | -6052 | -9089 | -6722 |
RPL12 | -6811 | -9149 | -8024 |
RPL13 | -3335 | -7644 | -6367 |
RPL13A | -7928 | -9374 | -6207 |
RPL14 | -6480 | -9670 | -8650 |
RPL15 | -953 | -8142 | -8235 |
RPL17 | -5249 | -9088 | -8079 |
RPL18 | -4911 | -8835 | -8406 |
RPL18A | -5869 | -8868 | -8439 |
RPL19 | -6071 | -8311 | -8149 |
RPL21 | -6241 | -9483 | -7230 |
RPL22 | -4587 | -9631 | -7480 |
RPL22L1 | -1593 | -8175 | 527 |
RPL23 | -3223 | -8346 | -7486 |
RPL23A | -9248 | -9950 | -4950 |
RPL24 | -5606 | -8873 | -7028 |
RPL26 | -6387 | -8678 | -8038 |
RPL26L1 | 7070 | 5940 | -5499 |
RPL27 | -2783 | -7783 | -8809 |
RPL27A | -6048 | -9020 | -8573 |
RPL28 | -1441 | -3852 | -5654 |
RPL29 | -3505 | -8593 | -8787 |
RPL3 | -8268 | -9928 | -8773 |
RPL30 | -6779 | -8902 | -8504 |
RPL31 | -4394 | -8741 | -8685 |
RPL32 | -6479 | -9317 | -7991 |
RPL34 | -6569 | -9464 | -6337 |
RPL35 | -7809 | -8156 | -7893 |
RPL35A | -5816 | -9263 | -7997 |
RPL36 | -5111 | -7467 | -8861 |
RPL36A | -7122 | -8881 | -8095 |
RPL36AL | 32 | -6621 | -8799 |
RPL37 | -6160 | -7834 | -9017 |
RPL37A | -3826 | -6808 | -8683 |
RPL38 | -5646 | -7941 | -8932 |
RPL39 | -2931 | -8607 | -8362 |
RPL39L | -8506 | -1648 | -4731 |
RPL3L | 4458 | 5102 | 10556 |
RPL4 | -3476 | -9521 | -7062 |
RPL41 | -6632 | -7535 | -8456 |
RPL5 | -4576 | -9853 | -7157 |
RPL6 | -3262 | -9281 | -3434 |
RPL7 | -1917 | -9737 | -8087 |
RPL7A | -3557 | -8259 | -8751 |
RPL8 | -1171 | -6076 | -8899 |
RPL9 | -1837 | -6796 | -4391 |
RPLP0 | -987 | -9199 | -8702 |
RPLP1 | 19 | -5994 | -8833 |
RPLP2 | -6844 | -9135 | -9001 |
RPS10 | -5601 | -8466 | -8823 |
RPS11 | -6992 | -7948 | -8743 |
RPS12 | -5788 | -9242 | -8852 |
RPS13 | -1717 | -8696 | -7869 |
RPS14 | -5278 | -8513 | -8637 |
RPS15 | -3565 | -6678 | -8273 |
RPS15A | -5550 | -8855 | -8431 |
RPS16 | -4518 | -8551 | -8704 |
RPS17 | -6038 | -8254 | -8928 |
RPS18 | -7474 | -8294 | -7671 |
RPS19 | -6725 | -7779 | -8460 |
RPS2 | -4354 | -9563 | -9021 |
RPS20 | -8585 | -9385 | -6156 |
RPS21 | -3952 | -8303 | -8855 |
RPS23 | -6081 | -9359 | -8319 |
RPS24 | -261 | -6793 | -4573 |
RPS25 | -6151 | -9636 | -7764 |
RPS26 | -1410 | -1143 | -462 |
RPS27 | -9432 | -9147 | -8693 |
RPS27A | -6700 | -9695 | -8668 |
RPS27L | 2048 | -490 | 9654 |
RPS28 | -4562 | -8056 | -8562 |
RPS29 | -7664 | -8609 | -8958 |
RPS3 | -5717 | -9270 | -8726 |
RPS3A | -4543 | -9806 | -4045 |
RPS4X | -6075 | -8620 | -4665 |
RPS4Y1 | 418 | 329 | 1713 |
RPS5 | -5502 | -9014 | -8342 |
RPS6 | -5956 | -9671 | -7892 |
RPS7 | -4803 | -9137 | -7874 |
RPS8 | -2041 | -8833 | -6710 |
RPS9 | 5358 | 1826 | -8433 |
RPSA | -6110 | -6604 | 3504 |
UBA52 | 1112 | -3471 | -8207 |
Formation of the ternary complex, and subsequently, the 43S complex
metric | value |
---|---|
setSize | 51 |
pMANOVA | 1.55e-36 |
p.adjustMANOVA | 6.18e-35 |
s.dist | 0.922 |
s.t0_v_pod | -0.0831 |
s.pod_crp | -0.662 |
s.t0_crp | -0.636 |
p.t0_v_pod | 0.305 |
p.pod_crp | 2.68e-16 |
p.t0_crp | 3.83e-15 |
Gene | pod_crp | t0_crp |
---|---|---|
RPS2 | -9563 | -9021 |
RPS27A | -9695 | -8668 |
RPS12 | -9242 | -8852 |
RPS3 | -9270 | -8726 |
RPS27 | -9147 | -8693 |
RPS23 | -9359 | -8319 |
RPS29 | -8609 | -8958 |
RPS6 | -9671 | -7892 |
RPS5 | -9014 | -8342 |
RPS25 | -9636 | -7764 |
RPS10 | -8466 | -8823 |
RPS15A | -8855 | -8431 |
RPS16 | -8551 | -8704 |
RPS17 | -8254 | -8928 |
RPS14 | -8513 | -8637 |
RPS21 | -8303 | -8855 |
EIF3L | -8228 | -8813 |
EIF3B | -9498 | -7620 |
RPS7 | -9137 | -7874 |
RPS11 | -7948 | -8743 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
EIF1AX | 1081 | -8356 | 3339 |
EIF2S1 | 4235 | -1636 | 6996 |
EIF2S2 | 6091 | 549 | 7102 |
EIF2S3 | 6653 | 2481 | 4095 |
EIF3A | 2132 | -1264 | -723 |
EIF3B | -7776 | -9498 | -7620 |
EIF3C | 285 | -4694 | -8882 |
EIF3D | 2605 | -5135 | -7554 |
EIF3E | 1902 | -9021 | 1399 |
EIF3F | 970 | -5176 | -8803 |
EIF3G | 871 | -2729 | -8872 |
EIF3H | 4677 | -7066 | -6135 |
EIF3I | 4649 | -2563 | -8353 |
EIF3J | 1885 | -6423 | 9055 |
EIF3K | 1468 | -2354 | -7325 |
EIF3L | 2560 | -8228 | -8813 |
EIF3M | 4533 | -6792 | 3750 |
FAU | -359 | -3599 | -8841 |
RPS10 | -5601 | -8466 | -8823 |
RPS11 | -6992 | -7948 | -8743 |
RPS12 | -5788 | -9242 | -8852 |
RPS13 | -1717 | -8696 | -7869 |
RPS14 | -5278 | -8513 | -8637 |
RPS15 | -3565 | -6678 | -8273 |
RPS15A | -5550 | -8855 | -8431 |
RPS16 | -4518 | -8551 | -8704 |
RPS17 | -6038 | -8254 | -8928 |
RPS18 | -7474 | -8294 | -7671 |
RPS19 | -6725 | -7779 | -8460 |
RPS2 | -4354 | -9563 | -9021 |
RPS20 | -8585 | -9385 | -6156 |
RPS21 | -3952 | -8303 | -8855 |
RPS23 | -6081 | -9359 | -8319 |
RPS24 | -261 | -6793 | -4573 |
RPS25 | -6151 | -9636 | -7764 |
RPS26 | -1410 | -1143 | -462 |
RPS27 | -9432 | -9147 | -8693 |
RPS27A | -6700 | -9695 | -8668 |
RPS27L | 2048 | -490 | 9654 |
RPS28 | -4562 | -8056 | -8562 |
RPS29 | -7664 | -8609 | -8958 |
RPS3 | -5717 | -9270 | -8726 |
RPS3A | -4543 | -9806 | -4045 |
RPS4X | -6075 | -8620 | -4665 |
RPS4Y1 | 418 | 329 | 1713 |
RPS5 | -5502 | -9014 | -8342 |
RPS6 | -5956 | -9671 | -7892 |
RPS7 | -4803 | -9137 | -7874 |
RPS8 | -2041 | -8833 | -6710 |
RPS9 | 5358 | 1826 | -8433 |
RPSA | -6110 | -6604 | 3504 |
WNT5A-dependent internalization of FZD4
metric | value |
---|---|
setSize | 13 |
pMANOVA | 9.7e-06 |
p.adjustMANOVA | 5.41e-05 |
s.dist | 0.917 |
s.t0_v_pod | 0.449 |
s.pod_crp | 0.525 |
s.t0_crp | -0.603 |
p.t0_v_pod | 0.00507 |
p.pod_crp | 0.00105 |
p.t0_crp | 0.000168 |
Gene | t0_crp | pod_crp |
---|---|---|
ARRB2 | -7583 | 10498 |
AP2M1 | -8821 | 8674 |
AP2A1 | -6175 | 11125 |
CLTB | -8646 | 7866 |
AP2A2 | -6585 | 10047 |
AP2S1 | -7630 | 7940 |
CLTA | -5807 | 7078 |
PRKCB | -4547 | 8456 |
CLTC | -1573 | 10126 |
AP2B1 | -1439 | 2884 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AP2A1 | 6737 | 11125 | -6175 |
AP2A2 | 7150 | 10047 | -6585 |
AP2B1 | -2641 | 2884 | -1439 |
AP2M1 | 8486 | 8674 | -8821 |
AP2S1 | 7903 | 7940 | -7630 |
ARRB2 | 8355 | 10498 | -7583 |
CLTA | 8244 | 7078 | -5807 |
CLTB | 6002 | 7866 | -8646 |
CLTC | 8849 | 10126 | -1573 |
DVL2 | -10804 | -5613 | -6082 |
FZD4 | -11295 | 3467 | 6990 |
PRKCA | 1123 | -2393 | -4303 |
PRKCB | 6993 | 8456 | -4547 |
Erythrocytes take up carbon dioxide and release oxygen
metric | value |
---|---|
setSize | 11 |
pMANOVA | 0.00111 |
p.adjustMANOVA | 0.00322 |
s.dist | 0.895 |
s.t0_v_pod | 0.68 |
s.pod_crp | 0.527 |
s.t0_crp | -0.247 |
p.t0_v_pod | 9.48e-05 |
p.pod_crp | 0.00248 |
p.t0_crp | 0.157 |
Gene | t0_v_pod | pod_crp |
---|---|---|
CYB5R1 | 9299 | 10846 |
CA1 | 9220 | 8103 |
CYB5R4 | 8289 | 8868 |
CYB5R2 | 8460 | 8619 |
SLC4A1 | 8987 | 7437 |
HBB | 8901 | 6625 |
AQP1 | 7364 | 7882 |
HBA1 | 8840 | 6172 |
CA4 | 2804 | 10795 |
CA2 | 3538 | 41 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AQP1 | 7364 | 7882 | -3543 |
CA1 | 9220 | 8103 | 1441 |
CA2 | 3538 | 41 | -772 |
CA4 | 2804 | 10795 | -633 |
CYB5R1 | 9299 | 10846 | -8590 |
CYB5R2 | 8460 | 8619 | -2064 |
CYB5R4 | 8289 | 8868 | 2856 |
CYB5RL | -10419 | -7341 | 1351 |
HBA1 | 8840 | 6172 | -11 |
HBB | 8901 | 6625 | 214 |
SLC4A1 | 8987 | 7437 | -1041 |
O2/CO2 exchange in erythrocytes
metric | value |
---|---|
setSize | 11 |
pMANOVA | 0.00111 |
p.adjustMANOVA | 0.00322 |
s.dist | 0.895 |
s.t0_v_pod | 0.68 |
s.pod_crp | 0.527 |
s.t0_crp | -0.247 |
p.t0_v_pod | 9.48e-05 |
p.pod_crp | 0.00248 |
p.t0_crp | 0.157 |
Gene | t0_v_pod | pod_crp |
---|---|---|
CYB5R1 | 9299 | 10846 |
CA1 | 9220 | 8103 |
CYB5R4 | 8289 | 8868 |
CYB5R2 | 8460 | 8619 |
SLC4A1 | 8987 | 7437 |
HBB | 8901 | 6625 |
AQP1 | 7364 | 7882 |
HBA1 | 8840 | 6172 |
CA4 | 2804 | 10795 |
CA2 | 3538 | 41 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AQP1 | 7364 | 7882 | -3543 |
CA1 | 9220 | 8103 | 1441 |
CA2 | 3538 | 41 | -772 |
CA4 | 2804 | 10795 | -633 |
CYB5R1 | 9299 | 10846 | -8590 |
CYB5R2 | 8460 | 8619 | -2064 |
CYB5R4 | 8289 | 8868 | 2856 |
CYB5RL | -10419 | -7341 | 1351 |
HBA1 | 8840 | 6172 | -11 |
HBB | 8901 | 6625 | 214 |
SLC4A1 | 8987 | 7437 | -1041 |
Retrograde neurotrophin signalling
metric | value |
---|---|
setSize | 12 |
pMANOVA | 0.000363 |
p.adjustMANOVA | 0.00125 |
s.dist | 0.893 |
s.t0_v_pod | 0.566 |
s.pod_crp | 0.517 |
s.t0_crp | -0.457 |
p.t0_v_pod | 0.00068 |
p.pod_crp | 0.00193 |
p.t0_crp | 0.00611 |
Gene | t0_v_pod | pod_crp |
---|---|---|
CLTC | 8849 | 10126 |
AP2A1 | 6737 | 11125 |
AP2M1 | 8486 | 8674 |
AP2A2 | 7150 | 10047 |
AP2S1 | 7903 | 7940 |
DNM2 | 6007 | 10193 |
CLTA | 8244 | 7078 |
DNM3 | 6942 | 3491 |
DNM1 | 3555 | 5937 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AP2A1 | 6737 | 11125 | -6175 |
AP2A2 | 7150 | 10047 | -6585 |
AP2B1 | -2641 | 2884 | -1439 |
AP2M1 | 8486 | 8674 | -8821 |
AP2S1 | 7903 | 7940 | -7630 |
CLTA | 8244 | 7078 | -5807 |
CLTC | 8849 | 10126 | -1573 |
DNAL4 | 3369 | -755 | -8239 |
DNM1 | 3555 | 5937 | 9244 |
DNM2 | 6007 | 10193 | -7994 |
DNM3 | 6942 | 3491 | -1083 |
NTRK1 | -7910 | -3772 | 7353 |
RNA Polymerase I Promoter Opening
metric | value |
---|---|
setSize | 19 |
pMANOVA | 8.92e-07 |
p.adjustMANOVA | 6.77e-06 |
s.dist | 0.886 |
s.t0_v_pod | 0.616 |
s.pod_crp | 0.412 |
s.t0_crp | -0.486 |
p.t0_v_pod | 3.31e-06 |
p.pod_crp | 0.00189 |
p.t0_crp | 0.000246 |
Gene | t0_v_pod | t0_crp |
---|---|---|
MAPK3 | 8803.0 | -9014.0 |
H2AJ | 9214.0 | -8302.0 |
H2BC12 | 8898.0 | -7833.0 |
H2AZ1 | 5955.0 | -8609.0 |
H2BC5 | 7881.0 | -5603.0 |
H2BC11 | 7791.0 | -5097.0 |
H2BC21 | 9125.0 | -3628.0 |
H3C15 | 6608.5 | -4548.5 |
H2BC9 | 5332.0 | -5547.0 |
H2AC6 | 7813.0 | -3405.0 |
H2BC15 | 5251.0 | -2358.0 |
H2BC17 | 7178.0 | -839.0 |
H2BC4 | 7279.0 | -558.0 |
H3-3A | 8519.0 | -45.0 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
H2AC20 | 4913.0 | 8767.0 | 5501.0 |
H2AC6 | 7813.0 | 5389.0 | -3405.0 |
H2AJ | 9214.0 | 11227.0 | -8302.0 |
H2AZ1 | 5955.0 | 4339.0 | -8609.0 |
H2AZ2 | -1192.0 | -5552.0 | -5889.0 |
H2BC11 | 7791.0 | 6057.0 | -5097.0 |
H2BC12 | 8898.0 | 9140.0 | -7833.0 |
H2BC15 | 5251.0 | 2455.0 | -2358.0 |
H2BC17 | 7178.0 | 6124.0 | -839.0 |
H2BC21 | 9125.0 | 9536.0 | -3628.0 |
H2BC4 | 7279.0 | 8798.0 | -558.0 |
H2BC5 | 7881.0 | 6685.0 | -5603.0 |
H2BC9 | 5332.0 | -5704.0 | -5547.0 |
H2BU1 | -6332.0 | 296.0 | 1215.0 |
H3-3A | 8519.0 | 8858.0 | -45.0 |
H3C15 | 6608.5 | 8802.5 | -4548.5 |
MAPK3 | 8803.0 | 9593.0 | -9014.0 |
MBD2 | 6491.0 | 7521.0 | 3253.0 |
UBTF | -9703.0 | -8220.0 | -5824.0 |
Selenoamino acid metabolism
metric | value |
---|---|
setSize | 114 |
pMANOVA | 2.96e-56 |
p.adjustMANOVA | 1.92e-54 |
s.dist | 0.876 |
s.t0_v_pod | -0.228 |
s.pod_crp | -0.617 |
s.t0_crp | -0.579 |
p.t0_v_pod | 2.52e-05 |
p.pod_crp | 4.37e-30 |
p.t0_crp | 1.11e-26 |
Gene | pod_crp | t0_crp |
---|---|---|
RPL3 | -9928 | -8773 |
RPS2 | -9563 | -9021 |
RPS27A | -9695 | -8668 |
RPL14 | -9670 | -8650 |
RPLP2 | -9135 | -9001 |
RPS12 | -9242 | -8852 |
RPS3 | -9270 | -8726 |
RPLP0 | -9199 | -8702 |
RPS27 | -9147 | -8693 |
RPL10 | -9003 | -8829 |
RPL7 | -9737 | -8087 |
RPS23 | -9359 | -8319 |
RPL27A | -9020 | -8573 |
RPS29 | -8609 | -8958 |
RPS6 | -9671 | -7892 |
RPL31 | -8741 | -8685 |
RPL30 | -8902 | -8504 |
RPL29 | -8593 | -8787 |
RPS5 | -9014 | -8342 |
RPL18A | -8868 | -8439 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AHCY | 460 | -2495 | -8323 |
AIMP1 | -5707 | -7963 | 10294 |
AIMP2 | -976 | -3324 | -1112 |
CBS | 6846 | 11022 | 11440 |
CTH | -7898 | -629 | 9466 |
DARS1 | 1060 | -6914 | 8724 |
EEF1E1 | -2031 | -2699 | 4504 |
EEFSEC | -9700 | -6468 | -2666 |
EPRS1 | -3100 | -6325 | 5993 |
FAU | -359 | -3599 | -8841 |
GNMT | 2014 | 2894 | -2674 |
GSR | 9078 | 10845 | -6395 |
HNMT | 8186 | 6356 | -2637 |
IARS1 | -11539 | -8971 | 6521 |
INMT | 2159 | -379 | 7393 |
KARS1 | -5204 | -8353 | 5267 |
LARS1 | -6211 | -9609 | 10684 |
MARS1 | -2525 | 7268 | 5522 |
PAPSS1 | 8852 | 10157 | 1039 |
PAPSS2 | -2738 | 11055 | 11302 |
PSTK | -9857 | -5686 | 3544 |
QARS1 | 85 | -3737 | -8534 |
RARS1 | -4641 | -3923 | 9769 |
RPL10 | -6311 | -9003 | -8829 |
RPL10A | -6458 | -8900 | -6147 |
RPL11 | -6052 | -9089 | -6722 |
RPL12 | -6811 | -9149 | -8024 |
RPL13 | -3335 | -7644 | -6367 |
RPL13A | -7928 | -9374 | -6207 |
RPL14 | -6480 | -9670 | -8650 |
RPL15 | -953 | -8142 | -8235 |
RPL17 | -5249 | -9088 | -8079 |
RPL18 | -4911 | -8835 | -8406 |
RPL18A | -5869 | -8868 | -8439 |
RPL19 | -6071 | -8311 | -8149 |
RPL21 | -6241 | -9483 | -7230 |
RPL22 | -4587 | -9631 | -7480 |
RPL22L1 | -1593 | -8175 | 527 |
RPL23 | -3223 | -8346 | -7486 |
RPL23A | -9248 | -9950 | -4950 |
RPL24 | -5606 | -8873 | -7028 |
RPL26 | -6387 | -8678 | -8038 |
RPL26L1 | 7070 | 5940 | -5499 |
RPL27 | -2783 | -7783 | -8809 |
RPL27A | -6048 | -9020 | -8573 |
RPL28 | -1441 | -3852 | -5654 |
RPL29 | -3505 | -8593 | -8787 |
RPL3 | -8268 | -9928 | -8773 |
RPL30 | -6779 | -8902 | -8504 |
RPL31 | -4394 | -8741 | -8685 |
RPL32 | -6479 | -9317 | -7991 |
RPL34 | -6569 | -9464 | -6337 |
RPL35 | -7809 | -8156 | -7893 |
RPL35A | -5816 | -9263 | -7997 |
RPL36 | -5111 | -7467 | -8861 |
RPL36A | -7122 | -8881 | -8095 |
RPL36AL | 32 | -6621 | -8799 |
RPL37 | -6160 | -7834 | -9017 |
RPL37A | -3826 | -6808 | -8683 |
RPL38 | -5646 | -7941 | -8932 |
RPL39 | -2931 | -8607 | -8362 |
RPL39L | -8506 | -1648 | -4731 |
RPL3L | 4458 | 5102 | 10556 |
RPL4 | -3476 | -9521 | -7062 |
RPL41 | -6632 | -7535 | -8456 |
RPL5 | -4576 | -9853 | -7157 |
RPL6 | -3262 | -9281 | -3434 |
RPL7 | -1917 | -9737 | -8087 |
RPL7A | -3557 | -8259 | -8751 |
RPL8 | -1171 | -6076 | -8899 |
RPL9 | -1837 | -6796 | -4391 |
RPLP0 | -987 | -9199 | -8702 |
RPLP1 | 19 | -5994 | -8833 |
RPLP2 | -6844 | -9135 | -9001 |
RPS10 | -5601 | -8466 | -8823 |
RPS11 | -6992 | -7948 | -8743 |
RPS12 | -5788 | -9242 | -8852 |
RPS13 | -1717 | -8696 | -7869 |
RPS14 | -5278 | -8513 | -8637 |
RPS15 | -3565 | -6678 | -8273 |
RPS15A | -5550 | -8855 | -8431 |
RPS16 | -4518 | -8551 | -8704 |
RPS17 | -6038 | -8254 | -8928 |
RPS18 | -7474 | -8294 | -7671 |
RPS19 | -6725 | -7779 | -8460 |
RPS2 | -4354 | -9563 | -9021 |
RPS20 | -8585 | -9385 | -6156 |
RPS21 | -3952 | -8303 | -8855 |
RPS23 | -6081 | -9359 | -8319 |
RPS24 | -261 | -6793 | -4573 |
RPS25 | -6151 | -9636 | -7764 |
RPS26 | -1410 | -1143 | -462 |
RPS27 | -9432 | -9147 | -8693 |
RPS27A | -6700 | -9695 | -8668 |
RPS27L | 2048 | -490 | 9654 |
RPS28 | -4562 | -8056 | -8562 |
RPS29 | -7664 | -8609 | -8958 |
RPS3 | -5717 | -9270 | -8726 |
RPS3A | -4543 | -9806 | -4045 |
RPS4X | -6075 | -8620 | -4665 |
RPS4Y1 | 418 | 329 | 1713 |
RPS5 | -5502 | -9014 | -8342 |
RPS6 | -5956 | -9671 | -7892 |
RPS7 | -4803 | -9137 | -7874 |
RPS8 | -2041 | -8833 | -6710 |
RPS9 | 5358 | 1826 | -8433 |
RPSA | -6110 | -6604 | 3504 |
SARS1 | -5712 | -6019 | -7676 |
SCLY | -7964 | -7618 | -1202 |
SECISBP2 | -9999 | -6967 | 10570 |
SEPHS2 | 7535 | 7977 | -4587 |
SEPSECS | -10939 | -7931 | 10064 |
TXNRD1 | 8062 | 9724 | -2030 |
UBA52 | 1112 | -3471 | -8207 |
Gap junction trafficking
metric | value |
---|---|
setSize | 13 |
pMANOVA | 0.000388 |
p.adjustMANOVA | 0.00132 |
s.dist | 0.872 |
s.t0_v_pod | 0.564 |
s.pod_crp | 0.553 |
s.t0_crp | -0.37 |
p.t0_v_pod | 0.000432 |
p.pod_crp | 0.000556 |
p.t0_crp | 0.0211 |
Gene | t0_v_pod | pod_crp |
---|---|---|
CLTC | 8849 | 10126 |
DAB2 | 7985 | 10458 |
GJD3 | 7874 | 10400 |
CLTCL1 | 8815 | 9065 |
AP2M1 | 8486 | 8674 |
DNM2 | 6007 | 10193 |
CLTA | 8244 | 7078 |
CLTB | 6002 | 7866 |
DNM1 | 3555 | 5937 |
GJB6 | 4708 | 3501 |
GJC1 | 512 | 4925 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AP2M1 | 8486 | 8674 | -8821 |
CLTA | 8244 | 7078 | -5807 |
CLTB | 6002 | 7866 | -8646 |
CLTC | 8849 | 10126 | -1573 |
CLTCL1 | 8815 | 9065 | -5876 |
DAB2 | 7985 | 10458 | -7333 |
DNM1 | 3555 | 5937 | 9244 |
DNM2 | 6007 | 10193 | -7994 |
GJB6 | 4708 | 3501 | -8822 |
GJC1 | 512 | 4925 | 4580 |
GJC2 | 1074 | -686 | -452 |
GJD3 | 7874 | 10400 | 4052 |
MYO6 | -11058 | -3503 | 7640 |
SRP-dependent cotranslational protein targeting to membrane
metric | value |
---|---|
setSize | 111 |
pMANOVA | 8.28e-60 |
p.adjustMANOVA | 5.63e-58 |
s.dist | 0.861 |
s.t0_v_pod | -0.134 |
s.pod_crp | -0.583 |
s.t0_crp | -0.62 |
p.t0_v_pod | 0.0148 |
p.pod_crp | 2.36e-26 |
p.t0_crp | 1.27e-29 |
Gene | t0_crp | pod_crp |
---|---|---|
RPL3 | -8773 | -9928 |
RPS2 | -9021 | -9563 |
RPS27A | -8668 | -9695 |
RPL14 | -8650 | -9670 |
RPLP2 | -9001 | -9135 |
RPS12 | -8852 | -9242 |
RPS3 | -8726 | -9270 |
RPLP0 | -8702 | -9199 |
RPS27 | -8693 | -9147 |
RPL10 | -8829 | -9003 |
RPL7 | -8087 | -9737 |
RPS23 | -8319 | -9359 |
RPL27A | -8573 | -9020 |
RPS29 | -8958 | -8609 |
RPS6 | -7892 | -9671 |
RPL31 | -8685 | -8741 |
RPL30 | -8504 | -8902 |
RPL29 | -8787 | -8593 |
RPS5 | -8342 | -9014 |
RPL18A | -8439 | -8868 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
DDOST | 6831 | 8345 | -8761 |
FAU | -359 | -3599 | -8841 |
RPL10 | -6311 | -9003 | -8829 |
RPL10A | -6458 | -8900 | -6147 |
RPL11 | -6052 | -9089 | -6722 |
RPL12 | -6811 | -9149 | -8024 |
RPL13 | -3335 | -7644 | -6367 |
RPL13A | -7928 | -9374 | -6207 |
RPL14 | -6480 | -9670 | -8650 |
RPL15 | -953 | -8142 | -8235 |
RPL17 | -5249 | -9088 | -8079 |
RPL18 | -4911 | -8835 | -8406 |
RPL18A | -5869 | -8868 | -8439 |
RPL19 | -6071 | -8311 | -8149 |
RPL21 | -6241 | -9483 | -7230 |
RPL22 | -4587 | -9631 | -7480 |
RPL22L1 | -1593 | -8175 | 527 |
RPL23 | -3223 | -8346 | -7486 |
RPL23A | -9248 | -9950 | -4950 |
RPL24 | -5606 | -8873 | -7028 |
RPL26 | -6387 | -8678 | -8038 |
RPL26L1 | 7070 | 5940 | -5499 |
RPL27 | -2783 | -7783 | -8809 |
RPL27A | -6048 | -9020 | -8573 |
RPL28 | -1441 | -3852 | -5654 |
RPL29 | -3505 | -8593 | -8787 |
RPL3 | -8268 | -9928 | -8773 |
RPL30 | -6779 | -8902 | -8504 |
RPL31 | -4394 | -8741 | -8685 |
RPL32 | -6479 | -9317 | -7991 |
RPL34 | -6569 | -9464 | -6337 |
RPL35 | -7809 | -8156 | -7893 |
RPL35A | -5816 | -9263 | -7997 |
RPL36 | -5111 | -7467 | -8861 |
RPL36A | -7122 | -8881 | -8095 |
RPL36AL | 32 | -6621 | -8799 |
RPL37 | -6160 | -7834 | -9017 |
RPL37A | -3826 | -6808 | -8683 |
RPL38 | -5646 | -7941 | -8932 |
RPL39 | -2931 | -8607 | -8362 |
RPL39L | -8506 | -1648 | -4731 |
RPL3L | 4458 | 5102 | 10556 |
RPL4 | -3476 | -9521 | -7062 |
RPL41 | -6632 | -7535 | -8456 |
RPL5 | -4576 | -9853 | -7157 |
RPL6 | -3262 | -9281 | -3434 |
RPL7 | -1917 | -9737 | -8087 |
RPL7A | -3557 | -8259 | -8751 |
RPL8 | -1171 | -6076 | -8899 |
RPL9 | -1837 | -6796 | -4391 |
RPLP0 | -987 | -9199 | -8702 |
RPLP1 | 19 | -5994 | -8833 |
RPLP2 | -6844 | -9135 | -9001 |
RPN1 | 7902 | 7066 | -6768 |
RPN2 | 7035 | 8748 | -1401 |
RPS10 | -5601 | -8466 | -8823 |
RPS11 | -6992 | -7948 | -8743 |
RPS12 | -5788 | -9242 | -8852 |
RPS13 | -1717 | -8696 | -7869 |
RPS14 | -5278 | -8513 | -8637 |
RPS15 | -3565 | -6678 | -8273 |
RPS15A | -5550 | -8855 | -8431 |
RPS16 | -4518 | -8551 | -8704 |
RPS17 | -6038 | -8254 | -8928 |
RPS18 | -7474 | -8294 | -7671 |
RPS19 | -6725 | -7779 | -8460 |
RPS2 | -4354 | -9563 | -9021 |
RPS20 | -8585 | -9385 | -6156 |
RPS21 | -3952 | -8303 | -8855 |
RPS23 | -6081 | -9359 | -8319 |
RPS24 | -261 | -6793 | -4573 |
RPS25 | -6151 | -9636 | -7764 |
RPS26 | -1410 | -1143 | -462 |
RPS27 | -9432 | -9147 | -8693 |
RPS27A | -6700 | -9695 | -8668 |
RPS27L | 2048 | -490 | 9654 |
RPS28 | -4562 | -8056 | -8562 |
RPS29 | -7664 | -8609 | -8958 |
RPS3 | -5717 | -9270 | -8726 |
RPS3A | -4543 | -9806 | -4045 |
RPS4X | -6075 | -8620 | -4665 |
RPS4Y1 | 418 | 329 | 1713 |
RPS5 | -5502 | -9014 | -8342 |
RPS6 | -5956 | -9671 | -7892 |
RPS7 | -4803 | -9137 | -7874 |
RPS8 | -2041 | -8833 | -6710 |
RPS9 | 5358 | 1826 | -8433 |
RPSA | -6110 | -6604 | 3504 |
SEC11A | 7799 | 6562 | -2808 |
SEC11C | -8699 | -6021 | 10562 |
SEC61A1 | 6361 | 7393 | -2601 |
SEC61A2 | -10455 | -5309 | 7759 |
SEC61B | 6910 | 4284 | -7952 |
SEC61G | 4656 | -3133 | 8410 |
SPCS1 | 2996 | -1687 | -2226 |
SPCS2 | 3184 | -967 | 7256 |
SPCS3 | 4326 | 1951 | 9517 |
SRP14 | 6234 | 4977 | 998 |
SRP19 | 4236 | -617 | 11340 |
SRP54 | 6501 | 7811 | 11918 |
SRP68 | 2001 | 779 | -302 |
SRP72 | -1470 | -3543 | 5095 |
SRP9 | 4400 | -3395 | 5210 |
SRPRA | 4999 | 8185 | -3928 |
SRPRB | -9099 | -7494 | 4311 |
SSR1 | 6498 | 1133 | 1939 |
SSR2 | 2796 | -2899 | -5127 |
SSR3 | 5856 | 2491 | 5639 |
SSR4 | 3109 | 1282 | -6690 |
TRAM1 | -4486 | -6455 | 7719 |
UBA52 | 1112 | -3471 | -8207 |
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
metric | value |
---|---|
setSize | 114 |
pMANOVA | 2.07e-55 |
p.adjustMANOVA | 1.17e-53 |
s.dist | 0.859 |
s.t0_v_pod | -0.195 |
s.pod_crp | -0.585 |
s.t0_crp | -0.597 |
p.t0_v_pod | 0.000316 |
p.pod_crp | 3.11e-27 |
p.t0_crp | 2.66e-28 |
Gene | t0_crp | pod_crp |
---|---|---|
RPL3 | -8773 | -9928 |
RPS2 | -9021 | -9563 |
RPS27A | -8668 | -9695 |
RPL14 | -8650 | -9670 |
RPLP2 | -9001 | -9135 |
RPS12 | -8852 | -9242 |
RPS3 | -8726 | -9270 |
RPLP0 | -8702 | -9199 |
RPS27 | -8693 | -9147 |
RPL10 | -8829 | -9003 |
RPL7 | -8087 | -9737 |
RPS23 | -8319 | -9359 |
RPL27A | -8573 | -9020 |
RPS29 | -8958 | -8609 |
RPS6 | -7892 | -9671 |
RPL31 | -8685 | -8741 |
RPL30 | -8504 | -8902 |
RPL29 | -8787 | -8593 |
RPS5 | -8342 | -9014 |
RPL18A | -8439 | -8868 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CASC3 | 5181 | 9457 | -2175 |
DCP1A | -5260 | -4817 | 9790 |
EIF4A3 | 7166 | 1494 | -7095 |
EIF4G1 | 7908 | 10325 | -6629 |
ETF1 | 7308 | 6760 | 4048 |
FAU | -359 | -3599 | -8841 |
GSPT1 | 6387 | -2011 | 8737 |
GSPT2 | -10067 | -7968 | 1941 |
MAGOH | 1045 | -4656 | -8927 |
MAGOHB | -9011 | -6701 | 7191 |
NCBP1 | -5659 | -933 | 11205 |
NCBP2 | -9239 | -9603 | 10774 |
PABPC1 | 5290 | -2972 | 2666 |
PNRC2 | -4406 | -3709 | 11240 |
PPP2CA | 8104 | 6731 | -306 |
PPP2R1A | 4542 | 5140 | -7934 |
PPP2R2A | 4102 | 1773 | 12144 |
RBM8A | -7139 | -1486 | -4793 |
RNPS1 | -11075 | -8003 | -3497 |
RPL10 | -6311 | -9003 | -8829 |
RPL10A | -6458 | -8900 | -6147 |
RPL11 | -6052 | -9089 | -6722 |
RPL12 | -6811 | -9149 | -8024 |
RPL13 | -3335 | -7644 | -6367 |
RPL13A | -7928 | -9374 | -6207 |
RPL14 | -6480 | -9670 | -8650 |
RPL15 | -953 | -8142 | -8235 |
RPL17 | -5249 | -9088 | -8079 |
RPL18 | -4911 | -8835 | -8406 |
RPL18A | -5869 | -8868 | -8439 |
RPL19 | -6071 | -8311 | -8149 |
RPL21 | -6241 | -9483 | -7230 |
RPL22 | -4587 | -9631 | -7480 |
RPL22L1 | -1593 | -8175 | 527 |
RPL23 | -3223 | -8346 | -7486 |
RPL23A | -9248 | -9950 | -4950 |
RPL24 | -5606 | -8873 | -7028 |
RPL26 | -6387 | -8678 | -8038 |
RPL26L1 | 7070 | 5940 | -5499 |
RPL27 | -2783 | -7783 | -8809 |
RPL27A | -6048 | -9020 | -8573 |
RPL28 | -1441 | -3852 | -5654 |
RPL29 | -3505 | -8593 | -8787 |
RPL3 | -8268 | -9928 | -8773 |
RPL30 | -6779 | -8902 | -8504 |
RPL31 | -4394 | -8741 | -8685 |
RPL32 | -6479 | -9317 | -7991 |
RPL34 | -6569 | -9464 | -6337 |
RPL35 | -7809 | -8156 | -7893 |
RPL35A | -5816 | -9263 | -7997 |
RPL36 | -5111 | -7467 | -8861 |
RPL36A | -7122 | -8881 | -8095 |
RPL36AL | 32 | -6621 | -8799 |
RPL37 | -6160 | -7834 | -9017 |
RPL37A | -3826 | -6808 | -8683 |
RPL38 | -5646 | -7941 | -8932 |
RPL39 | -2931 | -8607 | -8362 |
RPL39L | -8506 | -1648 | -4731 |
RPL3L | 4458 | 5102 | 10556 |
RPL4 | -3476 | -9521 | -7062 |
RPL41 | -6632 | -7535 | -8456 |
RPL5 | -4576 | -9853 | -7157 |
RPL6 | -3262 | -9281 | -3434 |
RPL7 | -1917 | -9737 | -8087 |
RPL7A | -3557 | -8259 | -8751 |
RPL8 | -1171 | -6076 | -8899 |
RPL9 | -1837 | -6796 | -4391 |
RPLP0 | -987 | -9199 | -8702 |
RPLP1 | 19 | -5994 | -8833 |
RPLP2 | -6844 | -9135 | -9001 |
RPS10 | -5601 | -8466 | -8823 |
RPS11 | -6992 | -7948 | -8743 |
RPS12 | -5788 | -9242 | -8852 |
RPS13 | -1717 | -8696 | -7869 |
RPS14 | -5278 | -8513 | -8637 |
RPS15 | -3565 | -6678 | -8273 |
RPS15A | -5550 | -8855 | -8431 |
RPS16 | -4518 | -8551 | -8704 |
RPS17 | -6038 | -8254 | -8928 |
RPS18 | -7474 | -8294 | -7671 |
RPS19 | -6725 | -7779 | -8460 |
RPS2 | -4354 | -9563 | -9021 |
RPS20 | -8585 | -9385 | -6156 |
RPS21 | -3952 | -8303 | -8855 |
RPS23 | -6081 | -9359 | -8319 |
RPS24 | -261 | -6793 | -4573 |
RPS25 | -6151 | -9636 | -7764 |
RPS26 | -1410 | -1143 | -462 |
RPS27 | -9432 | -9147 | -8693 |
RPS27A | -6700 | -9695 | -8668 |
RPS27L | 2048 | -490 | 9654 |
RPS28 | -4562 | -8056 | -8562 |
RPS29 | -7664 | -8609 | -8958 |
RPS3 | -5717 | -9270 | -8726 |
RPS3A | -4543 | -9806 | -4045 |
RPS4X | -6075 | -8620 | -4665 |
RPS4Y1 | 418 | 329 | 1713 |
RPS5 | -5502 | -9014 | -8342 |
RPS6 | -5956 | -9671 | -7892 |
RPS7 | -4803 | -9137 | -7874 |
RPS8 | -2041 | -8833 | -6710 |
RPS9 | 5358 | 1826 | -8433 |
RPSA | -6110 | -6604 | 3504 |
SMG1 | -4341 | -483 | 7115 |
SMG5 | 5264 | 4820 | -7444 |
SMG6 | -6032 | -474 | -2511 |
SMG7 | 6519 | 10196 | 7365 |
SMG8 | 2894 | 4950 | 6371 |
SMG9 | 204 | 6197 | 490 |
UBA52 | 1112 | -3471 | -8207 |
UPF1 | 4629 | 8973 | -3684 |
UPF2 | 957 | 1269 | 10321 |
UPF3A | -9509 | -8767 | -1235 |
UPF3B | -8003 | -5819 | 6796 |
Nonsense-Mediated Decay (NMD)
metric | value |
---|---|
setSize | 114 |
pMANOVA | 2.07e-55 |
p.adjustMANOVA | 1.17e-53 |
s.dist | 0.859 |
s.t0_v_pod | -0.195 |
s.pod_crp | -0.585 |
s.t0_crp | -0.597 |
p.t0_v_pod | 0.000316 |
p.pod_crp | 3.11e-27 |
p.t0_crp | 2.66e-28 |
Gene | t0_crp | pod_crp |
---|---|---|
RPL3 | -8773 | -9928 |
RPS2 | -9021 | -9563 |
RPS27A | -8668 | -9695 |
RPL14 | -8650 | -9670 |
RPLP2 | -9001 | -9135 |
RPS12 | -8852 | -9242 |
RPS3 | -8726 | -9270 |
RPLP0 | -8702 | -9199 |
RPS27 | -8693 | -9147 |
RPL10 | -8829 | -9003 |
RPL7 | -8087 | -9737 |
RPS23 | -8319 | -9359 |
RPL27A | -8573 | -9020 |
RPS29 | -8958 | -8609 |
RPS6 | -7892 | -9671 |
RPL31 | -8685 | -8741 |
RPL30 | -8504 | -8902 |
RPL29 | -8787 | -8593 |
RPS5 | -8342 | -9014 |
RPL18A | -8439 | -8868 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CASC3 | 5181 | 9457 | -2175 |
DCP1A | -5260 | -4817 | 9790 |
EIF4A3 | 7166 | 1494 | -7095 |
EIF4G1 | 7908 | 10325 | -6629 |
ETF1 | 7308 | 6760 | 4048 |
FAU | -359 | -3599 | -8841 |
GSPT1 | 6387 | -2011 | 8737 |
GSPT2 | -10067 | -7968 | 1941 |
MAGOH | 1045 | -4656 | -8927 |
MAGOHB | -9011 | -6701 | 7191 |
NCBP1 | -5659 | -933 | 11205 |
NCBP2 | -9239 | -9603 | 10774 |
PABPC1 | 5290 | -2972 | 2666 |
PNRC2 | -4406 | -3709 | 11240 |
PPP2CA | 8104 | 6731 | -306 |
PPP2R1A | 4542 | 5140 | -7934 |
PPP2R2A | 4102 | 1773 | 12144 |
RBM8A | -7139 | -1486 | -4793 |
RNPS1 | -11075 | -8003 | -3497 |
RPL10 | -6311 | -9003 | -8829 |
RPL10A | -6458 | -8900 | -6147 |
RPL11 | -6052 | -9089 | -6722 |
RPL12 | -6811 | -9149 | -8024 |
RPL13 | -3335 | -7644 | -6367 |
RPL13A | -7928 | -9374 | -6207 |
RPL14 | -6480 | -9670 | -8650 |
RPL15 | -953 | -8142 | -8235 |
RPL17 | -5249 | -9088 | -8079 |
RPL18 | -4911 | -8835 | -8406 |
RPL18A | -5869 | -8868 | -8439 |
RPL19 | -6071 | -8311 | -8149 |
RPL21 | -6241 | -9483 | -7230 |
RPL22 | -4587 | -9631 | -7480 |
RPL22L1 | -1593 | -8175 | 527 |
RPL23 | -3223 | -8346 | -7486 |
RPL23A | -9248 | -9950 | -4950 |
RPL24 | -5606 | -8873 | -7028 |
RPL26 | -6387 | -8678 | -8038 |
RPL26L1 | 7070 | 5940 | -5499 |
RPL27 | -2783 | -7783 | -8809 |
RPL27A | -6048 | -9020 | -8573 |
RPL28 | -1441 | -3852 | -5654 |
RPL29 | -3505 | -8593 | -8787 |
RPL3 | -8268 | -9928 | -8773 |
RPL30 | -6779 | -8902 | -8504 |
RPL31 | -4394 | -8741 | -8685 |
RPL32 | -6479 | -9317 | -7991 |
RPL34 | -6569 | -9464 | -6337 |
RPL35 | -7809 | -8156 | -7893 |
RPL35A | -5816 | -9263 | -7997 |
RPL36 | -5111 | -7467 | -8861 |
RPL36A | -7122 | -8881 | -8095 |
RPL36AL | 32 | -6621 | -8799 |
RPL37 | -6160 | -7834 | -9017 |
RPL37A | -3826 | -6808 | -8683 |
RPL38 | -5646 | -7941 | -8932 |
RPL39 | -2931 | -8607 | -8362 |
RPL39L | -8506 | -1648 | -4731 |
RPL3L | 4458 | 5102 | 10556 |
RPL4 | -3476 | -9521 | -7062 |
RPL41 | -6632 | -7535 | -8456 |
RPL5 | -4576 | -9853 | -7157 |
RPL6 | -3262 | -9281 | -3434 |
RPL7 | -1917 | -9737 | -8087 |
RPL7A | -3557 | -8259 | -8751 |
RPL8 | -1171 | -6076 | -8899 |
RPL9 | -1837 | -6796 | -4391 |
RPLP0 | -987 | -9199 | -8702 |
RPLP1 | 19 | -5994 | -8833 |
RPLP2 | -6844 | -9135 | -9001 |
RPS10 | -5601 | -8466 | -8823 |
RPS11 | -6992 | -7948 | -8743 |
RPS12 | -5788 | -9242 | -8852 |
RPS13 | -1717 | -8696 | -7869 |
RPS14 | -5278 | -8513 | -8637 |
RPS15 | -3565 | -6678 | -8273 |
RPS15A | -5550 | -8855 | -8431 |
RPS16 | -4518 | -8551 | -8704 |
RPS17 | -6038 | -8254 | -8928 |
RPS18 | -7474 | -8294 | -7671 |
RPS19 | -6725 | -7779 | -8460 |
RPS2 | -4354 | -9563 | -9021 |
RPS20 | -8585 | -9385 | -6156 |
RPS21 | -3952 | -8303 | -8855 |
RPS23 | -6081 | -9359 | -8319 |
RPS24 | -261 | -6793 | -4573 |
RPS25 | -6151 | -9636 | -7764 |
RPS26 | -1410 | -1143 | -462 |
RPS27 | -9432 | -9147 | -8693 |
RPS27A | -6700 | -9695 | -8668 |
RPS27L | 2048 | -490 | 9654 |
RPS28 | -4562 | -8056 | -8562 |
RPS29 | -7664 | -8609 | -8958 |
RPS3 | -5717 | -9270 | -8726 |
RPS3A | -4543 | -9806 | -4045 |
RPS4X | -6075 | -8620 | -4665 |
RPS4Y1 | 418 | 329 | 1713 |
RPS5 | -5502 | -9014 | -8342 |
RPS6 | -5956 | -9671 | -7892 |
RPS7 | -4803 | -9137 | -7874 |
RPS8 | -2041 | -8833 | -6710 |
RPS9 | 5358 | 1826 | -8433 |
RPSA | -6110 | -6604 | 3504 |
SMG1 | -4341 | -483 | 7115 |
SMG5 | 5264 | 4820 | -7444 |
SMG6 | -6032 | -474 | -2511 |
SMG7 | 6519 | 10196 | 7365 |
SMG8 | 2894 | 4950 | 6371 |
SMG9 | 204 | 6197 | 490 |
UBA52 | 1112 | -3471 | -8207 |
UPF1 | 4629 | 8973 | -3684 |
UPF2 | 957 | 1269 | 10321 |
UPF3A | -9509 | -8767 | -1235 |
UPF3B | -8003 | -5819 | 6796 |
Unwinding of DNA
metric | value |
---|---|
setSize | 12 |
pMANOVA | 0.00163 |
p.adjustMANOVA | 0.00455 |
s.dist | 0.854 |
s.t0_v_pod | -0.637 |
s.pod_crp | -0.568 |
s.t0_crp | 0.0087 |
p.t0_v_pod | 0.000133 |
p.pod_crp | 0.000652 |
p.t0_crp | 0.958 |
Gene | t0_v_pod | pod_crp |
---|---|---|
MCM3 | -11839 | -9914 |
MCM7 | -11768 | -9297 |
GINS4 | -9903 | -8248 |
MCM6 | -9393 | -8603 |
MCM8 | -10599 | -5689 |
MCM4 | -8404 | -7061 |
MCM2 | -6973 | -6855 |
GINS3 | -10170 | -3854 |
MCM5 | -7039 | -2312 |
GINS2 | -4661 | -3457 |
CDC45 | -2594 | -5110 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CDC45 | -2594 | -5110 | 1889 |
GINS1 | -4261 | 4225 | 7950 |
GINS2 | -4661 | -3457 | 4094 |
GINS3 | -10170 | -3854 | 5122 |
GINS4 | -9903 | -8248 | 3992 |
MCM2 | -6973 | -6855 | -3428 |
MCM3 | -11839 | -9914 | -2392 |
MCM4 | -8404 | -7061 | 3202 |
MCM5 | -7039 | -2312 | -5776 |
MCM6 | -9393 | -8603 | 109 |
MCM7 | -11768 | -9297 | -1374 |
MCM8 | -10599 | -5689 | 7587 |
RHO GTPases Activate WASPs and WAVEs
metric | value |
---|---|
setSize | 35 |
pMANOVA | 2.05e-09 |
p.adjustMANOVA | 2.58e-08 |
s.dist | 0.847 |
s.t0_v_pod | 0.608 |
s.pod_crp | 0.542 |
s.t0_crp | -0.232 |
p.t0_v_pod | 4.76e-10 |
p.pod_crp | 2.9e-08 |
p.t0_crp | 0.0178 |
Gene | t0_v_pod | pod_crp |
---|---|---|
WASF1 | 9357 | 11114 |
GRB2 | 9146 | 10542 |
ARPC1B | 9102 | 10587 |
ARPC1A | 8745 | 10779 |
CYFIP1 | 9108 | 10239 |
ACTB | 8859 | 10421 |
RAC1 | 8647 | 10438 |
WAS | 8421 | 10583 |
WASF2 | 8237 | 10611 |
ARPC5 | 8544 | 9930 |
MAPK3 | 8803 | 9593 |
NCKAP1L | 7557 | 11091 |
MAPK1 | 7381 | 10983 |
ACTG1 | 8423 | 9524 |
BTK | 7100 | 10653 |
ARPC3 | 8147 | 8602 |
ARPC4 | 7404 | 9441 |
ACTR2 | 7750 | 8769 |
ACTR3 | 7699 | 8747 |
ARPC2 | 7280 | 8886 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ABI1 | 6978 | 9231 | 9895 |
ABI2 | -10571 | -8147 | 5541 |
ABL1 | 224 | 6063 | -4841 |
ACTB | 8859 | 10421 | -4561 |
ACTG1 | 8423 | 9524 | -7556 |
ACTR2 | 7750 | 8769 | 5308 |
ACTR3 | 7699 | 8747 | 3145 |
ARPC1A | 8745 | 10779 | 2238 |
ARPC1B | 9102 | 10587 | -8003 |
ARPC2 | 7280 | 8886 | -214 |
ARPC3 | 8147 | 8602 | 3314 |
ARPC4 | 7404 | 9441 | -4920 |
ARPC5 | 8544 | 9930 | 1879 |
BAIAP2 | -215 | -1864 | -5732 |
BRK1 | 6929 | -2546 | -8964 |
BTK | 7100 | 10653 | 7751 |
CDC42 | 7425 | 8226 | 5599 |
CYFIP1 | 9108 | 10239 | -6102 |
CYFIP2 | -10031 | -766 | 1789 |
GRB2 | 9146 | 10542 | -5185 |
MAPK1 | 7381 | 10983 | -1505 |
MAPK3 | 8803 | 9593 | -9014 |
NCK1 | -11102 | -8947 | 3344 |
NCKAP1 | 7350 | 8736 | 3265 |
NCKAP1L | 7557 | 11091 | 1697 |
NCKIPSD | 326 | -3672 | -7752 |
PTK2 | 4418 | 385 | -619 |
RAC1 | 8647 | 10438 | 3441 |
WAS | 8421 | 10583 | -4535 |
WASF1 | 9357 | 11114 | -4960 |
WASF2 | 8237 | 10611 | -3673 |
WASF3 | 6713 | -1351 | -7526 |
WASL | 297 | 3268 | 7557 |
WIPF1 | 563 | 3110 | -2585 |
WIPF2 | 5640 | 8576 | 3912 |
RHO GTPases Activate NADPH Oxidases
metric | value |
---|---|
setSize | 21 |
pMANOVA | 2.87e-06 |
p.adjustMANOVA | 1.87e-05 |
s.dist | 0.844 |
s.t0_v_pod | 0.559 |
s.pod_crp | 0.472 |
s.t0_crp | -0.422 |
p.t0_v_pod | 9.31e-06 |
p.pod_crp | 0.000179 |
p.t0_crp | 0.000825 |
Gene | t0_v_pod | pod_crp |
---|---|---|
S100A8 | 9341 | 10975 |
MAPK14 | 8951 | 10908 |
S100A9 | 9353 | 10428 |
PRKCD | 8856 | 10959 |
NCF4 | 9111 | 10617 |
NCF2 | 9034 | 10598 |
RAC1 | 8647 | 10438 |
MAPK3 | 8803 | 9593 |
CYBB | 8879 | 9506 |
MAPK1 | 7381 | 10983 |
CYBA | 6822 | 9999 |
PRKCB | 6993 | 8456 |
NCF1 | 7224 | 7158 |
RAC2 | 5104 | 8122 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CYBA | 6822 | 9999 | -7207 |
CYBB | 8879 | 9506 | 1575 |
MAPK1 | 7381 | 10983 | -1505 |
MAPK11 | 3788 | -4619 | 1873 |
MAPK14 | 8951 | 10908 | -1066 |
MAPK3 | 8803 | 9593 | -9014 |
NCF1 | 7224 | 7158 | -2796 |
NCF2 | 9034 | 10598 | -2149 |
NCF4 | 9111 | 10617 | -6708 |
NOXA1 | -5279 | -4892 | -3091 |
PIK3C3 | 1606 | -1705 | 8122 |
PIK3R4 | -3937 | -2083 | 5203 |
PIN1 | -3103 | 571 | -8554 |
PRKCA | 1123 | -2393 | -4303 |
PRKCB | 6993 | 8456 | -4547 |
PRKCD | 8856 | 10959 | -3359 |
PRKCZ | -11275 | -5992 | -6068 |
RAC1 | 8647 | 10438 | 3441 |
RAC2 | 5104 | 8122 | -7294 |
S100A8 | 9341 | 10975 | -5317 |
S100A9 | 9353 | 10428 | -7018 |
Translation initiation complex formation
metric | value |
---|---|
setSize | 58 |
pMANOVA | 2.43e-36 |
p.adjustMANOVA | 9.45e-35 |
s.dist | 0.829 |
s.t0_v_pod | -0.0201 |
s.pod_crp | -0.582 |
s.t0_crp | -0.59 |
p.t0_v_pod | 0.792 |
p.pod_crp | 1.77e-14 |
p.t0_crp | 7.54e-15 |
Gene | t0_crp | pod_crp |
---|---|---|
RPS2 | -9021 | -9563 |
RPS27A | -8668 | -9695 |
RPS12 | -8852 | -9242 |
RPS3 | -8726 | -9270 |
RPS27 | -8693 | -9147 |
RPS23 | -8319 | -9359 |
RPS29 | -8958 | -8609 |
RPS6 | -7892 | -9671 |
RPS5 | -8342 | -9014 |
RPS25 | -7764 | -9636 |
RPS10 | -8823 | -8466 |
RPS15A | -8431 | -8855 |
RPS16 | -8704 | -8551 |
RPS17 | -8928 | -8254 |
RPS14 | -8637 | -8513 |
RPS21 | -8855 | -8303 |
EIF3L | -8813 | -8228 |
EIF3B | -7620 | -9498 |
RPS7 | -7874 | -9137 |
RPS11 | -8743 | -7948 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
EIF1AX | 1081 | -8356 | 3339 |
EIF2S1 | 4235 | -1636 | 6996 |
EIF2S2 | 6091 | 549 | 7102 |
EIF2S3 | 6653 | 2481 | 4095 |
EIF3A | 2132 | -1264 | -723 |
EIF3B | -7776 | -9498 | -7620 |
EIF3C | 285 | -4694 | -8882 |
EIF3D | 2605 | -5135 | -7554 |
EIF3E | 1902 | -9021 | 1399 |
EIF3F | 970 | -5176 | -8803 |
EIF3G | 871 | -2729 | -8872 |
EIF3H | 4677 | -7066 | -6135 |
EIF3I | 4649 | -2563 | -8353 |
EIF3J | 1885 | -6423 | 9055 |
EIF3K | 1468 | -2354 | -7325 |
EIF3L | 2560 | -8228 | -8813 |
EIF3M | 4533 | -6792 | 3750 |
EIF4A1 | 7476 | 5489 | -4905 |
EIF4A2 | -10809 | -9565 | 7689 |
EIF4B | 1237 | -8163 | -7131 |
EIF4E | 4757 | 1648 | 9908 |
EIF4G1 | 7908 | 10325 | -6629 |
EIF4H | 7634 | 7669 | -8926 |
FAU | -359 | -3599 | -8841 |
PABPC1 | 5290 | -2972 | 2666 |
RPS10 | -5601 | -8466 | -8823 |
RPS11 | -6992 | -7948 | -8743 |
RPS12 | -5788 | -9242 | -8852 |
RPS13 | -1717 | -8696 | -7869 |
RPS14 | -5278 | -8513 | -8637 |
RPS15 | -3565 | -6678 | -8273 |
RPS15A | -5550 | -8855 | -8431 |
RPS16 | -4518 | -8551 | -8704 |
RPS17 | -6038 | -8254 | -8928 |
RPS18 | -7474 | -8294 | -7671 |
RPS19 | -6725 | -7779 | -8460 |
RPS2 | -4354 | -9563 | -9021 |
RPS20 | -8585 | -9385 | -6156 |
RPS21 | -3952 | -8303 | -8855 |
RPS23 | -6081 | -9359 | -8319 |
RPS24 | -261 | -6793 | -4573 |
RPS25 | -6151 | -9636 | -7764 |
RPS26 | -1410 | -1143 | -462 |
RPS27 | -9432 | -9147 | -8693 |
RPS27A | -6700 | -9695 | -8668 |
RPS27L | 2048 | -490 | 9654 |
RPS28 | -4562 | -8056 | -8562 |
RPS29 | -7664 | -8609 | -8958 |
RPS3 | -5717 | -9270 | -8726 |
RPS3A | -4543 | -9806 | -4045 |
RPS4X | -6075 | -8620 | -4665 |
RPS4Y1 | 418 | 329 | 1713 |
RPS5 | -5502 | -9014 | -8342 |
RPS6 | -5956 | -9671 | -7892 |
RPS7 | -4803 | -9137 | -7874 |
RPS8 | -2041 | -8833 | -6710 |
RPS9 | 5358 | 1826 | -8433 |
RPSA | -6110 | -6604 | 3504 |
RHO GTPases Activate ROCKs
metric | value |
---|---|
setSize | 18 |
pMANOVA | 8.92e-05 |
p.adjustMANOVA | 0.000371 |
s.dist | 0.824 |
s.t0_v_pod | 0.541 |
s.pod_crp | 0.621 |
s.t0_crp | -0.0253 |
p.t0_v_pod | 7.03e-05 |
p.pod_crp | 5.02e-06 |
p.t0_crp | 0.853 |
Gene | pod_crp | t0_v_pod |
---|---|---|
MYL6 | 10011 | 8436 |
PAK1 | 9873 | 8100 |
CFL1 | 9633 | 8057 |
RHOA | 9259 | 8188 |
LIMK2 | 9535 | 7949 |
ROCK1 | 8572 | 7377 |
MYH9 | 9088 | 6594 |
PPP1CB | 6672 | 6960 |
PPP1R12A | 7701 | 5969 |
ROCK2 | 6540 | 6054 |
LIMK1 | 7956 | 4628 |
MYL12B | 5646 | 5029 |
PPP1R12B | 8370 | 1762 |
MYL9 | 1915 | 7587 |
RHOB | 7820 | 1244 |
MYH10 | 8510 | 647 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CFL1 | 8057 | 9633 | -8162 |
LIMK1 | 4628 | 7956 | -5779 |
LIMK2 | 7949 | 9535 | -1036 |
MYH10 | 647 | 8510 | 7323 |
MYH11 | -3419 | -2228 | 6330 |
MYH9 | 6594 | 9088 | -6312 |
MYL12B | 5029 | 5646 | -3168 |
MYL6 | 8436 | 10011 | -8786 |
MYL9 | 7587 | 1915 | -4389 |
PAK1 | 8100 | 9873 | 7050 |
PPP1CB | 6960 | 6672 | 7418 |
PPP1R12A | 5969 | 7701 | 8978 |
PPP1R12B | 1762 | 8370 | 5459 |
RHOA | 8188 | 9259 | -372 |
RHOB | 1244 | 7820 | 3590 |
RHOC | -11009 | 4597 | 68 |
ROCK1 | 7377 | 8572 | 9620 |
ROCK2 | 6054 | 6540 | 7093 |
MET activates RAP1 and RAC1
metric | value |
---|---|
setSize | 10 |
pMANOVA | 0.00615 |
p.adjustMANOVA | 0.0139 |
s.dist | 0.824 |
s.t0_v_pod | 0.53 |
s.pod_crp | 0.606 |
s.t0_crp | 0.178 |
p.t0_v_pod | 0.00371 |
p.pod_crp | 0.00091 |
p.t0_crp | 0.331 |
Gene | pod_crp | t0_v_pod |
---|---|---|
GRB2 | 10542 | 9146 |
RAC1 | 10438 | 8647 |
CRK | 10207 | 8756 |
HGF | 10236 | 8715 |
RAP1A | 7246 | 7198 |
GAB1 | 8548 | 5607 |
RAP1B | 6882 | 3179 |
CRKL | 5201 | 3927 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CRK | 8756 | 10207 | 5223 |
CRKL | 3927 | 5201 | -2305 |
DOCK7 | -2317 | -4063 | 7144 |
GAB1 | 5607 | 8548 | 9775 |
GRB2 | 9146 | 10542 | -5185 |
HGF | 8715 | 10236 | 7877 |
RAC1 | 8647 | 10438 | 3441 |
RAP1A | 7198 | 7246 | 9059 |
RAP1B | 3179 | 6882 | 6183 |
RAPGEF1 | -9501 | 5055 | -5674 |
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
metric | value |
---|---|
setSize | 59 |
pMANOVA | 1.34e-36 |
p.adjustMANOVA | 5.53e-35 |
s.dist | 0.821 |
s.t0_v_pod | -0.00808 |
s.pod_crp | -0.568 |
s.t0_crp | -0.593 |
p.t0_v_pod | 0.915 |
p.pod_crp | 4.24e-14 |
p.t0_crp | 3.25e-15 |
Gene | t0_crp | pod_crp |
---|---|---|
RPS2 | -9021 | -9563 |
RPS27A | -8668 | -9695 |
RPS12 | -8852 | -9242 |
RPS3 | -8726 | -9270 |
RPS27 | -8693 | -9147 |
RPS23 | -8319 | -9359 |
RPS29 | -8958 | -8609 |
RPS6 | -7892 | -9671 |
RPS5 | -8342 | -9014 |
RPS25 | -7764 | -9636 |
RPS10 | -8823 | -8466 |
RPS15A | -8431 | -8855 |
RPS16 | -8704 | -8551 |
RPS17 | -8928 | -8254 |
RPS14 | -8637 | -8513 |
RPS21 | -8855 | -8303 |
EIF3L | -8813 | -8228 |
EIF3B | -7620 | -9498 |
RPS7 | -7874 | -9137 |
RPS11 | -8743 | -7948 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
EIF1AX | 1081 | -8356 | 3339 |
EIF2S1 | 4235 | -1636 | 6996 |
EIF2S2 | 6091 | 549 | 7102 |
EIF2S3 | 6653 | 2481 | 4095 |
EIF3A | 2132 | -1264 | -723 |
EIF3B | -7776 | -9498 | -7620 |
EIF3C | 285 | -4694 | -8882 |
EIF3D | 2605 | -5135 | -7554 |
EIF3E | 1902 | -9021 | 1399 |
EIF3F | 970 | -5176 | -8803 |
EIF3G | 871 | -2729 | -8872 |
EIF3H | 4677 | -7066 | -6135 |
EIF3I | 4649 | -2563 | -8353 |
EIF3J | 1885 | -6423 | 9055 |
EIF3K | 1468 | -2354 | -7325 |
EIF3L | 2560 | -8228 | -8813 |
EIF3M | 4533 | -6792 | 3750 |
EIF4A1 | 7476 | 5489 | -4905 |
EIF4A2 | -10809 | -9565 | 7689 |
EIF4B | 1237 | -8163 | -7131 |
EIF4E | 4757 | 1648 | 9908 |
EIF4EBP1 | 5990 | 2800 | -6475 |
EIF4G1 | 7908 | 10325 | -6629 |
EIF4H | 7634 | 7669 | -8926 |
FAU | -359 | -3599 | -8841 |
PABPC1 | 5290 | -2972 | 2666 |
RPS10 | -5601 | -8466 | -8823 |
RPS11 | -6992 | -7948 | -8743 |
RPS12 | -5788 | -9242 | -8852 |
RPS13 | -1717 | -8696 | -7869 |
RPS14 | -5278 | -8513 | -8637 |
RPS15 | -3565 | -6678 | -8273 |
RPS15A | -5550 | -8855 | -8431 |
RPS16 | -4518 | -8551 | -8704 |
RPS17 | -6038 | -8254 | -8928 |
RPS18 | -7474 | -8294 | -7671 |
RPS19 | -6725 | -7779 | -8460 |
RPS2 | -4354 | -9563 | -9021 |
RPS20 | -8585 | -9385 | -6156 |
RPS21 | -3952 | -8303 | -8855 |
RPS23 | -6081 | -9359 | -8319 |
RPS24 | -261 | -6793 | -4573 |
RPS25 | -6151 | -9636 | -7764 |
RPS26 | -1410 | -1143 | -462 |
RPS27 | -9432 | -9147 | -8693 |
RPS27A | -6700 | -9695 | -8668 |
RPS27L | 2048 | -490 | 9654 |
RPS28 | -4562 | -8056 | -8562 |
RPS29 | -7664 | -8609 | -8958 |
RPS3 | -5717 | -9270 | -8726 |
RPS3A | -4543 | -9806 | -4045 |
RPS4X | -6075 | -8620 | -4665 |
RPS4Y1 | 418 | 329 | 1713 |
RPS5 | -5502 | -9014 | -8342 |
RPS6 | -5956 | -9671 | -7892 |
RPS7 | -4803 | -9137 | -7874 |
RPS8 | -2041 | -8833 | -6710 |
RPS9 | 5358 | 1826 | -8433 |
RPSA | -6110 | -6604 | 3504 |
Ribosomal scanning and start codon recognition
metric | value |
---|---|
setSize | 58 |
pMANOVA | 6.98e-35 |
p.adjustMANOVA | 2.5e-33 |
s.dist | 0.817 |
s.t0_v_pod | -0.0251 |
s.pod_crp | -0.572 |
s.t0_crp | -0.583 |
p.t0_v_pod | 0.741 |
p.pod_crp | 4.68e-14 |
p.t0_crp | 1.57e-14 |
Gene | t0_crp | pod_crp |
---|---|---|
RPS2 | -9021 | -9563 |
RPS27A | -8668 | -9695 |
RPS12 | -8852 | -9242 |
RPS3 | -8726 | -9270 |
RPS27 | -8693 | -9147 |
RPS23 | -8319 | -9359 |
RPS29 | -8958 | -8609 |
RPS6 | -7892 | -9671 |
RPS5 | -8342 | -9014 |
RPS25 | -7764 | -9636 |
RPS10 | -8823 | -8466 |
RPS15A | -8431 | -8855 |
RPS16 | -8704 | -8551 |
RPS17 | -8928 | -8254 |
RPS14 | -8637 | -8513 |
RPS21 | -8855 | -8303 |
EIF3L | -8813 | -8228 |
EIF3B | -7620 | -9498 |
RPS7 | -7874 | -9137 |
RPS11 | -8743 | -7948 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
EIF1AX | 1081 | -8356 | 3339 |
EIF2S1 | 4235 | -1636 | 6996 |
EIF2S2 | 6091 | 549 | 7102 |
EIF2S3 | 6653 | 2481 | 4095 |
EIF3A | 2132 | -1264 | -723 |
EIF3B | -7776 | -9498 | -7620 |
EIF3C | 285 | -4694 | -8882 |
EIF3D | 2605 | -5135 | -7554 |
EIF3E | 1902 | -9021 | 1399 |
EIF3F | 970 | -5176 | -8803 |
EIF3G | 871 | -2729 | -8872 |
EIF3H | 4677 | -7066 | -6135 |
EIF3I | 4649 | -2563 | -8353 |
EIF3J | 1885 | -6423 | 9055 |
EIF3K | 1468 | -2354 | -7325 |
EIF3L | 2560 | -8228 | -8813 |
EIF3M | 4533 | -6792 | 3750 |
EIF4A1 | 7476 | 5489 | -4905 |
EIF4A2 | -10809 | -9565 | 7689 |
EIF4B | 1237 | -8163 | -7131 |
EIF4E | 4757 | 1648 | 9908 |
EIF4G1 | 7908 | 10325 | -6629 |
EIF4H | 7634 | 7669 | -8926 |
EIF5 | 2162 | 2911 | 7027 |
FAU | -359 | -3599 | -8841 |
RPS10 | -5601 | -8466 | -8823 |
RPS11 | -6992 | -7948 | -8743 |
RPS12 | -5788 | -9242 | -8852 |
RPS13 | -1717 | -8696 | -7869 |
RPS14 | -5278 | -8513 | -8637 |
RPS15 | -3565 | -6678 | -8273 |
RPS15A | -5550 | -8855 | -8431 |
RPS16 | -4518 | -8551 | -8704 |
RPS17 | -6038 | -8254 | -8928 |
RPS18 | -7474 | -8294 | -7671 |
RPS19 | -6725 | -7779 | -8460 |
RPS2 | -4354 | -9563 | -9021 |
RPS20 | -8585 | -9385 | -6156 |
RPS21 | -3952 | -8303 | -8855 |
RPS23 | -6081 | -9359 | -8319 |
RPS24 | -261 | -6793 | -4573 |
RPS25 | -6151 | -9636 | -7764 |
RPS26 | -1410 | -1143 | -462 |
RPS27 | -9432 | -9147 | -8693 |
RPS27A | -6700 | -9695 | -8668 |
RPS27L | 2048 | -490 | 9654 |
RPS28 | -4562 | -8056 | -8562 |
RPS29 | -7664 | -8609 | -8958 |
RPS3 | -5717 | -9270 | -8726 |
RPS3A | -4543 | -9806 | -4045 |
RPS4X | -6075 | -8620 | -4665 |
RPS4Y1 | 418 | 329 | 1713 |
RPS5 | -5502 | -9014 | -8342 |
RPS6 | -5956 | -9671 | -7892 |
RPS7 | -4803 | -9137 | -7874 |
RPS8 | -2041 | -8833 | -6710 |
RPS9 | 5358 | 1826 | -8433 |
RPSA | -6110 | -6604 | 3504 |
Trafficking of GluR2-containing AMPA receptors
metric | value |
---|---|
setSize | 12 |
pMANOVA | 0.000828 |
p.adjustMANOVA | 0.00251 |
s.dist | 0.816 |
s.t0_v_pod | 0.469 |
s.pod_crp | 0.446 |
s.t0_crp | -0.497 |
p.t0_v_pod | 0.00491 |
p.pod_crp | 0.00746 |
p.t0_crp | 0.00288 |
Gene | t0_crp | t0_v_pod |
---|---|---|
AP2M1 | -8821 | 8486 |
AP2S1 | -7630 | 7903 |
AP2A2 | -6585 | 7150 |
AP2A1 | -6175 | 6737 |
NSF | -4591 | 8683 |
PRKCB | -4547 | 6993 |
PICK1 | -6801 | 3562 |
TSPAN7 | -2508 | 6381 |
PRKCA | -4303 | 1123 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AP2A1 | 6737 | 11125 | -6175 |
AP2A2 | 7150 | 10047 | -6585 |
AP2B1 | -2641 | 2884 | -1439 |
AP2M1 | 8486 | 8674 | -8821 |
AP2S1 | 7903 | 7940 | -7630 |
GRIA4 | -97 | 5446 | 8979 |
GRIP1 | -10075 | -9691 | 585 |
NSF | 8683 | 9705 | -4591 |
PICK1 | 3562 | 6662 | -6801 |
PRKCA | 1123 | -2393 | -4303 |
PRKCB | 6993 | 8456 | -4547 |
TSPAN7 | 6381 | 5014 | -2508 |
Josephin domain DUBs
metric | value |
---|---|
setSize | 10 |
pMANOVA | 0.000895 |
p.adjustMANOVA | 0.00269 |
s.dist | 0.815 |
s.t0_v_pod | 0.47 |
s.pod_crp | 0.227 |
s.t0_crp | -0.627 |
p.t0_v_pod | 0.0101 |
p.pod_crp | 0.214 |
p.t0_crp | 0.000599 |
Gene | t0_crp | t0_v_pod |
---|---|---|
JOSD2 | -8493 | 7810 |
VCP | -7331 | 6789 |
UBB | -6697 | 6548 |
RAD23B | -4784 | 8738 |
RAD23A | -5237 | 6424 |
UBC | -4003 | 4395 |
UBA52 | -8207 | 1112 |
JOSD1 | -4309 | 225 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ATXN3 | 1588 | -665 | 7310 |
JOSD1 | 225 | 5145 | -4309 |
JOSD2 | 7810 | 9762 | -8493 |
RAD23A | 6424 | 3997 | -5237 |
RAD23B | 8738 | 9953 | -4784 |
RPS27A | -6700 | -9695 | -8668 |
UBA52 | 1112 | -3471 | -8207 |
UBB | 6548 | 1016 | -6697 |
UBC | 4395 | 6071 | -4003 |
VCP | 6789 | 7704 | -7331 |
Influenza Viral RNA Transcription and Replication
metric | value |
---|---|
setSize | 135 |
pMANOVA | 7.99e-56 |
p.adjustMANOVA | 4.94e-54 |
s.dist | 0.811 |
s.t0_v_pod | -0.225 |
s.pod_crp | -0.573 |
s.t0_crp | -0.529 |
p.t0_v_pod | 6.45e-06 |
p.pod_crp | 1.21e-30 |
p.t0_crp | 2.39e-26 |
Gene | pod_crp | t0_crp |
---|---|---|
RPL3 | -9928 | -8773 |
RPS2 | -9563 | -9021 |
RPS27A | -9695 | -8668 |
RPL14 | -9670 | -8650 |
RPLP2 | -9135 | -9001 |
RPS12 | -9242 | -8852 |
RPS3 | -9270 | -8726 |
RPLP0 | -9199 | -8702 |
RPS27 | -9147 | -8693 |
RPL10 | -9003 | -8829 |
RPL7 | -9737 | -8087 |
RPS23 | -9359 | -8319 |
RPL27A | -9020 | -8573 |
RPS29 | -8609 | -8958 |
RPS6 | -9671 | -7892 |
RPL31 | -8741 | -8685 |
RPL30 | -8902 | -8504 |
RPL29 | -8593 | -8787 |
RPS5 | -9014 | -8342 |
RPL18A | -8868 | -8439 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AAAS | -8101 | -3313 | -2106 |
DNAJC3 | 8302 | 9670 | 4528 |
FAU | -359 | -3599 | -8841 |
GRSF1 | 5110 | -2905 | 1530 |
GTF2F1 | 4893 | 6665 | -7408 |
GTF2F2 | 5371 | 6192 | 438 |
HSP90AA1 | 1316 | -3995 | 7175 |
IPO5 | -10252 | -10100 | -1600 |
NDC1 | -11812 | -10048 | 3076 |
NUP107 | -10085 | -8258 | 10051 |
NUP133 | -7491 | -5322 | 4290 |
NUP153 | -6108 | 252 | 4792 |
NUP155 | -9900 | -7036 | 7468 |
NUP160 | -10219 | -8330 | 7352 |
NUP188 | -11270 | -7926 | -3035 |
NUP205 | -10971 | -7490 | 2507 |
NUP210 | -10384 | -3928 | -3875 |
NUP214 | 7800 | 9957 | -379 |
NUP35 | -10272 | -9698 | 3192 |
NUP37 | 3049 | -2260 | 1416 |
NUP42 | -5378 | -4024 | 11148 |
NUP43 | -9198 | -8341 | 11362 |
NUP50 | 4476 | 2618 | 7485 |
NUP54 | -8189 | -7106 | 12095 |
NUP58 | 8674 | 9426 | 5938 |
NUP62 | 763 | -2395 | -4223 |
NUP85 | -2971 | -3408 | 2948 |
NUP88 | -11046 | -9640 | 5761 |
NUP93 | -11266 | -6433 | 6407 |
NUP98 | 3075 | 5814 | 2773 |
PARP1 | -11409 | -8364 | -1542 |
POLR2A | -3010 | 7751 | -1889 |
POLR2B | -2462 | -3365 | 1497 |
POLR2C | 1603 | -488 | -4803 |
POLR2D | -3902 | -6831 | 4997 |
POLR2E | 7450 | 5062 | -8755 |
POLR2F | 4555 | 4218 | -8409 |
POLR2G | 3477 | 4138 | -8391 |
POLR2H | -2867 | -6175 | -6959 |
POLR2I | 394 | -3908 | -8198 |
POLR2J | 6580 | 5544 | -7980 |
POLR2K | -1750 | -4885 | 7558 |
POLR2L | 5244 | 2000 | -9013 |
POM121 | -8013 | -140 | -3047 |
POM121C | -6940 | -1697 | -6610 |
RAE1 | 5105 | 4962 | 4462 |
RANBP2 | -814 | -1130 | 7725 |
RPL10 | -6311 | -9003 | -8829 |
RPL10A | -6458 | -8900 | -6147 |
RPL11 | -6052 | -9089 | -6722 |
RPL12 | -6811 | -9149 | -8024 |
RPL13 | -3335 | -7644 | -6367 |
RPL13A | -7928 | -9374 | -6207 |
RPL14 | -6480 | -9670 | -8650 |
RPL15 | -953 | -8142 | -8235 |
RPL17 | -5249 | -9088 | -8079 |
RPL18 | -4911 | -8835 | -8406 |
RPL18A | -5869 | -8868 | -8439 |
RPL19 | -6071 | -8311 | -8149 |
RPL21 | -6241 | -9483 | -7230 |
RPL22 | -4587 | -9631 | -7480 |
RPL22L1 | -1593 | -8175 | 527 |
RPL23 | -3223 | -8346 | -7486 |
RPL23A | -9248 | -9950 | -4950 |
RPL24 | -5606 | -8873 | -7028 |
RPL26 | -6387 | -8678 | -8038 |
RPL26L1 | 7070 | 5940 | -5499 |
RPL27 | -2783 | -7783 | -8809 |
RPL27A | -6048 | -9020 | -8573 |
RPL28 | -1441 | -3852 | -5654 |
RPL29 | -3505 | -8593 | -8787 |
RPL3 | -8268 | -9928 | -8773 |
RPL30 | -6779 | -8902 | -8504 |
RPL31 | -4394 | -8741 | -8685 |
RPL32 | -6479 | -9317 | -7991 |
RPL34 | -6569 | -9464 | -6337 |
RPL35 | -7809 | -8156 | -7893 |
RPL35A | -5816 | -9263 | -7997 |
RPL36 | -5111 | -7467 | -8861 |
RPL36A | -7122 | -8881 | -8095 |
RPL36AL | 32 | -6621 | -8799 |
RPL37 | -6160 | -7834 | -9017 |
RPL37A | -3826 | -6808 | -8683 |
RPL38 | -5646 | -7941 | -8932 |
RPL39 | -2931 | -8607 | -8362 |
RPL39L | -8506 | -1648 | -4731 |
RPL3L | 4458 | 5102 | 10556 |
RPL4 | -3476 | -9521 | -7062 |
RPL41 | -6632 | -7535 | -8456 |
RPL5 | -4576 | -9853 | -7157 |
RPL6 | -3262 | -9281 | -3434 |
RPL7 | -1917 | -9737 | -8087 |
RPL7A | -3557 | -8259 | -8751 |
RPL8 | -1171 | -6076 | -8899 |
RPL9 | -1837 | -6796 | -4391 |
RPLP0 | -987 | -9199 | -8702 |
RPLP1 | 19 | -5994 | -8833 |
RPLP2 | -6844 | -9135 | -9001 |
RPS10 | -5601 | -8466 | -8823 |
RPS11 | -6992 | -7948 | -8743 |
RPS12 | -5788 | -9242 | -8852 |
RPS13 | -1717 | -8696 | -7869 |
RPS14 | -5278 | -8513 | -8637 |
RPS15 | -3565 | -6678 | -8273 |
RPS15A | -5550 | -8855 | -8431 |
RPS16 | -4518 | -8551 | -8704 |
RPS17 | -6038 | -8254 | -8928 |
RPS18 | -7474 | -8294 | -7671 |
RPS19 | -6725 | -7779 | -8460 |
RPS2 | -4354 | -9563 | -9021 |
RPS20 | -8585 | -9385 | -6156 |
RPS21 | -3952 | -8303 | -8855 |
RPS23 | -6081 | -9359 | -8319 |
RPS24 | -261 | -6793 | -4573 |
RPS25 | -6151 | -9636 | -7764 |
RPS26 | -1410 | -1143 | -462 |
RPS27 | -9432 | -9147 | -8693 |
RPS27A | -6700 | -9695 | -8668 |
RPS27L | 2048 | -490 | 9654 |
RPS28 | -4562 | -8056 | -8562 |
RPS29 | -7664 | -8609 | -8958 |
RPS3 | -5717 | -9270 | -8726 |
RPS3A | -4543 | -9806 | -4045 |
RPS4X | -6075 | -8620 | -4665 |
RPS4Y1 | 418 | 329 | 1713 |
RPS5 | -5502 | -9014 | -8342 |
RPS6 | -5956 | -9671 | -7892 |
RPS7 | -4803 | -9137 | -7874 |
RPS8 | -2041 | -8833 | -6710 |
RPS9 | 5358 | 1826 | -8433 |
RPSA | -6110 | -6604 | 3504 |
SEC13 | 5675 | 7411 | -5667 |
SEH1L | -5868 | -9546 | 7736 |
TPR | -6786 | -3724 | 8739 |
UBA52 | 1112 | -3471 | -8207 |
PD-1 signaling
metric | value |
---|---|
setSize | 28 |
pMANOVA | 4.9e-07 |
p.adjustMANOVA | 4.09e-06 |
s.dist | 0.811 |
s.t0_v_pod | -0.579 |
s.pod_crp | -0.562 |
s.t0_crp | -0.0759 |
p.t0_v_pod | 1.13e-07 |
p.pod_crp | 2.6e-07 |
p.t0_crp | 0.487 |
Gene | t0_v_pod | pod_crp |
---|---|---|
LCK | -11482 | -9528 |
TRBC1 | -11646 | -9275 |
TRAC | -11130 | -9675 |
HLA-DRA | -11649 | -8978 |
CD247 | -11982 | -8713 |
CD3E | -10952 | -9221 |
TRBV12-3 | -10099 | -9942 |
HLA-DPB1 | -11887 | -8370 |
HLA-DPA1 | -11954 | -8190 |
CD3D | -11049 | -8270 |
CD3G | -11173 | -8084 |
TRAV19 | -9587 | -9220 |
HLA-DQB2 | -9085 | -9628 |
TRAV29DV5 | -9353 | -9250 |
TRBV7-9 | -9220 | -8276 |
HLA-DQA1 | -11633 | -6364 |
CD274 | -7301 | -7868 |
HLA-DQA2 | -4652 | -8746 |
PDCD1 | -6559 | -5492 |
CD4 | -5228 | -6856 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CD247 | -11982 | -8713 | -6364 |
CD274 | -7301 | -7868 | 10440 |
CD3D | -11049 | -8270 | 2178 |
CD3E | -10952 | -9221 | 5038 |
CD3G | -11173 | -8084 | 8697 |
CD4 | -5228 | -6856 | -6272 |
CSK | 5158 | 9258 | -7001 |
HLA-DPA1 | -11954 | -8190 | 4347 |
HLA-DPB1 | -11887 | -8370 | -2273 |
HLA-DQA1 | -11633 | -6364 | 10152 |
HLA-DQA2 | -4652 | -8746 | -8618 |
HLA-DQB1 | -6199 | -4437 | 3070 |
HLA-DQB2 | -9085 | -9628 | -6796 |
HLA-DRA | -11649 | -8978 | 726 |
HLA-DRB1 | -7792 | -330 | 8671 |
HLA-DRB5 | -4806 | 741 | 5896 |
LCK | -11482 | -9528 | -3384 |
PDCD1 | -6559 | -5492 | -7034 |
PDCD1LG2 | -3235 | 271 | 9937 |
PTPN11 | 5253 | 6456 | 949 |
PTPN6 | 6014 | 10265 | -797 |
TRAC | -11130 | -9675 | 7034 |
TRAV19 | -9587 | -9220 | -3070 |
TRAV29DV5 | -9353 | -9250 | -1621 |
TRAV8-4 | -7010 | -4747 | 11211 |
TRBC1 | -11646 | -9275 | 1902 |
TRBV12-3 | -10099 | -9942 | -8483 |
TRBV7-9 | -9220 | -8276 | -4880 |
Neutrophil degranulation
metric | value |
---|---|
setSize | 458 |
pMANOVA | 1.1e-119 |
p.adjustMANOVA | 1.5e-116 |
s.dist | 0.809 |
s.t0_v_pod | 0.586 |
s.pod_crp | 0.454 |
s.t0_crp | -0.326 |
p.t0_v_pod | 2.13e-103 |
p.pod_crp | 1.37e-62 |
p.t0_crp | 5.89e-33 |
Gene | t0_v_pod | pod_crp |
---|---|---|
IDH1 | 9345 | 11201 |
SIRPA | 9348 | 11197 |
CR1 | 9325 | 11185 |
MCEMP1 | 9342 | 11134 |
DOK3 | 9228 | 11223 |
HK3 | 9225 | 11211 |
HP | 9293 | 11099 |
GNS | 9200 | 11194 |
SIGLEC9 | 9223 | 11166 |
S100A12 | 9352 | 10996 |
CTSD | 9272 | 11084 |
RNASE2 | 9344 | 10982 |
ATP6V0A1 | 9262 | 11071 |
S100A8 | 9341 | 10975 |
TIMP2 | 9297 | 11004 |
ITGAM | 9238 | 11057 |
QSOX1 | 9140 | 11154 |
CD63 | 9129 | 11140 |
CTSB | 9204 | 11040 |
NCSTN | 9030 | 11232 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
A1BG | 5492 | -1455 | -9006 |
ABCA13 | 4715 | -6909 | -3146 |
ACAA1 | 8162 | 10869 | -5822 |
ACLY | 5100 | 10091 | -439 |
ACTR10 | 7490 | 5826 | 4427 |
ACTR1B | -10176 | -5928 | -7545 |
ACTR2 | 7750 | 8769 | 5308 |
ADAM10 | 8645 | 9824 | 976 |
ADAM8 | 5565 | 8811 | -6126 |
ADGRE3 | 403 | 1228 | -5005 |
ADGRE5 | -2508 | 8810 | -4306 |
ADGRG3 | 8074 | 10815 | 2235 |
AGA | -4482 | -7647 | -8525 |
AGL | -3052 | 314 | 9307 |
AGPAT2 | 9099 | 10848 | -8544 |
ALAD | 8376 | 10268 | -6627 |
ALDH3B1 | 8521 | 10856 | -2824 |
ALDOA | 9092 | 10672 | -7000 |
ALDOC | -3342 | -5589 | 1109 |
ALOX5 | 8850 | 10969 | -3729 |
AMPD3 | 8588 | 10009 | -5478 |
ANO6 | 7924 | 3373 | -3706 |
ANPEP | 9190 | 11017 | -5152 |
ANXA2 | 8405 | 10514 | -659 |
AOC1 | 6421 | 2487 | -8769 |
AP1M1 | 6619 | 9444 | -8556 |
AP2A2 | 7150 | 10047 | -6585 |
APAF1 | 8863 | 8697 | 1510 |
APEH | 989 | 4901 | -7164 |
APRT | -2695 | -7554 | -8911 |
ARG1 | 8615 | 9890 | -1331 |
ARHGAP9 | 6170 | 9546 | -7133 |
ARL8A | 8119 | 9885 | -8707 |
ARMC8 | 6310 | 4556 | 4444 |
ARPC5 | 8544 | 9930 | 1879 |
ARSA | 3455 | 8337 | 2766 |
ARSB | 7459 | 9871 | 1891 |
ASAH1 | 8390 | 10601 | 3560 |
ATAD3B | -9747 | -8327 | -4100 |
ATG7 | 8007 | 6018 | -5002 |
ATP11A | 8262 | 10596 | -2465 |
ATP11B | 5982 | 8404 | 4128 |
ATP6AP2 | 7911 | 4871 | -616 |
ATP6V0A1 | 9262 | 11071 | -4129 |
ATP6V0C | 8974 | 10793 | -5635 |
ATP6V1D | 8894 | 9815 | 2539 |
ATP8A1 | -11486 | -9190 | 1368 |
ATP8B4 | 6869 | 5203 | -3317 |
AZU1 | 5442 | -9352 | -7594 |
B2M | -6684 | -6918 | 6987 |
B4GALT1 | 4248 | 7664 | -6063 |
BIN2 | 5672 | 9564 | -6866 |
BPI | 6575 | -5386 | -5701 |
BRI3 | 8865 | 10760 | -6047 |
BST1 | 9319 | 10460 | -4980 |
BST2 | -7131 | -773 | 6780 |
C3 | -11900 | -3375 | 4028 |
C3AR1 | 7890 | 11082 | 11718 |
C5AR1 | 8976 | 10855 | -5364 |
C6orf120 | 6106 | 6765 | -1488 |
CAB39 | 8146 | 9237 | -1402 |
CAMP | 4730 | -8389 | -5922 |
CAND1 | -6331 | -7033 | 6832 |
CANT1 | 7591 | 9121 | -3707 |
CAP1 | 7984 | 9767 | -3179 |
CAPN1 | 8424 | 10386 | -7700 |
CAT | 8970 | 9931 | -691 |
CCT2 | -8525 | -9995 | 2579 |
CCT8 | 6464 | -2734 | -1857 |
CD14 | 8944 | 9321 | -7666 |
CD177 | 2440 | 10861 | -7286 |
CD300A | -2090 | 10182 | 8407 |
CD33 | 7944 | 6852 | -2431 |
CD36 | 9283 | 10747 | -147 |
CD44 | 8201 | 9117 | -5995 |
CD47 | -11753 | -9136 | 9265 |
CD53 | 7764 | 10130 | -1874 |
CD55 | 8991 | 10715 | -1801 |
CD58 | 6556 | 9534 | 7069 |
CD59 | 5783 | 4214 | -5137 |
CD63 | 9129 | 11140 | -8819 |
CD68 | 8394 | 10363 | -4426 |
CD93 | 9335 | 10737 | -7812 |
CDA | 9152 | 10663 | -6623 |
CDK13 | -8104 | 2102 | 313 |
CEACAM1 | 8296 | 8922 | 4645 |
CEACAM3 | 6743 | 10732 | 9607 |
CEACAM6 | 4464 | -8250 | -4308 |
CEACAM8 | 4898 | -7520 | -4626 |
CEP290 | -8867 | -8129 | 11979 |
CFD | 1971 | 458 | -1136 |
CFP | 7333 | 8749 | -7816 |
CHI3L1 | -645 | -5737 | 1602 |
CHIT1 | 5931 | -1877 | -3573 |
CKAP4 | 9210 | 10623 | -4859 |
CLEC12A | 4490 | 2312 | 4243 |
CLEC4C | -11454 | 2201 | 5124 |
CLEC4D | 9029 | 10217 | 651 |
CLEC5A | 8339 | 8368 | -3929 |
CMTM6 | 7771 | 8833 | 6791 |
CNN2 | 6554 | 9009 | -1280 |
COMMD3 | -1344 | -2640 | 4398 |
COMMD9 | 7845 | 7070 | -1283 |
COPB1 | 7213 | 7893 | 6691 |
COTL1 | 7812 | 10155 | -1806 |
CPNE1 | -3302 | -1619 | -6859 |
CPNE3 | 5796 | 2958 | 652 |
CPPED1 | 8225 | 9823 | -674 |
CR1 | 9325 | 11185 | -4186 |
CRACR2A | -8758 | 1203 | -3907 |
CREG1 | 9322 | 8569 | -7750 |
CRISP3 | 7439 | 1404 | -774 |
CRISPLD2 | 8953 | 10618 | -1904 |
CSNK2B | 3930 | 5816 | -2975 |
CST3 | 2193 | 1733 | -2734 |
CSTB | 6806 | 9334 | -3641 |
CTSA | 9351 | 10646 | -7182 |
CTSB | 9204 | 11040 | -5546 |
CTSC | 2312 | 9136 | 1722 |
CTSD | 9272 | 11084 | -8465 |
CTSG | 5056 | -9475 | -7645 |
CTSH | 6273 | 4941 | -6379 |
CTSS | 8240 | 6436 | 2971 |
CTSZ | 8825 | 9776 | -7490 |
CXCL1 | 5749 | 6987 | 4091 |
CXCR1 | 6768 | 9194 | 6911 |
CXCR2 | 5785 | 6647 | 6291 |
CYB5R3 | 8753 | 10581 | -7650 |
CYBA | 6822 | 9999 | -7207 |
CYBB | 8879 | 9506 | 1575 |
CYFIP1 | 9108 | 10239 | -6102 |
CYSTM1 | 8924 | 10420 | -5096 |
DBNL | 7633 | 9654 | -7933 |
DDOST | 6831 | 8345 | -8761 |
DDX3X | 6524 | 1679 | -1993 |
DEFA1 | 5979 | -7653 | -7167 |
DEFA4 | 5976 | -7696 | -6681 |
DEGS1 | 6085 | 3108 | -2810 |
DERA | 8364 | 9203 | 5762 |
DGAT1 | 5245 | 5124 | -7354 |
DIAPH1 | -848 | 7043 | -2195 |
DNAJC13 | 8133 | 9754 | 8263 |
DNAJC3 | 8302 | 9670 | 4528 |
DNAJC5 | 8537 | 10191 | -7582 |
DNASE1L1 | 8491 | 11170 | -4686 |
DOCK2 | 7609 | 9981 | -3978 |
DOK3 | 9228 | 11223 | -3807 |
DPP7 | -4437 | -5988 | -8505 |
DSC1 | -6691 | -9602 | 1668 |
DSN1 | -10430 | -5283 | 10410 |
DSP | -1779 | -566 | -1774 |
DYNC1H1 | -7417 | 1692 | -1406 |
DYNC1LI1 | 6841 | 8160 | 7235 |
DYNLL1 | 5873 | 1517 | -3390 |
DYNLT1 | 4406 | 6846 | 5710 |
EEF1A1 | -4918 | -9723 | -8179 |
EEF2 | 304 | -6254 | -8868 |
ELANE | 7212 | -8344 | -7334 |
ENPP4 | -9264 | -305 | 2386 |
EPX | -4683 | -4759 | 7154 |
ERP44 | 6807 | 4776 | 6518 |
FABP5 | 5940 | 7802 | 1781 |
FAF2 | 5487 | 7491 | -1530 |
FCAR | 8958 | 10044 | -6856 |
FCER1G | 8004 | 11006 | -528 |
FCGR2A | 8699 | 10289 | -8 |
FCGR3B | 4269 | 1379 | 4683 |
FCN1 | 8960 | 7852 | -7616 |
FGL2 | 669 | -5991 | 7110 |
FGR | 8344 | 11109 | -5786 |
FOLR3 | 7339 | 2713 | -8591 |
FPR1 | 9137 | 11011 | -4973 |
FPR2 | 8942 | 10687 | 2047 |
FRK | -24 | 2650 | 7579 |
FRMPD3 | -11117 | -543 | -2992 |
FTH1 | 4846 | 6807 | -5091 |
FTL | 8523 | 9929 | -4319 |
FUCA1 | 7298 | 6401 | -7341 |
FUCA2 | 8173 | 5966 | 582 |
GAA | 7846 | 8503 | -6546 |
GALNS | 6998 | 8916 | -3718 |
GCA | 9275 | 10797 | 2682 |
GDI2 | 7175 | 6869 | 4678 |
GGH | 6119 | 7146 | 3797 |
GHDC | 4117 | 1837 | -6797 |
GLA | 8430 | 10411 | -2771 |
GLB1 | 8581 | 10042 | -4137 |
GLIPR1 | 7623 | 4633 | 2385 |
GM2A | 8906 | 10650 | -78 |
GMFG | 8129 | 9300 | -5985 |
GNS | 9200 | 11194 | -1445 |
GOLGA7 | 4015 | 13 | 2077 |
GPI | 6198 | 7032 | -6824 |
GPR84 | 8980 | 10446 | -3871 |
GRN | 9150 | 10641 | -4496 |
GSDMD | 1942 | 368 | -5187 |
GSN | 8605 | 10374 | -6685 |
GSTP1 | 134 | -750 | -6981 |
GUSB | 7607 | 10966 | -6245 |
GYG1 | 8861 | 10677 | -6619 |
HBB | 8901 | 6625 | 214 |
HEBP2 | 8266 | 8439 | -4927 |
HEXB | 8631 | 7597 | -3321 |
HGSNAT | 1854 | -729 | -724 |
HK3 | 9225 | 11211 | -2877 |
HLA-A | -2510 | -5961 | -8529 |
HLA-B | 643 | -97 | -2281 |
HLA-C | 1010 | 2942 | -503 |
HLA-H | -3771 | -2724 | -8250 |
HMGB1 | -251 | -6674 | 2350 |
HMOX2 | -11464 | -8766 | -7843 |
HP | 9293 | 11099 | -798 |
HPSE | 8342 | 8707 | -212 |
HRNR | -7096 | -5064 | -5189 |
HSP90AA1 | 1316 | -3995 | 7175 |
HSP90AB1 | -6629 | -9144 | 1353 |
HSPA1A | 7946 | 9200 | -6997 |
HSPA1B | 6382 | 8681 | 4806 |
HSPA6 | 6426 | 9521 | -4661 |
HSPA8 | -10578 | -9101 | 3859 |
HUWE1 | -7700 | 1206 | -252 |
HVCN1 | 4856 | -247 | -2410 |
IDH1 | 9345 | 11201 | 6150 |
IGF2R | 7044 | 10313 | -7332 |
ILF2 | -1939 | -4357 | -2170 |
IMPDH1 | 9136 | 11090 | -5341 |
IMPDH2 | -9588 | -10097 | -8492 |
IQGAP1 | 8024 | 9867 | -3260 |
IQGAP2 | 6509 | 8319 | 3083 |
IST1 | 5786 | 8867 | 2323 |
ITGAL | -10503 | 3613 | -516 |
ITGAM | 9238 | 11057 | -8230 |
ITGAV | 6022 | 7746 | 1880 |
ITGAX | 7227 | 11021 | -1577 |
ITGB2 | 8792 | 10665 | -8561 |
JUP | -5176 | -2651 | 3631 |
KCMF1 | 7749 | 8286 | -2160 |
KCNAB2 | -101 | 6304 | -8462 |
KPNB1 | 2414 | 5550 | 9459 |
KRT1 | 4492 | -5241 | -8754 |
LAIR1 | 7078 | 11064 | -2790 |
LAMP1 | 7515 | 9556 | -8572 |
LAMP2 | 8640 | 8904 | 3715 |
LAMTOR1 | 9251 | 9126 | -8916 |
LAMTOR2 | 7454 | 7902 | -8721 |
LAMTOR3 | 7461 | 5332 | 7456 |
LCN2 | 7639 | 2282 | -3121 |
LGALS3 | 8608 | 9045 | -4982 |
LILRB2 | 7933 | 11217 | -890 |
LILRB3 | 8723 | 10252 | -7693 |
LPCAT1 | -7171 | 7598 | -4789 |
LRG1 | 8532 | 10590 | -5774 |
LRMP | 435 | 6120 | 10126 |
LRRC7 | -1927 | -336 | -2325 |
LTA4H | 9104 | 10358 | -1769 |
LTF | 6220 | -4442 | -4930 |
LYZ | 7107 | -1056 | -3630 |
MAGT1 | 2594 | 4301 | 5100 |
MAN2B1 | 6781 | 5710 | -7800 |
MANBA | 7276 | 7591 | 5365 |
MAPK1 | 7381 | 10983 | -1505 |
MAPK14 | 8951 | 10908 | -1066 |
MCEMP1 | 9342 | 11134 | -8949 |
METTL7A | 6820 | 6645 | 6104 |
MGAM | 8897 | 10750 | -4312 |
MGST1 | 9321 | 9683 | -822 |
MIF | -3748 | -7077 | -8030 |
MLEC | 2308 | 788 | -2323 |
MME | 909 | 688 | 2548 |
MMP25 | 8377 | 10851 | -120 |
MMP8 | 9075 | 8583 | -2470 |
MMP9 | 1677 | 10720 | -6355 |
MNDA | 9119 | 8766 | 5667 |
MOSPD2 | 8122 | 10733 | 11765 |
MPO | 7325 | -8236 | -7397 |
MS4A3 | 2347 | -6976 | 6053 |
MVP | 6950 | 8482 | -4741 |
NAPRT | 7301 | 9959 | 189 |
NBEAL2 | 6982 | 10552 | -3567 |
NCKAP1L | 7557 | 11091 | 1697 |
NCSTN | 9030 | 11232 | -1399 |
NDUFC2 | 6011 | 5883 | -7880 |
NEU1 | 8877 | 10875 | -617 |
NFAM1 | 8933 | 10694 | -5991 |
NFASC | 859 | 4318 | 7979 |
NFKB1 | 6191 | 2835 | -2693 |
NHLRC3 | 1266 | 4965 | 11735 |
NIT2 | -11340 | -9124 | 7526 |
NME2 | 1837 | -782 | -1310 |
NPC2 | 5393 | 3297 | 956 |
NRAS | 5302 | 4863 | 8490 |
OLFM4 | 8580 | 7541 | -4736 |
OLR1 | 2469 | -7594 | -895 |
ORM1 | 7849 | 2059 | -8909 |
ORM2 | -2501 | 560 | -2723 |
ORMDL3 | -9667 | -6157 | -853 |
OSCAR | 8915 | 11206 | 2637 |
OSTF1 | 7314 | 8222 | -2867 |
P2RX1 | 8303 | 11222 | 2987 |
PA2G4 | -3797 | -5231 | 2149 |
PADI2 | 9100 | 10075 | -7484 |
PAFAH1B2 | 6842 | 5935 | 2533 |
PDAP1 | 5831 | 8882 | -8627 |
PDXK | 8494 | 8151 | -6347 |
PECAM1 | 7735 | 10233 | 1119 |
PFKL | -3189 | -3493 | -7437 |
PGAM1 | 9274 | 10921 | -8026 |
PGLYRP1 | 7789 | 4866 | -6404 |
PGM1 | 5767 | 7151 | -7570 |
PGM2 | 9185 | 10200 | -3971 |
PGRMC1 | 7677 | -58 | -4759 |
PIGR | -484 | 6272 | 9900 |
PKM | 9231 | 10340 | -7599 |
PLAC8 | 8319 | 10913 | 3690 |
PLAU | 4847 | 3871 | -6314 |
PLAUR | 8292 | 10309 | -3513 |
PLD1 | 9148 | 10884 | 229 |
PLEKHO2 | 7935 | 10847 | -971 |
PNP | 8287 | 7938 | 3845 |
PPBP | 5961 | -1947 | -7603 |
PPIA | -6535 | -6473 | -6217 |
PPIE | -8695 | -6316 | 5179 |
PRCP | 8088 | 8399 | -2828 |
PRDX4 | -144 | -825 | 7123 |
PRDX6 | 8787 | 5038 | -7088 |
PRKCD | 8856 | 10959 | -3359 |
PRTN3 | 6667 | -9322 | -8765 |
PSAP | 7040 | 8768 | -2863 |
PSEN1 | 7839 | 10248 | 3387 |
PSMA2 | 5278 | -2806 | -1833 |
PSMA5 | -5853 | -7450 | 4304 |
PSMB1 | 3345 | -3591 | -5724 |
PSMB7 | 8350 | 8341 | -8652 |
PSMC2 | 2579 | 4502 | 3881 |
PSMC3 | 1963 | 907 | -7500 |
PSMD1 | 7134 | 8074 | 4202 |
PSMD11 | 6145 | 7675 | 7728 |
PSMD12 | 6467 | 6745 | 11721 |
PSMD13 | 5869 | 3731 | -6995 |
PSMD14 | 2592 | 932 | 4701 |
PSMD2 | 7300 | 8030 | -8672 |
PSMD3 | 4569 | 4259 | -8415 |
PSMD6 | 7726 | 7218 | -378 |
PSMD7 | 5884 | 2068 | 2622 |
PTAFR | 9195 | 10014 | -7596 |
PTGES2 | -6690 | -5442 | -6883 |
PTPN6 | 6014 | 10265 | -797 |
PTPRB | -7344 | -4300 | -5646 |
PTPRC | 2227 | 7917 | 8607 |
PTPRJ | 7666 | 10161 | -5457 |
PTPRN2 | 5122 | 4811 | -3114 |
PTX3 | 5722 | 1554 | 5507 |
PYCARD | 8497 | 10357 | -5026 |
PYGB | 486 | -412 | -6731 |
PYGL | 9257 | 10752 | -6451 |
QPCT | 9168 | 10510 | -4766 |
QSOX1 | 9140 | 11154 | -8086 |
RAB10 | 8776 | 10755 | 1116 |
RAB14 | 6991 | 5417 | 7340 |
RAB18 | 7683 | 6954 | 7861 |
RAB24 | 5293 | 9481 | 4480 |
RAB27A | 8279 | 9475 | 3475 |
RAB31 | 9196 | 10473 | 2382 |
RAB37 | -11438 | -1046 | 2472 |
RAB3A | 8006 | 6219 | -8039 |
RAB3D | 9051 | 10488 | -3922 |
RAB44 | 567 | -3404 | -1019 |
RAB4B | 3111 | 8330 | -6106 |
RAB5B | 6599 | 8142 | -4226 |
RAB5C | 8513 | 9699 | -8329 |
RAB6A | 8020 | 9791 | 6218 |
RAB7A | 8598 | 9942 | -5117 |
RAB9B | -6329 | -4156 | 4841 |
RAC1 | 8647 | 10438 | 3441 |
RAP1A | 7198 | 7246 | 9059 |
RAP1B | 3179 | 6882 | 6183 |
RAP2B | -765 | 3879 | -1790 |
RAP2C | 4551 | 7501 | 6549 |
RETN | 8848 | 10541 | -4059 |
RHOA | 8188 | 9259 | -372 |
RHOF | -11981 | -8651 | -3351 |
RHOG | 8352 | 10449 | -6499 |
RNASE2 | 9344 | 10982 | 1974 |
RNASE3 | 7359 | -367 | -3193 |
RNASET2 | 5844 | 7859 | -2853 |
ROCK1 | 7377 | 8572 | 9620 |
S100A11 | 8796 | 10711 | -1731 |
S100A12 | 9352 | 10996 | -7985 |
S100A8 | 9341 | 10975 | -5317 |
S100A9 | 9353 | 10428 | -7018 |
S100P | 8199 | 9751 | -6386 |
SCAMP1 | 1855 | -7288 | 5386 |
SDCBP | 9153 | 9780 | 406 |
SELL | 8762 | 9807 | 1921 |
SERPINA1 | 9013 | 11191 | 4539 |
SERPINB1 | 9273 | 10874 | -2564 |
SERPINB10 | 8783 | 5575 | 278 |
SERPINB6 | 5778 | 5230 | -8063 |
SIGLEC14 | 5028 | 5607 | -2429 |
SIGLEC5 | 8033 | 9099 | -2695 |
SIGLEC9 | 9223 | 11166 | -6231 |
SIRPA | 9348 | 11197 | -7771 |
SIRPB1 | 7723 | 7051 | -7813 |
SLC11A1 | 9014 | 11243 | -1476 |
SLC15A4 | 3690 | 10495 | 5525 |
SLC27A2 | -3718 | -6253 | 10610 |
SLC2A3 | 8869 | 10524 | -5904 |
SLC2A5 | 2031 | -6454 | 1585 |
SLC44A2 | 2678 | 5131 | -6555 |
SLCO4C1 | 3185 | 8367 | 5198 |
SLPI | 5237 | -3373 | 2979 |
SNAP23 | 8487 | 7435 | 3626 |
SNAP29 | 6302 | 9024 | -8052 |
SPTAN1 | -11074 | -9433 | -5265 |
SRP14 | 6234 | 4977 | 998 |
STBD1 | 5477 | 5608 | -1804 |
STING1 | 4736 | 93 | -6182 |
STK10 | -3780 | 8865 | -5028 |
STK11IP | 3554 | 8746 | -8134 |
STOM | 6613 | 7887 | 1218 |
SURF4 | 6954 | 8190 | -6777 |
SVIP | 2022 | -3033 | 4377 |
SYNGR1 | -4479 | 844 | -4339 |
TARM1 | 5246 | 3916 | 749 |
TBC1D10C | -11505 | -7582 | -7751 |
TCIRG1 | 7082 | 10931 | -5721 |
TCN1 | 6098 | -1695 | 692 |
TICAM2 | 6249 | 4224 | 8248 |
TIMP2 | 9297 | 11004 | -6123 |
TLR2 | 8950 | 10352 | 3541 |
TMBIM1 | 8229 | 10023 | -7768 |
TMC6 | -10267 | -6526 | -2845 |
TMEM179B | 443 | -1658 | -1392 |
TMEM30A | 7913 | 6946 | 4350 |
TMEM63A | -8824 | -7951 | 3518 |
TNFAIP6 | 8594 | 10371 | 2110 |
TNFRSF1B | 5964 | 9907 | -4810 |
TOLLIP | 8432 | 9528 | -8125 |
TOM1 | 9044 | 10410 | -8578 |
TRAPPC1 | 7688 | 8957 | -5965 |
TRPM2 | 8949 | 10927 | -7268 |
TSPAN14 | 6870 | 10567 | -3835 |
TUBB | -6718 | -1662 | -584 |
TUBB4B | 7133 | 8322 | -3933 |
TXNDC5 | 391 | -2127 | 9431 |
TYROBP | 7427 | 9484 | -6868 |
UBR4 | -2044 | 6523 | 1736 |
UNC13D | 7492 | 11054 | -5971 |
VAMP8 | 5157 | -137 | -8777 |
VAPA | 8881 | 9482 | 555 |
VAT1 | 9118 | 10769 | -8358 |
VCL | 7218 | 6129 | -4751 |
VCP | 6789 | 7704 | -7331 |
VNN1 | 8939 | 10798 | -327 |
VPS35L | 6034 | 9179 | 4071 |
XRCC5 | 5322 | 1817 | 1094 |
XRCC6 | -4326 | -8119 | -5161 |
YPEL5 | 6593 | 7201 | 3811 |
Major pathway of rRNA processing in the nucleolus and cytosol
metric | value |
---|---|
setSize | 180 |
pMANOVA | 2.04e-68 |
p.adjustMANOVA | 1.73e-66 |
s.dist | 0.808 |
s.t0_v_pod | -0.306 |
s.pod_crp | -0.637 |
s.t0_crp | -0.391 |
p.t0_v_pod | 1.3e-12 |
p.pod_crp | 1.75e-49 |
p.t0_crp | 1.36e-19 |
Gene | pod_crp | t0_crp |
---|---|---|
FBL | -9913 | -8826 |
RPL3 | -9928 | -8773 |
RPS2 | -9563 | -9021 |
RPS27A | -9695 | -8668 |
RPL14 | -9670 | -8650 |
RPLP2 | -9135 | -9001 |
RPS12 | -9242 | -8852 |
RPS3 | -9270 | -8726 |
RPLP0 | -9199 | -8702 |
RPS27 | -9147 | -8693 |
RPL10 | -9003 | -8829 |
RPL7 | -9737 | -8087 |
WDR46 | -9028 | -8694 |
RPS23 | -9359 | -8319 |
RPL27A | -9020 | -8573 |
RPS29 | -8609 | -8958 |
RPS6 | -9671 | -7892 |
RPL31 | -8741 | -8685 |
RPL30 | -8902 | -8504 |
RPL29 | -8593 | -8787 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
BMS1 | -11315 | -9598 | -1337 |
BOP1 | -5039 | -6568 | -8304 |
BYSL | -4316 | -4876 | -6332 |
C1D | 3484 | -321 | 11355 |
CSNK1D | 2374 | 8356 | -7947 |
CSNK1E | -9964 | -6501 | -4870 |
DCAF13 | -5386 | -7538 | -2062 |
DDX21 | 3087 | -1187 | 8531 |
DDX47 | -10949 | -9306 | 8082 |
DDX49 | 4816 | 4046 | -8272 |
DDX52 | 448 | 1780 | 12323 |
DHX37 | -7983 | -4720 | -3600 |
DIS3 | -4187 | -4119 | 11534 |
EBNA1BP2 | -3970 | -7889 | -588 |
EMG1 | -9856 | -8716 | 8730 |
ERI1 | 5474 | 6607 | 11232 |
EXOSC1 | -979 | -487 | 5176 |
EXOSC10 | -11028 | -6804 | 6476 |
EXOSC2 | -10724 | -9725 | -4656 |
EXOSC3 | 503 | -40 | 4327 |
EXOSC4 | 7485 | 9870 | -6235 |
EXOSC5 | -4428 | -8367 | -7087 |
EXOSC6 | -9514 | -7432 | -3150 |
EXOSC7 | -10290 | -8445 | -8729 |
EXOSC8 | -11104 | -9351 | 7169 |
EXOSC9 | -9917 | -8765 | 10776 |
FAU | -359 | -3599 | -8841 |
FBL | -9855 | -9913 | -8826 |
FCF1 | 4428 | 450 | 6199 |
FTSJ3 | -3900 | -1188 | -3676 |
GNL3 | -8199 | -9931 | 4303 |
HEATR1 | -10009 | -7253 | 5481 |
IMP3 | -9143 | -6887 | -5060 |
IMP4 | -10629 | -7130 | -5576 |
ISG20L2 | 3737 | 3123 | 6401 |
KRR1 | -8329 | -7693 | 8202 |
LAS1L | -11905 | -9651 | -4481 |
LTV1 | -4162 | -7094 | 5542 |
MPHOSPH10 | -7519 | -8812 | 11917 |
MPHOSPH6 | 2168 | -3175 | 1284 |
MTREX | -2574 | -4473 | 5717 |
NCL | -8953 | -9308 | -4346 |
NIP7 | -5682 | -7752 | 4552 |
NOB1 | -9986 | -8880 | -5059 |
NOC4L | -5298 | 1593 | 234 |
NOL11 | -10134 | -9903 | 8964 |
NOL12 | 4887 | 4239 | -4051 |
NOL6 | -10564 | -7807 | -3599 |
NOL9 | -9891 | -8758 | 9241 |
NOP14 | -10522 | -9613 | -4168 |
NOP56 | -11395 | -9416 | 246 |
NOP58 | -9623 | -10002 | 8617 |
PDCD11 | -11166 | -6522 | -2344 |
PELP1 | -10584 | -8205 | -1289 |
PES1 | -1993 | -7123 | -8715 |
PNO1 | -6627 | -7977 | 9345 |
PWP2 | -1190 | -5399 | -7041 |
RBM28 | -11316 | -5688 | 1861 |
RCL1 | -751 | -7663 | -1012 |
RIOK1 | -3702 | -4836 | 2397 |
RIOK2 | 927 | -8052 | 9706 |
RIOK3 | 8621 | 7003 | 9886 |
RPL10 | -6311 | -9003 | -8829 |
RPL10A | -6458 | -8900 | -6147 |
RPL11 | -6052 | -9089 | -6722 |
RPL12 | -6811 | -9149 | -8024 |
RPL13 | -3335 | -7644 | -6367 |
RPL13A | -7928 | -9374 | -6207 |
RPL14 | -6480 | -9670 | -8650 |
RPL15 | -953 | -8142 | -8235 |
RPL17 | -5249 | -9088 | -8079 |
RPL18 | -4911 | -8835 | -8406 |
RPL18A | -5869 | -8868 | -8439 |
RPL19 | -6071 | -8311 | -8149 |
RPL21 | -6241 | -9483 | -7230 |
RPL22 | -4587 | -9631 | -7480 |
RPL22L1 | -1593 | -8175 | 527 |
RPL23 | -3223 | -8346 | -7486 |
RPL23A | -9248 | -9950 | -4950 |
RPL24 | -5606 | -8873 | -7028 |
RPL26 | -6387 | -8678 | -8038 |
RPL26L1 | 7070 | 5940 | -5499 |
RPL27 | -2783 | -7783 | -8809 |
RPL27A | -6048 | -9020 | -8573 |
RPL28 | -1441 | -3852 | -5654 |
RPL29 | -3505 | -8593 | -8787 |
RPL3 | -8268 | -9928 | -8773 |
RPL30 | -6779 | -8902 | -8504 |
RPL31 | -4394 | -8741 | -8685 |
RPL32 | -6479 | -9317 | -7991 |
RPL34 | -6569 | -9464 | -6337 |
RPL35 | -7809 | -8156 | -7893 |
RPL35A | -5816 | -9263 | -7997 |
RPL36 | -5111 | -7467 | -8861 |
RPL36A | -7122 | -8881 | -8095 |
RPL36AL | 32 | -6621 | -8799 |
RPL37 | -6160 | -7834 | -9017 |
RPL37A | -3826 | -6808 | -8683 |
RPL38 | -5646 | -7941 | -8932 |
RPL39 | -2931 | -8607 | -8362 |
RPL39L | -8506 | -1648 | -4731 |
RPL3L | 4458 | 5102 | 10556 |
RPL4 | -3476 | -9521 | -7062 |
RPL41 | -6632 | -7535 | -8456 |
RPL5 | -4576 | -9853 | -7157 |
RPL6 | -3262 | -9281 | -3434 |
RPL7 | -1917 | -9737 | -8087 |
RPL7A | -3557 | -8259 | -8751 |
RPL8 | -1171 | -6076 | -8899 |
RPL9 | -1837 | -6796 | -4391 |
RPLP0 | -987 | -9199 | -8702 |
RPLP1 | 19 | -5994 | -8833 |
RPLP2 | -6844 | -9135 | -9001 |
RPP14 | 2981 | -2190 | 7808 |
RPP21 | -5178 | -4239 | -7477 |
RPP25 | -7963 | -8660 | -2890 |
RPP30 | -7818 | -8612 | 8067 |
RPP38 | -6833 | -7656 | 6479 |
RPP40 | -4680 | -10040 | 3381 |
RPS10 | -5601 | -8466 | -8823 |
RPS11 | -6992 | -7948 | -8743 |
RPS12 | -5788 | -9242 | -8852 |
RPS13 | -1717 | -8696 | -7869 |
RPS14 | -5278 | -8513 | -8637 |
RPS15 | -3565 | -6678 | -8273 |
RPS15A | -5550 | -8855 | -8431 |
RPS16 | -4518 | -8551 | -8704 |
RPS17 | -6038 | -8254 | -8928 |
RPS18 | -7474 | -8294 | -7671 |
RPS19 | -6725 | -7779 | -8460 |
RPS2 | -4354 | -9563 | -9021 |
RPS20 | -8585 | -9385 | -6156 |
RPS21 | -3952 | -8303 | -8855 |
RPS23 | -6081 | -9359 | -8319 |
RPS24 | -261 | -6793 | -4573 |
RPS25 | -6151 | -9636 | -7764 |
RPS26 | -1410 | -1143 | -462 |
RPS27 | -9432 | -9147 | -8693 |
RPS27A | -6700 | -9695 | -8668 |
RPS27L | 2048 | -490 | 9654 |
RPS28 | -4562 | -8056 | -8562 |
RPS29 | -7664 | -8609 | -8958 |
RPS3 | -5717 | -9270 | -8726 |
RPS3A | -4543 | -9806 | -4045 |
RPS4X | -6075 | -8620 | -4665 |
RPS4Y1 | 418 | 329 | 1713 |
RPS5 | -5502 | -9014 | -8342 |
RPS6 | -5956 | -9671 | -7892 |
RPS7 | -4803 | -9137 | -7874 |
RPS8 | -2041 | -8833 | -6710 |
RPS9 | 5358 | 1826 | -8433 |
RPSA | -6110 | -6604 | 3504 |
RRP1 | -3003 | -3032 | 2020 |
RRP36 | -1645 | -390 | -5014 |
RRP7A | -2734 | -5222 | -4553 |
RRP9 | -9748 | -8570 | -7939 |
SENP3 | 2970 | 77 | -3111 |
SNORD3A | -2477 | 10412 | 10967 |
SNU13 | -6637 | -8467 | -6973 |
TBL3 | -3341 | 732 | -6317 |
TEX10 | -9440 | -8887 | 11517 |
TSR1 | -9409 | -9696 | 4264 |
UBA52 | 1112 | -3471 | -8207 |
UTP11 | 4582 | -37 | 6683 |
UTP14A | -1788 | -3304 | 3687 |
UTP14C | -2032 | -2400 | 5261 |
UTP15 | -10264 | -9128 | 11648 |
UTP18 | 5055 | 3815 | 4880 |
UTP20 | -10191 | -7402 | 9700 |
UTP3 | -2829 | -4799 | -4079 |
UTP4 | -11142 | -9672 | 3675 |
UTP6 | -4362 | -8588 | 8987 |
WDR12 | 5156 | -723 | 7083 |
WDR18 | -2260 | -3796 | -3450 |
WDR3 | -6394 | -6991 | 570 |
WDR36 | -3825 | -5050 | 5877 |
WDR43 | -7419 | -9367 | 167 |
WDR46 | -10623 | -9028 | -8694 |
WDR75 | -9593 | -9795 | 7835 |
XRN2 | 9240 | 10090 | -4182 |
rRNA processing in the nucleus and cytosol
metric | value |
---|---|
setSize | 190 |
pMANOVA | 2.79e-71 |
p.adjustMANOVA | 3.17e-69 |
s.dist | 0.806 |
s.t0_v_pod | -0.307 |
s.pod_crp | -0.633 |
s.t0_crp | -0.393 |
p.t0_v_pod | 2.77e-13 |
p.pod_crp | 2.17e-51 |
p.t0_crp | 9.47e-21 |
Gene | pod_crp | t0_crp |
---|---|---|
FBL | -9913 | -8826 |
RPL3 | -9928 | -8773 |
RPS2 | -9563 | -9021 |
RPS27A | -9695 | -8668 |
RPL14 | -9670 | -8650 |
RPLP2 | -9135 | -9001 |
RPS12 | -9242 | -8852 |
RPS3 | -9270 | -8726 |
RPLP0 | -9199 | -8702 |
RPS27 | -9147 | -8693 |
RPL10 | -9003 | -8829 |
RPL7 | -9737 | -8087 |
WDR46 | -9028 | -8694 |
RPS23 | -9359 | -8319 |
RPL27A | -9020 | -8573 |
RPS29 | -8609 | -8958 |
RPS6 | -9671 | -7892 |
RPL31 | -8741 | -8685 |
RPL30 | -8902 | -8504 |
RPL29 | -8593 | -8787 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
BMS1 | -11315 | -9598 | -1337 |
BOP1 | -5039 | -6568 | -8304 |
BYSL | -4316 | -4876 | -6332 |
C1D | 3484 | -321 | 11355 |
CSNK1D | 2374 | 8356 | -7947 |
CSNK1E | -9964 | -6501 | -4870 |
DCAF13 | -5386 | -7538 | -2062 |
DDX21 | 3087 | -1187 | 8531 |
DDX47 | -10949 | -9306 | 8082 |
DDX49 | 4816 | 4046 | -8272 |
DDX52 | 448 | 1780 | 12323 |
DHX37 | -7983 | -4720 | -3600 |
DIMT1 | -7711 | -9624 | 8995 |
DIS3 | -4187 | -4119 | 11534 |
DKC1 | -11282 | -10110 | -3751 |
EBNA1BP2 | -3970 | -7889 | -588 |
EMG1 | -9856 | -8716 | 8730 |
ERI1 | 5474 | 6607 | 11232 |
EXOSC1 | -979 | -487 | 5176 |
EXOSC10 | -11028 | -6804 | 6476 |
EXOSC2 | -10724 | -9725 | -4656 |
EXOSC3 | 503 | -40 | 4327 |
EXOSC4 | 7485 | 9870 | -6235 |
EXOSC5 | -4428 | -8367 | -7087 |
EXOSC6 | -9514 | -7432 | -3150 |
EXOSC7 | -10290 | -8445 | -8729 |
EXOSC8 | -11104 | -9351 | 7169 |
EXOSC9 | -9917 | -8765 | 10776 |
FAU | -359 | -3599 | -8841 |
FBL | -9855 | -9913 | -8826 |
FCF1 | 4428 | 450 | 6199 |
FTSJ3 | -3900 | -1188 | -3676 |
GAR1 | -6703 | -7382 | 238 |
GNL3 | -8199 | -9931 | 4303 |
HEATR1 | -10009 | -7253 | 5481 |
IMP3 | -9143 | -6887 | -5060 |
IMP4 | -10629 | -7130 | -5576 |
ISG20L2 | 3737 | 3123 | 6401 |
KRR1 | -8329 | -7693 | 8202 |
LAS1L | -11905 | -9651 | -4481 |
LTV1 | -4162 | -7094 | 5542 |
MPHOSPH10 | -7519 | -8812 | 11917 |
MPHOSPH6 | 2168 | -3175 | 1284 |
MTREX | -2574 | -4473 | 5717 |
NAT10 | -11593 | -9800 | -2380 |
NCL | -8953 | -9308 | -4346 |
NHP2 | -3373 | -6510 | -7363 |
NIP7 | -5682 | -7752 | 4552 |
NOB1 | -9986 | -8880 | -5059 |
NOC4L | -5298 | 1593 | 234 |
NOL11 | -10134 | -9903 | 8964 |
NOL12 | 4887 | 4239 | -4051 |
NOL6 | -10564 | -7807 | -3599 |
NOL9 | -9891 | -8758 | 9241 |
NOP10 | 8200 | 10199 | -7289 |
NOP14 | -10522 | -9613 | -4168 |
NOP2 | -9624 | -8280 | -6603 |
NOP56 | -11395 | -9416 | 246 |
NOP58 | -9623 | -10002 | 8617 |
PDCD11 | -11166 | -6522 | -2344 |
PELP1 | -10584 | -8205 | -1289 |
PES1 | -1993 | -7123 | -8715 |
PNO1 | -6627 | -7977 | 9345 |
PWP2 | -1190 | -5399 | -7041 |
RBM28 | -11316 | -5688 | 1861 |
RCL1 | -751 | -7663 | -1012 |
RIOK1 | -3702 | -4836 | 2397 |
RIOK2 | 927 | -8052 | 9706 |
RIOK3 | 8621 | 7003 | 9886 |
RPL10 | -6311 | -9003 | -8829 |
RPL10A | -6458 | -8900 | -6147 |
RPL11 | -6052 | -9089 | -6722 |
RPL12 | -6811 | -9149 | -8024 |
RPL13 | -3335 | -7644 | -6367 |
RPL13A | -7928 | -9374 | -6207 |
RPL14 | -6480 | -9670 | -8650 |
RPL15 | -953 | -8142 | -8235 |
RPL17 | -5249 | -9088 | -8079 |
RPL18 | -4911 | -8835 | -8406 |
RPL18A | -5869 | -8868 | -8439 |
RPL19 | -6071 | -8311 | -8149 |
RPL21 | -6241 | -9483 | -7230 |
RPL22 | -4587 | -9631 | -7480 |
RPL22L1 | -1593 | -8175 | 527 |
RPL23 | -3223 | -8346 | -7486 |
RPL23A | -9248 | -9950 | -4950 |
RPL24 | -5606 | -8873 | -7028 |
RPL26 | -6387 | -8678 | -8038 |
RPL26L1 | 7070 | 5940 | -5499 |
RPL27 | -2783 | -7783 | -8809 |
RPL27A | -6048 | -9020 | -8573 |
RPL28 | -1441 | -3852 | -5654 |
RPL29 | -3505 | -8593 | -8787 |
RPL3 | -8268 | -9928 | -8773 |
RPL30 | -6779 | -8902 | -8504 |
RPL31 | -4394 | -8741 | -8685 |
RPL32 | -6479 | -9317 | -7991 |
RPL34 | -6569 | -9464 | -6337 |
RPL35 | -7809 | -8156 | -7893 |
RPL35A | -5816 | -9263 | -7997 |
RPL36 | -5111 | -7467 | -8861 |
RPL36A | -7122 | -8881 | -8095 |
RPL36AL | 32 | -6621 | -8799 |
RPL37 | -6160 | -7834 | -9017 |
RPL37A | -3826 | -6808 | -8683 |
RPL38 | -5646 | -7941 | -8932 |
RPL39 | -2931 | -8607 | -8362 |
RPL39L | -8506 | -1648 | -4731 |
RPL3L | 4458 | 5102 | 10556 |
RPL4 | -3476 | -9521 | -7062 |
RPL41 | -6632 | -7535 | -8456 |
RPL5 | -4576 | -9853 | -7157 |
RPL6 | -3262 | -9281 | -3434 |
RPL7 | -1917 | -9737 | -8087 |
RPL7A | -3557 | -8259 | -8751 |
RPL8 | -1171 | -6076 | -8899 |
RPL9 | -1837 | -6796 | -4391 |
RPLP0 | -987 | -9199 | -8702 |
RPLP1 | 19 | -5994 | -8833 |
RPLP2 | -6844 | -9135 | -9001 |
RPP14 | 2981 | -2190 | 7808 |
RPP21 | -5178 | -4239 | -7477 |
RPP25 | -7963 | -8660 | -2890 |
RPP30 | -7818 | -8612 | 8067 |
RPP38 | -6833 | -7656 | 6479 |
RPP40 | -4680 | -10040 | 3381 |
RPS10 | -5601 | -8466 | -8823 |
RPS11 | -6992 | -7948 | -8743 |
RPS12 | -5788 | -9242 | -8852 |
RPS13 | -1717 | -8696 | -7869 |
RPS14 | -5278 | -8513 | -8637 |
RPS15 | -3565 | -6678 | -8273 |
RPS15A | -5550 | -8855 | -8431 |
RPS16 | -4518 | -8551 | -8704 |
RPS17 | -6038 | -8254 | -8928 |
RPS18 | -7474 | -8294 | -7671 |
RPS19 | -6725 | -7779 | -8460 |
RPS2 | -4354 | -9563 | -9021 |
RPS20 | -8585 | -9385 | -6156 |
RPS21 | -3952 | -8303 | -8855 |
RPS23 | -6081 | -9359 | -8319 |
RPS24 | -261 | -6793 | -4573 |
RPS25 | -6151 | -9636 | -7764 |
RPS26 | -1410 | -1143 | -462 |
RPS27 | -9432 | -9147 | -8693 |
RPS27A | -6700 | -9695 | -8668 |
RPS27L | 2048 | -490 | 9654 |
RPS28 | -4562 | -8056 | -8562 |
RPS29 | -7664 | -8609 | -8958 |
RPS3 | -5717 | -9270 | -8726 |
RPS3A | -4543 | -9806 | -4045 |
RPS4X | -6075 | -8620 | -4665 |
RPS4Y1 | 418 | 329 | 1713 |
RPS5 | -5502 | -9014 | -8342 |
RPS6 | -5956 | -9671 | -7892 |
RPS7 | -4803 | -9137 | -7874 |
RPS8 | -2041 | -8833 | -6710 |
RPS9 | 5358 | 1826 | -8433 |
RPSA | -6110 | -6604 | 3504 |
RRP1 | -3003 | -3032 | 2020 |
RRP36 | -1645 | -390 | -5014 |
RRP7A | -2734 | -5222 | -4553 |
RRP9 | -9748 | -8570 | -7939 |
SENP3 | 2970 | 77 | -3111 |
SNORD3A | -2477 | 10412 | 10967 |
SNU13 | -6637 | -8467 | -6973 |
TBL3 | -3341 | 732 | -6317 |
TEX10 | -9440 | -8887 | 11517 |
THUMPD1 | -9477 | -9754 | 7788 |
TRMT112 | 732 | -2281 | -8647 |
TSR1 | -9409 | -9696 | 4264 |
TSR3 | 3808 | 1485 | -8865 |
UBA52 | 1112 | -3471 | -8207 |
UTP11 | 4582 | -37 | 6683 |
UTP14A | -1788 | -3304 | 3687 |
UTP14C | -2032 | -2400 | 5261 |
UTP15 | -10264 | -9128 | 11648 |
UTP18 | 5055 | 3815 | 4880 |
UTP20 | -10191 | -7402 | 9700 |
UTP3 | -2829 | -4799 | -4079 |
UTP4 | -11142 | -9672 | 3675 |
UTP6 | -4362 | -8588 | 8987 |
WDR12 | 5156 | -723 | 7083 |
WDR18 | -2260 | -3796 | -3450 |
WDR3 | -6394 | -6991 | 570 |
WDR36 | -3825 | -5050 | 5877 |
WDR43 | -7419 | -9367 | 167 |
WDR46 | -10623 | -9028 | -8694 |
WDR75 | -9593 | -9795 | 7835 |
XRN2 | 9240 | 10090 | -4182 |
Platelet sensitization by LDL
metric | value |
---|---|
setSize | 16 |
pMANOVA | 0.000633 |
p.adjustMANOVA | 0.002 |
s.dist | 0.798 |
s.t0_v_pod | 0.552 |
s.pod_crp | 0.566 |
s.t0_crp | -0.107 |
p.t0_v_pod | 0.000131 |
p.pod_crp | 8.9e-05 |
p.t0_crp | 0.458 |
Gene | pod_crp | t0_v_pod |
---|---|---|
MAPK14 | 10908 | 8951 |
FGR | 11109 | 8344 |
PLA2G4A | 9642 | 9025 |
PECAM1 | 10233 | 7735 |
PPP2R5B | 9746 | 6679 |
PTPN6 | 10265 | 6014 |
PPP2R5A | 9666 | 5821 |
PPP2CB | 7359 | 7596 |
PPP2CA | 6731 | 8104 |
LRP8 | 9495 | 4522 |
PTPN11 | 6456 | 5253 |
PPP2R1A | 5140 | 4542 |
PPP2R5D | 6530 | 2405 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
FGR | 8344 | 11109 | -5786 |
LRP8 | 4522 | 9495 | -1527 |
MAPK14 | 8951 | 10908 | -1066 |
PECAM1 | 7735 | 10233 | 1119 |
PLA2G4A | 9025 | 9642 | -1028 |
PPP2CA | 8104 | 6731 | -306 |
PPP2CB | 7596 | 7359 | 4715 |
PPP2R1A | 4542 | 5140 | -7934 |
PPP2R1B | -241 | 88 | 5847 |
PPP2R5A | 5821 | 9666 | 6005 |
PPP2R5B | 6679 | 9746 | 773 |
PPP2R5C | -10916 | -5174 | 3373 |
PPP2R5D | 2405 | 6530 | -1893 |
PPP2R5E | -675 | -2578 | 5737 |
PTPN11 | 5253 | 6456 | 949 |
PTPN6 | 6014 | 10265 | -797 |
p130Cas linkage to MAPK signaling for integrins
metric | value |
---|---|
setSize | 11 |
pMANOVA | 0.000997 |
p.adjustMANOVA | 0.00296 |
s.dist | 0.798 |
s.t0_v_pod | 0.666 |
s.pod_crp | 0.382 |
s.t0_crp | -0.218 |
p.t0_v_pod | 0.000132 |
p.pod_crp | 0.0282 |
p.t0_crp | 0.211 |
Gene | t0_v_pod | pod_crp |
---|---|---|
APBB1IP | 8600 | 10436 |
CRK | 8756 | 10207 |
TLN1 | 8386 | 10017 |
ITGA2B | 8744 | 7297 |
RAP1A | 7198 | 7246 |
VWF | 6550 | 3834 |
ITGB3 | 8161 | 2918 |
RAP1B | 3179 | 6882 |
PTK2 | 4418 | 385 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
APBB1IP | 8600 | 10436 | -610 |
CRK | 8756 | 10207 | 5223 |
FN1 | 8154 | -1816 | 4140 |
ITGA2B | 8744 | 7297 | -5705 |
ITGB3 | 8161 | 2918 | -7520 |
PTK2 | 4418 | 385 | -619 |
RAP1A | 7198 | 7246 | 9059 |
RAP1B | 3179 | 6882 | 6183 |
SRC | -8520 | -6371 | -3347 |
TLN1 | 8386 | 10017 | -6948 |
VWF | 6550 | 3834 | -7272 |
NOTCH4 Activation and Transmission of Signal to the Nucleus
metric | value |
---|---|
setSize | 10 |
pMANOVA | 0.0112 |
p.adjustMANOVA | 0.0233 |
s.dist | 0.797 |
s.t0_v_pod | 0.528 |
s.pod_crp | 0.577 |
s.t0_crp | -0.155 |
p.t0_v_pod | 0.00386 |
p.pod_crp | 0.00158 |
p.t0_crp | 0.395 |
Gene | pod_crp | t0_v_pod |
---|---|---|
NCSTN | 11232 | 9030 |
ADAM10 | 9824 | 8645 |
PSEN1 | 10248 | 7839 |
JAG1 | 8125 | 8599 |
APH1B | 9329 | 6194 |
PSENEN | 7006 | 5662 |
YWHAZ | 5153 | 5555 |
APH1A | 2543 | 4092 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ADAM10 | 8645 | 9824 | 976 |
APH1A | 4092 | 2543 | -8533 |
APH1B | 6194 | 9329 | 7523 |
JAG1 | 8599 | 8125 | -6709 |
NCSTN | 9030 | 11232 | -1399 |
NOTCH4 | -5056 | 10115 | 2220 |
PSEN1 | 7839 | 10248 | 3387 |
PSEN2 | -7449 | -6368 | -96 |
PSENEN | 5662 | 7006 | -3411 |
YWHAZ | 5555 | 5153 | 6004 |
Hyaluronan metabolism
metric | value |
---|---|
setSize | 13 |
pMANOVA | 0.00112 |
p.adjustMANOVA | 0.00326 |
s.dist | 0.795 |
s.t0_v_pod | 0.513 |
s.pod_crp | 0.429 |
s.t0_crp | -0.43 |
p.t0_v_pod | 0.00137 |
p.pod_crp | 0.00741 |
p.t0_crp | 0.00732 |
Gene | t0_v_pod | t0_crp |
---|---|---|
HYAL2 | 8935 | -8015 |
CHP1 | 9101 | -5812 |
CD44 | 8201 | -5995 |
GUSB | 7607 | -6245 |
SLC9A1 | 7847 | -5759 |
HEXB | 8631 | -3321 |
HYAL3 | 5168 | -3394 |
ABCC5 | 2460 | -6111 |
HEXA | 1251 | -6759 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ABCC5 | 2460 | 1575 | -6111 |
CD44 | 8201 | 9117 | -5995 |
CEMIP | -7161 | -5011 | 2494 |
CHP1 | 9101 | 9868 | -5812 |
GUSB | 7607 | 10966 | -6245 |
HAS3 | -5989 | 3310 | -750 |
HEXA | 1251 | -1954 | -6759 |
HEXB | 8631 | 7597 | -3321 |
HMMR | 3770 | 1842 | 1914 |
HYAL1 | 4123 | 8255 | 9608 |
HYAL2 | 8935 | 11003 | -8015 |
HYAL3 | 5168 | -884 | -3394 |
SLC9A1 | 7847 | 11135 | -5759 |
Detoxification of Reactive Oxygen Species
metric | value |
---|---|
setSize | 32 |
pMANOVA | 3.13e-08 |
p.adjustMANOVA | 3.27e-07 |
s.dist | 0.792 |
s.t0_v_pod | 0.561 |
s.pod_crp | 0.436 |
s.t0_crp | -0.35 |
p.t0_v_pod | 3.93e-08 |
p.pod_crp | 1.93e-05 |
p.t0_crp | 0.000609 |
Gene | t0_v_pod | pod_crp |
---|---|---|
GSR | 9078 | 10845 |
NCF4 | 9111 | 10617 |
NCF2 | 9034 | 10598 |
PRDX3 | 9206 | 10292 |
CAT | 8970 | 9931 |
CYBB | 8879 | 9506 |
P4HB | 8307 | 9921 |
ERO1A | 8793 | 9302 |
TXNRD1 | 8062 | 9724 |
PRDX5 | 8392 | 9127 |
TXN | 8155 | 9128 |
CYBA | 6822 | 9999 |
GPX1 | 9156 | 6881 |
NCF1 | 7224 | 7158 |
TXNRD2 | 7414 | 6361 |
PRDX6 | 8787 | 5038 |
SOD2 | 4346 | 7197 |
ATOX1 | 4294 | 6444 |
PRDX1 | 6927 | 3767 |
TXN2 | 4601 | 2594 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ATOX1 | 4294 | 6444 | -6057 |
ATP7A | 688 | 5910 | 1701 |
CAT | 8970 | 9931 | -691 |
CCS | 1525 | -1637 | -7219 |
CYBA | 6822 | 9999 | -7207 |
CYBB | 8879 | 9506 | 1575 |
CYCS | -1315 | -4434 | 5135 |
ERO1A | 8793 | 9302 | 9176 |
GPX1 | 9156 | 6881 | -8782 |
GPX2 | -3430 | 3337 | 8521 |
GPX3 | 674 | 9456 | -2777 |
GPX7 | -8599 | -8935 | -5711 |
GSR | 9078 | 10845 | -6395 |
GSTP1 | 134 | -750 | -6981 |
NCF1 | 7224 | 7158 | -2796 |
NCF2 | 9034 | 10598 | -2149 |
NCF4 | 9111 | 10617 | -6708 |
NOX4 | 1105 | 5673 | 9217 |
NOX5 | 1165 | 5152 | 10464 |
NUDT2 | 2964 | 70 | -5706 |
P4HB | 8307 | 9921 | -7996 |
PRDX1 | 6927 | 3767 | 3340 |
PRDX2 | 3398 | -4018 | -5960 |
PRDX3 | 9206 | 10292 | 2736 |
PRDX5 | 8392 | 9127 | -8941 |
PRDX6 | 8787 | 5038 | -7088 |
SOD1 | -4704 | -7395 | -4250 |
SOD2 | 4346 | 7197 | 3619 |
TXN | 8155 | 9128 | -994 |
TXN2 | 4601 | 2594 | -8158 |
TXNRD1 | 8062 | 9724 | -2030 |
TXNRD2 | 7414 | 6361 | -7504 |
Insulin receptor recycling
metric | value |
---|---|
setSize | 21 |
pMANOVA | 1.06e-05 |
p.adjustMANOVA | 5.76e-05 |
s.dist | 0.79 |
s.t0_v_pod | 0.568 |
s.pod_crp | 0.404 |
s.t0_crp | -0.371 |
p.t0_v_pod | 6.47e-06 |
p.pod_crp | 0.00134 |
p.t0_crp | 0.00326 |
Gene | t0_v_pod | pod_crp |
---|---|---|
ATP6V0A1 | 9262 | 11071 |
ATP6V0D1 | 9088 | 10812 |
ATP6V0C | 8974 | 10793 |
ATP6AP1 | 8032 | 11126 |
ATP6V1D | 8894 | 9815 |
ATP6V1A | 9144 | 9387 |
ATP6V1B2 | 8904 | 9293 |
ATP6V1C1 | 8400 | 9733 |
ATP6V0B | 8458 | 9622 |
TCIRG1 | 7082 | 10931 |
INSR | 8152 | 9251 |
ATP6V0E1 | 8456 | 8299 |
ATP6V1E1 | 7912 | 8087 |
ATP6V1H | 7939 | 7019 |
ATP6V1F | 5802 | 3776 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ATP6AP1 | 8032 | 11126 | -8542 |
ATP6V0A1 | 9262 | 11071 | -4129 |
ATP6V0A2 | -11850 | -6562 | 10591 |
ATP6V0B | 8458 | 9622 | -7822 |
ATP6V0C | 8974 | 10793 | -5635 |
ATP6V0D1 | 9088 | 10812 | -6200 |
ATP6V0E1 | 8456 | 8299 | -6597 |
ATP6V0E2 | -11202 | -9428 | 81 |
ATP6V1A | 9144 | 9387 | 639 |
ATP6V1B2 | 8904 | 9293 | -2076 |
ATP6V1C1 | 8400 | 9733 | 1842 |
ATP6V1C2 | -2175 | -2908 | 1018 |
ATP6V1D | 8894 | 9815 | 2539 |
ATP6V1E1 | 7912 | 8087 | 1529 |
ATP6V1E2 | 5657 | -3873 | -6954 |
ATP6V1F | 5802 | 3776 | -8689 |
ATP6V1G1 | 3892 | -4753 | -2897 |
ATP6V1G2 | -9197 | -9115 | 3143 |
ATP6V1H | 7939 | 7019 | -2464 |
INSR | 8152 | 9251 | -2060 |
TCIRG1 | 7082 | 10931 | -5721 |
Activation of the pre-replicative complex
metric | value |
---|---|
setSize | 32 |
pMANOVA | 6.26e-08 |
p.adjustMANOVA | 6.35e-07 |
s.dist | 0.779 |
s.t0_v_pod | -0.482 |
s.pod_crp | -0.604 |
s.t0_crp | 0.105 |
p.t0_v_pod | 2.37e-06 |
p.pod_crp | 3.4e-09 |
p.t0_crp | 0.304 |
Gene | pod_crp | t0_v_pod |
---|---|---|
MCM3 | -9914 | -11839 |
POLA1 | -9813 | -11789 |
RPA1 | -9771 | -11644 |
MCM7 | -9297 | -11768 |
POLE3 | -9259 | -11228 |
DBF4 | -8879 | -10581 |
PRIM1 | -9138 | -9858 |
POLA2 | -7923 | -11222 |
ORC3 | -7862 | -10371 |
MCM6 | -8603 | -9393 |
RPA3 | -9192 | -8609 |
ORC2 | -8229 | -9594 |
ORC5 | -8511 | -9161 |
POLE2 | -7736 | -9613 |
MCM8 | -5689 | -10599 |
MCM4 | -7061 | -8404 |
MCM2 | -6855 | -6973 |
PRIM2 | -7087 | -5389 |
CDC7 | -4471 | -7583 |
POLE | -4060 | -7317 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CDC45 | -2594 | -5110 | 1889 |
CDC6 | 2356 | -1584 | 3684 |
CDC7 | -7583 | -4471 | -125 |
CDK2 | -4840 | -3595 | 835 |
CDT1 | -285 | -3417 | -3854 |
DBF4 | -10581 | -8879 | 10352 |
GMNN | 1412 | 2147 | 7406 |
MCM10 | 769 | -4565 | 4390 |
MCM2 | -6973 | -6855 | -3428 |
MCM3 | -11839 | -9914 | -2392 |
MCM4 | -8404 | -7061 | 3202 |
MCM5 | -7039 | -2312 | -5776 |
MCM6 | -9393 | -8603 | 109 |
MCM7 | -11768 | -9297 | -1374 |
MCM8 | -10599 | -5689 | 7587 |
ORC1 | -2459 | -2954 | 1035 |
ORC2 | -9594 | -8229 | 7471 |
ORC3 | -10371 | -7862 | 10286 |
ORC4 | -1988 | -6242 | 8361 |
ORC5 | -9161 | -8511 | 9855 |
ORC6 | 1174 | 5286 | 4883 |
POLA1 | -11789 | -9813 | 1029 |
POLA2 | -11222 | -7923 | 8950 |
POLE | -7317 | -4060 | 2599 |
POLE2 | -9613 | -7736 | 11428 |
POLE3 | -11228 | -9259 | -7832 |
POLE4 | 5453 | -1843 | -7470 |
PRIM1 | -9858 | -9138 | 10019 |
PRIM2 | -5389 | -7087 | 2832 |
RPA1 | -11644 | -9771 | -3472 |
RPA2 | -6094 | -4789 | 4026 |
RPA3 | -8609 | -9192 | 2284 |
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
metric | value |
---|---|
setSize | 13 |
pMANOVA | 0.00427 |
p.adjustMANOVA | 0.0102 |
s.dist | 0.776 |
s.t0_v_pod | 0.555 |
s.pod_crp | 0.535 |
s.t0_crp | -0.0839 |
p.t0_v_pod | 0.000528 |
p.pod_crp | 0.000832 |
p.t0_crp | 0.601 |
Gene | t0_v_pod | pod_crp |
---|---|---|
RAC1 | 8647 | 10438 |
CRK | 8756 | 10207 |
RHOA | 8188 | 9259 |
PXN | 6144 | 9961 |
DOCK1 | 7206 | 7497 |
PTK6 | 5877 | 9124 |
ELMO2 | 4353 | 10016 |
ELMO1 | 6172 | 5403 |
NRAS | 5302 | 4863 |
KRAS | 3668 | 6068 |
RASA1 | 2093 | 6185 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ARHGAP35 | -3266 | -2187 | -6810 |
CRK | 8756 | 10207 | 5223 |
DOCK1 | 7206 | 7497 | -6177 |
ELMO1 | 6172 | 5403 | -5996 |
ELMO2 | 4353 | 10016 | 2305 |
HRAS | -3288 | -5249 | -5447 |
KRAS | 3668 | 6068 | 10842 |
NRAS | 5302 | 4863 | 8490 |
PTK6 | 5877 | 9124 | 607 |
PXN | 6144 | 9961 | -7143 |
RAC1 | 8647 | 10438 | 3441 |
RASA1 | 2093 | 6185 | 10904 |
RHOA | 8188 | 9259 | -372 |
ROS and RNS production in phagocytes
metric | value |
---|---|
setSize | 31 |
pMANOVA | 1.4e-08 |
p.adjustMANOVA | 1.54e-07 |
s.dist | 0.775 |
s.t0_v_pod | 0.597 |
s.pod_crp | 0.371 |
s.t0_crp | -0.324 |
p.t0_v_pod | 8.47e-09 |
p.pod_crp | 0.000346 |
p.t0_crp | 0.00177 |
Gene | t0_v_pod | pod_crp |
---|---|---|
ATP6V0A1 | 9262 | 11071 |
SLC11A1 | 9014 | 11243 |
ATP6V0D1 | 9088 | 10812 |
ATP6V0C | 8974 | 10793 |
NCF4 | 9111 | 10617 |
NCF2 | 9034 | 10598 |
ATP6V1D | 8894 | 9815 |
ATP6V1A | 9144 | 9387 |
CYBB | 8879 | 9506 |
ATP6V1B2 | 8904 | 9293 |
ATP6V1C1 | 8400 | 9733 |
ATP6V0B | 8458 | 9622 |
TCIRG1 | 7082 | 10931 |
ATP6V0E1 | 8456 | 8299 |
CYBA | 6822 | 9999 |
ATP6V1E1 | 7912 | 8087 |
ATP6V1H | 7939 | 7019 |
NCF1 | 7224 | 7158 |
RAC2 | 5104 | 8122 |
ATP6V1F | 5802 | 3776 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ATP6V0A1 | 9262 | 11071 | -4129 |
ATP6V0A2 | -11850 | -6562 | 10591 |
ATP6V0B | 8458 | 9622 | -7822 |
ATP6V0C | 8974 | 10793 | -5635 |
ATP6V0D1 | 9088 | 10812 | -6200 |
ATP6V0E1 | 8456 | 8299 | -6597 |
ATP6V0E2 | -11202 | -9428 | 81 |
ATP6V1A | 9144 | 9387 | 639 |
ATP6V1B2 | 8904 | 9293 | -2076 |
ATP6V1C1 | 8400 | 9733 | 1842 |
ATP6V1C2 | -2175 | -2908 | 1018 |
ATP6V1D | 8894 | 9815 | 2539 |
ATP6V1E1 | 7912 | 8087 | 1529 |
ATP6V1E2 | 5657 | -3873 | -6954 |
ATP6V1F | 5802 | 3776 | -8689 |
ATP6V1G1 | 3892 | -4753 | -2897 |
ATP6V1G2 | -9197 | -9115 | 3143 |
ATP6V1H | 7939 | 7019 | -2464 |
CYBA | 6822 | 9999 | -7207 |
CYBB | 8879 | 9506 | 1575 |
HVCN1 | 4856 | -247 | -2410 |
LPO | 6414 | 2519 | 7391 |
MPO | 7325 | -8236 | -7397 |
NCF1 | 7224 | 7158 | -2796 |
NCF2 | 9034 | 10598 | -2149 |
NCF4 | 9111 | 10617 | -6708 |
NOS1 | 1355 | 3987 | 9572 |
NOS3 | -2018 | -7144 | 672 |
RAC2 | 5104 | 8122 | -7294 |
SLC11A1 | 9014 | 11243 | -1476 |
TCIRG1 | 7082 | 10931 | -5721 |
Signaling by Leptin
metric | value |
---|---|
setSize | 10 |
pMANOVA | 0.00824 |
p.adjustMANOVA | 0.018 |
s.dist | 0.768 |
s.t0_v_pod | 0.565 |
s.pod_crp | 0.388 |
s.t0_crp | -0.347 |
p.t0_v_pod | 0.00198 |
p.pod_crp | 0.0337 |
p.t0_crp | 0.0576 |
Gene | t0_v_pod | pod_crp |
---|---|---|
SOCS3 | 9315 | 10630 |
IRS2 | 8429 | 9284 |
STAT3 | 7972 | 9583 |
STAT5B | 6825 | 8618 |
STAT5A | 6864 | 7733 |
PTPN11 | 5253 | 6456 |
JAK2 | 2670 | 4389 |
LEPR | 6397 | 1782 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
IRS1 | 1728 | -6009 | -4997 |
IRS2 | 8429 | 9284 | -8471 |
JAK2 | 2670 | 4389 | 12253 |
LEPR | 6397 | 1782 | -3458 |
PTPN11 | 5253 | 6456 | 949 |
SH2B1 | -8374 | -5465 | 219 |
SOCS3 | 9315 | 10630 | -8810 |
STAT3 | 7972 | 9583 | 2630 |
STAT5A | 6864 | 7733 | -5435 |
STAT5B | 6825 | 8618 | -5382 |
rRNA processing
metric | value |
---|---|
setSize | 217 |
pMANOVA | 8.4e-73 |
p.adjustMANOVA | 1.04e-70 |
s.dist | 0.766 |
s.t0_v_pod | -0.289 |
s.pod_crp | -0.589 |
s.t0_crp | -0.394 |
p.t0_v_pod | 2.16e-13 |
p.pod_crp | 7.88e-51 |
p.t0_crp | 1.25e-23 |
Gene | pod_crp | t0_crp |
---|---|---|
FBL | -9913 | -8826 |
RPL3 | -9928 | -8773 |
RPS2 | -9563 | -9021 |
RPS27A | -9695 | -8668 |
RPL14 | -9670 | -8650 |
RPLP2 | -9135 | -9001 |
RPS12 | -9242 | -8852 |
RPS3 | -9270 | -8726 |
RPLP0 | -9199 | -8702 |
RPS27 | -9147 | -8693 |
RPL10 | -9003 | -8829 |
RPL7 | -9737 | -8087 |
WDR46 | -9028 | -8694 |
RPS23 | -9359 | -8319 |
RPL27A | -9020 | -8573 |
RPS29 | -8609 | -8958 |
RPS6 | -9671 | -7892 |
RPL31 | -8741 | -8685 |
RPL30 | -8902 | -8504 |
RPL29 | -8593 | -8787 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
BMS1 | -11315 | -9598 | -1337 |
BOP1 | -5039 | -6568 | -8304 |
BYSL | -4316 | -4876 | -6332 |
C1D | 3484 | -321 | 11355 |
CSNK1D | 2374 | 8356 | -7947 |
CSNK1E | -9964 | -6501 | -4870 |
DCAF13 | -5386 | -7538 | -2062 |
DDX21 | 3087 | -1187 | 8531 |
DDX47 | -10949 | -9306 | 8082 |
DDX49 | 4816 | 4046 | -8272 |
DDX52 | 448 | 1780 | 12323 |
DHX37 | -7983 | -4720 | -3600 |
DIMT1 | -7711 | -9624 | 8995 |
DIS3 | -4187 | -4119 | 11534 |
DKC1 | -11282 | -10110 | -3751 |
EBNA1BP2 | -3970 | -7889 | -588 |
ELAC2 | -11406 | -5361 | -4879 |
EMG1 | -9856 | -8716 | 8730 |
ERI1 | 5474 | 6607 | 11232 |
EXOSC1 | -979 | -487 | 5176 |
EXOSC10 | -11028 | -6804 | 6476 |
EXOSC2 | -10724 | -9725 | -4656 |
EXOSC3 | 503 | -40 | 4327 |
EXOSC4 | 7485 | 9870 | -6235 |
EXOSC5 | -4428 | -8367 | -7087 |
EXOSC6 | -9514 | -7432 | -3150 |
EXOSC7 | -10290 | -8445 | -8729 |
EXOSC8 | -11104 | -9351 | 7169 |
EXOSC9 | -9917 | -8765 | 10776 |
FAU | -359 | -3599 | -8841 |
FBL | -9855 | -9913 | -8826 |
FCF1 | 4428 | 450 | 6199 |
FTSJ3 | -3900 | -1188 | -3676 |
GAR1 | -6703 | -7382 | 238 |
GNL3 | -8199 | -9931 | 4303 |
HEATR1 | -10009 | -7253 | 5481 |
HSD17B10 | 4141 | 2954 | -6913 |
IMP3 | -9143 | -6887 | -5060 |
IMP4 | -10629 | -7130 | -5576 |
ISG20L2 | 3737 | 3123 | 6401 |
KRR1 | -8329 | -7693 | 8202 |
LAS1L | -11905 | -9651 | -4481 |
LTV1 | -4162 | -7094 | 5542 |
MPHOSPH10 | -7519 | -8812 | 11917 |
MPHOSPH6 | 2168 | -3175 | 1284 |
MRM1 | -10179 | -8498 | -2345 |
MRM2 | 1450 | -5146 | -2492 |
MRM3 | -7261 | -5685 | -2876 |
MT-ATP6 | -2053 | -2188 | -8001 |
MT-ATP8 | -2987 | 187 | -8982 |
MT-CO1 | 678 | -448 | -1768 |
MT-CO2 | 48 | -2508 | -6448 |
MT-CO3 | 40 | -5134 | -7824 |
MT-CYB | -2209 | -2018 | -4143 |
MT-ND1 | -3510 | -5053 | -5687 |
MT-ND2 | -6337 | -6070 | -4921 |
MT-ND3 | -3542 | -5498 | -7149 |
MT-ND4 | 833 | 4453 | 5892 |
MT-ND4L | -1983 | 2305 | -6967 |
MT-ND5 | -2122 | -922 | -3737 |
MT-RNR1 | -298 | -5072 | -2647 |
MT-RNR2 | 2099 | -403 | -1533 |
MT-TF | -2683 | 2741 | -4160 |
MT-TL1 | -2901 | 4476 | -2094 |
MT-TV | -3544 | 3333 | -5432 |
MTERF4 | -10547 | -9888 | -3942 |
MTREX | -2574 | -4473 | 5717 |
NAT10 | -11593 | -9800 | -2380 |
NCL | -8953 | -9308 | -4346 |
NHP2 | -3373 | -6510 | -7363 |
NIP7 | -5682 | -7752 | 4552 |
NOB1 | -9986 | -8880 | -5059 |
NOC4L | -5298 | 1593 | 234 |
NOL11 | -10134 | -9903 | 8964 |
NOL12 | 4887 | 4239 | -4051 |
NOL6 | -10564 | -7807 | -3599 |
NOL9 | -9891 | -8758 | 9241 |
NOP10 | 8200 | 10199 | -7289 |
NOP14 | -10522 | -9613 | -4168 |
NOP2 | -9624 | -8280 | -6603 |
NOP56 | -11395 | -9416 | 246 |
NOP58 | -9623 | -10002 | 8617 |
NSUN4 | -4645 | 2320 | 8079 |
PDCD11 | -11166 | -6522 | -2344 |
PELP1 | -10584 | -8205 | -1289 |
PES1 | -1993 | -7123 | -8715 |
PNO1 | -6627 | -7977 | 9345 |
PRORP | 3361 | -1707 | 4824 |
PWP2 | -1190 | -5399 | -7041 |
RBM28 | -11316 | -5688 | 1861 |
RCL1 | -751 | -7663 | -1012 |
RIOK1 | -3702 | -4836 | 2397 |
RIOK2 | 927 | -8052 | 9706 |
RIOK3 | 8621 | 7003 | 9886 |
RPL10 | -6311 | -9003 | -8829 |
RPL10A | -6458 | -8900 | -6147 |
RPL11 | -6052 | -9089 | -6722 |
RPL12 | -6811 | -9149 | -8024 |
RPL13 | -3335 | -7644 | -6367 |
RPL13A | -7928 | -9374 | -6207 |
RPL14 | -6480 | -9670 | -8650 |
RPL15 | -953 | -8142 | -8235 |
RPL17 | -5249 | -9088 | -8079 |
RPL18 | -4911 | -8835 | -8406 |
RPL18A | -5869 | -8868 | -8439 |
RPL19 | -6071 | -8311 | -8149 |
RPL21 | -6241 | -9483 | -7230 |
RPL22 | -4587 | -9631 | -7480 |
RPL22L1 | -1593 | -8175 | 527 |
RPL23 | -3223 | -8346 | -7486 |
RPL23A | -9248 | -9950 | -4950 |
RPL24 | -5606 | -8873 | -7028 |
RPL26 | -6387 | -8678 | -8038 |
RPL26L1 | 7070 | 5940 | -5499 |
RPL27 | -2783 | -7783 | -8809 |
RPL27A | -6048 | -9020 | -8573 |
RPL28 | -1441 | -3852 | -5654 |
RPL29 | -3505 | -8593 | -8787 |
RPL3 | -8268 | -9928 | -8773 |
RPL30 | -6779 | -8902 | -8504 |
RPL31 | -4394 | -8741 | -8685 |
RPL32 | -6479 | -9317 | -7991 |
RPL34 | -6569 | -9464 | -6337 |
RPL35 | -7809 | -8156 | -7893 |
RPL35A | -5816 | -9263 | -7997 |
RPL36 | -5111 | -7467 | -8861 |
RPL36A | -7122 | -8881 | -8095 |
RPL36AL | 32 | -6621 | -8799 |
RPL37 | -6160 | -7834 | -9017 |
RPL37A | -3826 | -6808 | -8683 |
RPL38 | -5646 | -7941 | -8932 |
RPL39 | -2931 | -8607 | -8362 |
RPL39L | -8506 | -1648 | -4731 |
RPL3L | 4458 | 5102 | 10556 |
RPL4 | -3476 | -9521 | -7062 |
RPL41 | -6632 | -7535 | -8456 |
RPL5 | -4576 | -9853 | -7157 |
RPL6 | -3262 | -9281 | -3434 |
RPL7 | -1917 | -9737 | -8087 |
RPL7A | -3557 | -8259 | -8751 |
RPL8 | -1171 | -6076 | -8899 |
RPL9 | -1837 | -6796 | -4391 |
RPLP0 | -987 | -9199 | -8702 |
RPLP1 | 19 | -5994 | -8833 |
RPLP2 | -6844 | -9135 | -9001 |
RPP14 | 2981 | -2190 | 7808 |
RPP21 | -5178 | -4239 | -7477 |
RPP25 | -7963 | -8660 | -2890 |
RPP30 | -7818 | -8612 | 8067 |
RPP38 | -6833 | -7656 | 6479 |
RPP40 | -4680 | -10040 | 3381 |
RPS10 | -5601 | -8466 | -8823 |
RPS11 | -6992 | -7948 | -8743 |
RPS12 | -5788 | -9242 | -8852 |
RPS13 | -1717 | -8696 | -7869 |
RPS14 | -5278 | -8513 | -8637 |
RPS15 | -3565 | -6678 | -8273 |
RPS15A | -5550 | -8855 | -8431 |
RPS16 | -4518 | -8551 | -8704 |
RPS17 | -6038 | -8254 | -8928 |
RPS18 | -7474 | -8294 | -7671 |
RPS19 | -6725 | -7779 | -8460 |
RPS2 | -4354 | -9563 | -9021 |
RPS20 | -8585 | -9385 | -6156 |
RPS21 | -3952 | -8303 | -8855 |
RPS23 | -6081 | -9359 | -8319 |
RPS24 | -261 | -6793 | -4573 |
RPS25 | -6151 | -9636 | -7764 |
RPS26 | -1410 | -1143 | -462 |
RPS27 | -9432 | -9147 | -8693 |
RPS27A | -6700 | -9695 | -8668 |
RPS27L | 2048 | -490 | 9654 |
RPS28 | -4562 | -8056 | -8562 |
RPS29 | -7664 | -8609 | -8958 |
RPS3 | -5717 | -9270 | -8726 |
RPS3A | -4543 | -9806 | -4045 |
RPS4X | -6075 | -8620 | -4665 |
RPS4Y1 | 418 | 329 | 1713 |
RPS5 | -5502 | -9014 | -8342 |
RPS6 | -5956 | -9671 | -7892 |
RPS7 | -4803 | -9137 | -7874 |
RPS8 | -2041 | -8833 | -6710 |
RPS9 | 5358 | 1826 | -8433 |
RPSA | -6110 | -6604 | 3504 |
RRP1 | -3003 | -3032 | 2020 |
RRP36 | -1645 | -390 | -5014 |
RRP7A | -2734 | -5222 | -4553 |
RRP9 | -9748 | -8570 | -7939 |
SENP3 | 2970 | 77 | -3111 |
SNORD3A | -2477 | 10412 | 10967 |
SNU13 | -6637 | -8467 | -6973 |
TBL3 | -3341 | 732 | -6317 |
TEX10 | -9440 | -8887 | 11517 |
TFB1M | -10994 | -6834 | 7318 |
THUMPD1 | -9477 | -9754 | 7788 |
TRMT10C | -4336 | -8279 | 8670 |
TRMT112 | 732 | -2281 | -8647 |
TSR1 | -9409 | -9696 | 4264 |
TSR3 | 3808 | 1485 | -8865 |
UBA52 | 1112 | -3471 | -8207 |
UTP11 | 4582 | -37 | 6683 |
UTP14A | -1788 | -3304 | 3687 |
UTP14C | -2032 | -2400 | 5261 |
UTP15 | -10264 | -9128 | 11648 |
UTP18 | 5055 | 3815 | 4880 |
UTP20 | -10191 | -7402 | 9700 |
UTP3 | -2829 | -4799 | -4079 |
UTP4 | -11142 | -9672 | 3675 |
UTP6 | -4362 | -8588 | 8987 |
WDR12 | 5156 | -723 | 7083 |
WDR18 | -2260 | -3796 | -3450 |
WDR3 | -6394 | -6991 | 570 |
WDR36 | -3825 | -5050 | 5877 |
WDR43 | -7419 | -9367 | 167 |
WDR46 | -10623 | -9028 | -8694 |
WDR75 | -9593 | -9795 | 7835 |
XRN2 | 9240 | 10090 | -4182 |
DNA strand elongation
metric | value |
---|---|
setSize | 32 |
pMANOVA | 6.4e-07 |
p.adjustMANOVA | 5.09e-06 |
s.dist | 0.762 |
s.t0_v_pod | -0.522 |
s.pod_crp | -0.555 |
s.t0_crp | 0.027 |
p.t0_v_pod | 3.22e-07 |
p.pod_crp | 5.52e-08 |
p.t0_crp | 0.791 |
Gene | pod_crp | t0_v_pod |
---|---|---|
MCM3 | -9914 | -11839 |
POLA1 | -9813 | -11789 |
RPA1 | -9771 | -11644 |
MCM7 | -9297 | -11768 |
LIG1 | -9441 | -10705 |
POLD2 | -10025 | -10015 |
RFC3 | -9377 | -10151 |
RFC4 | -8869 | -10361 |
PRIM1 | -9138 | -9858 |
POLA2 | -7923 | -11222 |
RFC5 | -7548 | -11357 |
GINS4 | -8248 | -9903 |
MCM6 | -8603 | -9393 |
RPA3 | -9192 | -8609 |
FEN1 | -6460 | -10254 |
MCM8 | -5689 | -10599 |
MCM4 | -7061 | -8404 |
MCM2 | -6855 | -6973 |
PCNA | -7076 | -5771 |
GINS3 | -3854 | -10170 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CDC45 | -2594 | -5110 | 1889 |
DNA2 | -2786 | -6282 | 10381 |
FEN1 | -10254 | -6460 | -2374 |
GINS1 | -4261 | 4225 | 7950 |
GINS2 | -4661 | -3457 | 4094 |
GINS3 | -10170 | -3854 | 5122 |
GINS4 | -9903 | -8248 | 3992 |
LIG1 | -10705 | -9441 | -1548 |
MCM2 | -6973 | -6855 | -3428 |
MCM3 | -11839 | -9914 | -2392 |
MCM4 | -8404 | -7061 | 3202 |
MCM5 | -7039 | -2312 | -5776 |
MCM6 | -9393 | -8603 | 109 |
MCM7 | -11768 | -9297 | -1374 |
MCM8 | -10599 | -5689 | 7587 |
PCNA | -5771 | -7076 | 6465 |
POLA1 | -11789 | -9813 | 1029 |
POLA2 | -11222 | -7923 | 8950 |
POLD1 | 202 | -2557 | -6206 |
POLD2 | -10015 | -10025 | -5321 |
POLD3 | 8737 | 10508 | 2974 |
POLD4 | 6250 | 8949 | -6951 |
PRIM1 | -9858 | -9138 | 10019 |
PRIM2 | -5389 | -7087 | 2832 |
RFC1 | -7180 | -5058 | 9646 |
RFC2 | 4890 | 5426 | -5388 |
RFC3 | -10151 | -9377 | 2304 |
RFC4 | -10361 | -8869 | 7610 |
RFC5 | -11357 | -7548 | 3954 |
RPA1 | -11644 | -9771 | -3472 |
RPA2 | -6094 | -4789 | 4026 |
RPA3 | -8609 | -9192 | 2284 |
Dissolution of Fibrin Clot
metric | value |
---|---|
setSize | 12 |
pMANOVA | 0.00397 |
p.adjustMANOVA | 0.00969 |
s.dist | 0.762 |
s.t0_v_pod | 0.566 |
s.pod_crp | 0.412 |
s.t0_crp | -0.301 |
p.t0_v_pod | 0.000687 |
p.pod_crp | 0.0136 |
p.t0_crp | 0.0708 |
Gene | t0_v_pod | pod_crp |
---|---|---|
SERPINB2 | 9277 | 10520 |
ANXA2 | 8405 | 10514 |
PLAUR | 8292 | 10309 |
SERPINB8 | 9049 | 9092 |
SERPINE2 | 6363 | 6996 |
SERPINE1 | 7371 | 4960 |
S100A10 | 6764 | 5278 |
SERPINB6 | 5778 | 5230 |
PLAU | 4847 | 3871 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ANXA2 | 8405 | 10514 | -659 |
PLAT | -1225 | -6169 | 4704 |
PLAU | 4847 | 3871 | -6314 |
PLAUR | 8292 | 10309 | -3513 |
PLG | -1938 | 216 | 9671 |
S100A10 | 6764 | 5278 | -5383 |
SERPINB2 | 9277 | 10520 | -51 |
SERPINB6 | 5778 | 5230 | -8063 |
SERPINB8 | 9049 | 9092 | -557 |
SERPINE1 | 7371 | 4960 | -5579 |
SERPINE2 | 6363 | 6996 | -650 |
SERPINF2 | -6350 | -1362 | -2370 |
Mucopolysaccharidoses
metric | value |
---|---|
setSize | 11 |
pMANOVA | 0.00638 |
p.adjustMANOVA | 0.0144 |
s.dist | 0.751 |
s.t0_v_pod | 0.455 |
s.pod_crp | 0.442 |
s.t0_crp | -0.403 |
p.t0_v_pod | 0.009 |
p.pod_crp | 0.0112 |
p.t0_crp | 0.0207 |
Gene | t0_v_pod | pod_crp |
---|---|---|
GNS | 9200 | 11194 |
GLB1 | 8581 | 10042 |
GUSB | 7607 | 10966 |
ARSB | 7459 | 9871 |
GALNS | 6998 | 8916 |
HYAL1 | 4123 | 8255 |
SGSH | 5835 | 2861 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ARSB | 7459 | 9871 | 1891 |
GALNS | 6998 | 8916 | -3718 |
GLB1 | 8581 | 10042 | -4137 |
GNS | 9200 | 11194 | -1445 |
GUSB | 7607 | 10966 | -6245 |
HGSNAT | 1854 | -729 | -724 |
HYAL1 | 4123 | 8255 | 9608 |
IDS | -2558 | 1326 | -2416 |
IDUA | -5636 | -6345 | -5699 |
NAGLU | -4608 | 1701 | -7629 |
SGSH | 5835 | 2861 | -8621 |
Spry regulation of FGF signaling
metric | value |
---|---|
setSize | 16 |
pMANOVA | 0.000398 |
p.adjustMANOVA | 0.00135 |
s.dist | 0.749 |
s.t0_v_pod | 0.475 |
s.pod_crp | 0.372 |
s.t0_crp | -0.445 |
p.t0_v_pod | 0.00101 |
p.pod_crp | 0.0101 |
p.t0_crp | 0.00208 |
Gene | t0_v_pod | t0_crp |
---|---|---|
MAPK3 | 8803 | -9014 |
GRB2 | 9146 | -5185 |
UBB | 6548 | -6697 |
PPP2R1A | 4542 | -7934 |
UBC | 4395 | -4003 |
MKNK1 | 8042 | -1799 |
CBL | 7368 | -1624 |
MAPK1 | 7381 | -1505 |
UBA52 | 1112 | -8207 |
PPP2CA | 8104 | -306 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
BRAF | 1298 | 4328 | 6880 |
CBL | 7368 | 9736 | -1624 |
GRB2 | 9146 | 10542 | -5185 |
MAPK1 | 7381 | 10983 | -1505 |
MAPK3 | 8803 | 9593 | -9014 |
MKNK1 | 8042 | 10147 | -1799 |
PPP2CA | 8104 | 6731 | -306 |
PPP2CB | 7596 | 7359 | 4715 |
PPP2R1A | 4542 | 5140 | -7934 |
PTPN11 | 5253 | 6456 | 949 |
RPS27A | -6700 | -9695 | -8668 |
SPRY2 | -4453 | 3846 | -3763 |
SRC | -8520 | -6371 | -3347 |
UBA52 | 1112 | -3471 | -8207 |
UBB | 6548 | 1016 | -6697 |
UBC | 4395 | 6071 | -4003 |
Pentose phosphate pathway
metric | value |
---|---|
setSize | 13 |
pMANOVA | 0.00223 |
p.adjustMANOVA | 0.00601 |
s.dist | 0.748 |
s.t0_v_pod | 0.488 |
s.pod_crp | 0.375 |
s.t0_crp | -0.425 |
p.t0_v_pod | 0.00233 |
p.pod_crp | 0.0191 |
p.t0_crp | 0.00796 |
Gene | t0_v_pod | t0_crp |
---|---|---|
G6PD | 8853 | -8678 |
PGD | 9320 | -7817 |
TKT | 9183 | -7915 |
PGLS | 5997 | -8746 |
TALDO1 | 9295 | -5166 |
PGM2 | 9185 | -3971 |
RPIA | 1431 | -6976 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
DERA | 8364 | 9203 | 5762 |
G6PD | 8853 | 10748 | -8678 |
PGD | 9320 | 11020 | -7817 |
PGLS | 5997 | 5015 | -8746 |
PGM2 | 9185 | 10200 | -3971 |
PRPS1 | -11716 | -9746 | -3296 |
PRPS2 | 3530 | -3107 | 9229 |
RBKS | -3058 | 3857 | -3699 |
RPE | 2570 | 6736 | 3479 |
RPIA | 1431 | -5387 | -6976 |
SHPK | -2467 | 536 | 270 |
TALDO1 | 9295 | 10214 | -5166 |
TKT | 9183 | 10070 | -7915 |
DNA methylation
metric | value |
---|---|
setSize | 20 |
pMANOVA | 2.54e-05 |
p.adjustMANOVA | 0.000122 |
s.dist | 0.747 |
s.t0_v_pod | 0.517 |
s.pod_crp | 0.325 |
s.t0_crp | -0.431 |
p.t0_v_pod | 6.35e-05 |
p.pod_crp | 0.0119 |
p.t0_crp | 0.000836 |
Gene | t0_v_pod | t0_crp |
---|---|---|
H2AJ | 9214.0 | -8302.0 |
H2BC12 | 8898.0 | -7833.0 |
H2AZ1 | 5955.0 | -8609.0 |
H2BC5 | 7881.0 | -5603.0 |
H2BC11 | 7791.0 | -5097.0 |
H2BC21 | 9125.0 | -3628.0 |
H3C15 | 6608.5 | -4548.5 |
H2BC9 | 5332.0 | -5547.0 |
H2AC6 | 7813.0 | -3405.0 |
H2BC15 | 5251.0 | -2358.0 |
DNMT3B | 4250.0 | -1957.0 |
H2BC17 | 7178.0 | -839.0 |
H2BC4 | 7279.0 | -558.0 |
H3-3A | 8519.0 | -45.0 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
DNMT1 | -11896.0 | -9596.0 | -4032.0 |
DNMT3A | -2963.0 | -2031.0 | -3936.0 |
DNMT3B | 4250.0 | 3685.0 | -1957.0 |
H2AC20 | 4913.0 | 8767.0 | 5501.0 |
H2AC6 | 7813.0 | 5389.0 | -3405.0 |
H2AJ | 9214.0 | 11227.0 | -8302.0 |
H2AZ1 | 5955.0 | 4339.0 | -8609.0 |
H2AZ2 | -1192.0 | -5552.0 | -5889.0 |
H2BC11 | 7791.0 | 6057.0 | -5097.0 |
H2BC12 | 8898.0 | 9140.0 | -7833.0 |
H2BC15 | 5251.0 | 2455.0 | -2358.0 |
H2BC17 | 7178.0 | 6124.0 | -839.0 |
H2BC21 | 9125.0 | 9536.0 | -3628.0 |
H2BC4 | 7279.0 | 8798.0 | -558.0 |
H2BC5 | 7881.0 | 6685.0 | -5603.0 |
H2BC9 | 5332.0 | -5704.0 | -5547.0 |
H2BU1 | -6332.0 | 296.0 | 1215.0 |
H3-3A | 8519.0 | 8858.0 | -45.0 |
H3C15 | 6608.5 | 8802.5 | -4548.5 |
UHRF1 | 168.0 | 3272.0 | 6414.0 |
COPI-independent Golgi-to-ER retrograde traffic
metric | value |
---|---|
setSize | 33 |
pMANOVA | 4.56e-07 |
p.adjustMANOVA | 3.83e-06 |
s.dist | 0.745 |
s.t0_v_pod | 0.563 |
s.pod_crp | 0.464 |
s.t0_crp | -0.151 |
p.t0_v_pod | 2.13e-08 |
p.pod_crp | 3.98e-06 |
p.t0_crp | 0.132 |
Gene | t0_v_pod | pod_crp |
---|---|---|
GALNT2 | 8697 | 10689 |
DCTN2 | 9002 | 10231 |
PLA2G4A | 9025 | 9642 |
DCTN4 | 8255 | 10493 |
BICD2 | 8602 | 9551 |
RAB6A | 8020 | 9791 |
CAPZA1 | 8008 | 9383 |
CAPZB | 7893 | 9424 |
ACTR1A | 6899 | 10132 |
CAPZA2 | 8457 | 8110 |
DYNC1LI1 | 6841 | 8160 |
DCTN6 | 7193 | 7445 |
RAB18 | 7683 | 6954 |
DYNC1I2 | 7619 | 6633 |
DCTN1 | 5019 | 9411 |
ACTR10 | 7490 | 5826 |
PAFAH1B1 | 5405 | 7756 |
GALNT1 | 6420 | 6427 |
PAFAH1B2 | 6842 | 5935 |
DCTN3 | 5913 | 6554 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ACTR10 | 7490 | 5826 | 4427 |
ACTR1A | 6899 | 10132 | -6961 |
AGPAT3 | 4753 | 7831 | 3495 |
BICD1 | -7111 | -2288 | 4117 |
BICD2 | 8602 | 9551 | -8611 |
CAPZA1 | 8008 | 9383 | 6293 |
CAPZA2 | 8457 | 8110 | 4868 |
CAPZB | 7893 | 9424 | -5476 |
DCTN1 | 5019 | 9411 | -7351 |
DCTN2 | 9002 | 10231 | -8920 |
DCTN3 | 5913 | 6554 | -7228 |
DCTN4 | 8255 | 10493 | 6145 |
DCTN5 | -3959 | 295 | -1163 |
DCTN6 | 7193 | 7445 | 8123 |
DYNC1H1 | -7417 | 1692 | -1406 |
DYNC1I1 | 4145 | 2854 | 3166 |
DYNC1I2 | 7619 | 6633 | -395 |
DYNC1LI1 | 6841 | 8160 | 7235 |
DYNC1LI2 | 4229 | 7547 | 2299 |
DYNLL1 | 5873 | 1517 | -3390 |
DYNLL2 | -3859 | -4882 | -5771 |
GALNT1 | 6420 | 6427 | 3010 |
GALNT2 | 8697 | 10689 | -8116 |
PAFAH1B1 | 5405 | 7756 | -1518 |
PAFAH1B2 | 6842 | 5935 | 2533 |
PAFAH1B3 | 4373 | -4023 | -8571 |
PLA2G4A | 9025 | 9642 | -1028 |
PLA2G6 | -11761 | -7143 | -5121 |
RAB18 | 7683 | 6954 | 7861 |
RAB3GAP1 | 5695 | 5118 | 10806 |
RAB3GAP2 | 4385 | 6528 | 10304 |
RAB6A | 8020 | 9791 | 6218 |
RAB6B | 5972 | -1836 | -8619 |
Formation of ATP by chemiosmotic coupling
metric | value |
---|---|
setSize | 18 |
pMANOVA | 3.36e-07 |
p.adjustMANOVA | 2.93e-06 |
s.dist | 0.743 |
s.t0_v_pod | 0.427 |
s.pod_crp | 0.0375 |
s.t0_crp | -0.607 |
p.t0_v_pod | 0.00171 |
p.pod_crp | 0.783 |
p.t0_crp | 8.2e-06 |
Gene | t0_crp | t0_v_pod |
---|---|---|
ATP5MF | -8734 | 6431 |
ATP5MG | -8801 | 5447 |
ATP5F1A | -6958 | 6353 |
ATP5F1E | -7071 | 6058 |
ATP5PB | -5394 | 7438 |
ATP5MC3 | -6713 | 5829 |
ATP5F1B | -4476 | 6409 |
ATP5PF | -4251 | 6286 |
ATP5F1D | -8739 | 2944 |
ATP5MC2 | -8407 | 2932 |
ATP5ME | -8860 | 2644 |
ATP5PO | -2631 | 4739 |
ATP5PD | -1250 | 7521 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ATP5F1A | 6353 | -2835 | -6958 |
ATP5F1B | 6409 | 5998 | -4476 |
ATP5F1C | 6596 | 1241 | 2451 |
ATP5F1D | 2944 | -986 | -8739 |
ATP5F1E | 6058 | 2254 | -7071 |
ATP5MC1 | -7353 | -6919 | -1264 |
ATP5MC2 | 2932 | 1574 | -8407 |
ATP5MC3 | 5829 | 3275 | -6713 |
ATP5ME | 2644 | 3572 | -8860 |
ATP5MF | 6431 | 6294 | -8734 |
ATP5MG | 5447 | 547 | -8801 |
ATP5PB | 7438 | 3444 | -5394 |
ATP5PD | 7521 | 5119 | -1250 |
ATP5PF | 6286 | 3290 | -4251 |
ATP5PO | 4739 | -2304 | -2631 |
DMAC2L | -7023 | -4321 | 11151 |
MT-ATP6 | -2053 | -2188 | -8001 |
MT-ATP8 | -2987 | 187 | -8982 |
Diseases associated with the TLR signaling cascade
metric | value |
---|---|
setSize | 23 |
pMANOVA | 7.96e-05 |
p.adjustMANOVA | 0.000335 |
s.dist | 0.739 |
s.t0_v_pod | 0.534 |
s.pod_crp | 0.48 |
s.t0_crp | -0.177 |
p.t0_v_pod | 9.12e-06 |
p.pod_crp | 6.8e-05 |
p.t0_crp | 0.143 |
Gene | t0_v_pod | pod_crp |
---|---|---|
CD36 | 9283 | 10747 |
TLR5 | 9045 | 10981 |
TLR2 | 8950 | 10352 |
MYD88 | 8009 | 11117 |
TLR1 | 8782 | 9888 |
CD14 | 8944 | 9321 |
TLR4 | 8864 | 9402 |
LY96 | 8649 | 9181 |
TLR6 | 8694 | 8940 |
BTK | 7100 | 10653 |
CHUK | 7844 | 8599 |
TICAM1 | 6221 | 8752 |
IKBKG | 5315 | 9298 |
TIRAP | 5571 | 8733 |
UNC93B1 | 4129 | 10343 |
NFKBIA | 6712 | 5405 |
NFKB1 | 6191 | 2835 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
BTK | 7100 | 10653 | 7751 |
CD14 | 8944 | 9321 | -7666 |
CD36 | 9283 | 10747 | -147 |
CHUK | 7844 | 8599 | 3409 |
IKBKB | -5208 | 1744 | -158 |
IKBKG | 5315 | 9298 | -5591 |
LY96 | 8649 | 9181 | 4818 |
MYD88 | 8009 | 11117 | 3555 |
NFKB1 | 6191 | 2835 | -2693 |
NFKB2 | -1150 | -3508 | -3084 |
NFKBIA | 6712 | 5405 | -8067 |
RELA | -1770 | -201 | -7116 |
TICAM1 | 6221 | 8752 | 3413 |
TIRAP | 5571 | 8733 | -2324 |
TLR1 | 8782 | 9888 | 5302 |
TLR10 | -2886 | -7042 | -560 |
TLR2 | 8950 | 10352 | 3541 |
TLR3 | -11172 | -7386 | 6867 |
TLR4 | 8864 | 9402 | -2478 |
TLR5 | 9045 | 10981 | 2232 |
TLR6 | 8694 | 8940 | -2193 |
TRAF3 | -5390 | -7513 | -6014 |
UNC93B1 | 4129 | 10343 | 1911 |
Diseases of Immune System
metric | value |
---|---|
setSize | 23 |
pMANOVA | 7.96e-05 |
p.adjustMANOVA | 0.000335 |
s.dist | 0.739 |
s.t0_v_pod | 0.534 |
s.pod_crp | 0.48 |
s.t0_crp | -0.177 |
p.t0_v_pod | 9.12e-06 |
p.pod_crp | 6.8e-05 |
p.t0_crp | 0.143 |
Gene | t0_v_pod | pod_crp |
---|---|---|
CD36 | 9283 | 10747 |
TLR5 | 9045 | 10981 |
TLR2 | 8950 | 10352 |
MYD88 | 8009 | 11117 |
TLR1 | 8782 | 9888 |
CD14 | 8944 | 9321 |
TLR4 | 8864 | 9402 |
LY96 | 8649 | 9181 |
TLR6 | 8694 | 8940 |
BTK | 7100 | 10653 |
CHUK | 7844 | 8599 |
TICAM1 | 6221 | 8752 |
IKBKG | 5315 | 9298 |
TIRAP | 5571 | 8733 |
UNC93B1 | 4129 | 10343 |
NFKBIA | 6712 | 5405 |
NFKB1 | 6191 | 2835 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
BTK | 7100 | 10653 | 7751 |
CD14 | 8944 | 9321 | -7666 |
CD36 | 9283 | 10747 | -147 |
CHUK | 7844 | 8599 | 3409 |
IKBKB | -5208 | 1744 | -158 |
IKBKG | 5315 | 9298 | -5591 |
LY96 | 8649 | 9181 | 4818 |
MYD88 | 8009 | 11117 | 3555 |
NFKB1 | 6191 | 2835 | -2693 |
NFKB2 | -1150 | -3508 | -3084 |
NFKBIA | 6712 | 5405 | -8067 |
RELA | -1770 | -201 | -7116 |
TICAM1 | 6221 | 8752 | 3413 |
TIRAP | 5571 | 8733 | -2324 |
TLR1 | 8782 | 9888 | 5302 |
TLR10 | -2886 | -7042 | -560 |
TLR2 | 8950 | 10352 | 3541 |
TLR3 | -11172 | -7386 | 6867 |
TLR4 | 8864 | 9402 | -2478 |
TLR5 | 9045 | 10981 | 2232 |
TLR6 | 8694 | 8940 | -2193 |
TRAF3 | -5390 | -7513 | -6014 |
UNC93B1 | 4129 | 10343 | 1911 |
Pre-NOTCH Processing in Golgi
metric | value |
---|---|
setSize | 18 |
pMANOVA | 0.00012 |
p.adjustMANOVA | 0.00048 |
s.dist | 0.735 |
s.t0_v_pod | 0.411 |
s.pod_crp | 0.487 |
s.t0_crp | -0.367 |
p.t0_v_pod | 0.00257 |
p.pod_crp | 0.000349 |
p.t0_crp | 0.00701 |
Gene | pod_crp | t0_v_pod |
---|---|---|
FURIN | 10706 | 8922 |
NOTCH3 | 11203 | 7778 |
ATP2A2 | 10179 | 7915 |
RAB6A | 9791 | 8020 |
ST3GAL4 | 10043 | 5708 |
SEL1L | 7782 | 6751 |
NOTCH1 | 9352 | 4653 |
NOTCH2 | 8283 | 5211 |
B4GALT1 | 7664 | 4248 |
TMED2 | 5294 | 5971 |
RFNG | 4058 | 7126 |
ST3GAL6 | 3195 | 6610 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ATP2A1 | -4516 | 3945 | 5730 |
ATP2A2 | 7915 | 10179 | -2373 |
ATP2A3 | -905 | 3617 | -3734 |
B4GALT1 | 4248 | 7664 | -6063 |
FURIN | 8922 | 10706 | -8995 |
LFNG | -8085 | 1201 | -3665 |
MFNG | -5809 | -7578 | -8998 |
NOTCH1 | 4653 | 9352 | -5530 |
NOTCH2 | 5211 | 8283 | -3841 |
NOTCH3 | 7778 | 11203 | -5298 |
NOTCH4 | -5056 | 10115 | 2220 |
RAB6A | 8020 | 9791 | 6218 |
RFNG | 7126 | 4058 | -7848 |
SEL1L | 6751 | 7782 | 958 |
ST3GAL3 | 499 | -5226 | -3252 |
ST3GAL4 | 5708 | 10043 | -7303 |
ST3GAL6 | 6610 | 3195 | 4614 |
TMED2 | 5971 | 5294 | 6374 |
Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
metric | value |
---|---|
setSize | 11 |
pMANOVA | 0.0154 |
p.adjustMANOVA | 0.0305 |
s.dist | 0.732 |
s.t0_v_pod | 0.476 |
s.pod_crp | 0.549 |
s.t0_crp | -0.088 |
p.t0_v_pod | 0.00629 |
p.pod_crp | 0.00161 |
p.t0_crp | 0.613 |
Gene | pod_crp | t0_v_pod |
---|---|---|
LYN | 10614 | 7691 |
PIK3CB | 8995 | 8886 |
IRS2 | 9284 | 8429 |
EPOR | 10228 | 7117 |
PIK3CD | 8829 | 5965 |
GAB1 | 8548 | 5607 |
PIK3CG | 8997 | 1820 |
JAK2 | 4389 | 2670 |
PIK3CA | 2117 | 4580 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
EPOR | 7117 | 10228 | -4401 |
GAB1 | 5607 | 8548 | 9775 |
IRS2 | 8429 | 9284 | -8471 |
JAK2 | 2670 | 4389 | 12253 |
LYN | 7691 | 10614 | 7111 |
PIK3CA | 4580 | 2117 | 7009 |
PIK3CB | 8886 | 8995 | 800 |
PIK3CD | 5965 | 8829 | -6091 |
PIK3CG | 1820 | 8997 | 1774 |
PIK3R1 | -9187 | -8803 | -5081 |
PIK3R5 | -2255 | 7483 | -6821 |
Golgi Cisternae Pericentriolar Stack Reorganization
metric | value |
---|---|
setSize | 14 |
pMANOVA | 0.00397 |
p.adjustMANOVA | 0.00969 |
s.dist | 0.731 |
s.t0_v_pod | 0.549 |
s.pod_crp | 0.481 |
s.t0_crp | 0.0291 |
p.t0_v_pod | 0.000374 |
p.pod_crp | 0.00183 |
p.t0_crp | 0.851 |
Gene | t0_v_pod | pod_crp |
---|---|---|
RAB1A | 8899 | 9804 |
MAPK3 | 8803 | 9593 |
MAPK1 | 7381 | 10983 |
RAB1B | 8182 | 9884 |
RAB2A | 8464 | 9430 |
GORASP1 | 6516 | 9480 |
GOLGA2 | 6117 | 9269 |
CCNB2 | 3649 | 7198 |
PLK1 | 2978 | 5349 |
BLZF1 | 3253 | 3702 |
USO1 | 4113 | 2405 |
CCNB1 | 461 | 728 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
BLZF1 | 3253 | 3702 | 12053 |
CCNB1 | 461 | 728 | 6815 |
CCNB2 | 3649 | 7198 | 3957 |
CDK1 | 1527 | -2576 | 8213 |
GOLGA2 | 6117 | 9269 | -3697 |
GORASP1 | 6516 | 9480 | -1306 |
GORASP2 | -6792 | -5521 | 897 |
MAPK1 | 7381 | 10983 | -1505 |
MAPK3 | 8803 | 9593 | -9014 |
PLK1 | 2978 | 5349 | 1784 |
RAB1A | 8899 | 9804 | 1916 |
RAB1B | 8182 | 9884 | -8628 |
RAB2A | 8464 | 9430 | 6039 |
USO1 | 4113 | 2405 | 9996 |
Phosphorylation of CD3 and TCR zeta chains
metric | value |
---|---|
setSize | 27 |
pMANOVA | 1.07e-05 |
p.adjustMANOVA | 5.8e-05 |
s.dist | 0.728 |
s.t0_v_pod | -0.537 |
s.pod_crp | -0.486 |
s.t0_crp | -0.0775 |
p.t0_v_pod | 1.39e-06 |
p.pod_crp | 1.22e-05 |
p.t0_crp | 0.486 |
Gene | t0_v_pod | pod_crp |
---|---|---|
LCK | -11482 | -9528 |
TRBC1 | -11646 | -9275 |
TRAC | -11130 | -9675 |
HLA-DRA | -11649 | -8978 |
CD247 | -11982 | -8713 |
CD3E | -10952 | -9221 |
TRBV12-3 | -10099 | -9942 |
HLA-DPB1 | -11887 | -8370 |
HLA-DPA1 | -11954 | -8190 |
CD3D | -11049 | -8270 |
CD3G | -11173 | -8084 |
TRAV19 | -9587 | -9220 |
HLA-DQB2 | -9085 | -9628 |
TRAV29DV5 | -9353 | -9250 |
TRBV7-9 | -9220 | -8276 |
HLA-DQA1 | -11633 | -6364 |
HLA-DQA2 | -4652 | -8746 |
CD4 | -5228 | -6856 |
TRAV8-4 | -7010 | -4747 |
HLA-DQB1 | -6199 | -4437 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CD247 | -11982 | -8713 | -6364 |
CD3D | -11049 | -8270 | 2178 |
CD3E | -10952 | -9221 | 5038 |
CD3G | -11173 | -8084 | 8697 |
CD4 | -5228 | -6856 | -6272 |
CSK | 5158 | 9258 | -7001 |
HLA-DPA1 | -11954 | -8190 | 4347 |
HLA-DPB1 | -11887 | -8370 | -2273 |
HLA-DQA1 | -11633 | -6364 | 10152 |
HLA-DQA2 | -4652 | -8746 | -8618 |
HLA-DQB1 | -6199 | -4437 | 3070 |
HLA-DQB2 | -9085 | -9628 | -6796 |
HLA-DRA | -11649 | -8978 | 726 |
HLA-DRB1 | -7792 | -330 | 8671 |
HLA-DRB5 | -4806 | 741 | 5896 |
LCK | -11482 | -9528 | -3384 |
PAG1 | 5207 | 5991 | 810 |
PTPN22 | -1191 | 6886 | 8220 |
PTPRC | 2227 | 7917 | 8607 |
PTPRJ | 7666 | 10161 | -5457 |
TRAC | -11130 | -9675 | 7034 |
TRAV19 | -9587 | -9220 | -3070 |
TRAV29DV5 | -9353 | -9250 | -1621 |
TRAV8-4 | -7010 | -4747 | 11211 |
TRBC1 | -11646 | -9275 | 1902 |
TRBV12-3 | -10099 | -9942 | -8483 |
TRBV7-9 | -9220 | -8276 | -4880 |
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
metric | value |
---|---|
setSize | 20 |
pMANOVA | 0.000146 |
p.adjustMANOVA | 0.000566 |
s.dist | 0.725 |
s.t0_v_pod | 0.513 |
s.pod_crp | 0.383 |
s.t0_crp | -0.342 |
p.t0_v_pod | 7.17e-05 |
p.pod_crp | 0.00306 |
p.t0_crp | 0.00808 |
Gene | t0_v_pod | pod_crp |
---|---|---|
LMNB1 | 9186 | 10717 |
CDK5 | 8475 | 10442 |
CAPN1 | 8424 | 10386 |
FOXO3 | 8540 | 9639 |
YWHAE | 8892 | 8844 |
CAPNS1 | 7613 | 10022 |
BCL2L11 | 7274 | 9012 |
GOLGA2 | 6117 | 9269 |
APP | 9022 | 6180 |
CAST | 8036 | 6183 |
SOD2 | 4346 | 7197 |
PRDX1 | 6927 | 3767 |
JUN | 3688 | 3095 |
LMNA | 3849 | 2060 |
CAPN2 | 1055 | 5319 |
CDC25A | 2888 | 315 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
APP | 9022 | 6180 | -6109 |
BCL2L11 | 7274 | 9012 | -799 |
CAPN1 | 8424 | 10386 | -7700 |
CAPN2 | 1055 | 5319 | 5265 |
CAPNS1 | 7613 | 10022 | -4453 |
CAST | 8036 | 6183 | -3098 |
CDC25A | 2888 | 315 | -3716 |
CDC25B | -11657 | -9722 | 2652 |
CDK5 | 8475 | 10442 | -708 |
CDK5R1 | -1075 | 1351 | -6946 |
FASLG | -12008 | -7205 | -3008 |
FOXO3 | 8540 | 9639 | -6589 |
GOLGA2 | 6117 | 9269 | -3697 |
JUN | 3688 | 3095 | -5986 |
LMNA | 3849 | 2060 | -5944 |
LMNB1 | 9186 | 10717 | 8859 |
PRDX1 | 6927 | 3767 | 3340 |
PRDX2 | 3398 | -4018 | -5960 |
SOD2 | 4346 | 7197 | 3619 |
YWHAE | 8892 | 8844 | 1002 |
Neurodegenerative Diseases
metric | value |
---|---|
setSize | 20 |
pMANOVA | 0.000146 |
p.adjustMANOVA | 0.000566 |
s.dist | 0.725 |
s.t0_v_pod | 0.513 |
s.pod_crp | 0.383 |
s.t0_crp | -0.342 |
p.t0_v_pod | 7.17e-05 |
p.pod_crp | 0.00306 |
p.t0_crp | 0.00808 |
Gene | t0_v_pod | pod_crp |
---|---|---|
LMNB1 | 9186 | 10717 |
CDK5 | 8475 | 10442 |
CAPN1 | 8424 | 10386 |
FOXO3 | 8540 | 9639 |
YWHAE | 8892 | 8844 |
CAPNS1 | 7613 | 10022 |
BCL2L11 | 7274 | 9012 |
GOLGA2 | 6117 | 9269 |
APP | 9022 | 6180 |
CAST | 8036 | 6183 |
SOD2 | 4346 | 7197 |
PRDX1 | 6927 | 3767 |
JUN | 3688 | 3095 |
LMNA | 3849 | 2060 |
CAPN2 | 1055 | 5319 |
CDC25A | 2888 | 315 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
APP | 9022 | 6180 | -6109 |
BCL2L11 | 7274 | 9012 | -799 |
CAPN1 | 8424 | 10386 | -7700 |
CAPN2 | 1055 | 5319 | 5265 |
CAPNS1 | 7613 | 10022 | -4453 |
CAST | 8036 | 6183 | -3098 |
CDC25A | 2888 | 315 | -3716 |
CDC25B | -11657 | -9722 | 2652 |
CDK5 | 8475 | 10442 | -708 |
CDK5R1 | -1075 | 1351 | -6946 |
FASLG | -12008 | -7205 | -3008 |
FOXO3 | 8540 | 9639 | -6589 |
GOLGA2 | 6117 | 9269 | -3697 |
JUN | 3688 | 3095 | -5986 |
LMNA | 3849 | 2060 | -5944 |
LMNB1 | 9186 | 10717 | 8859 |
PRDX1 | 6927 | 3767 | 3340 |
PRDX2 | 3398 | -4018 | -5960 |
SOD2 | 4346 | 7197 | 3619 |
YWHAE | 8892 | 8844 | 1002 |
rRNA modification in the nucleus and cytosol
metric | value |
---|---|
setSize | 59 |
pMANOVA | 8.26e-14 |
p.adjustMANOVA | 1.54e-12 |
s.dist | 0.722 |
s.t0_v_pod | -0.397 |
s.pod_crp | -0.584 |
s.t0_crp | -0.152 |
p.t0_v_pod | 1.32e-07 |
p.pod_crp | 8.38e-15 |
p.t0_crp | 0.0435 |
Gene | pod_crp | t0_v_pod |
---|---|---|
DKC1 | -10110 | -11282 |
NAT10 | -9800 | -11593 |
BMS1 | -9598 | -11315 |
UTP4 | -9672 | -11142 |
NOP56 | -9416 | -11395 |
DDX47 | -9306 | -10949 |
NOP14 | -9613 | -10522 |
NOL11 | -9903 | -10134 |
FBL | -9913 | -9855 |
NOP58 | -10002 | -9623 |
WDR46 | -9028 | -10623 |
WDR75 | -9795 | -9593 |
UTP15 | -9128 | -10264 |
THUMPD1 | -9754 | -9477 |
EMG1 | -8716 | -9856 |
RRP9 | -8570 | -9748 |
NOL6 | -7807 | -10564 |
NOP2 | -8280 | -9624 |
IMP4 | -7130 | -10629 |
UTP20 | -7402 | -10191 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
BMS1 | -11315 | -9598 | -1337 |
DCAF13 | -5386 | -7538 | -2062 |
DDX47 | -10949 | -9306 | 8082 |
DDX49 | 4816 | 4046 | -8272 |
DDX52 | 448 | 1780 | 12323 |
DHX37 | -7983 | -4720 | -3600 |
DIMT1 | -7711 | -9624 | 8995 |
DKC1 | -11282 | -10110 | -3751 |
EMG1 | -9856 | -8716 | 8730 |
FBL | -9855 | -9913 | -8826 |
FCF1 | 4428 | 450 | 6199 |
GAR1 | -6703 | -7382 | 238 |
HEATR1 | -10009 | -7253 | 5481 |
IMP3 | -9143 | -6887 | -5060 |
IMP4 | -10629 | -7130 | -5576 |
KRR1 | -8329 | -7693 | 8202 |
MPHOSPH10 | -7519 | -8812 | 11917 |
NAT10 | -11593 | -9800 | -2380 |
NHP2 | -3373 | -6510 | -7363 |
NOC4L | -5298 | 1593 | 234 |
NOL11 | -10134 | -9903 | 8964 |
NOL6 | -10564 | -7807 | -3599 |
NOP10 | 8200 | 10199 | -7289 |
NOP14 | -10522 | -9613 | -4168 |
NOP2 | -9624 | -8280 | -6603 |
NOP56 | -11395 | -9416 | 246 |
NOP58 | -9623 | -10002 | 8617 |
PDCD11 | -11166 | -6522 | -2344 |
PNO1 | -6627 | -7977 | 9345 |
PWP2 | -1190 | -5399 | -7041 |
RCL1 | -751 | -7663 | -1012 |
RPS14 | -5278 | -8513 | -8637 |
RPS2 | -4354 | -9563 | -9021 |
RPS6 | -5956 | -9671 | -7892 |
RPS7 | -4803 | -9137 | -7874 |
RPS9 | 5358 | 1826 | -8433 |
RRP36 | -1645 | -390 | -5014 |
RRP7A | -2734 | -5222 | -4553 |
RRP9 | -9748 | -8570 | -7939 |
SNORD3A | -2477 | 10412 | 10967 |
SNU13 | -6637 | -8467 | -6973 |
TBL3 | -3341 | 732 | -6317 |
THUMPD1 | -9477 | -9754 | 7788 |
TRMT112 | 732 | -2281 | -8647 |
TSR3 | 3808 | 1485 | -8865 |
UTP11 | 4582 | -37 | 6683 |
UTP14A | -1788 | -3304 | 3687 |
UTP14C | -2032 | -2400 | 5261 |
UTP15 | -10264 | -9128 | 11648 |
UTP18 | 5055 | 3815 | 4880 |
UTP20 | -10191 | -7402 | 9700 |
UTP3 | -2829 | -4799 | -4079 |
UTP4 | -11142 | -9672 | 3675 |
UTP6 | -4362 | -8588 | 8987 |
WDR3 | -6394 | -6991 | 570 |
WDR36 | -3825 | -5050 | 5877 |
WDR43 | -7419 | -9367 | 167 |
WDR46 | -10623 | -9028 | -8694 |
WDR75 | -9593 | -9795 | 7835 |
EGFR downregulation
metric | value |
---|---|
setSize | 27 |
pMANOVA | 1.4e-06 |
p.adjustMANOVA | 9.99e-06 |
s.dist | 0.713 |
s.t0_v_pod | 0.46 |
s.pod_crp | 0.294 |
s.t0_crp | -0.459 |
p.t0_v_pod | 3.48e-05 |
p.pod_crp | 0.00823 |
p.t0_crp | 3.69e-05 |
Gene | t0_v_pod | t0_crp |
---|---|---|
EPN1 | 7922 | -7974 |
SH3GL1 | 7509 | -8046 |
GRB2 | 9146 | -5185 |
AREG | 5897 | -7756 |
EGF | 8050 | -5617 |
TGFA | 8740 | -5172 |
UBB | 6548 | -6697 |
HBEGF | 4954 | -8152 |
PTPN12 | 8023 | -4074 |
EPS15L1 | 3621 | -5039 |
UBC | 4395 | -4003 |
SPRY1 | 2289 | -7416 |
EREG | 1875 | -7212 |
CBL | 7368 | -1624 |
UBA52 | 1112 | -8207 |
SH3KBP1 | 6089 | -751 |
HGS | 4468 | -507 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AREG | 5897 | 2368 | -7756 |
ARHGEF7 | -4434 | -471 | -6407 |
CBL | 7368 | 9736 | -1624 |
CDC42 | 7425 | 8226 | 5599 |
EGF | 8050 | 5218 | -5617 |
EPGN | 2642 | -1230 | 1721 |
EPN1 | 7922 | 10507 | -7974 |
EPS15 | 4097 | 5996 | 11320 |
EPS15L1 | 3621 | 8342 | -5039 |
EREG | 1875 | -246 | -7212 |
GRB2 | 9146 | 10542 | -5185 |
HBEGF | 4954 | 2048 | -8152 |
HGS | 4468 | 9176 | -507 |
PTPN12 | 8023 | 7625 | -4074 |
PTPN3 | -85 | 188 | -1690 |
PTPRK | -7011 | -9114 | -7295 |
RPS27A | -6700 | -9695 | -8668 |
SH3GL1 | 7509 | 9479 | -8046 |
SH3KBP1 | 6089 | 5825 | -751 |
SPRY1 | 2289 | -1262 | -7416 |
SPRY2 | -4453 | 3846 | -3763 |
STAM | 1275 | 898 | 3823 |
STAM2 | 6075 | 7339 | 11256 |
TGFA | 8740 | 10781 | -5172 |
UBA52 | 1112 | -3471 | -8207 |
UBB | 6548 | 1016 | -6697 |
UBC | 4395 | 6071 | -4003 |
Activation of ATR in response to replication stress
metric | value |
---|---|
setSize | 36 |
pMANOVA | 2.43e-07 |
p.adjustMANOVA | 2.15e-06 |
s.dist | 0.713 |
s.t0_v_pod | -0.452 |
s.pod_crp | -0.516 |
s.t0_crp | 0.194 |
p.t0_v_pod | 2.73e-06 |
p.pod_crp | 8.15e-08 |
p.t0_crp | 0.0435 |
Gene | pod_crp | t0_v_pod |
---|---|---|
MCM3 | -9914 | -11839 |
RAD1 | -9868 | -11845 |
RPA1 | -9771 | -11644 |
MCM7 | -9297 | -11768 |
RFC3 | -9377 | -10151 |
DBF4 | -8879 | -10581 |
RFC4 | -8869 | -10361 |
RFC5 | -7548 | -11357 |
RAD17 | -8465 | -9973 |
RAD9A | -7436 | -11083 |
ORC3 | -7862 | -10371 |
MCM6 | -8603 | -9393 |
RPA3 | -9192 | -8609 |
ORC2 | -8229 | -9594 |
ORC5 | -8511 | -9161 |
MCM8 | -5689 | -10599 |
MCM4 | -7061 | -8404 |
ATR | -5316 | -10018 |
MCM2 | -6855 | -6973 |
ATRIP | -3584 | -11134 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ATR | -10018 | -5316 | 8973 |
ATRIP | -11134 | -3584 | 6208 |
CDC25A | 2888 | 315 | -3716 |
CDC45 | -2594 | -5110 | 1889 |
CDC6 | 2356 | -1584 | 3684 |
CDC7 | -7583 | -4471 | -125 |
CDK2 | -4840 | -3595 | 835 |
CHEK1 | -2421 | -6118 | 4970 |
CLSPN | 3606 | 1952 | 9332 |
DBF4 | -10581 | -8879 | 10352 |
HUS1 | -145 | 4198 | 8777 |
MCM10 | 769 | -4565 | 4390 |
MCM2 | -6973 | -6855 | -3428 |
MCM3 | -11839 | -9914 | -2392 |
MCM4 | -8404 | -7061 | 3202 |
MCM5 | -7039 | -2312 | -5776 |
MCM6 | -9393 | -8603 | 109 |
MCM7 | -11768 | -9297 | -1374 |
MCM8 | -10599 | -5689 | 7587 |
ORC1 | -2459 | -2954 | 1035 |
ORC2 | -9594 | -8229 | 7471 |
ORC3 | -10371 | -7862 | 10286 |
ORC4 | -1988 | -6242 | 8361 |
ORC5 | -9161 | -8511 | 9855 |
ORC6 | 1174 | 5286 | 4883 |
RAD1 | -11845 | -9868 | 7325 |
RAD17 | -9973 | -8465 | 7802 |
RAD9A | -11083 | -7436 | 3975 |
RAD9B | 3065 | 6526 | 8458 |
RFC2 | 4890 | 5426 | -5388 |
RFC3 | -10151 | -9377 | 2304 |
RFC4 | -10361 | -8869 | 7610 |
RFC5 | -11357 | -7548 | 3954 |
RPA1 | -11644 | -9771 | -3472 |
RPA2 | -6094 | -4789 | 4026 |
RPA3 | -8609 | -9192 | 2284 |
Lagging Strand Synthesis
metric | value |
---|---|
setSize | 20 |
pMANOVA | 0.000414 |
p.adjustMANOVA | 0.0014 |
s.dist | 0.71 |
s.t0_v_pod | -0.452 |
s.pod_crp | -0.546 |
s.t0_crp | 0.038 |
p.t0_v_pod | 0.000465 |
p.pod_crp | 2.35e-05 |
p.t0_crp | 0.769 |
Gene | pod_crp | t0_v_pod |
---|---|---|
POLA1 | -9813 | -11789 |
RPA1 | -9771 | -11644 |
LIG1 | -9441 | -10705 |
POLD2 | -10025 | -10015 |
RFC3 | -9377 | -10151 |
RFC4 | -8869 | -10361 |
PRIM1 | -9138 | -9858 |
POLA2 | -7923 | -11222 |
RFC5 | -7548 | -11357 |
RPA3 | -9192 | -8609 |
FEN1 | -6460 | -10254 |
PCNA | -7076 | -5771 |
PRIM2 | -7087 | -5389 |
RFC1 | -5058 | -7180 |
RPA2 | -4789 | -6094 |
DNA2 | -6282 | -2786 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
DNA2 | -2786 | -6282 | 10381 |
FEN1 | -10254 | -6460 | -2374 |
LIG1 | -10705 | -9441 | -1548 |
PCNA | -5771 | -7076 | 6465 |
POLA1 | -11789 | -9813 | 1029 |
POLA2 | -11222 | -7923 | 8950 |
POLD1 | 202 | -2557 | -6206 |
POLD2 | -10015 | -10025 | -5321 |
POLD3 | 8737 | 10508 | 2974 |
POLD4 | 6250 | 8949 | -6951 |
PRIM1 | -9858 | -9138 | 10019 |
PRIM2 | -5389 | -7087 | 2832 |
RFC1 | -7180 | -5058 | 9646 |
RFC2 | 4890 | 5426 | -5388 |
RFC3 | -10151 | -9377 | 2304 |
RFC4 | -10361 | -8869 | 7610 |
RFC5 | -11357 | -7548 | 3954 |
RPA1 | -11644 | -9771 | -3472 |
RPA2 | -6094 | -4789 | 4026 |
RPA3 | -8609 | -9192 | 2284 |
Budding and maturation of HIV virion
metric | value |
---|---|
setSize | 26 |
pMANOVA | 1.32e-05 |
p.adjustMANOVA | 6.96e-05 |
s.dist | 0.708 |
s.t0_v_pod | 0.525 |
s.pod_crp | 0.373 |
s.t0_crp | -0.293 |
p.t0_v_pod | 3.5e-06 |
p.pod_crp | 0.00098 |
p.t0_crp | 0.00975 |
Gene | t0_v_pod | pod_crp |
---|---|---|
UBAP1 | 8559 | 10174 |
CHMP4B | 8718 | 9980 |
CHMP2A | 8635 | 10030 |
VPS37C | 7888 | 10221 |
CHMP3 | 8217 | 8485 |
NEDD4L | 7755 | 8958 |
TSG101 | 7669 | 7800 |
PDCD6IP | 6440 | 9153 |
VPS37A | 6379 | 8637 |
MVB12A | 7290 | 6903 |
CHMP5 | 4886 | 9864 |
MVB12B | 5115 | 8610 |
CHMP6 | 5434 | 7713 |
VPS37B | 3869 | 8493 |
UBC | 4395 | 6071 |
VPS4B | 5151 | 4876 |
VTA1 | 6101 | 3904 |
CHMP2B | 5641 | 3060 |
CHMP4A | 2384 | 3434 |
UBB | 6548 | 1016 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CHMP2A | 8635 | 10030 | -7692 |
CHMP2B | 5641 | 3060 | 6804 |
CHMP3 | 8217 | 8485 | 705 |
CHMP4A | 2384 | 3434 | 4816 |
CHMP4B | 8718 | 9980 | -8710 |
CHMP5 | 4886 | 9864 | 11784 |
CHMP6 | 5434 | 7713 | -8792 |
CHMP7 | -8503 | -9011 | -215 |
MVB12A | 7290 | 6903 | -8242 |
MVB12B | 5115 | 8610 | -695 |
NEDD4L | 7755 | 8958 | -3521 |
PDCD6IP | 6440 | 9153 | 8901 |
PPIA | -6535 | -6473 | -6217 |
RPS27A | -6700 | -9695 | -8668 |
TSG101 | 7669 | 7800 | 4356 |
UBA52 | 1112 | -3471 | -8207 |
UBAP1 | 8559 | 10174 | -5375 |
UBB | 6548 | 1016 | -6697 |
UBC | 4395 | 6071 | -4003 |
VPS28 | 4156 | -749 | -8515 |
VPS37A | 6379 | 8637 | 9727 |
VPS37B | 3869 | 8493 | -7026 |
VPS37C | 7888 | 10221 | -935 |
VPS4A | 777 | 167 | -8270 |
VPS4B | 5151 | 4876 | 7128 |
VTA1 | 6101 | 3904 | 9297 |
Processive synthesis on the lagging strand
metric | value |
---|---|
setSize | 15 |
pMANOVA | 0.00333 |
p.adjustMANOVA | 0.00831 |
s.dist | 0.7 |
s.t0_v_pod | -0.431 |
s.pod_crp | -0.552 |
s.t0_crp | -0.0108 |
p.t0_v_pod | 0.00386 |
p.pod_crp | 0.000214 |
p.t0_crp | 0.942 |
Gene | pod_crp | t0_v_pod |
---|---|---|
POLA1 | -9813 | -11789 |
RPA1 | -9771 | -11644 |
LIG1 | -9441 | -10705 |
POLD2 | -10025 | -10015 |
PRIM1 | -9138 | -9858 |
POLA2 | -7923 | -11222 |
RPA3 | -9192 | -8609 |
FEN1 | -6460 | -10254 |
PCNA | -7076 | -5771 |
PRIM2 | -7087 | -5389 |
RPA2 | -4789 | -6094 |
DNA2 | -6282 | -2786 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
DNA2 | -2786 | -6282 | 10381 |
FEN1 | -10254 | -6460 | -2374 |
LIG1 | -10705 | -9441 | -1548 |
PCNA | -5771 | -7076 | 6465 |
POLA1 | -11789 | -9813 | 1029 |
POLA2 | -11222 | -7923 | 8950 |
POLD1 | 202 | -2557 | -6206 |
POLD2 | -10015 | -10025 | -5321 |
POLD3 | 8737 | 10508 | 2974 |
POLD4 | 6250 | 8949 | -6951 |
PRIM1 | -9858 | -9138 | 10019 |
PRIM2 | -5389 | -7087 | 2832 |
RPA1 | -11644 | -9771 | -3472 |
RPA2 | -6094 | -4789 | 4026 |
RPA3 | -8609 | -9192 | 2284 |
InlB-mediated entry of Listeria monocytogenes into host cell
metric | value |
---|---|
setSize | 12 |
pMANOVA | 0.00869 |
p.adjustMANOVA | 0.0188 |
s.dist | 0.7 |
s.t0_v_pod | 0.525 |
s.pod_crp | 0.361 |
s.t0_crp | -0.29 |
p.t0_v_pod | 0.00164 |
p.pod_crp | 0.0306 |
p.t0_crp | 0.0822 |
Gene | t0_v_pod | pod_crp |
---|---|---|
GRB2 | 9146 | 10542 |
CBL | 7368 | 9736 |
SH3GL1 | 7509 | 9479 |
STAM2 | 6075 | 7339 |
HGS | 4468 | 9176 |
SH3KBP1 | 6089 | 5825 |
UBC | 4395 | 6071 |
EPS15 | 4097 | 5996 |
UBB | 6548 | 1016 |
STAM | 1275 | 898 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CBL | 7368 | 9736 | -1624 |
EPS15 | 4097 | 5996 | 11320 |
GRB2 | 9146 | 10542 | -5185 |
HGS | 4468 | 9176 | -507 |
RPS27A | -6700 | -9695 | -8668 |
SH3GL1 | 7509 | 9479 | -8046 |
SH3KBP1 | 6089 | 5825 | -751 |
STAM | 1275 | 898 | 3823 |
STAM2 | 6075 | 7339 | 11256 |
UBA52 | 1112 | -3471 | -8207 |
UBB | 6548 | 1016 | -6697 |
UBC | 4395 | 6071 | -4003 |
Influenza Infection
metric | value |
---|---|
setSize | 154 |
pMANOVA | 8.65e-49 |
p.adjustMANOVA | 4.36e-47 |
s.dist | 0.699 |
s.t0_v_pod | -0.181 |
s.pod_crp | -0.499 |
s.t0_crp | -0.455 |
p.t0_v_pod | 0.000107 |
p.pod_crp | 1.06e-26 |
p.t0_crp | 1.61e-22 |
Gene | pod_crp | t0_crp |
---|---|---|
RPL3 | -9928 | -8773 |
RPS2 | -9563 | -9021 |
RPS27A | -9695 | -8668 |
RPL14 | -9670 | -8650 |
RPLP2 | -9135 | -9001 |
RPS12 | -9242 | -8852 |
RPS3 | -9270 | -8726 |
RPLP0 | -9199 | -8702 |
RPS27 | -9147 | -8693 |
RPL10 | -9003 | -8829 |
RPL7 | -9737 | -8087 |
RPS23 | -9359 | -8319 |
RPL27A | -9020 | -8573 |
RPS29 | -8609 | -8958 |
RPS6 | -9671 | -7892 |
RPL31 | -8741 | -8685 |
RPL30 | -8902 | -8504 |
RPL29 | -8593 | -8787 |
RPS5 | -9014 | -8342 |
RPL18A | -8868 | -8439 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AAAS | -8101 | -3313 | -2106 |
CALR | 6254 | 7615 | 3125 |
CANX | 5462 | 3303 | 265 |
CLTA | 8244 | 7078 | -5807 |
CLTC | 8849 | 10126 | -1573 |
CPSF4 | -9100 | -4004 | -6293 |
DNAJC3 | 8302 | 9670 | 4528 |
EIF2AK2 | -8803 | 5541 | 12317 |
FAU | -359 | -3599 | -8841 |
GRSF1 | 5110 | -2905 | 1530 |
GTF2F1 | 4893 | 6665 | -7408 |
GTF2F2 | 5371 | 6192 | 438 |
HSP90AA1 | 1316 | -3995 | 7175 |
HSPA1A | 7946 | 9200 | -6997 |
IPO5 | -10252 | -10100 | -1600 |
ISG15 | -11672 | -5052 | 11864 |
KPNA1 | 1286 | -1299 | 6174 |
KPNA2 | -6675 | -2520 | 5087 |
KPNA3 | 916 | -1951 | 8594 |
KPNA4 | 4899 | 5641 | 9435 |
KPNA5 | -11535 | -8989 | 11307 |
KPNB1 | 2414 | 5550 | 9459 |
NDC1 | -11812 | -10048 | 3076 |
NUP107 | -10085 | -8258 | 10051 |
NUP133 | -7491 | -5322 | 4290 |
NUP153 | -6108 | 252 | 4792 |
NUP155 | -9900 | -7036 | 7468 |
NUP160 | -10219 | -8330 | 7352 |
NUP188 | -11270 | -7926 | -3035 |
NUP205 | -10971 | -7490 | 2507 |
NUP210 | -10384 | -3928 | -3875 |
NUP214 | 7800 | 9957 | -379 |
NUP35 | -10272 | -9698 | 3192 |
NUP37 | 3049 | -2260 | 1416 |
NUP42 | -5378 | -4024 | 11148 |
NUP43 | -9198 | -8341 | 11362 |
NUP50 | 4476 | 2618 | 7485 |
NUP54 | -8189 | -7106 | 12095 |
NUP58 | 8674 | 9426 | 5938 |
NUP62 | 763 | -2395 | -4223 |
NUP85 | -2971 | -3408 | 2948 |
NUP88 | -11046 | -9640 | 5761 |
NUP93 | -11266 | -6433 | 6407 |
NUP98 | 3075 | 5814 | 2773 |
PABPN1 | -522 | -1776 | -6898 |
PARP1 | -11409 | -8364 | -1542 |
POLR2A | -3010 | 7751 | -1889 |
POLR2B | -2462 | -3365 | 1497 |
POLR2C | 1603 | -488 | -4803 |
POLR2D | -3902 | -6831 | 4997 |
POLR2E | 7450 | 5062 | -8755 |
POLR2F | 4555 | 4218 | -8409 |
POLR2G | 3477 | 4138 | -8391 |
POLR2H | -2867 | -6175 | -6959 |
POLR2I | 394 | -3908 | -8198 |
POLR2J | 6580 | 5544 | -7980 |
POLR2K | -1750 | -4885 | 7558 |
POLR2L | 5244 | 2000 | -9013 |
POM121 | -8013 | -140 | -3047 |
POM121C | -6940 | -1697 | -6610 |
RAE1 | 5105 | 4962 | 4462 |
RAN | -6558 | -8447 | 285 |
RANBP2 | -814 | -1130 | 7725 |
RPL10 | -6311 | -9003 | -8829 |
RPL10A | -6458 | -8900 | -6147 |
RPL11 | -6052 | -9089 | -6722 |
RPL12 | -6811 | -9149 | -8024 |
RPL13 | -3335 | -7644 | -6367 |
RPL13A | -7928 | -9374 | -6207 |
RPL14 | -6480 | -9670 | -8650 |
RPL15 | -953 | -8142 | -8235 |
RPL17 | -5249 | -9088 | -8079 |
RPL18 | -4911 | -8835 | -8406 |
RPL18A | -5869 | -8868 | -8439 |
RPL19 | -6071 | -8311 | -8149 |
RPL21 | -6241 | -9483 | -7230 |
RPL22 | -4587 | -9631 | -7480 |
RPL22L1 | -1593 | -8175 | 527 |
RPL23 | -3223 | -8346 | -7486 |
RPL23A | -9248 | -9950 | -4950 |
RPL24 | -5606 | -8873 | -7028 |
RPL26 | -6387 | -8678 | -8038 |
RPL26L1 | 7070 | 5940 | -5499 |
RPL27 | -2783 | -7783 | -8809 |
RPL27A | -6048 | -9020 | -8573 |
RPL28 | -1441 | -3852 | -5654 |
RPL29 | -3505 | -8593 | -8787 |
RPL3 | -8268 | -9928 | -8773 |
RPL30 | -6779 | -8902 | -8504 |
RPL31 | -4394 | -8741 | -8685 |
RPL32 | -6479 | -9317 | -7991 |
RPL34 | -6569 | -9464 | -6337 |
RPL35 | -7809 | -8156 | -7893 |
RPL35A | -5816 | -9263 | -7997 |
RPL36 | -5111 | -7467 | -8861 |
RPL36A | -7122 | -8881 | -8095 |
RPL36AL | 32 | -6621 | -8799 |
RPL37 | -6160 | -7834 | -9017 |
RPL37A | -3826 | -6808 | -8683 |
RPL38 | -5646 | -7941 | -8932 |
RPL39 | -2931 | -8607 | -8362 |
RPL39L | -8506 | -1648 | -4731 |
RPL3L | 4458 | 5102 | 10556 |
RPL4 | -3476 | -9521 | -7062 |
RPL41 | -6632 | -7535 | -8456 |
RPL5 | -4576 | -9853 | -7157 |
RPL6 | -3262 | -9281 | -3434 |
RPL7 | -1917 | -9737 | -8087 |
RPL7A | -3557 | -8259 | -8751 |
RPL8 | -1171 | -6076 | -8899 |
RPL9 | -1837 | -6796 | -4391 |
RPLP0 | -987 | -9199 | -8702 |
RPLP1 | 19 | -5994 | -8833 |
RPLP2 | -6844 | -9135 | -9001 |
RPS10 | -5601 | -8466 | -8823 |
RPS11 | -6992 | -7948 | -8743 |
RPS12 | -5788 | -9242 | -8852 |
RPS13 | -1717 | -8696 | -7869 |
RPS14 | -5278 | -8513 | -8637 |
RPS15 | -3565 | -6678 | -8273 |
RPS15A | -5550 | -8855 | -8431 |
RPS16 | -4518 | -8551 | -8704 |
RPS17 | -6038 | -8254 | -8928 |
RPS18 | -7474 | -8294 | -7671 |
RPS19 | -6725 | -7779 | -8460 |
RPS2 | -4354 | -9563 | -9021 |
RPS20 | -8585 | -9385 | -6156 |
RPS21 | -3952 | -8303 | -8855 |
RPS23 | -6081 | -9359 | -8319 |
RPS24 | -261 | -6793 | -4573 |
RPS25 | -6151 | -9636 | -7764 |
RPS26 | -1410 | -1143 | -462 |
RPS27 | -9432 | -9147 | -8693 |
RPS27A | -6700 | -9695 | -8668 |
RPS27L | 2048 | -490 | 9654 |
RPS28 | -4562 | -8056 | -8562 |
RPS29 | -7664 | -8609 | -8958 |
RPS3 | -5717 | -9270 | -8726 |
RPS3A | -4543 | -9806 | -4045 |
RPS4X | -6075 | -8620 | -4665 |
RPS4Y1 | 418 | 329 | 1713 |
RPS5 | -5502 | -9014 | -8342 |
RPS6 | -5956 | -9671 | -7892 |
RPS7 | -4803 | -9137 | -7874 |
RPS8 | -2041 | -8833 | -6710 |
RPS9 | 5358 | 1826 | -8433 |
RPSA | -6110 | -6604 | 3504 |
SEC13 | 5675 | 7411 | -5667 |
SEH1L | -5868 | -9546 | 7736 |
SLC25A6 | 6178 | -5564 | -9035 |
TGFB1 | 5094 | 5452 | -7584 |
TPR | -6786 | -3724 | 8739 |
UBA52 | 1112 | -3471 | -8207 |
XPO1 | -1169 | -3195 | 11634 |
IRAK1 recruits IKK complex
metric | value |
---|---|
setSize | 10 |
pMANOVA | 0.029 |
p.adjustMANOVA | 0.0522 |
s.dist | 0.699 |
s.t0_v_pod | 0.533 |
s.pod_crp | 0.404 |
s.t0_crp | -0.203 |
p.t0_v_pod | 0.00352 |
p.pod_crp | 0.0271 |
p.t0_crp | 0.267 |
Gene | t0_v_pod | pod_crp |
---|---|---|
PELI3 | 7600 | 8988 |
CHUK | 7844 | 8599 |
PELI2 | 8183 | 6100 |
IKBKG | 5315 | 9298 |
IRAK1 | 6047 | 7868 |
PELI1 | 6623 | 4760 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CHUK | 7844 | 8599 | 3409 |
IKBKB | -5208 | 1744 | -158 |
IKBKG | 5315 | 9298 | -5591 |
IRAK1 | 6047 | 7868 | -7655 |
PELI1 | 6623 | 4760 | 2085 |
PELI2 | 8183 | 6100 | -2290 |
PELI3 | 7600 | 8988 | -8891 |
TRAF6 | -229 | 4631 | 6648 |
UBE2N | 1923 | -2057 | 7242 |
UBE2V1 | 5568 | -1241 | 73 |
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
metric | value |
---|---|
setSize | 10 |
pMANOVA | 0.029 |
p.adjustMANOVA | 0.0522 |
s.dist | 0.699 |
s.t0_v_pod | 0.533 |
s.pod_crp | 0.404 |
s.t0_crp | -0.203 |
p.t0_v_pod | 0.00352 |
p.pod_crp | 0.0271 |
p.t0_crp | 0.267 |
Gene | t0_v_pod | pod_crp |
---|---|---|
PELI3 | 7600 | 8988 |
CHUK | 7844 | 8599 |
PELI2 | 8183 | 6100 |
IKBKG | 5315 | 9298 |
IRAK1 | 6047 | 7868 |
PELI1 | 6623 | 4760 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CHUK | 7844 | 8599 | 3409 |
IKBKB | -5208 | 1744 | -158 |
IKBKG | 5315 | 9298 | -5591 |
IRAK1 | 6047 | 7868 | -7655 |
PELI1 | 6623 | 4760 | 2085 |
PELI2 | 8183 | 6100 | -2290 |
PELI3 | 7600 | 8988 | -8891 |
TRAF6 | -229 | 4631 | 6648 |
UBE2N | 1923 | -2057 | 7242 |
UBE2V1 | 5568 | -1241 | 73 |
Smooth Muscle Contraction
metric | value |
---|---|
setSize | 31 |
pMANOVA | 2.08e-06 |
p.adjustMANOVA | 1.42e-05 |
s.dist | 0.698 |
s.t0_v_pod | 0.494 |
s.pod_crp | 0.369 |
s.t0_crp | -0.329 |
p.t0_v_pod | 1.95e-06 |
p.pod_crp | 0.000381 |
p.t0_crp | 0.00153 |
Gene | t0_v_pod | pod_crp |
---|---|---|
DYSF | 9303 | 11209 |
ANXA2 | 8405 | 10514 |
MYL6B | 8049 | 10602 |
MYL6 | 8436 | 10011 |
TLN1 | 8386 | 10017 |
ITGA1 | 8585 | 9368 |
PAK1 | 8100 | 9873 |
TPM3 | 7927 | 9850 |
TPM4 | 9085 | 8573 |
PAK2 | 8056 | 8912 |
PXN | 6144 | 9961 |
VCL | 7218 | 6129 |
CALD1 | 8086 | 5462 |
TPM1 | 7918 | 5288 |
ANXA1 | 7722 | 5179 |
MYL12A | 6801 | 5368 |
MYL12B | 5029 | 5646 |
MYL5 | 3245 | 6615 |
ITGB5 | 6823 | 2971 |
MYL9 | 7587 | 1915 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ACTA2 | -426 | -157 | -1984 |
ANXA1 | 7722 | 5179 | -7190 |
ANXA2 | 8405 | 10514 | -659 |
ANXA6 | 325 | 4237 | -7210 |
CALD1 | 8086 | 5462 | -2715 |
CALM1 | -2039 | -1234 | 3538 |
DYSF | 9303 | 11209 | -1125 |
GUCY1B2 | -4887 | -5571 | -2578 |
ITGA1 | 8585 | 9368 | 3499 |
ITGB5 | 6823 | 2971 | -5811 |
MYH11 | -3419 | -2228 | 6330 |
MYL12A | 6801 | 5368 | -1845 |
MYL12B | 5029 | 5646 | -3168 |
MYL5 | 3245 | 6615 | -1221 |
MYL6 | 8436 | 10011 | -8786 |
MYL6B | 8049 | 10602 | -33 |
MYL9 | 7587 | 1915 | -4389 |
MYLK | 6528 | 1255 | -1100 |
MYLPF | -8570 | -6318 | -3584 |
PAK1 | 8100 | 9873 | 7050 |
PAK2 | 8056 | 8912 | 4639 |
PXN | 6144 | 9961 | -7143 |
SORBS1 | 1465 | 8839 | 1248 |
SORBS3 | -10631 | -10071 | -8082 |
TLN1 | 8386 | 10017 | -6948 |
TPM1 | 7918 | 5288 | -4678 |
TPM2 | -8870 | -7925 | -4857 |
TPM3 | 7927 | 9850 | 2062 |
TPM4 | 9085 | 8573 | -6015 |
TRIM72 | 1866 | 4978 | 10002 |
VCL | 7218 | 6129 | -4751 |
Signal transduction by L1
metric | value |
---|---|
setSize | 20 |
pMANOVA | 0.000429 |
p.adjustMANOVA | 0.00144 |
s.dist | 0.698 |
s.t0_v_pod | 0.438 |
s.pod_crp | 0.507 |
s.t0_crp | -0.194 |
p.t0_v_pod | 0.00069 |
p.pod_crp | 8.61e-05 |
p.t0_crp | 0.132 |
Gene | pod_crp | t0_v_pod |
---|---|---|
RAC1 | 10438 | 8647 |
MAP2K1 | 9974 | 8910 |
MAPK3 | 9593 | 8803 |
MAPK1 | 10983 | 7381 |
PAK1 | 9873 | 8100 |
ITGA5 | 9684 | 7543 |
ITGA2B | 7297 | 8744 |
CSNK2A1 | 8910 | 6113 |
ITGA9 | 7707 | 6840 |
MAP2K2 | 7135 | 6699 |
ITGAV | 7746 | 6022 |
CSNK2A2 | 7252 | 6301 |
ITGB3 | 2918 | 8161 |
CSNK2B | 5816 | 3930 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CSNK2A1 | 6113 | 8910 | 2123 |
CSNK2A2 | 6301 | 7252 | 2705 |
CSNK2B | 3930 | 5816 | -2975 |
FGFR1 | -5175 | 6536 | 3650 |
ITGA2B | 8744 | 7297 | -5705 |
ITGA5 | 7543 | 9684 | -8177 |
ITGA9 | 6840 | 7707 | 250 |
ITGAV | 6022 | 7746 | 1880 |
ITGB1 | -94 | -3054 | 6089 |
ITGB3 | 8161 | 2918 | -7520 |
L1CAM | -6144 | -3106 | 10087 |
MAP2K1 | 8910 | 9974 | -7128 |
MAP2K2 | 6699 | 7135 | -8945 |
MAPK1 | 7381 | 10983 | -1505 |
MAPK3 | 8803 | 9593 | -9014 |
NCAM1 | -11351 | -5120 | -7102 |
NRP1 | -8419 | 6156 | 10552 |
PAK1 | 8100 | 9873 | 7050 |
RAC1 | 8647 | 10438 | 3441 |
VAV2 | -3931 | 2731 | 1831 |
Cargo concentration in the ER
metric | value |
---|---|
setSize | 30 |
pMANOVA | 1.41e-05 |
p.adjustMANOVA | 7.42e-05 |
s.dist | 0.697 |
s.t0_v_pod | 0.52 |
s.pod_crp | 0.463 |
s.t0_crp | -0.0357 |
p.t0_v_pod | 8.05e-07 |
p.pod_crp | 1.14e-05 |
p.t0_crp | 0.735 |
Gene | t0_v_pod | pod_crp |
---|---|---|
F5 | 9324 | 11214 |
SERPINA1 | 9013 | 11191 |
TGFA | 8740 | 10781 |
CTSZ | 8825 | 9776 |
SEC24D | 7988 | 10607 |
SEC24A | 7544 | 9271 |
LMAN2 | 6976 | 9335 |
PREB | 6281 | 10184 |
STX5 | 7060 | 8427 |
F8 | 6919 | 7922 |
SEC23A | 7225 | 7044 |
COL7A1 | 6218 | 7869 |
MIA2 | 5506 | 8089 |
SAR1B | 6391 | 6817 |
SEC22B | 5797 | 6207 |
MCFD2 | 6995 | 5086 |
TMED2 | 5971 | 5294 |
SEC24B | 3576 | 7263 |
CD59 | 5783 | 4214 |
CTSC | 2312 | 9136 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AREG | 5897 | 2368 | -7756 |
CD59 | 5783 | 4214 | -5137 |
CNIH1 | 7662 | -2681 | -3990 |
CNIH2 | 648 | 4148 | 3099 |
CNIH3 | -8703 | -4413 | -4085 |
COL7A1 | 6218 | 7869 | -7155 |
CTSC | 2312 | 9136 | 1722 |
CTSZ | 8825 | 9776 | -7490 |
F5 | 9324 | 11214 | 2591 |
F8 | 6919 | 7922 | 3429 |
GOSR2 | -1435 | 5925 | 9218 |
LMAN1 | -10289 | -8494 | 11039 |
LMAN2 | 6976 | 9335 | -5645 |
LMAN2L | 6837 | 1573 | -7399 |
MCFD2 | 6995 | 5086 | -3771 |
MIA2 | 5506 | 8089 | 11791 |
MIA3 | -6036 | -3666 | 10964 |
PREB | 6281 | 10184 | -4539 |
SAR1B | 6391 | 6817 | 12088 |
SEC22B | 5797 | 6207 | 11141 |
SEC23A | 7225 | 7044 | 5580 |
SEC24A | 7544 | 9271 | 7048 |
SEC24B | 3576 | 7263 | 6566 |
SEC24C | -2506 | 8866 | -1909 |
SEC24D | 7988 | 10607 | 5650 |
SERPINA1 | 9013 | 11191 | 4539 |
STX5 | 7060 | 8427 | -7349 |
TGFA | 8740 | 10781 | -5172 |
TMED10 | 321 | -4392 | -3223 |
TMED2 | 5971 | 5294 | 6374 |
GRB2:SOS provides linkage to MAPK signaling for Integrins
metric | value |
---|---|
setSize | 12 |
pMANOVA | 0.00325 |
p.adjustMANOVA | 0.00812 |
s.dist | 0.697 |
s.t0_v_pod | 0.581 |
s.pod_crp | 0.325 |
s.t0_crp | -0.208 |
p.t0_v_pod | 0.000497 |
p.pod_crp | 0.051 |
p.t0_crp | 0.212 |
Gene | t0_v_pod | pod_crp |
---|---|---|
GRB2 | 9146 | 10542 |
APBB1IP | 8600 | 10436 |
TLN1 | 8386 | 10017 |
ITGA2B | 8744 | 7297 |
RAP1A | 7198 | 7246 |
VWF | 6550 | 3834 |
ITGB3 | 8161 | 2918 |
RAP1B | 3179 | 6882 |
PTK2 | 4418 | 385 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
APBB1IP | 8600 | 10436 | -610 |
FN1 | 8154 | -1816 | 4140 |
GRB2 | 9146 | 10542 | -5185 |
ITGA2B | 8744 | 7297 | -5705 |
ITGB3 | 8161 | 2918 | -7520 |
PTK2 | 4418 | 385 | -619 |
RAP1A | 7198 | 7246 | 9059 |
RAP1B | 3179 | 6882 | 6183 |
SOS1 | -5511 | -2964 | 11031 |
SRC | -8520 | -6371 | -3347 |
TLN1 | 8386 | 10017 | -6948 |
VWF | 6550 | 3834 | -7272 |
Transferrin endocytosis and recycling
metric | value |
---|---|
setSize | 26 |
pMANOVA | 2.18e-05 |
p.adjustMANOVA | 0.000106 |
s.dist | 0.696 |
s.t0_v_pod | 0.509 |
s.pod_crp | 0.37 |
s.t0_crp | -0.298 |
p.t0_v_pod | 7.03e-06 |
p.pod_crp | 0.00109 |
p.t0_crp | 0.00847 |
Gene | t0_v_pod | pod_crp |
---|---|---|
ATP6V0A1 | 9262 | 11071 |
ATP6V0D1 | 9088 | 10812 |
ATP6V0C | 8974 | 10793 |
ATP6AP1 | 8032 | 11126 |
ATP6V1D | 8894 | 9815 |
ATP6V1A | 9144 | 9387 |
ATP6V1B2 | 8904 | 9293 |
ATP6V1C1 | 8400 | 9733 |
ATP6V0B | 8458 | 9622 |
MCOLN1 | 7624 | 10550 |
TCIRG1 | 7082 | 10931 |
ATP6V0E1 | 8456 | 8299 |
ATP6V1E1 | 7912 | 8087 |
STEAP3 | 5915 | 9626 |
ATP6V1H | 7939 | 7019 |
ATP6V1F | 5802 | 3776 |
HFE | 8632 | 1838 |
TFRC | 1513 | 4799 |
TF | 1093 | 1234 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ATP6AP1 | 8032 | 11126 | -8542 |
ATP6V0A1 | 9262 | 11071 | -4129 |
ATP6V0A2 | -11850 | -6562 | 10591 |
ATP6V0B | 8458 | 9622 | -7822 |
ATP6V0C | 8974 | 10793 | -5635 |
ATP6V0D1 | 9088 | 10812 | -6200 |
ATP6V0E1 | 8456 | 8299 | -6597 |
ATP6V0E2 | -11202 | -9428 | 81 |
ATP6V1A | 9144 | 9387 | 639 |
ATP6V1B2 | 8904 | 9293 | -2076 |
ATP6V1C1 | 8400 | 9733 | 1842 |
ATP6V1C2 | -2175 | -2908 | 1018 |
ATP6V1D | 8894 | 9815 | 2539 |
ATP6V1E1 | 7912 | 8087 | 1529 |
ATP6V1E2 | 5657 | -3873 | -6954 |
ATP6V1F | 5802 | 3776 | -8689 |
ATP6V1G1 | 3892 | -4753 | -2897 |
ATP6V1G2 | -9197 | -9115 | 3143 |
ATP6V1H | 7939 | 7019 | -2464 |
HFE | 8632 | 1838 | -1502 |
MCOLN1 | 7624 | 10550 | -5540 |
STEAP3 | 5915 | 9626 | -3861 |
TCIRG1 | 7082 | 10931 | -5721 |
TF | 1093 | 1234 | 5787 |
TFR2 | -9464 | -3974 | -88 |
TFRC | 1513 | 4799 | 11773 |
EPHB-mediated forward signaling
metric | value |
---|---|
setSize | 32 |
pMANOVA | 8.88e-06 |
p.adjustMANOVA | 5.05e-05 |
s.dist | 0.696 |
s.t0_v_pod | 0.504 |
s.pod_crp | 0.475 |
s.t0_crp | -0.067 |
p.t0_v_pod | 8.17e-07 |
p.pod_crp | 3.24e-06 |
p.t0_crp | 0.512 |
Gene | t0_v_pod | pod_crp |
---|---|---|
ARPC1B | 9102 | 10587 |
ITSN1 | 9131 | 10546 |
ARPC1A | 8745 | 10779 |
ACTB | 8859 | 10421 |
RAC1 | 8647 | 10438 |
ARPC5 | 8544 | 9930 |
LYN | 7691 | 10614 |
ACTG1 | 8423 | 9524 |
PAK1 | 8100 | 9873 |
CFL1 | 8057 | 9633 |
RHOA | 8188 | 9259 |
LIMK2 | 7949 | 9535 |
ARPC3 | 8147 | 8602 |
ARPC4 | 7404 | 9441 |
ACTR2 | 7750 | 8769 |
ACTR3 | 7699 | 8747 |
ARPC2 | 7280 | 8886 |
ROCK1 | 7377 | 8572 |
CDC42 | 7425 | 8226 |
ROCK2 | 6054 | 6540 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ACTB | 8859 | 10421 | -4561 |
ACTG1 | 8423 | 9524 | -7556 |
ACTR2 | 7750 | 8769 | 5308 |
ACTR3 | 7699 | 8747 | 3145 |
ARHGEF28 | -9954 | 2366 | 6119 |
ARPC1A | 8745 | 10779 | 2238 |
ARPC1B | 9102 | 10587 | -8003 |
ARPC2 | 7280 | 8886 | -214 |
ARPC3 | 8147 | 8602 | 3314 |
ARPC4 | 7404 | 9441 | -4920 |
ARPC5 | 8544 | 9930 | 1879 |
CDC42 | 7425 | 8226 | 5599 |
CFL1 | 8057 | 9633 | -8162 |
FYN | -11320 | -5187 | -4239 |
HRAS | -3288 | -5249 | -5447 |
ITSN1 | 9131 | 10546 | 7645 |
KALRN | -3584 | -8050 | -3602 |
LIMK1 | 4628 | 7956 | -5779 |
LIMK2 | 7949 | 9535 | -1036 |
LYN | 7691 | 10614 | 7111 |
PAK1 | 8100 | 9873 | 7050 |
PTK2 | 4418 | 385 | -619 |
RAC1 | 8647 | 10438 | 3441 |
RASA1 | 2093 | 6185 | 10904 |
RHOA | 8188 | 9259 | -372 |
ROCK1 | 7377 | 8572 | 9620 |
ROCK2 | 6054 | 6540 | 7093 |
SDC2 | 5335 | 2307 | 307 |
SRC | -8520 | -6371 | -3347 |
TIAM1 | 645 | -3498 | -4756 |
WASL | 297 | 3268 | 7557 |
YES1 | -11781 | -2829 | 4373 |
Nucleobase biosynthesis
metric | value |
---|---|
setSize | 13 |
pMANOVA | 0.00259 |
p.adjustMANOVA | 0.00678 |
s.dist | 0.696 |
s.t0_v_pod | -0.356 |
s.pod_crp | -0.578 |
s.t0_crp | -0.152 |
p.t0_v_pod | 0.0263 |
p.pod_crp | 0.000306 |
p.t0_crp | 0.343 |
Gene | pod_crp | t0_v_pod |
---|---|---|
ATIC | -10033 | -10848 |
PPAT | -9990 | -10811 |
UMPS | -9953 | -10137 |
PFAS | -9357 | -10685 |
IMPDH2 | -10097 | -9588 |
CAD | -8790 | -9437 |
PAICS | -9426 | -5189 |
DHODH | -5949 | -5446 |
GMPS | -5172 | -5248 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
ADSL | 5026 | -6357 | -5016 |
ATIC | -10848 | -10033 | 3861 |
CAD | -9437 | -8790 | 108 |
DHODH | -5446 | -5949 | -1359 |
GART | -3463 | 4522 | 11398 |
GMPS | -5248 | -5172 | 4941 |
IMPDH1 | 9136 | 11090 | -5341 |
IMPDH2 | -9588 | -10097 | -8492 |
LHPP | 11 | -3554 | -3618 |
PAICS | -5189 | -9426 | 6536 |
PFAS | -10685 | -9357 | -6662 |
PPAT | -10811 | -9990 | 6064 |
UMPS | -10137 | -9953 | -1981 |
AKT phosphorylates targets in the cytosol
metric | value |
---|---|
setSize | 14 |
pMANOVA | 0.00448 |
p.adjustMANOVA | 0.0107 |
s.dist | 0.695 |
s.t0_v_pod | 0.427 |
s.pod_crp | 0.444 |
s.t0_crp | -0.322 |
p.t0_v_pod | 0.00563 |
p.pod_crp | 0.00405 |
p.t0_crp | 0.0368 |
Gene | pod_crp | t0_v_pod |
---|---|---|
CASP9 | 10977 | 7569 |
GSK3A | 9812 | 7643 |
CHUK | 8599 | 7844 |
AKT1S1 | 8292 | 7745 |
MKRN1 | 6512 | 8671 |
BAD | 7176 | 6794 |
GSK3B | 7062 | 6543 |
MDM2 | 5980 | 4268 |
CDKN1A | 5485 | 4466 |
AKT1 | 6430 | 3582 |
AKT2 | 5450 | 427 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AKT1 | 3582 | 6430 | -8210 |
AKT1S1 | 7745 | 8292 | -8660 |
AKT2 | 427 | 5450 | -7867 |
AKT3 | -11493 | -8782 | 2868 |
BAD | 6794 | 7176 | -8894 |
CASP9 | 7569 | 10977 | 362 |
CDKN1A | 4466 | 5485 | 454 |
CDKN1B | -7924 | -3108 | -677 |
CHUK | 7844 | 8599 | 3409 |
GSK3A | 7643 | 9812 | -6274 |
GSK3B | 6543 | 7062 | -1469 |
MDM2 | 4268 | 5980 | 12082 |
MKRN1 | 8671 | 6512 | -52 |
TSC2 | -798 | 4273 | -2115 |
GAB1 signalosome
metric | value |
---|---|
setSize | 15 |
pMANOVA | 0.00142 |
p.adjustMANOVA | 0.00403 |
s.dist | 0.695 |
s.t0_v_pod | 0.471 |
s.pod_crp | 0.301 |
s.t0_crp | -0.413 |
p.t0_v_pod | 0.00159 |
p.pod_crp | 0.0433 |
p.t0_crp | 0.00558 |
Gene | t0_v_pod | t0_crp |
---|---|---|
GRB2 | 9146 | -5185 |
AREG | 5897 | -7756 |
EGF | 8050 | -5617 |
TGFA | 8740 | -5172 |
PXN | 6144 | -7143 |
HBEGF | 4954 | -8152 |
CSK | 5158 | -7001 |
EREG | 1875 | -7212 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
AREG | 5897 | 2368 | -7756 |
CSK | 5158 | 9258 | -7001 |
EGF | 8050 | 5218 | -5617 |
EPGN | 2642 | -1230 | 1721 |
EREG | 1875 | -246 | -7212 |
GAB1 | 5607 | 8548 | 9775 |
GRB2 | 9146 | 10542 | -5185 |
HBEGF | 4954 | 2048 | -8152 |
PAG1 | 5207 | 5991 | 810 |
PIK3CA | 4580 | 2117 | 7009 |
PIK3R1 | -9187 | -8803 | -5081 |
PTPN11 | 5253 | 6456 | 949 |
PXN | 6144 | 9961 | -7143 |
SRC | -8520 | -6371 | -3347 |
TGFA | 8740 | 10781 | -5172 |
MAP2K and MAPK activation
metric | value |
---|---|
setSize | 34 |
pMANOVA | 1.53e-06 |
p.adjustMANOVA | 1.08e-05 |
s.dist | 0.694 |
s.t0_v_pod | 0.516 |
s.pod_crp | 0.405 |
s.t0_crp | -0.225 |
p.t0_v_pod | 1.87e-07 |
p.pod_crp | 4.36e-05 |
p.t0_crp | 0.023 |
Gene | t0_v_pod | pod_crp |
---|---|---|
MARK3 | 8555 | 10592 |
APBB1IP | 8600 | 10436 |
MAP2K1 | 8910 | 9974 |
ARRB2 | 8355 | 10498 |
MAPK3 | 8803 | 9593 |
TLN1 | 8386 | 10017 |
MAPK1 | 7381 | 10983 |
IQGAP1 | 8024 | 9867 |
RAF1 | 7759 | 9532 |
ITGA2B | 8744 | 7297 |
LAMTOR2 | 7454 | 7902 |
RAP1A | 7198 | 7246 |
MAP2K2 | 6699 | 7135 |
CSK | 5158 | 9258 |
VCL | 7218 | 6129 |
KSR1 | 4126 | 10392 |
LAMTOR3 | 7461 | 5332 |
YWHAB | 6298 | 4679 |
NRAS | 5302 | 4863 |
VWF | 6550 | 3834 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
APBB1IP | 8600 | 10436 | -610 |
ARAF | 2624 | 6025 | -5160 |
ARRB1 | 1985 | 3920 | -7962 |
ARRB2 | 8355 | 10498 | -7583 |
BRAF | 1298 | 4328 | 6880 |
CNKSR1 | -6846 | -8211 | 3517 |
CNKSR2 | -4628 | -4445 | 5043 |
CSK | 5158 | 9258 | -7001 |
FN1 | 8154 | -1816 | 4140 |
HRAS | -3288 | -5249 | -5447 |
IQGAP1 | 8024 | 9867 | -3260 |
ITGA2B | 8744 | 7297 | -5705 |
ITGB3 | 8161 | 2918 | -7520 |
KRAS | 3668 | 6068 | 10842 |
KSR1 | 4126 | 10392 | 3433 |
KSR2 | -3268 | 227 | 3301 |
LAMTOR2 | 7454 | 7902 | -8721 |
LAMTOR3 | 7461 | 5332 | 7456 |
MAP2K1 | 8910 | 9974 | -7128 |
MAP2K2 | 6699 | 7135 | -8945 |
MAPK1 | 7381 | 10983 | -1505 |
MAPK3 | 8803 | 9593 | -9014 |
MARK3 | 8555 | 10592 | 9836 |
NRAS | 5302 | 4863 | 8490 |
PEBP1 | -10920 | -9815 | 2352 |
RAF1 | 7759 | 9532 | -1258 |
RAP1A | 7198 | 7246 | 9059 |
RAP1B | 3179 | 6882 | 6183 |
SRC | -8520 | -6371 | -3347 |
TLN1 | 8386 | 10017 | -6948 |
VCL | 7218 | 6129 | -4751 |
VWF | 6550 | 3834 | -7272 |
WDR83 | 3684 | 5880 | -5672 |
YWHAB | 6298 | 4679 | 8802 |
ERKs are inactivated
metric | value |
---|---|
setSize | 13 |
pMANOVA | 0.00696 |
p.adjustMANOVA | 0.0154 |
s.dist | 0.694 |
s.t0_v_pod | 0.432 |
s.pod_crp | 0.41 |
s.t0_crp | -0.355 |
p.t0_v_pod | 0.00697 |
p.pod_crp | 0.0104 |
p.t0_crp | 0.0266 |
Gene | t0_v_pod | pod_crp |
---|---|---|
MAPK3 | 8803 | 9593 |
MAPK1 | 7381 | 10983 |
DUSP3 | 9122 | 8391 |
PPP2CB | 7596 | 7359 |
PPP2CA | 8104 | 6731 |
PPP2R1A | 4542 | 5140 |
PPP2R5D | 2405 | 6530 |
VRK3 | 1271 | 7119 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
DUSP3 | 9122 | 8391 | -6855 |
DUSP4 | -6077 | -2102 | -2865 |
DUSP6 | 4313 | -3036 | 669 |
DUSP7 | -3126 | -2437 | -6062 |
MAPK1 | 7381 | 10983 | -1505 |
MAPK3 | 8803 | 9593 | -9014 |
MAPK7 | -1318 | 9865 | -4166 |
PPP2CA | 8104 | 6731 | -306 |
PPP2CB | 7596 | 7359 | 4715 |
PPP2R1A | 4542 | 5140 | -7934 |
PPP2R1B | -241 | 88 | 5847 |
PPP2R5D | 2405 | 6530 | -1893 |
VRK3 | 1271 | 7119 | 1541 |
Signal regulatory protein family interactions
metric | value |
---|---|
setSize | 12 |
pMANOVA | 0.00777 |
p.adjustMANOVA | 0.0171 |
s.dist | 0.689 |
s.t0_v_pod | 0.409 |
s.pod_crp | 0.343 |
s.t0_crp | -0.437 |
p.t0_v_pod | 0.0143 |
p.pod_crp | 0.0396 |
p.t0_crp | 0.0088 |
Gene | t0_crp | t0_v_pod |
---|---|---|
SIRPA | -7771 | 9348 |
SIRPB1 | -7813 | 7723 |
PTK2B | -7454 | 7814 |
TYROBP | -6868 | 7427 |
GRB2 | -5185 | 9146 |
PTPN6 | -797 | 6014 |
SKAP2 | -484 | 9139 |
PTK2 | -619 | 4418 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CD47 | -11753 | -9136 | 9265 |
GRB2 | 9146 | 10542 | -5185 |
PTK2 | 4418 | 385 | -619 |
PTK2B | 7814 | 10976 | -7454 |
PTPN11 | 5253 | 6456 | 949 |
PTPN6 | 6014 | 10265 | -797 |
SIRPA | 9348 | 11197 | -7771 |
SIRPB1 | 7723 | 7051 | -7813 |
SIRPG | -9557 | -10115 | -6013 |
SKAP2 | 9139 | 9949 | -484 |
SRC | -8520 | -6371 | -3347 |
TYROBP | 7427 | 9484 | -6868 |
Prolonged ERK activation events
metric | value |
---|---|
setSize | 13 |
pMANOVA | 0.0133 |
p.adjustMANOVA | 0.0271 |
s.dist | 0.687 |
s.t0_v_pod | 0.452 |
s.pod_crp | 0.514 |
s.t0_crp | -0.0617 |
p.t0_v_pod | 0.0048 |
p.pod_crp | 0.00132 |
p.t0_crp | 0.7 |
Gene | pod_crp | t0_v_pod |
---|---|---|
CRK | 10207 | 8756 |
MAP2K1 | 9974 | 8910 |
MAPK3 | 9593 | 8803 |
MAPK1 | 10983 | 7381 |
KIDINS220 | 9198 | 6965 |
RAP1A | 7246 | 7198 |
MAP2K2 | 7135 | 6699 |
YWHAB | 4679 | 6298 |
CRKL | 5201 | 3927 |
BRAF | 4328 | 1298 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
BRAF | 1298 | 4328 | 6880 |
CRK | 8756 | 10207 | 5223 |
CRKL | 3927 | 5201 | -2305 |
FRS2 | -3337 | -1133 | 7109 |
KIDINS220 | 6965 | 9198 | 3097 |
MAP2K1 | 8910 | 9974 | -7128 |
MAP2K2 | 6699 | 7135 | -8945 |
MAPK1 | 7381 | 10983 | -1505 |
MAPK3 | 8803 | 9593 | -9014 |
NTRK1 | -7910 | -3772 | 7353 |
RAP1A | 7198 | 7246 | 9059 |
RAPGEF1 | -9501 | 5055 | -5674 |
YWHAB | 6298 | 4679 | 8802 |
Endosomal Sorting Complex Required For Transport (ESCRT)
metric | value |
---|---|
setSize | 29 |
pMANOVA | 1.02e-05 |
p.adjustMANOVA | 5.57e-05 |
s.dist | 0.687 |
s.t0_v_pod | 0.519 |
s.pod_crp | 0.381 |
s.t0_crp | -0.238 |
p.t0_v_pod | 1.28e-06 |
p.pod_crp | 0.000382 |
p.t0_crp | 0.0265 |
Gene | t0_v_pod | pod_crp |
---|---|---|
UBAP1 | 8559 | 10174 |
CHMP4B | 8718 | 9980 |
CHMP2A | 8635 | 10030 |
VPS37C | 7888 | 10221 |
VPS25 | 7522 | 9304 |
CHMP3 | 8217 | 8485 |
TSG101 | 7669 | 7800 |
VPS37A | 6379 | 8637 |
MVB12A | 7290 | 6903 |
CHMP5 | 4886 | 9864 |
STAM2 | 6075 | 7339 |
MVB12B | 5115 | 8610 |
CHMP6 | 5434 | 7713 |
HGS | 4468 | 9176 |
VPS37B | 3869 | 8493 |
SNF8 | 5893 | 5369 |
UBC | 4395 | 6071 |
VPS4B | 5151 | 4876 |
VTA1 | 6101 | 3904 |
CHMP2B | 5641 | 3060 |
t0_v_pod | pod_crp | t0_crp | |
---|---|---|---|
CHMP2A | 8635 | 10030 | -7692 |
CHMP2B | 5641 | 3060 | 6804 |
CHMP3 | 8217 | 8485 | 705 |
CHMP4A | 2384 | 3434 | 4816 |
CHMP4B | 8718 | 9980 | -8710 |
CHMP5 | 4886 | 9864 | 11784 |
CHMP6 | 5434 | 7713 | -8792 |
CHMP7 | -8503 | -9011 | -215 |
HGS | 4468 | 9176 | -507 |
MVB12A | 7290 | 6903 | -8242 |
MVB12B | 5115 | 8610 | -695 |
RPS27A | -6700 | -9695 | -8668 |
SNF8 | 5893 | 5369 | -7548 |
STAM | 1275 | 898 | 3823 |
STAM2 | 6075 | 7339 | 11256 |
TSG101 | 7669 | 7800 | 4356 |
UBA52 | 1112 | -3471 | -8207 |
UBAP1 | 8559 | 10174 | -5375 |
UBB | 6548 | 1016 | -6697 |
UBC | 4395 | 6071 | -4003 |
VPS25 | 7522 | 9304 | -6721 |
VPS28 | 4156 | -749 | -8515 |
VPS36 | -6615 | -4475 | 11400 |
VPS37A | 6379 | 8637 | 9727 |
VPS37B | 3869 | 8493 | -7026 |
VPS37C | 7888 | 10221 | -935 |
VPS4A | 777 | 167 | -8270 |
VPS4B | 5151 | 4876 | 7128 |
VTA1 | 6101 | 3904 | 9297 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.0.2 (2020-06-22)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 18.04.5 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.7.1
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.7.1
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.1.0 GGally_2.0.0
## [3] beeswarm_0.2.3 gtools_3.8.2
## [5] echarts4r_0.3.2 mitch_1.0.6
## [7] MASS_7.3-52 fgsea_1.14.0
## [9] gplots_3.0.3 DESeq2_1.28.1
## [11] SummarizedExperiment_1.18.1 DelayedArray_0.14.0
## [13] matrixStats_0.56.0 Biobase_2.48.0
## [15] GenomicRanges_1.40.0 GenomeInfoDb_1.24.2
## [17] IRanges_2.22.2 S4Vectors_0.26.1
## [19] BiocGenerics_0.34.0 reshape2_1.4.4
## [21] forcats_0.5.0 stringr_1.4.0
## [23] dplyr_1.0.0 purrr_0.3.4
## [25] readr_1.3.1 tidyr_1.1.0
## [27] tibble_3.0.1 ggplot2_3.3.2
## [29] tidyverse_1.3.0
##
## loaded via a namespace (and not attached):
## [1] colorspace_1.4-1 ellipsis_0.3.1 rprojroot_1.3-2
## [4] XVector_0.28.0 fs_1.4.2 rstudioapi_0.11
## [7] farver_2.0.3 bit64_0.9-7 AnnotationDbi_1.50.1
## [10] fansi_0.4.1 lubridate_1.7.9 xml2_1.3.2
## [13] splines_4.0.2 geneplotter_1.66.0 knitr_1.29
## [16] jsonlite_1.7.0 broom_0.5.6 annotate_1.66.0
## [19] dbplyr_1.4.4 shiny_1.5.0 compiler_4.0.2
## [22] httr_1.4.1 backports_1.1.8 assertthat_0.2.1
## [25] Matrix_1.2-18 fastmap_1.0.1 cli_2.0.2
## [28] later_1.1.0.1 htmltools_0.5.0 tools_4.0.2
## [31] gtable_0.3.0 glue_1.4.1 GenomeInfoDbData_1.2.3
## [34] fastmatch_1.1-0 Rcpp_1.0.4.6 cellranger_1.1.0
## [37] vctrs_0.3.1 gdata_2.18.0 nlme_3.1-148
## [40] xfun_0.15 testthat_2.3.2 rvest_0.3.5
## [43] mime_0.9 lifecycle_0.2.0 XML_3.99-0.3
## [46] zlibbioc_1.34.0 scales_1.1.1 hms_0.5.3
## [49] promises_1.1.1 RColorBrewer_1.1-2 yaml_2.2.1
## [52] memoise_1.1.0 gridExtra_2.3 reshape_0.8.8
## [55] stringi_1.4.6 RSQLite_2.2.0 highr_0.8
## [58] genefilter_1.70.0 desc_1.2.0 caTools_1.18.0
## [61] BiocParallel_1.22.0 rlang_0.4.6 pkgconfig_2.0.3
## [64] bitops_1.0-6 evaluate_0.14 lattice_0.20-41
## [67] labeling_0.3 htmlwidgets_1.5.1 bit_1.1-15.2
## [70] tidyselect_1.1.0 plyr_1.8.6 magrittr_1.5
## [73] R6_2.4.1 generics_0.0.2 DBI_1.1.0
## [76] pillar_1.4.4 haven_2.3.1 withr_2.2.0
## [79] survival_3.2-3 RCurl_1.98-1.2 modelr_0.1.8
## [82] crayon_1.3.4 KernSmooth_2.23-17 rmarkdown_2.3
## [85] locfit_1.5-9.4 grid_4.0.2 readxl_1.3.1
## [88] data.table_1.12.8 blob_1.2.1 reprex_0.3.0
## [91] digest_0.6.25 pbmcapply_1.5.0 xtable_1.8-4
## [94] httpuv_1.5.4 munsell_0.5.0
END of report